NASA Astrophysics Data System (ADS)
2014-06-01
Chairpersons Dr Dinesh Sathyamoorthy, Science & Technology Research Institute for Defence (STRIDE), Ministry of Defence, Malaysia Associate Professor Sr Dr Abdul Rashid Mohamed Shariff, Universiti Putra Malaysia (UPM), Malaysia Dr Ahmad Fikri Abdullah, Universiti Putra Malaysia (UPM), Malaysia Dr Farrah Melissa Muharram, Universiti Putra Malaysia (UPM), Malaysia Members Professor Dr Li Jing, Beijing Normal University, China Professor Dr Iyyanki Muralikrishna, Administrative Staff College of India (ASCI), India Professor Dr Alias Abdul Rahman, Universiti Teknologi Malaysia (UTM), Malaysia Professor Dr Ismat Mohamed El Hassan, King Saud University, Saudi Arabia Professor Dr George Miliaresis, Open University of Cyprus, Cyprus Professor Dr Christine Pohl, Universiti Teknologi Malaysia (UTM), Malaysia Professor Dr Mahender Kotha, Goa University, India Associate Professor Dr Paolo Gamba, University of Pavia, Italy Associate Professor Dr Behara Seshadri Daya Sagar, Indian Statistical Institute (ISI), India Associate Professor Sr Ranjit Singh, Infrastructure University Kuala Lumpur (IUKL), Malaysia Associate Professor Dr Abdul Nasir Matori, Universiti Teknologi Petronas (UTP), Malaysia Associate Dr Lucian Dragut, West University of Timişoara, Romania Associate Professor Dr Saied Pirasteh, Islamic Azad University, Iran Associate Professor Dr Peter Yuen, Cranfield University, United Kingdom Associate Professor Dr Lim Hwee San, Universiti Sains Malaysia (USM), Malaysia Associate Professor Dr Wayan Suparta, Universiti Kebangsaan Malaysia (UKM), Malaysia Associate Professor Dr Tuong Thuy Vu, The University of Nottingham Malaysia Campus, Malaysia Associate Professor Dr Maged Mahmoud Marghany, Universiti Teknologi Malaysia (UTM), Malaysia Associate Professor Dr Rami Al-Ruzouq, University of Sharjah, UAE Associate Professor Dr Biswajeet Pradhan, Universiti Putra Malaysia (UPM), Malaysia Associate Professor Dr Helmi Zulhaidi Mohd Shafri, Universiti Putra Malaysia (UPM), Malaysia Associate Professor Dr Benny Peter, Universiti Teknologi Malaysia (UTM), Malaysia Associate Professor Dr Norzailawati Mohd Nor, International Islamic University Malaysia (IIUM), Malaysia Dr Josée Lévesque, Defence Research and Development Canada (DRDC), Canada Dr Ali Ariapour, Islamic Azad University, Iran Dr Zulkiflee Abd Latif, Universiti Teknologi MARA (UiTM), Malaysia Dr Lim Tien Sze, Multimedia University (MMU), Malaysia Dr Ruzinoor Che Mat, Universiti Utara Malaysia (UUM), Malaysia Dr Eran Sadek Said Md Sadek, Universiti Teknologi MARA (UiTM), Malaysia Dr Siti Khairunniza Bejo, Universiti Putra Malaysia (UPM) Dr Ramin Nourqolipour, National Organization of Forest, Range and Watershed Manage Sr Mohktar Azizi Mohd Din, Universiti Malaya Col (Rt) Frederic Hernoust, Magelli Marzieh Mokarram, University of Isf Mohd Fadhil Abuhan, Royal Malaysian Police, Malaysia
2014-03-01
for OR Analysts Dr. Jim Morris Overview of Academic Research Opportunities for OR Analysts Dr. Daniel Behringer September 21, 2012 Prize Winners...In Operations Research: Experiences and Perspectives Dr. Jim Morris and Major Brady Vaira (USAF) November 30, 2012 How Does Industry Use OR to...X X Ms. Lynda Liptak Applied Research Associates Publishing With MORS X X X X X Dr. Jim Morris US Air Force Operations Research in
2011-08-09
Elena Bankowski (Research Engineer) & Mr. Steven Zielinski (Engineer). •Oakland University Research Team: Dr. Andrei Slavin (Chair, Physics...Dr. Grace Bochenek, the Chief Scientist Dr. Dave Gorsich and GVSS Associate Director Mr. Steve Knott for their support of this innovative research
Extremophiles and Space Exploration
NASA Technical Reports Server (NTRS)
Paulino Lima, Ivan Glaucio
2016-01-01
In this presentation, Dr. Paulino Lima will give a brief introduction of the Universities Space Research Association, and an overview of Dr. Lynn Rothschild's research projects at NASA Ames with emphasis on his research projects.
Silverman, Earl D
2017-05-01
The 72nd Annual Meeting of The Canadian Rheumatology Association (CRA) was held at The Westin Ottawa, Ottawa, Ontario, Canada, February 8-11, 2017. The program consisted of presentations covering original research, symposia, awards, and lectures. Highlights of the meeting include the following 2017 award winners: Dr. Vinod Chandran, Young Investigator; Dr. Jacques P. Brown, Distinguished Investigator; Dr. David Robinson, Teacher-Educator; Dr. Michel Zummer, Distinguished Rheumatologist; Ms. Rebecca Gole, Best Abstract on SLE Research by a Trainee - Ian Watson Award; Ms. Bailey Russell, Best Abstract on Clinical or Epidemiology Research by a Trainee - Phil Rosen Award; Dr. Sahil Koppikar and Dr. Henry Averns, Practice Reflection Award; Dr. Shirine Usmani, Best Abstract on Basic Science Research by a Trainee; Ms. Carol Dou, Best Abstract for Research by an Undergraduate Student; Dr. Dania Basodan, Best Abstract on Research by a Rheumatology Resident; Dr. Claire Barber, Best Abstract on Adult Research by Young Faculty; Ms. Audrea Chen, Best Abstract by a Medical Student; Dr. Kun Huang, Best Abstract by a Post-Graduate Resident; and Dr. Ryan Lewinson, Best Abstract by a Post-Graduate Research Trainee. Lectures and other events included a Keynote Lecture by Jonathon Fowles: Exercise is Medicine: Is Exercise a Good or Bad Thing for People with Arthritis?; State of the Art Lecture by Matthew Warman: Insights into Bone Biology and Therapeutics Gleaned from the Sustained Investigation of Rare Diseases; Dunlop-Dottridge Lecture by Allen Steere: Lyme Disease: A New Problem for Rheumatologists in Canada; and the Great Debate: Be it Resolved that the Least Expensive Treatment Should be Chosen. Switch, Switch, Switch! Arguing for: Jonathan Chan and Antonio Avina, and against: Marinka Twilt and Glen Hazlewood. Topics such as rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, Sjögren syndrome, psoriatic arthritis, spondyloarthritis, vasculitis, osteoarthritis, fibromyalgia, pediatric rheumatology, and their respective diagnoses, treatments, and outcomes are reflected in the abstracts, which we are pleased to publish in this issue of The Journal .
2011-08-01
Thomas Meitzler (Team Leader, Research Engineer), Dr. Elena Bankowski (Research Engineer) & Mr. Steven Zielinski (Engineer). •Oakland University...our experiments. •We would like to thank TARDEC Director Dr. Grace Bochenek, the Chief Scientist Dr. Dave Gorsich and GVSS Associate Director Mr. Steve
ERIC Educational Resources Information Center
Schatt, Matthew D.
2009-01-01
The Ohio Music Education Association (OMEA) Research Committee annually hosts a Graduate Research Forum in conjunction with the OMEA's Professional Development Conference. In 2009, the guest speaker was Dr. Wendy Sims, Director of Music Education at the University of Missouri--Columbia and Editor of the Journal of Research in Music Education. An…
2008-09-01
68 (4), 883–887. Li, C-W.; Yamanishi, J. Ceram. Eng. Sci. Proc. 1989, 10, 632–645. Li, J.-G.; Ikegami , T .; Lee, J.-H.; Mori, T .; J. Am. Ceram. Soc...and Opening Remarks Dr. Allen Grum Associate Director for Science and Technology (S& T ), ARL The Impact of Research on Soldier Protection Ms. Jill...Crystal Systems, Dr. Chandra Khattak 3. MSI, Dr. Les Bowen 4. TA& T , Dr. Larry Fehrenbacher 5. CeraNova, Dr. Marina Pascucci Session IV
Review of Two-Stage FEL Research at KMS Fusion.
1983-01-21
vi ty Research and Engineering Technical Library (3 copies) NST. Station, MS 39529 Information Office Library Branch The Pentagon Naval Explosive ...Shafer Associates, Inc. Office of Naval Research 10 Lakeside Office Park Arlington, VA 22217 Wakefield, MA 01880 Dr. Don Prosnitz Dr. T. C. Marshall
Dr. von Braun With Management Team
NASA Technical Reports Server (NTRS)
1961-01-01
Dr. von Braun is shown in this photograph, which was probably taken in the early 1960s, with members of his management team. Pictured from left to right are, Werner Kuers, Director of the Manufacturing Engineering Division; Dr. Walter Haeussermarn, Director of the Astrionics Division; Dr. William Mrazek, Propulsion and Vehicle Engineering Division; Dr. von Braun; Dieter Grau, Director of the Quality Assurance Division; Dr. Oswald Lange, Director of the Saturn Systems Office; and Erich Neubert , Associate Deputy Director for Research and Development.
PREFACE: The 3rd ISESCO International Workshop and Conference On Nanotechnology 2012 (IWCN2012)
NASA Astrophysics Data System (ADS)
Umar, Akrajas Ali; Yahaya, Muhammad; Mat Salleh, Muhamad
2013-04-01
The ISESCO Conference on Nanomaterials and Applications (IWCN2012) is one of a series of nanotechnology seminars organized by ISESCO, Malaysian Solid State Science and Technology Society (MASS), the Universiti Kebangsaan Malaysia. IWCN2012 is the third seminar, following IWCN2007 and IWCN2010, held in the Universiti Kebangsaaan Malaysia, Bangi Malaysia from 5-7 December 2012. The conference was attended by more than 250 participants from 15 countries, including 150 students. The conference and workshop provided a forum for researchers and students, policymakers and other professionals especially from the ISESCO Member States to exchange information, enhance understanding and more importantly to engage in the development of new nanoscience and nanotechnology research in multidisciplinary areas in physics, chemistry and biology. Together with the conference, the third Meeting of the ISESCO Expert Panel on Nanotechnology was held to chart the future activities in Nanoscience and Nanotechnology in ISESCO member countries. The objective of the conference is to communicate and discuss recent progress in nanoscience and nanotechnology research and its potential applications in future economic growth. The main focus for the present activity is on energy and environment. The conference received 105 papers in total and 50 of them were selected to be considered for publication in Journal of Physics: Conference Series. However, finally, after undergoing vigorous and thorough revisions by respected editors and reviewers in the fields, 29 papers were accepted. This volume covers the follwing topics: Nanomaterials Synthesis and Characterization Nanomaterials for Energy and Catalysis Nanoelectronics, Sensors and MEMS Devices Nanophotonics We are indebted to all the keynote speakers, invited speakers, participant and authors for their contribution to this event. Their contribution has led to the success of this conference. We are also very grateful for the time, effort and unwavering support dedicated by all the referees. Their tireless work has helped guarantee the high scientific level of this series. Many thanks are also addressed to the ISESCO, COMSATS, MASS, UKM and FST for their financial support. Logistics support provided by IMEN and MNA is also much appreciated. We realized that this volume would never have materialized without the hard work of Ms Siti Khatijah Md Saad who helped the editorial secretariat in many ways communicating with the authors and reviewers and checking and typesetting the papers in the final stage. Finally, great appreciation is addressed to all who have worked hard and given support ensuring that the conference was a success. Editors Associate Professor Dr Akrajas Ali Umar Professor Dr Muhamad Mat Salleh Professor Dato' Dr Muhammad Yahaya IWCN 2012 Organizing Committee International Advisory Board Professor Dato' Dr Muhammad Yahaya (UKM, Malaysia) Dr Faiq Bilal (ISESCO, Morocco) Professor Dr Michael Graetzel (Switzerland) Professor Dr Muhamad Rasat (Malaysia) Prof Dr Masbah R T Siregar (Indonesia) Associate Professor Dr Munetaka Oyama (Japan) Professor Dr Ismat Shah (USA) Professor Dr Muhamad Mat Salleh (Malaysia) Chairman Associate Professor Dr Mohammad Kassim Co-Chairman Dr Mohammad Hafizuddin Haji Jumali Secretary Dr Lorna Jeffry Minggu Treasurer Dr Sharina Abu Hanifah Committee Members Associate Professor Dr Mohd Azmi Abd Hamid Associate Professor Dr Akrajas Ali Umar Dr Zahari Ibarahim Dr Rozidawati Awang Dr Farah Hannan Anuar Secretariat Dr Khuzaimah Mohd Firdauz Ismail Izura Izzuddin Nor Huwaida Janil Jamil Siti Khatijah Md Saad Noor Razinah Rahmat Mark Lee Wun Fui Ng Kim Hang Lee Thian Khoon Law Kung Pui Choong Yan Yi
2014 Sensorimotor Risk Standing Review Panel
NASA Technical Reports Server (NTRS)
Steinberg, Susan
2014-01-01
The Sensorimotor Risk Standing Review Panel (from here on referred to as the SRP) met on December 17 - 18, 2014 in Houston, TX to review the current status of the Risk of Impaired Control of Spacecraft, Associated Systems and Immediate Vehicle Egress due to Vestibular/Sensorimotor Alteration Associated with Space Flight (Sensorimotor Risk) in the Integrated Research Plan (IRP). During the meeting, the SRP received an in-depth briefing of the current status of the Sensorimotor Risk from Dr. Jacob Bloomberg, the Human Research Program (HRP) Sensorimotor Discipline Lead Scientist and Dr. Millard Reschke, the Chief Scientist of the Neuroscience Laboratories at the NASA Johnson Space Center (JSC). The SRP was impressed with the information that Dr. Bloomberg and Dr. Reschke presented and think that the in-person meeting (instead of WebEx/teleconference) allowed for more interactive and thoughtful conversations.
Genetics in Diabetic Retinopathy: Current Concepts and New Insights
Simó-Servat, Olga; Hernández, Cristina; Simó, Rafael
2013-01-01
There is emerging evidence which indicates the essential role of genetic factors in the development of diabetic retinopathy (DR). In this regard it should be highlighted that genetic factors account for 25-50% of the risk of developing DR. Therefore, the use of genetic analysis to identify those diabetic patients most prone to developing DR might be useful in designing a more individualized treatment. In this regard, there are three main research strategies: candidate gene studies, linkage studies and Genome-Wide Association Studies (GWAS). In the candidate gene approach, several genes encoding proteins closely related to DR development have been analyzed. The linkage studies analyze shared alleles among family members with DR under the assumption that these predispose to a more aggressive development of DR. Finally, Genome-Wide Association Studies (GWAS) are a new tool involving a massive evaluation of single nucleotide polymorphisms (SNP) in large samples. In this review the available information using these three methodologies is critically analyzed. A genetic approach in order to identify new candidates in the pathogenesis of DR would permit us to design more targeted therapeutic strategies in order to decrease this devastating complication of diabetes. Basic researchers, ophthalmologists, diabetologists and geneticists should work together in order to gain new insights into this issue. PMID:24403848
1978-06-01
Products Util- ization and Marketing Research Laboratory, Richard B. Russcll Agricultural Research Center, Agricultural Research Service, United States...was to determine the effect of the salt phosphate treatment on rehydration. Dr. Arthur J. Mercuri, Chief, Animal Products Utilization and Marketing ... Research Laboratory served as Project Lj.ader, with Fir. A. A. Klose and Dr. W. E. Townsend, Frincipal investigators, and Ms. Brenda Lyon, Technician
Gornick, Marian; Greenberg, Jay N.; Eggers, Paul W.; Dobson, Allen
1985-01-01
Marian Gornick is Director, Division of Beneficiary Studies, in the Office of Research, Health Care Financing Administration. She has been involved in research studies relating to Medicare and Medicaid since the programs were first implemented. Jay N. Greenberg is on the faculty of the Heller Graduate School, Brandeis University. Dr. Greenberg serves as the Associate Director for Research of the school's Health Policy Center. Paul W. Eggers is Chief, Program Evaluation Branch, in the Office of Research, Health Care Financing Administration (HCFA). Dr. Eggers’ research activities involve the evaluation of the impact of HCFA programs on the beneficiaries. Allen Dobson is Director, Office of Research, Health Care Financing Administration. Dr. Dobson is responsible for directing the planning and development of the Agency's research agenda. PMID:10311371
SIDD: A Semantically Integrated Database towards a Global View of Human Disease
Cheng, Liang; Wang, Guohua; Li, Jie; Zhang, Tianjiao; Xu, Peigang; Wang, Yadong
2013-01-01
Background A number of databases have been developed to collect disease-related molecular, phenotypic and environmental features (DR-MPEs), such as genes, non-coding RNAs, genetic variations, drugs, phenotypes and environmental factors. However, each of current databases focused on only one or two DR-MPEs. There is an urgent demand to develop an integrated database, which can establish semantic associations among disease-related databases and link them to provide a global view of human disease at the biological level. This database, once developed, will facilitate researchers to query various DR-MPEs through disease, and investigate disease mechanisms from different types of data. Methodology To establish an integrated disease-associated database, disease vocabularies used in different databases are mapped to Disease Ontology (DO) through semantic match. 4,284 and 4,186 disease terms from Medical Subject Headings (MeSH) and Online Mendelian Inheritance in Man (OMIM) respectively are mapped to DO. Then, the relationships between DR-MPEs and diseases are extracted and merged from different source databases for reducing the data redundancy. Conclusions A semantically integrated disease-associated database (SIDD) is developed, which integrates 18 disease-associated databases, for researchers to browse multiple types of DR-MPEs in a view. A web interface allows easy navigation for querying information through browsing a disease ontology tree or searching a disease term. Furthermore, a network visualization tool using Cytoscape Web plugin has been implemented in SIDD. It enhances the SIDD usage when viewing the relationships between diseases and DR-MPEs. The current version of SIDD (Jul 2013) documents 4,465,131 entries relating to 139,365 DR-MPEs, and to 3,824 human diseases. The database can be freely accessed from: http://mlg.hit.edu.cn/SIDD. PMID:24146757
An interview with Peter H. Buschang.
Buschang, Peter H; dos Santos-Pinto, Ary; Araújo, Eustáquio; Ribeiro, Gerson Luiz Ulema; Jacob, Helder Baldi; Gandini Júnior, Luiz Gonzaga
2014-01-01
Dr. Peter Buschang is regent professor and director of orthodontic research. He has been at Texas A&M University Baylor College of Dentistry since 1988. Dr. Buschang received his PhD in 1980 from the University of Texas at Austin; he spent 3 years as a NIDR postdoctoral fellow at the University of Connecticut, and five years as a FRSQ scholar at the University of Montreal. Every year, Dr. Buschang teaches in 16 different courses, 7 of which he directs. In addition to more than 100 lecture hours per year, he spends hundreds of hours mentoring students. For his teaching efforts, Dr. Buschang was awarded the Robert E. Gaylord Award of Excellence in Orthodontic education in 1992, 1998, 2004, and 2010. He also gives 1-2 day evidence-based CE courses throughout the world. The residents he has taught recently honored him by pledging to fund the Peter H. Buschang Endowed Professorship of Orthodontics. His research interests pertain to craniofacial growth and assessment of treatment effects. Dr. Buschang has been funded regularly over the years by the Medical Research Council of Canada, Fonds de le Recherche en Santé du Québec, the NIH, and the American Association of Orthodontics Foundation. He has mentored over 140 Master's and PhD students, and 49 dental students. Dr. Buschang has published over 250 peer-reviewed articles, 15 book chapters and 198 abstracts. He has given over 150 invited talks and lectures in 14 different countries. For his work with the American Board of Orthodontics, Dr. Buschang was awarded the Earl E. and Wilma S. Shepard Award. Dr. Buschang is the only non-orthodontist ever to have been made an honorary member of both the American Association of Orthodontics (2005) and the Edward H. Angle Society of Orthodontics (2009), the two most prestigious orthodontic groups.
Meet EPA Scientist Maureen R. Gwinn, M.S. Ph.D. DABT
EPA biologist Dr. Maureen Gwinn works on human health hazard assessments for the Agency's IRIS program. Dr. Gwinn currently serves as the Associate Program Director for Community Health in EPA's Sustainable and Healthy Communities national research program
Thomas, Rebecca L.; Distiller, Larry; Luzio, Stephen D.; Chowdhury, Sharmistha Roy; Melville, Vanessa J.; Kramer, Brian; Owens, David R.
2013-01-01
OBJECTIVE To describe the prevalence and associated risk factors for diabetic retinopathy (DR) within a multiethnic population at presentation to a diabetes clinic in South Africa. RESEARCH DESIGN AND METHODS Retinal photography was conducted using a nonmydriatic digital camera without mydriasis and graded by one of three senior graders. Logistic regression analyses were used to assess the association between any DR, referable DR, and clinical risk factors. RESULTS A total of 1,537 persons with type 1 and 3,978 with type 2 diabetes were included. Prevalence of any DR in type 1 diabetes was 35.2% (background DR 26% and referable DR 9.2%) and in type 2 diabetes was 20.5% (14.1 and 6.4%, respectively). In type 1 diabetes, there was an increased risk of any DR in Asian Indians, whereas the risk of referable DR was increased for indigenous Africans compared with Caucasians. In type 2 diabetes, the risk was increased for all non-Caucasians compared with Caucasians. Longer duration of diabetes and elevated HbA1c were independently associated with any and referable DR in both type 1 and type 2 diabetes, with the addition of hypertension and smoking in type 1 diabetes when adjusted for age at diagnosis of diabetes, sex, and ethnicity. CONCLUSIONS The prevalence of DR in this population from South Africa was similar to that reported globally; however, ethnic differences were observed. Increasing duration of diabetes and poor glycemic control were the strongest risk factors associated with any and referable DR in both type 1 and type 2 diabetes. PMID:23033236
Newborn HLA-DR,DQ genotype screening: age- and ethnicity-specific type 1 diabetes risk estimates
Emery, Lisa M; Babu, Sunanda; Bugawan, Teodorica L; Norris, Jill M; Erlich, Henry A; Eisenbarth, George S; Rewers, Marian
2005-01-01
Objective Certain human leukocyte antigen (HLA)-DR,DQ genotypes have been associated with type 1 diabetes mellitus (T1DM) risk, although it is unknown whether the association is due to alleles, haplotypes, genotypes, the formation of heterodimers, or all of the above. To characterize the role of the HLA-DR,DQ genotype and ethnicity on the onset age of T1DM, we analyzed these factors in patients with T1DM and the general population. Methods One thousand three hundred twenty-two well-characterized patients with T1DM were compared with 3339 children from the general population of Denver, Colorado, USA. Because of the extensive available data across age and ethnic groups, this study population is unique. Results The HLA-DR3/4,DQB1*0302, DRX/4,DQB1*0302 (where X = 1, 4, 8, and 9), and HLA-DR3/3 genotypes were associated with T1DM, supporting previous research. Additionally, the DR3/9 genotype showed a positive association with T1DM, which has not previously been described in Caucasian populations. The HLA-DR3/4*0302 genotype was most strongly associated with T1DM in diabetic individuals with the youngest onset age. Genotype frequencies were similar between Hispanics and non-Hispanic whites, except for the DR3/3 genotype, which was more likely to be found in non-Hispanic whites. Conclusions These results indicate that there are multiple alleles and genotypes associated with T1DM and that the risk associated with different genetic markers depends on the age of disease onset, suggesting that some markers may be involved in more rapid disease progression. PMID:16109069
Research into Queueing Network Theory.
1977-09-01
and Zeigler, B. (1975) "Equilibrium properties of arbitrarily interconnected queueing netowrks ," Tech. Report 75-4, Computer and Communication...Associate. The project was extremely fortunate to secure the services of Dr. Wendel. Dr. Wendel was a project member for one month in the summer of
2014-07-23
Jack Kaye Maniac Lecture, July 23, 2014 Dr. Jack Kaye, Associate Director for Research at NASA Headquarters presented a Maniac Talk entitled, "An Unlikely but Rewarding Journey--From Quantum Chemistry to Earth Science Research Program Leadership." Jack took stock of his 30+ years at NASA, noting the people, opportunities, lessons learned, and choices that helped him get to where he is today and accomplish what he have.
United States Air Force Summer Faculty Research Program (1983). Program Management Report.
1983-12-01
845-5011 Dr. John Eoll Degree: Ph.D., Astrophysics, 1976 Assistant Professor Specialty: Radiaton Transport , Fluid Lernir-Rhyne College Dynamics...Applications Newark, DE 19711 Assigned: RADC (302) 738-8173 Dr. Gregory Jones Degree: Ph.D., Mathematics, 1972 Associate Professor Specialty: Computability...1965 Associate Professor Specialty: Magnetic Resonance, University of Dayton Transport Properties Physics Department Assigned: ML Dayton, OH 45469 5
Dr. Ronald Hines serves as Associate Director for Health for the National Health and Environmental Effects Research Laboratory (NHEERL) within the U.S. Environmental Protection Agency's Office of Research and Development (ORD).
Bioremediation Approaches for Treating Low Concentrations of N-Nitrosodimethylamine in Groundwater
2008-10-01
OCTOBER 2008 Dr. Paul Hatzinger Shaw Environmental, Inc. Dr. Jalal Hawari Biotechnology Research Institute National Research Council, Canada...N-NITROSODIMETHYLAMINE (NDMA) IN GROUNDWATER W912-HQ-05-C-0041 NA ER-1456 NA NA Hatzinger, Paul B., Ph.D. Hawari, Jalal, Ph.D. Shaw Environmental, Inc...Leeson. 2007. US Environmental Protection Agency (USEPA) National Association of Remedial Project Managers (NARPM) Training Course. 2007. DoD’s
Annual Progress Report, January 1, 1969 through December 31, 1969.
1970-02-01
or extended. E. The Role of CAI in Curriculum Revision I The Intermediate Science Curriculum Study (ISCS)* (Dr. Ernest Burkman, i Director and Dr David...Educational Research, FSU. Henry T. Lippert , Ed.D., 1967, Education, University of Illinois, Research Associate in the CAI Center and Assistant...Walter Dick, and Henry T Lippert , Tech Report 3, Florida State University, Tallahassee, 1968 "A Systematic Investigation of Three Facets of Programmed
Brünker, Peter; Wartha, Katharina; Friess, Thomas; Grau-Richards, Sandra; Waldhauer, Inja; Koller, Claudia Ferrara; Weiser, Barbara; Majety, Meher; Runza, Valeria; Niu, Huifeng; Packman, Kathryn; Feng, Ningping; Daouti, Sherif; Hosse, Ralf J; Mössner, Ekkehard; Weber, Thomas G; Herting, Frank; Scheuer, Werner; Sade, Hadassah; Shao, Cuiying; Liu, Bin; Wang, Peng; Xu, Gary; Vega-Harring, Suzana; Klein, Christian; Bosslet, Klaus; Umaña, Pablo
2016-05-01
Dysregulated cellular apoptosis and resistance to cell death are hallmarks of neoplastic initiation and disease progression. Therefore, the development of agents that overcome apoptosis dysregulation in tumor cells is an attractive therapeutic approach. Activation of the extrinsic apoptotic pathway is strongly dependent on death receptor (DR) hyperclustering on the cell surface. However, strategies to activate DR5 or DR4 through agonistic antibodies have had only limited clinical success. To pursue an alternative approach for tumor-targeted induction of apoptosis, we engineered a bispecific antibody (BsAb), which simultaneously targets fibroblast-activation protein (FAP) on cancer-associated fibroblasts in tumor stroma and DR5 on tumor cells. We hypothesized that bivalent binding to both FAP and DR5 leads to avidity-driven hyperclustering of DR5 and subsequently strong induction of apoptosis in tumor cells but not in normal cells. Here, we show that RG7386, an optimized FAP-DR5 BsAb, triggers potent tumor cell apoptosis in vitro and in vivo in preclinical tumor models with FAP-positive stroma. RG7386 antitumor efficacy was strictly FAP dependent, was independent of FcR cross-linking, and was superior to conventional DR5 antibodies. In combination with irinotecan or doxorubicin, FAP-DR5 treatment resulted in substantial tumor regression in patient-derived xenograft models. FAP-DR5 also demonstrated single-agent activity against FAP-expressing malignant cells, due to cross-binding of FAP and DR5 across tumor cells. Taken together, these data demonstrate that RG7386, a novel and potent antitumor agent in both mono- and combination therapies, overcomes limitations of previous DR5 antibodies and represents a promising approach to conquer tumor-associated resistance to apoptosis. Mol Cancer Ther; 15(5); 946-57. ©2016 AACR. ©2016 American Association for Cancer Research.
Blast Loading of Closures for Use on Shelters-II
1984-02-01
Duquerque, NM 87102 1700 Main Street Santa Monica, CA 90406 Ebcrle Smith Associates, Inc. ATTN: Mr. Lyndon ýlch I R&D Associates 950 West Fort Strect ATTN: Dr...American Research Div ATTN: R~rvay G. Ryland 7449 North Natchez Avenue 5266 Hollister Ave, Suite 324 Niles , iL 60648 Santa Barbara, CA 93111 58 IIII!!I I...Building 1 Stan Martin & Associates West Lafayette, IN 47906 ATTN: Dr. Stanley B. Martin 860 Vista Drive 1 Director "Redwood City, CA 94062 Program for
Armed Forces Institute of Pathology Becomes CDC Registered Testing Site for Human Swine Influenza
2010-01-01
naval officer and pathologist during his nearly three decades of military service. Adrien Ravizee, research associate, is pipetting cells used to...grow influenza virus to new flasks and plates, so the cells can be infected with influenza virus as Dr. Sue Cross, virologist, left and Dr...Izadjoo said. “The collection can be used for validating improved diagnostic swine flu assays.” Dr. Sue Cross, a virologist, used cell cultures
United States Air Force Summer Faculty Research Program, 1988. Program Technical Report. Volume 4
1988-12-01
Professor SDecialty: Gas Phase Ion-Molecule Chem. Dept. of Chemistry Assigned: Air Force Geophysics Lab. Louisiana State University Choppin Hall...For Lucid Dr. Darin DeForest 55 Pre-Sort Processor Phase Distortion Dr. Paul Dingman Evaluation 56 A PROLOG Natural Language Front End Dr. Hugh...analysis in the electron impact mode. The column used was 25m x 0.25am ID bonded phase FSOT capillary column (#952525 Alltech and Associates), coated with
Andrén Aronsson, Carin; Uusitalo, Ulla; Vehik, Kendra; Yang, Jimin; Silvis, Katherine; Hummel, Sandra; Virtanen, Suvi M; Norris, Jill M
2015-10-01
Infant's age at introduction to certain complementary foods (CF) has in previous studies been associated with islet autoimmunity, which is an early marker for type 1 diabetes (T1D). Various maternal sociodemographic factors have been found to be associated with early introduction to CF. The aims of this study were to describe early infant feeding and identify sociodemographic factors associated with early introduction to CF in a multinational cohort of infants with an increased genetic risk for T1D. The Environmental Determinants of Diabetes in the Young study is a prospective longitudinal birth cohort study. Infants (N = 6404) screened for T1D high risk human leucocyte antigen-DQ genotypes (DR3/4, DR4/4, DR4/8, DR3/3, DR4/4, DR4/1, DR4/13, DR4/9 and DR3/9) were followed for 2 years at six clinical research centres: three in the United States (Colorado, Georgia/Florida, Washington) and three in Europe (Sweden, Finland, Germany). Age at first introduction to any food was reported at clinical visits every third month from the age of 3 months. Maternal sociodemographic data were self-reported through questionnaires. Age at first introduction to CF was primarily associated with country of residence. Root vegetables and fruits were usually the first CF introduced in Finland and Sweden and cereals were usually the first CF introduced in the United States. Between 15% and 20% of the infants were introduced to solid foods before the age of 4 months. Young maternal age (<25 years), low educational level (<12 years) and smoking during pregnancy were significant predictors of early introduction to CF in this cohort. Infants with a relative with T1D were more likely to be introduced to CF later. © 2013 John Wiley & Sons Ltd.
Stability Analysis of Plates and Shells
NASA Technical Reports Server (NTRS)
Knight, Norman F., Jr. (Compiler); Nemeth, Michael P. (Compiler)
1998-01-01
This special publication contains the papers presented at the special sessions honoring Dr. Manuel Stein during the 38th AIAA/ASME/ASCE/AHS/ASC Structures, Structural Dynamics, and Materials Conference held in Kissimmee, Florida, Apdl 7-10, 1997. This volume, and the SDM special sessions, are dedicated to the memory of Dr. Manuel Stein, a major pioneer in structural mechanics, plate and shell buckling, and composite structures. Many of the papers presented are the work of Manny's colleagues and co-workers and are a result, directly or indirectly, of his influence. Dr. Stein earned his Ph.D. in Engineering Mechanics from Virginia Polytechnic Institute and State University in 1958. He worked in the Structural Mechanics Branch at the NASA Langley Research Center from 1943 until 1989. Following his retirement, Dr. Stein continued his involvement with NASA as a Distinguished Research Associate.
VizieR Online Data Catalog: PACS Evolutionary Probe (PEP-DR1) catalogs (Lutz+, 2011)
NASA Astrophysics Data System (ADS)
Lutz, D.; Poglitsch, A.; Altieri, B.; Andreani, P.; Aussel, H.; Berta, S.; Bongiovanni, A.; Brisbin, D.; Cava, A.; Cepa, J.; Cimatti, A.; Daddi, E.; Dominguez-Sanchez, H.; Elbaz, D.; Foerster Schreiber, N. M.; Genzel, R.; Grazian, A.; Gruppioni, C.; Harwit, M.; Le Floc'h, E.; Magdis, G.; Magnelli, B.; Maiolino, R.; Nordon, R.; Perez Garcia, A. M.; Popesso, P.; Pozzi, F.; Riguccini, L.; Rodighiero, G.; Saintonge, A.; Sanchez Portal, M.; Santini, P.; Shao, L.; Sturm, E.; Tacconi, L. J.; Valtchanov, I.; Wetzstein, M.; Wieprecht, E.
2013-11-01
PACS catalogs built by the PEP team, with key contributions by Stefano Berta, Benjamin Magnelli, Paola Popesso, Dieter Lutz, Francesca Pozzi, Bruno Altieri, Herve Aussel, Hoseong Hwang, Emeric Le Floc'h, Georgios Magdis, Raanan Nordon, Albrecht Poglitsch, Laurie Riguccini, Amelie Saintonge, Li Shao. For more details, please refer to Lutz et al. (2011A&A...532A..90L) and to the PDF documentation associated to the release. Data and catalogs can be retrieved from the web page http://www.mpe.mpg.de/ir/Research/PEP/publicdatareleases.php See the PDF documentation associated to the PEP DR1 release, http://www.mpe.mpg.de/resources/PEP/DR1tarballs/readmePEP_global.pdf and http://www.mpe.mpg.de/resources/PEP/DR1tarballs/readmePEP_SPIRE.pdf for more details. (69 data files).
Goyal, Amit [Oak Ridge National Lab. (ORNL), Oak Ridge, TN (United States)
2018-04-27
Dr. Amit Goyal, a high temperature superconductivity (HTS) researcher at Oak Ridge National Laboratory, was named a 2011 winner of the Department of Energy's Ernest Orlando Lawrence Award honoring U.S. scientists and engineers for exceptional contributions in research and development supporting DOE and its mission. Winner of the award in the inaugural category of Energy Science and Innovation, Dr. Goyal was cited for his work in 'pioneering research and transformative contributions to the field of applied high temperature superconductivity, including fundamental materials science advances and technical innovations enabling large-scale applications of these novel materials.' Following his basic research in grain-to-grain supercurrent transport, Dr. Goyal focused his energy in transitioning this fundamental understanding into cutting-edge technologies. Under OE sponsorship, Dr. Goyal co-invented the Rolling Assisted Bi-Axially Textured Substrate technology (RABiTS) that is used as a substrate for second generation HTS wires. OE support also led to the invention of Structural Single Crystal Faceted Fiber Substrate (SSIFFS) and the 3-D Self Assembly of Nanodot Columns. These inventions and associated R&D resulted in 7 R&D 100 Awards including the 2010 R&D Magazine's Innovator of the Year Award, 3 Federal Laboratory Consortium Excellence in Technology Transfer National Awards, a DOE Energy 100 Award and many others. As a world authority on HTS materials, Dr. Goyal has presented OE-sponsored results in more than 150 invited talks, co-authored more than 350 papers and is a fellow of 7 professional societies.
A Student of History: Perspectives on the Contributions of Estelle Brodman
McClure, Lucretia W.
2008-01-01
Purpose: This paper is a reflection on the contributions of Estelle Brodman, PhD, as a historian through her publications and activities in the areas of medical history and history of medical librarianship. Methods: The publication record of Dr. Brodman was reviewed to identify the resources most relevant to the history of medicine and history of medical librarianship. Brief Description: As a historian, Dr. Brodman used manuscript collections to carry out original research. Publications resulting from her research and historical activities influenced her library colleagues to embrace history and brought new information to historians, scholars, and students. Dr. Brodman was the driving force behind the development of the Medical Library Association's oral history program. PMID:18654654
ERIC Educational Resources Information Center
Bond, Vanessa L.
2011-01-01
Dr. James R. Austin, Professor of Music Education and Associate Dean for Undergraduate Studies at the University of Colorado at Boulder, was the guest speaker for the 2011 Ohio Music Education Association (OMEA) Research Committee's Graduate Research Forum held in conjunction with the annual OMEA Professional Development Conference. During his…
NASA Astrophysics Data System (ADS)
2016-02-01
The iMEC 2015 is the second International Manufacturing Engineering Conference organized by the Faculty of Manufacturing, Universiti Malaysia Pahang (UMP), held from 12-14th November 2015 in Kuala Lumpur, Malaysia, with a theme "Materials, Manufacturing and Systems for Tomorrow". For the first time, iMEC is organized together with 3rd Asia- Pacific Conference on Manufacturing System (APCOMS 2015) which owned by Fakulti Teknologi Industri, Institut Teknologi Bandung (ITB), Indonesia. This is an extended collaboration between UMP and ITB to intensify knowledge sharing and experiences between higher learning institutions. This conference (iMEC & APCOMS 2015) is a platform for knowledge exchange and the growth of ideas, particularly in manufacturing engineering. The conference aims to bring researchers, academics, scientists, students, engineers and practitioners from around the world together to present their latest findings, ideas, developments and applications related to manufacturing engineering and other related research areas. With rapid advancements in manufacturing engineering, iMEC is an appropriate medium for the associated community to keep pace with the changes. In 2015, the conference theme is “Materials, Manufacturing and Systems for Tomorrow” which reflects the acceleration of knowledge and technology in global manufacturing. The papers in these proceedings are examples of the work presented at the conference. They represent the tip of the iceberg, as the conference attracted over 200 abstracts from Malaysia, Indonesia, Japan, United Kingdom, Australia, India, Bangladesh, South Africa, Turkey and Morocco and 151 full papers were accepted in these proceedings. The conference was run in four parallel sessions with 160 presenters sharing their latest finding in the areas of manufacturing process, systems, advanced materials and automation. The first keynote presentation was given by Prof. B. S. Murthy (IIT, Madras) on "Nanomaterials with Exceptional Properties Synthesized through Top Down Approach”, which was warmly welcomed by an eager and highly motivated audience. The second keynote speaker was Prof. Ir. Dradjad Irianto (ITB, Indonesia) on “Collaborative Manufacturing for Small-medium Enterprises”. The organizers are very grateful to them for supporting the conference and sharing their latest research results with the conference participants. The conference organizers would like to express our sincere gratitude and thanks to the honorary chairman Prof. Dato, Dr. Daing Nasir Ibrahim and Prof. Dr. Wan Azhar Wan Yusoff and organizing committee members of iMEC2015, Assoc. Prof. Dr. A.K. Prasada Rao (chairman), Dr. Ing. Mohd Azmir Mohd Azhari (co-chairman), and all committee members Assoc. Prof. Dr. Ahmad Razlan Yusoff, Assoc. Prof. Dr. Ismed Iskandar, Dr Noraini Mohd Razali, Dr Muhammed Nafis Osman Zahid, Dr Noor Mazni Ismail, Dr Izwan Ismail, Dr Zamzuri Hamedon, Dr Faiz Mohd Turan, Ms Suraya Sulaiman and secretariat Miss Zuryaty, Mrs Wan Norshihah, Mr. Mohd Khairulnazri and Mr Rafilah and also a million thanks to the steering committee from APCOMS Prof. Dr. Kadarsyah Suryadi, Prof. Dr. Bermawi, P. Iskandar, Prof. Dr. Abdul Hakim Halim, Prof. Dr. Dradjad Irianto, Dr. TMA Ari Samadhi, Ir. I Made Dana Tangkas and APCOMS organizing committee Prof. Dr. Abdul Hakim Halim (chair), Dr. Rachmawati Wangsaputra (co-chair) and other committee members Dr. Iwan Inrawan Wiratmadja, Dr. Anas Ma'ruf, Dr. Sukoyo and Dr. Wisnu Aribowo. The editorial board are indebted to all of the reviewers who were willing to spend their precious time in reviewing the papers. Thanks also to all who contributed direct or indirectly in making this conference a success, especially Mr. Mohd Khairulnazri in helping the editors complete the proceedings. Dr. Zamzuri Hamedon Editor in-chief iMEC & APCOMS 2015 Associate Editors 1. Assoc. Prof. Dr. A.K. Prasada Rao 2. Assoc. Prof. Dr. Ahmad Razlan Yusoff 3. Dr. Ing. Mohd Azmir Mohd Azhari 4. Dr. Muhammed Nafis Osman Zahid 5. Dr. Faiz Mohd Turan
Current Issues in Teacher Education: An Interview with Dr. Linda Darling-Hammond
ERIC Educational Resources Information Center
Martin, Linda E.; Mulvihill, Thalia M.
2017-01-01
Dr. Linda Darling-Hammond is the Charles E. Ducommun Professor of Education Emeritus at the Stanford Graduate School of Education at Stanford University. She is former president of the American Educational Research Association (AERA) and member of the National Academy of Education and the American Academy of Arts and Sciences. She also served as a…
Robotic Technology: An Assessment and Forecast,
1984-07-01
Research Associates# Inc. Dr. Roger Nagel# Lehigh University Dr. Charles Rosen# Machine Intelligence Corporations and Mr. Jack Thornton# Robot Insider...amr (Subcontractors: systems for assembly and Adopt Technology# inspection Stanford University. SRI) AFSC MANTECH o McDonnell Douglas o Machine ...supervisory controls man- machine interaction and system integration. - .. _ - Foreign R& The U.S. faces a strong technological challenge in robotics from
New knowledge network evaluation method for design rationale management
NASA Astrophysics Data System (ADS)
Jing, Shikai; Zhan, Hongfei; Liu, Jihong; Wang, Kuan; Jiang, Hao; Zhou, Jingtao
2015-01-01
Current design rationale (DR) systems have not demonstrated the value of the approach in practice since little attention is put to the evaluation method of DR knowledge. To systematize knowledge management process for future computer-aided DR applications, a prerequisite is to provide the measure for the DR knowledge. In this paper, a new knowledge network evaluation method for DR management is presented. The method characterizes the DR knowledge value from four perspectives, namely, the design rationale structure scale, association knowledge and reasoning ability, degree of design justification support and degree of knowledge representation conciseness. The DR knowledge comprehensive value is also measured by the proposed method. To validate the proposed method, different style of DR knowledge network and the performance of the proposed measure are discussed. The evaluation method has been applied in two realistic design cases and compared with the structural measures. The research proposes the DR knowledge evaluation method which can provide object metric and selection basis for the DR knowledge reuse during the product design process. In addition, the method is proved to be more effective guidance and support for the application and management of DR knowledge.
2014-01-01
Background The study describes the relationship of retinal vascular geometry (RVG) to severity of diabetic retinopathy (DR), and its predictive role for subsequent development of proliferative diabetic retinopathy (PDR). Methods The research project comprises of two stages. Firstly, a comparative study of diabetic patients with different grades of DR. (No DR: Minimal non-proliferative DR: Severe non-proliferative DR: PDR) (10:10: 12: 19). Analysed RVG features including vascular widths and branching angles were compared between patient cohorts. A preliminary statistical model for determination of the retinopathy grade of patients, using these features, is presented. Secondly, in a longitudinal predictive study, RVG features were analysed for diabetic patients with progressive DR over 7 years. RVG at baseline was examined to determine risk for subsequent PDR development. Results In the comparative study, increased DR severity was associated with gradual vascular dilatation (p = 0.000), and widening of the bifurcating angle (p = 0.000) with increase in smaller-child-vessel branching angle (p = 0.027). Type 2 diabetes and increased diabetes duration were associated with increased vascular width (p = <0.05 In the predictive study, at baseline, reduced small-child vascular width (OR = 0.73 (95% CI 0.58-0.92)), was predictive of future progression to PDR. Conclusions The study findings suggest that RVG alterations can act as novel markers indicative of progression of DR severity and establishment of PDR. RVG may also have a potential predictive role in determining the risk of future retinopathy progression. PMID:25001248
Fan, Wen-Ying; Liu, Ning-Pu
2015-01-01
AIM To collectively evaluate the association of intercellular adhesion molecule-1 (ICAM-1) gene K469E polymorphism (rs5498) with diabetic retinopathy (DR) in patients with type 2 diabetic mellitus (T2DM). METHODS Overall review of available literatures relating K469E polymorphism to the risk of DR was conducted on 4 electronic databases. Meta-analysis was performed by Stata 12.0 to calculate pooled odds ratios (ORs). Potential sources of heterogeneity and bias were explored. RESULTS Seven studies with genotype frequency data including 1120 cases with DR and 956 diabetic controls free of DR were included. Meta-analysis did not show significant association of K469E polymorphism with DR (P>0.05). A statistically significant association was detected between the K469E polymorphism and proliferative diabetic retinopathy (PDR) in Asians only in dominant model (GG+AG vs AA) with pooled OR of 0.729 (95%CI: 0.564-0.942, P=0.016, Pheterogeneity=0.143), however, this association was not detected in recessive model (GA+AA vs GG; OR=1.178, 95%CI: 0.898-1.545, P=0.236, Pheterogeneity=0.248) or allelic model (G vs A; OR=0.769, 95% CI: 0.576-1.026, P=0.074, Pheterogeneity=0.094). No publication bias was found by Funnel plot, Begg's and Egger's test. CONCLUSION This research found no statistically significant association between ICAM-1 gene K469E polymorphism and DR in patients with T2DM, but showed significant association of the K469E polymorphism with PDR in Asian diabetic patients only in dominant model. Further investigation would be required to consolidate the conclusion. PMID:26086016
2003-08-20
KENNEDY SPACE CENTER, FLA. - NASA leaders discuss the Agency’s One NASA initiative with selected employees at the KSC Visitor Complex IMAX Theater®. From left are KSC Director Jim Kennedy; James Jennings, NASA’s associate deputy administrator for institutions and asset management; Ed Weiler, associate administrator for Space Science; Kevin Peterson, Dryden Flight Research Center director; incoming KSC Deputy Director Woodrow Whitlow; and implementation team lead Johnny Stevenson. Glenn Research Center Director Dr. Julian Earls gave a motivational speech during the luncheon held at the Visitor Complex Debus Conference Center.
2009-08-01
the proposed general casualty estimation process. The next two briefings described the technical details of the development and content of the...Forces Radiobiological Research Institute (AFRRI) Dr. Gene McClellan, Applied Research Associates (ARA) COL John Mercier, AFRRI Dr. Kyle Millage...marrow damage occurs; lethality ranges from LD50/60 to LD99/60; death occurs within 3.5 to 6 weeks with the radiation injury alone but is accelerated
Cui, Borui; Gao, Dian-ce; Xiao, Fu; ...
2016-12-23
This article provides a method in comprehensive evaluation of cost-saving potential of active cool thermal energy storage (CTES) integrated with HVAC system for demand management in non-residential building. The active storage is beneficial by shifting peak demand for peak load management (PLM) as well as providing longer duration and larger capacity of demand response (DR). In this research, a model-based optimal design method using genetic algorithm is developed to optimize the capacity of active CTES aiming for maximizing the life-cycle cost saving concerning capital cost associated with storage capacity as well as incentives from both fast DR and PLM. Inmore » the method, the active CTES operates under a fast DR control strategy during DR events while under the storage-priority operation mode to shift peak demand during normal days. The optimal storage capacities, maximum annual net cost saving and corresponding power reduction set-points during DR event are obtained by using the proposed optimal design method. Lastly, this research provides guidance in comprehensive evaluation of cost-saving potential of CTES integrated with HVAC system for building demand management including both fast DR and PLM.« less
DOE Office of Scientific and Technical Information (OSTI.GOV)
Cui, Borui; Gao, Dian-ce; Xiao, Fu
This article provides a method in comprehensive evaluation of cost-saving potential of active cool thermal energy storage (CTES) integrated with HVAC system for demand management in non-residential building. The active storage is beneficial by shifting peak demand for peak load management (PLM) as well as providing longer duration and larger capacity of demand response (DR). In this research, a model-based optimal design method using genetic algorithm is developed to optimize the capacity of active CTES aiming for maximizing the life-cycle cost saving concerning capital cost associated with storage capacity as well as incentives from both fast DR and PLM. Inmore » the method, the active CTES operates under a fast DR control strategy during DR events while under the storage-priority operation mode to shift peak demand during normal days. The optimal storage capacities, maximum annual net cost saving and corresponding power reduction set-points during DR event are obtained by using the proposed optimal design method. Lastly, this research provides guidance in comprehensive evaluation of cost-saving potential of CTES integrated with HVAC system for building demand management including both fast DR and PLM.« less
Digital Tracking and Control of Retinal Images
1993-05-01
combination of Ketamine (35 mg/kg) and Rompan (5.9 mg/kg). The rabbit’s eye was then dilated with Atropine and a speculum inserted to open the eyelid. A...experiments 251 xviii Chapter 1 Introduction 1.1 Overview Dr. A.J. Welch, Dr. H. Grady Rylander III M.D., and associated researchers have worked toward the...obtain a high contrast image of the retina. Specifically, it is used to image microaneurysms associated with critical retinal diseases long before the
We are Not Hard-to-Reach: Community Competent Research to Address Racial Tobacco-Related Disparities
Dr. Webb Hooper is Associate Director for Cancer Disparities Research and Director of the Office of Cancer Disparities Research in the Case Comprehensive Cancer Center at Case Western Reserve University. She is also Professor of Oncology, Family Medicine & Community Health and Psychological Sciences. Dr. Webb Hooper is a licensed clinical health psychologist whose research interests are in chronic illness prevention and cancer risk behaviors, with an emphasis on minority health and racial/ethnic disparities. Much of her research focuses on tobacco use and weight management interventions, the development of culturally specific approaches, and understanding relationships between behavior change and race/ethnicity, cultural variables, modifiable risk factors, and the biological stress response. Dr. Webb Hooper has received international recognition for her contributions to nicotine and tobacco research, and is a leader in the field of cancer health disparities. Her research goal is to make a significant public health impact by reducing the prevalence of cancer and cancer health disparities in high-risk populations. Her long-term goal is to help eliminate disparities in chronic diseases. Dr. Webb Hooper’s research has been funded with over $9 million dollars by the National Cancer Institute (NCI), American Cancer Society (ACS), CVS Health Foundation, and the Florida Department of Health James and Esther King Biomedical Research Program. In addition, Dr. Webb Hooper serves on committees for the NIH, several peer-reviewed journal editorial boards, is an Associate Editor of the Ethnicity & Disease Journal, and is Co-Chair of the Health Disparities Network of the Society for Research on Nicotine and Tobacco. WebEx When it's time, join the meeting. Meeting number (access code): 857 862 211 Meeting password: Colloqu1@ Join by phone 1-650-479-3207 Call-in toll number (US/Canada) Can't join the meeting? IMPORTANT NOTICE: Please note that this WebEx service allows audio and other information sent during the session to be recorded, which may be discoverable in a legal matter. By joining this session, you automatically consent to such recordings. If you do not consent to being recorded, discuss your concerns with the host or do not join the session.
[Pharmacologists in the camps in the Third Reich--part second].
Labuzek, Krzysztof; Prusek, Katarzyna; Gonciarz, Maciej; Okopień, Boguslaw
2013-10-01
SS Hygiene Institute provided adequate funding for research on the treatment of mycobacterial infections, and two scientists who became famous in the subject were Dr. Waldemar Hoven (KL Buchenwald) and Dr. Kurt Heissmeyer (KL Neuengamme). They conducted researches not only on adult prisoners, but also on the Jewish children. Studies of tuberculosis were also conducted under the auspices of the German Medical Association by Dr. Rudolf Brachtel. In turn, Dr. Klaus Schilling dealt with the treatment and immunoprophylaxis of malaria. He tested such substances, as pyramidon, aspirin, quinine and atebrin on more than 1200 prisoners. These sulfonamide-derived drugs, were also studied by prof. Karl Gebhardt and Dr. Fritz Fischer. They assessed the efficacy of these drugs in the treatment of "dirty" wounds incurred by German soldiers. Dr. Heinrich Schutz, Karl Babor and Waldemar Wolter they were enthusiasts in so-called biochemical therapy, based on the use of substances of natural origin, such as salt. After termination of War, during the Nuremberg Trials, many of them evaded responsibility, they were running medical practices, some were publishing. However, despite those facts, trials of Nazi war criminals were not result less, they opened world's eyes for the necessity of clarifying rudiments of human subject research, they gave foundations to define records like The Convention for the Protection of Human Rights and Dignity of the Human Being with regard to the Application of Biology and Medicine or Good Clinical Practice.
Freefall Research Education Outreach
NASA Technical Reports Server (NTRS)
1996-01-01
Dr. Michael Wargo, program scientist for materials science at NASA headquarters, explains the math and physics principles associated with freefall research to attendees at the arnual conference of the National Council of Teachers of Mathematics.
2007-09-09
Research, Engineering and Systems) Dr. John C. Sommerer NRAC, Vice Chair; Director, S&T, Johns Hopkins Applied Physics Laboratory Dr. Walt...O’Donohue, Staff Officer General Dynamics Robotic Systems John H. Northrop & Associates Mr. John H. Northrop, Executive Director General Dynamics...Equipment, US Army LtCol John Lemondes, PM Soldier as a System LTL Efforts US Army Mr. Bob Conklin, Staff UK LTL Efforts Equipment Capability
DOE Office of Scientific and Technical Information (OSTI.GOV)
Goyal, Amit
Dr. Amit Goyal, a high temperature superconductivity (HTS) researcher at Oak Ridge National Laboratory, was named a 2011 winner of the Department of Energy's Ernest Orlando Lawrence Award honoring U.S. scientists and engineers for exceptional contributions in research and development supporting DOE and its mission. Winner of the award in the inaugural category of Energy Science and Innovation, Dr. Goyal was cited for his work in 'pioneering research and transformative contributions to the field of applied high temperature superconductivity, including fundamental materials science advances and technical innovations enabling large-scale applications of these novel materials.' Following his basic research in grain-to-grainmore » supercurrent transport, Dr. Goyal focused his energy in transitioning this fundamental understanding into cutting-edge technologies. Under OE sponsorship, Dr. Goyal co-invented the Rolling Assisted Bi-Axially Textured Substrate technology (RABiTS) that is used as a substrate for second generation HTS wires. OE support also led to the invention of Structural Single Crystal Faceted Fiber Substrate (SSIFFS) and the 3-D Self Assembly of Nanodot Columns. These inventions and associated R&D resulted in 7 R&D 100 Awards including the 2010 R&D Magazine's Innovator of the Year Award, 3 Federal Laboratory Consortium Excellence in Technology Transfer National Awards, a DOE Energy 100 Award and many others. As a world authority on HTS materials, Dr. Goyal has presented OE-sponsored results in more than 150 invited talks, co-authored more than 350 papers and is a fellow of 7 professional societies.« less
Science Matters Podcast: Climate Change Research
Listen to a podcast with Dr. Andy Miller, the Associate Director for Climate for the Agency's Air, Climate, and Energy Research Program, as he answers questions about climate change research, or read some of the highlights from the conversation here.
Man, Ryan Eyn Kidd; Sasongko, Muhammad Bayu; Xie, Jing; Best, William J; Noonan, Jonathan E; Lo, Tiffany Ching Shen; Wang, Jie Jin; Luu, Chi D; Lamoureux, Ecosse L
2014-09-30
The mechanisms supporting the protective relationship between a longer axial length (AL) and a decreased risk of diabetic retinopathy (DR) remain unclear. Previous studies have demonstrated reduced retinal blood flow in axial myopia, and it has been suggested that the compromised retinal capillaries in diabetes are less likely to leak and rupture as a result of this decreased flow. In this study, we therefore investigated if reduced retinal capillary flow (RCF) is a potential mechanism underpinning this protective relationship. Retinal capillary flow was assessed using the Heidelberg Retinal Flowmeter in 150 eyes of 85 patients with diabetes aged 18+ years from the Royal Victorian Eye and Ear Hospital and St. Vincent's Hospital (Melbourne), Australia. Axial length was measured using the Intraocular Lens Master. Diabetic retinopathy was graded from two-field retinal photographs into none, mild, moderate, and severe DR using the modified Airlie House classification system. A total of 74 out of 150 eyes (49.3%) had DR. A longer AL was associated with decreased odds of DR presence (per mm increase in AL, odds ratio [OR] 0.61, 95% confidence interval [CI] 0.41-0.91) and DR severity (OR: 0.65; 95% CI: 0.44-0.95). However, no association was found between AL and RCF (per mm increase in AL, regression coefficient [β] -1.80, 95% CI -13.50 to 9.50) or between RCF and DR (per unit increase in RCF, OR 1.00; 95% CI 0.99-1.00). Our finding suggests that diminished RCF may not be a major factor underlying the protective association between axial elongation and DR. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.
Digital Tools for Cancer Prevention: Extending Reach and Engagement
Judith (Jodi) Prochaska, PhD, MPH, is Associate Professor of Medicine with the Stanford Prevention Research Center and a member of the Stanford Cancer Institute. Dr. Prochaska is a Principal Investigator on multiple research awards from the National Institutes of Health and the State of California Tobacco-Related Disease Research Program. Her research program is leveraging technology (e.g., web, text, social media) to bring tobacco cessation treatment into novel settings and to populations with high smoking prevalence. With attention to medical education and clinical practice, Dr. Prochaska has disseminated tobacco treatment curricula as part of Rx for Change (http://rxforchange.ucsf.edu). She has authored 175 peer-reviewed publications, serves on the Editorial Board of JAMA Internal Medicine, and is on the advisory board for Optum’s Quit for Life Tobacco Quitline. Dr. Prochaska is President of the Society for Research on Nicotine and Tobacco (SRNT), the international scientific society aimed at stimulating the generation and dissemination of new knowledge concerning nicotine and tobacco from bench to bedside and through to health policy.
77 FR 22320 - Findings of Research Misconduct
Federal Register 2010, 2011, 2012, 2013, 2014
2012-04-13
... DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Secretary Findings of Research Misconduct... Research Integrity (ORI) has taken final action in the following case: Peter J. Francis, M.D., Ph.D... Dr. Peter J. Francis, Associate Professor, Casey Eye Institute, OHSU, engaged in research misconduct...
Shen, Lishuang; Diroma, Maria Angela; Gonzalez, Michael; Navarro-Gomez, Daniel; Leipzig, Jeremy; Lott, Marie T; van Oven, Mannis; Wallace, Douglas C; Muraresku, Colleen Clarke; Zolkipli-Cunningham, Zarazuela; Chinnery, Patrick F; Attimonelli, Marcella; Zuchner, Stephan; Falk, Marni J; Gai, Xiaowu
2016-06-01
MSeqDR is the Mitochondrial Disease Sequence Data Resource, a centralized and comprehensive genome and phenome bioinformatics resource built by the mitochondrial disease community to facilitate clinical diagnosis and research investigations of individual patient phenotypes, genomes, genes, and variants. A central Web portal (https://mseqdr.org) integrates community knowledge from expert-curated databases with genomic and phenotype data shared by clinicians and researchers. MSeqDR also functions as a centralized application server for Web-based tools to analyze data across both mitochondrial and nuclear DNA, including investigator-driven whole exome or genome dataset analyses through MSeqDR-Genesis. MSeqDR-GBrowse genome browser supports interactive genomic data exploration and visualization with custom tracks relevant to mtDNA variation and mitochondrial disease. MSeqDR-LSDB is a locus-specific database that currently manages 178 mitochondrial diseases, 1,363 genes associated with mitochondrial biology or disease, and 3,711 pathogenic variants in those genes. MSeqDR Disease Portal allows hierarchical tree-style disease exploration to evaluate their unique descriptions, phenotypes, and causative variants. Automated genomic data submission tools are provided that capture ClinVar compliant variant annotations. PhenoTips will be used for phenotypic data submission on deidentified patients using human phenotype ontology terminology. The development of a dynamic informed patient consent process to guide data access is underway to realize the full potential of these resources. © 2016 WILEY PERIODICALS, INC.
Shen, Lishuang; Diroma, Maria Angela; Gonzalez, Michael; Navarro-Gomez, Daniel; Leipzig, Jeremy; Lott, Marie T.; van Oven, Mannis; Wallace, Douglas C.; Muraresku, Colleen Clarke; Zolkipli-Cunningham, Zarazuela; Chinnery, Patrick F.; Attimonelli, Marcella; Zuchner, Stephan
2016-01-01
MSeqDR is the Mitochondrial Disease Sequence Data Resource, a centralized and comprehensive genome and phenome bioinformatics resource built by the mitochondrial disease community to facilitate clinical diagnosis and research investigations of individual patient phenotypes, genomes, genes, and variants. A central Web portal (https://mseqdr.org) integrates community knowledge from expert-curated databases with genomic and phenotype data shared by clinicians and researchers. MSeqDR also functions as a centralized application server for Web-based tools to analyze data across both mitochondrial and nuclear DNA, including investigator-driven whole exome or genome dataset analyses through MSeqDR-Genesis. MSeqDR-GBrowse supports interactive genomic data exploration and visualization with custom tracks relevant to mtDNA variation and disease. MSeqDR-LSDB is a locus specific database that currently manages 178 mitochondrial diseases, 1,363 genes associated with mitochondrial biology or disease, and 3,711 pathogenic variants in those genes. MSeqDR Disease Portal allows hierarchical tree-style disease exploration to evaluate their unique descriptions, phenotypes, and causative variants. Automated genomic data submission tools are provided that capture ClinVar-compliant variant annotations. PhenoTips is used for phenotypic data submission on de-identified patients using human phenotype ontology terminology. Development of a dynamic informed patient consent process to guide data access is underway to realize the full potential of these resources. PMID:26919060
Shortwave Hyperspectral Observations During MAGIC Final Campaign Summary
DOE Office of Scientific and Technical Information (OSTI.GOV)
McBride, P. J.; Marshak, A.; Yang, W.
The Marine ARM GPCI1 Investigation of Clouds (MAGIC) field campaign was initiated to improve our understanding of low-level marine clouds that have a significant influence on the Earth’s climate. The campaign was conducted using an ARM mobile facility deployed on a commercial ship traveling between Honolulu, Hawaii, and Los Angeles, California, from October 2012 to September 2013. The solar spectral flux radiometer (SSFR) was deployed on July 6, 2013, through the end of the campaign. The SSFR was calibrated and installed by Warren Gore of NASA Ames Research Center, and the data is and will be analyzed by Drs. Alexandermore » Marshak and Weidong Yang of NASA Goddard Space Flight Center, Dr. Samuel LeBlanc of NASA Ames Research Center, Dr. Sebastian Schmidt of the University of Colorado-Boulder, and Dr. Patrick McBride of Atmospheric & Space Technology Research Associates in Boulder, Colorado.« less
Calabrese, Edward J
2017-10-30
This paper describes an episode in the life of the prominent plant radiation geneticist, Lewis J. Stadler (1897-1954) during which he became a target of the Federal Bureau of Investigation (FBI) concerning loyalty to the United States due to possible associations with the communist party. The research is based on considerable private correspondence of Dr. Stadler, the FBI interrogatory questions and Dr. Stadler's answers and letters of support for Dr. Stadler by leading scientists such as, Hermann J. Muller.
View of Mission Control Center during Apollo 13 splashdown
NASA Technical Reports Server (NTRS)
1970-01-01
Dr. Thomas O. Paine (center), NASA Administrator, and other NASA Officials joined others in applauding the successful splashdown of the Apollo 13 crewmen. Others among the large crowd in the Mission Operations Control Room of the Mission Control Center, Manned Spacecraft Center (MSC) at the time of recovery were U.S. Air Force Lt. Gen. Samuel C. Phillips (extreme left), who formerly served as Apollo program Director, Office of Manned Space Flight, NASA Headquarters; Dr. Charles A. Berry (third from left), Director, Medical Research and Operations Directorate, MSC; and Dr. George M. Low, Associate NASA Administrator.
W.E. Henry Symposium compendium: The importance of magnetism in physics and material science
DOE Office of Scientific and Technical Information (OSTI.GOV)
Carwell, H.
This compendium contains papers presented at the W. E. Henry Symposium, The Importance of Magnetism in Physics and Material Science. The one-day symposium was conducted to recognize the achievements of Dr. Warren Elliot Henry as educator, scientist, and inventor in a career spanning almost 70 years. Dr. Henry, who is 88 years old, attended the symposium. Nobel Laureate, Dr. Glenn Seaborg, a friend and colleague for over 40 years, attended the event and shared his personal reminiscences. Dr. Seaborg is Associate Director-At-Large at the Lawrence Berkeley National Laboratory. The Compendium begins with three papers which demonstrate the ongoing importance ofmore » magnetism in physics and material science. Other contributions cover the highlights of Dr. Henry`s career as a researcher, educator, and inventor. Colleagues and former students share insights on the impact of Dr. Henry`s research in the field of magnetism, low temperature physics, and solid state physics; his influence on students as an educator; and his character, intellect and ingenuity, and passion for learning and teaching. They share a glimpse of the environment and times that molded him as a man, and the circumstances under which he made his great achievements despite the many challenges he faced.« less
Learning to REDUCE: A Reduced Electricity Consumption Prediction Ensemble
DOE Office of Scientific and Technical Information (OSTI.GOV)
Aman, Saima; Chelmis, Charalampos; Prasanna, Viktor
Utilities use Demand Response (DR) to balance supply and demand in the electric grid by involving customers in efforts to reduce electricity consumption during peak periods. To implement and adapt DR under dynamically changing conditions of the grid, reliable prediction of reduced consumption is critical. However, despite the wealth of research on electricity consumption prediction and DR being long in practice, the problem of reduced consumption prediction remains largely un-addressed. In this paper, we identify unique computational challenges associated with the prediction of reduced consumption and contrast this to that of normal consumption and DR baseline prediction.We propose a novelmore » ensemble model that leverages different sequences of daily electricity consumption on DR event days as well as contextual attributes for reduced consumption prediction. We demonstrate the success of our model on a large, real-world, high resolution dataset from a university microgrid comprising of over 950 DR events across a diverse set of 32 buildings. Our model achieves an average error of 13.5%, an 8.8% improvement over the baseline. Our work is particularly relevant for buildings where electricity consumption is not tied to strict schedules. Our results and insights should prove useful to the researchers and practitioners working in the sustainable energy domain.« less
Bibliography of Doctor Chul Park
NASA Technical Reports Server (NTRS)
Gochberg, Lawrence A.; Venkatapathy, Ethiraj; Park, Chul
1995-01-01
This document contains a comprehensive bibliography of the published works, and a short biography, of Dr. Chul Park. The contents of this bibliography were compiled primarily from the NASA RECON data base. The RECON citations have been modified to appear in a uniform format with all other listed citations . These other citations were located by computer searches in the INSPEC, NTIS, COMPENDEX, and Chemical Abstracts data bases, as well as through the cooperation of Dr. Chul Park, and his associates in the Reacting Flow Environments Branch at NASA Ames Research Center. All citations are presented in an approximate reverse chronological order from the present date. This work was created to honor the occasion of Dr. Chul Park's retirement on December 14, 1994, after 27 years of distinguished government service at the NASA Ames Research Center.
History of the Kolff Laboratory turbine driven electrohydraulic artificial heart.
Topaz, S R; Flinders, T; Topaz, H A; Jones, D
1998-11-01
The concept of an electrically powered total artificial heart has been pursued by Dr. Kolff and his associates since the 1960s. Since the 1980s these efforts have been concentrated upon the development of the electrohydraulic total artificial heart, a turbine pump powered by a brushless DC motor. Dr. Kolff realized the benefits of pulsatile flow and device response to Starling's Law, and these concepts have formed the basis of subsequent design decisions. Design iterations have both solved existing problems and exposed new challenges. The current device design is greatly improved over early attempts due to the incorporation of technologies that have recently become available as the result of progress in the fields of materials and electronics and due to the lessons learned over many years of research under the guidance of Dr. Kolff. This article describes, from its inception, the last major research project of Dr. Kolff prior to his retirement. The discussion centers around development, problems and their solutions, and the reasoning for given solutions.
Evaluation of the Fun with Books Program: An Interview with Katrina Bledsoe
ERIC Educational Resources Information Center
Fitzpatrick, Jody L.; Christie, Christina A., Ed.
2007-01-01
This article presents an interview with Katrina Bledsoe, a senior research associate with Planning, Research & Evaluation Services (PRES) Associates in Washington, D.C. Dr. Bledsoe was a faculty member in the Psychology Department at The College of New Jersey. She was trained under Stewart Donaldson at Claremont Graduate University (CGU) and…
Helicobacter pylori research: historical insights and future directions
Fock, Kwong Ming; Graham, David Y.; Malfertheiner, Peter
2014-01-01
Helicobacter pylori leads to chronic gastritis, peptic ulcer disease and gastric cancer. With increasing issues of antibiotic resistance and changing epidemiology of this pathogen, new approaches are needed for effective management. In 1984, Dr Barry Marshall and Dr Robin Warren reported the association of Helicobacter pylori with peptic ulcers in The Lancet—a discovery that earned them the Nobel prize in Physiology or Medicine in 2005—but what progress have we made since then? Here, we have invited three international experts to give their insights into the advances in H. pylori research over the past 30 years and where research should be focused in the future. PMID:23752823
Linezolid-Associated Optic Neuropathy in Drug-Resistant Tuberculosis Patients in Mumbai, India
Mehta, Salil; Das, Mrinalini; Laxmeshwar, Chinmay; Jonckheere, Sylvie; Thi, Sein Sein; Isaakidis, Petros
2016-01-01
Background Patients on linezolid-containing drug-resistant TB (DR-TB) regimen often develop adverse-events, particularly peripheral and optic neuropathy. Programmatic data and experiences of linezolid-associated optic neuropathy from high DR-TB burden settings are lacking. The study aimed to determine the frequency of and risk-factors associated with linezolid-associated optic neuropathy and document the experiences related to treatment/care of DR-TB patients on linezolid-containing regimens. Methods This was a retrospective cohort study using routine clinical and laboratory data in Médecins Sans Frontières (MSF) HIV/DR-TB clinic in collaboration with Lilavati Hospital & Research Center, Mumbai, India. All DR-TB patients on linezolid-containing treatment regimens were included in the study and underwent routine evaluations for systemic and/or ocular complaints. Ophthalmological evaluation by a consultant ophthalmologist included visual-acuity screening, slit-lamp examination and dilated fundus examination. Results During January 2013-April 2016, 86 of 136 patients (with/without HIV co-infection) initiated linezolid-containing DR-TB treatment. The median age of these 86 patients was 25 (20–35) years and 47% were males. 20 percent of them had HIV co-infection. Of 86, 24 (27.9%) had at least one episode of ocular complaints (the majority blurred-vision) and among them, five (5.8%) had optic neuropathy. Patients received appropriate treatment and improvements were observed. None of the demographic/clinical factors were associated with optic neuropathy in Poissons or multivariate binary logistic-regression models. Discussion This is the first report focusing on optic neuropathy in a cohort of complex DR-TB patients, including patients co-infected with HIV, receiving linezolid-containing regimens. In our study, one out of four patients on linezolid had at least one episode of ocular complaints; therefore, systematic monitoring of patients by primary physicians/nurses, and access to specialized diagnostic-services by specialists are needed. As linezolid will be increasingly added to treatment regimens of DR-TB patients, programmes should allocate adequate resources for early diagnosis, prevention and management of this disabling adverse event. PMID:27611434
A conversation with Susan Band Horwitz.
Horwitz, Susan Band; Goldman, I David
2015-01-01
Susan Band Horwitz is a Distinguished Professor and holds the Falkenstein Chair in Cancer Research at Albert Einstein College of Medicine in New York. She is co-chair of the Department of Molecular Pharmacology and associate director for therapeutics at the Albert Einstein Cancer Center. After graduating from Bryn Mawr College, Dr. Horwitz received her PhD in biochemistry from Brandeis University. She has had a continuing interest in natural products as a source of new drugs for the treatment of cancer. Her most seminal research contribution has been in the development of Taxol(®). Dr. Horwitz and her colleagues made the discovery that Taxol had a unique mechanism of action and suggested that it was a prototype for a new class of antitumor drugs. Although Taxol was an antimitotic agent blocking cells in the metaphase stage of the cell cycle, Dr. Horwitz recognized that Taxol was blocking mitosis in a way different from that of other known agents. Her group demonstrated that the binding site for Taxol was on the β-tubulin subunit. The interaction of Taxol with the β-tubulin subunit resulted in stabilized microtubules, essentially paralyzing the cytoskeleton, thereby preventing cell division. Dr. Horwitz served as president (2002-2003) of the American Association for Cancer Research (AACR). She is a member of the National Academy of Sciences, the Institute of Medicine, the American Academy of Arts and Sciences, and the American Philosophical Society. She has received numerous honors and awards, including the C. Chester Stock Award from Memorial Sloan Kettering Cancer Center, the Warren Alpert Foundation Prize from Harvard Medical School, the Bristol-Myers Squibb Award for Distinguished Achievement in Cancer Research, the American Cancer Society's Medal of Honor, and the AACR Award for Lifetime Achievement in Cancer Research. The following interview was conducted on January 23, 2014.
Polyvalent Vaccines Targeting Oncogenic Driver Pathways
Mary L. (Nora) Disis, MD, is the Athena Distinguished Professor of Breast Cancer Research and Associate Dean for Translational Health Sciences in the University of Washington (UW) School of Medicine. She is a Professor of Medicine and Adjunct Professor of Pathology and Obstetrics and Gynecology at UW, and a Member of the Fred Hutchinson Cancer Research Center (FHCRC). She is also an American Cancer Society Clinical Professor and a Komen Scholar. In addition to directing work in the Tumor Vaccine Group, Dr. Disis is the Director of the Institute of Translational Health Sciences and the Director for the Center for Translational Medicine in Women’s Health at the UW. Dr. Disis is an expert in breast and ovarian cancer immunology and translational research. She is one of the pioneering investigators who discovered that HER-2/neu is a tumor antigen. Her work has led to several clinical trials which evaluate boosting immunity to HER-2/neu with cancer vaccines. Her research interest is in the discovery of new molecular immunologic targets in solid tumors for the development of vaccine and cellular therapy for the treatment and prevention of common malignancies. Dr. Disis is a member of Alpha Omega Alpha and the American Society of Clinical Investigation. She is also the Editor-in-Chief for JAMA Oncology, and is a member of several committees and task forces for both the American Society of Clinical Oncology (ASCO) and the American Association for Cancer Research (AACR). Dr. Disis received her MD from the University of Nebraska Medical School and completed a residency and chief residency in Internal Medicine at the University of Illinois in Chicago and her fellowship in oncology at UW/FHCRC.
Epitaxial Garnet Investigation; Technical Report, Foreign Travel
1988-10-25
Pure yttrium iron garnet (YIG) films are grown on GGG substrates by * liquid phase epitaxy ( LPE ) in production lots. In addition, one or two...epitaxial garnet films for Philips Dr. Krumme * Dr. Doormann 3-6-87 Thomson - CSF Research Center, Orsay, France Dr. J. P. Castera Dr. P. L. Meunier all...research physicists who grow, characterize, Dr. J. Y. Beguin or use epitaxial garnet films for Thomson CSF. Dr. J. L. Rolland Dr. P. Friez The
Savannah River Ecology Laboratory. Annual technical progress report of ecological research
DOE Office of Scientific and Technical Information (OSTI.GOV)
Smith, M.H.
1996-07-31
The Savannah River Ecology Laboratory (SREL) is a research unit of the University of Georgia (UGA). The overall mission of the Laboratory is to acquire and communicate knowledge of ecological processes and principles. SREL conducts basic and applied ecological research, as well as education and outreach programs, under a contract with the U.S. Department of Energy (DOE) at the Savannah River Site (SRS) near Aiken, South Carolina. Significant accomplishments were made during the past year in the areas of research, education and service. The Laboratory`s research mission was fulfilled with the publication of two books and 143 journal articles andmore » book chapters by faculty, technical and students, and visiting scientists. An additional three books and about 80 journal articles currently are in press. Faculty, technician and students presented 193 lectures, scientific presentations, and posters to colleges and universities, including minority institutions. Dr. J Vaun McArthur organized and conducted the Third Annual SREL Symposium on the Environment: New Concepts in Strewn Ecology: An Integrative Approach. Dr. Michael Newman conducted a 5-day course titled Quantitative Methods in Ecotoxicology, and Dr. Brian Teppen of The Advanced Analytical Center for Environmental Sciences (AACES) taught a 3-day short course titled Introduction to Molecular Modeling of Environmental Systems. Dr. I. Lehr Brisbin co-hosted a meeting of the Crocodile Special Interest Group. Dr. Rebecca Sharitz attended four symposia in Japan during May and June 1996 and conducted meetings of the Executive Committee and Board of the International Association for Ecology (ENTECOL).« less
HLA DR phenotypic frequencies and genetic risk of Type 1 diabetes in west region of Algeria, Tlemcen
Aribi, Mourad; Moulessehoul, Soraya; Benabadji, Ahmed-Bakir; Kendoucitani, Mohammed
2004-01-01
Background The main genomic region controlling the predisposition to type 1 diabetes is the Human Leukocyte Antigens (HLA) class II of the major histocompatibility complex. Association with different HLA types depends also on the studied populations. In our investigation, we tried to measure the phenotypic HLA class II association frequencies of DR3 and/or DR4 antigens, using a serologic method called microlymphocytotoxicity analysis, in diabetic and nondiabetic (ND) subjects originating from the west-Algerian region of Tlemcen. The aim of the present study was to determine which HLA DR antigens represent a high susceptibility to develop the disease in this area. Using a case-control retrospective study design, we randomly recruited ninety-one related subjects, 39 type 1 diabetics and 52 ND as controls, at the Internal Medicine Board of Medical Centre University of Tlemcen. Results DR3 antigen frequencies were comparable between the type 1 diabetics and the ND subjects and showed no association with the disease (p = 1.000, OR = 0.95), whereas DR4 and DR3DR4 antigens were associated with susceptibility to develop type 1 diabetes (DR4; OR = 2.10, DR3DR4; OR = 1.30). Also, no incidence for DR3 (p = 0.2646) or DR3DR4 (p = 0.0699) antigen frequencies was related to the sex ratio. However, significant differences in HLA DR4 frequencies between type 1 diabetics and ND were found to be related to sex (p = 0.0085). Conclusion Taken together, our investigation showed that the strongest association with type 1 diabetes was noticed in the presence of HLA DR4 antigens followed by DR3DR4 antigens. This study highlighted a characteristic of Tlemcen population; a history of consanguineous marriages. Association studies between the disease and genetic polymorphisms should be undertaken in a population where consanguinity is more limited to reduce confounding in result interpretations. PMID:15331022
Milutinovic, Snezana; Kashyap, Arun K; Yanagi, Teruki; Wimer, Carina; Zhou, Sihong; O'Neil, Ryann; Kurtzman, Aaron L; Faynboym, Alexsandr; Xu, Li; Hannum, Charles H; Diaz, Paul W; Matsuzawa, Shu-ichi; Horowitz, Michael; Horowitz, Lawrence; Bhatt, Ramesh R; Reed, John C
2016-01-01
Death receptors of the TNF family are found on the surface of most cancer cells and their activation typically kills cancer cells through the stimulation of the extrinsic apoptotic pathway. The endogenous ligand for death receptors 4 and 5 (DR4 and DR5) is TNF-related apoptosis-inducing ligand, TRAIL (Apo2L). As most untransformed cells are not susceptible to TRAIL-induced apoptosis, death receptor activators have emerged as promising cancer therapeutic agents. One strategy to stimulate death receptors in cancer patients is to use soluble human recombinant TRAIL protein, but this agent has limitations of a short half-life and decoy receptor sequestration. Another strategy that attempted to evade decoy receptor sequestration and to provide improved pharmacokinetic properties was to generate DR4 or DR5 agonist antibodies. The resulting monoclonal agonist antibodies overcame the limitations of short half-life and avoided decoy receptor sequestration, but are limited by activating only one of the two death receptors. Here, we describe a DR4 and DR5 dual agonist produced using Surrobody technology that activates both DR4 and DR5 to induce apoptotic death of cancer cells in vitro and in vivo and also avoids decoy receptor sequestration. This fully human anti-DR4/DR5 Surrobody displays superior potency to DR4- and DR5-specific antibodies, even when combined with TRAIL-sensitizing proapoptotic agents. Moreover, cancer cells were less likely to acquire resistance to Surrobody than either anti-DR4 or anti-DR5 monospecific antibodies. Taken together, Surrobody shows promising preclinical proapoptotic activity against cancer cells, meriting further exploration of its potential as a novel cancer therapeutic agent. ©2015 American Association for Cancer Research.
The influence of differential response on decision-making in child protective service agencies.
Janczewski, Colleen E
2015-01-01
Differential response (DR) profoundly changes the decision pathways of public child welfare systems, yet little is known about how DR shapes the experiences of children whose reports receive an investigation rather than an alternate response. Using data from the National Child Abuse and Neglect Data System (NCANDS), this study examined the relationship between DR implementation and decision outcomes in neglect cases, as measured by investigation, substantiation, and removal rates in 297 U.S. counties. Multivariate regression models included county-level measures of child poverty and proportions of African American children. Path analyses were also conducted to identify mediating effects of prior decision points and moderating effects of DR on poverty and race's influence on decision outcomes. Results indicate that compared to non-DR counties, those implementing DR have significantly lower investigation and substantiation rates within county populations but higher substantiation rates among investigated cases. Regression models showed significant reductions in removal rates associated with DR implementation, but these effects became insignificant in path models that accounted for mediation effects of previous decision points. Findings also suggest that DR implementation may reduce the positive association between child poverty rates and investigation rates, but additional studies with larger samples are needed to confirm this moderation effect. Two methods of calculating decision outcomes, population- and decision-based enumeration, were used, and policy and research implications of each are discussed. This study demonstrates that despite their inherit complexity, large administrative datasets such as NCANDS can be used to assess the impact of wide-scale system change across jurisdictions. Copyright © 2014 Elsevier Ltd. All rights reserved.
Li, Yuan; Wu, Qun Hong; Jiao, Ming Li; Fan, Xiao Hong; Hu, Quan; Hao, Yan Hua; Liu, Ruo Hong; Zhang, Wei; Cui, Yu; Han, Li Yuan
2015-01-01
To evaluate whether the adiponectin gene is associated with diabetic retinopathy (DR) risk and interaction with environmental factors modifies the DR risk, and to investigate the relationship between serum adiponectin levels and DR. Four adiponectin polymorphisms were evaluated in 372 DR cases and 145 controls. Differences in environmental factors between cases and controls were evaluated by unconditional logistic regression analysis. The model-free multifactor dimensionality reduction method and traditional multiple regression models were applied to explore interactions between the polymorphisms and environmental factors. Using the Bonferroni method, we found no significant associations between four adiponectin polymorphisms and DR susceptibility. Multivariate logistic regression found that physical activity played a protective role in the progress of DR, whereas family history of diabetes (odds ratio 1.75) and insulin therapy (odds ratio 1.78) were associated with an increased risk for DR. The interaction between the C-11377 G (rs266729) polymorphism and insulin therapy might be associated with DR risk. Family history of diabetes combined with insulin therapy also increased the risk of DR. No adiponectin gene polymorphisms influenced the serum adiponectin levels. Serum adiponectin levels did not differ between the DR group and non-DR group. No significant association was identified between four adiponectin polymorphisms and DR susceptibility after stringent Bonferroni correction. The interaction between C-11377G (rs266729) polymorphism and insulin therapy, as well as the interaction between family history of diabetes and insulin therapy, might be associated with DR susceptibility.
Yamaoka, Toshimitsu; Ohmori, Tohru; Ohba, Motoi; Arata, Satoru; Kishino, Yasunari; Murata, Yasunori; Kusumoto, Sojiro; Ishida, Hiroo; Shirai, Takao; Hirose, Takashi; Ohnishi, Tsukasa; Sasaki, Yasutsuna
2016-12-01
Met-amplified EGFR-tyrosine kinase inhibitor (TKI)-resistant non-small cell lung cancer (NSCLC) harboring an activating EGFR mutation is responsive to concurrent EGFR-TKI and Met-TKI treatment in a preclinical model. Here, we determined that Met-amplified gefitinib-resistant cells acquire dual resistance to inhibition of EGFR and Met tyrosine kinase activities. PC-9 lung adenocarcinoma cells harboring 15-bp deletions (Del E746_A750) in EGFR exon 19 were treated with increasing concentrations of the Met-TKI PHA665752 and 1 μmol/L gefitinib for 1 year; three resistant clones were established via Met amplification. The three dual-resistance cell lines (PC-9DR2, PC-9DR4, and PC-9DR6, designated as DR2, DR4, and DR6, respectively) exhibited different mechanisms for evading both EGFR and Met inhibition. None of the clones harbored a secondary mutation of EGFR T790M or a Met mutation. Insulin-like growth factor (IGF)/IGF1 receptor activation in DR2 and DR4 cells acted as a bypass signaling pathway. Met expression was attenuated to a greater extent in DR2 than in PC-9 cells, but was maintained in DR4 cells by overexpression of IGF-binding protein 3. In DR6 cells, Met was further amplified by association with HSP90, which protected Met from degradation and induced SET and MYND domain-containing 3 (SMYD3)-mediated Met transcription. This is the first report describing the acquisition of dual resistance mechanisms in NSCLC harboring an activating EGFR mutation to Met-TKI and EGFR-TKI following previous EGFR-TKI treatment. These results might inform the development of more effective therapeutic strategies for NSCLC treatment. Mol Cancer Ther; 15(12); 3040-54. ©2016 AACR. ©2016 American Association for Cancer Research.
House Committee on Science, Space, and Technology Hearing
2018-05-17
NASA Associate Administrator for the Human Exploration and Operations Mission Directorate William Gerstenmaier, left, Dr. Bhavya Lal, a researcher at the Institute for Defense Analysis's Science and Technology Policy Institute, center, and Dr. Elizabeth Cantwell, chief executive officer at the Arizona State University Research Enterprise, right, listen as Rep. Brian Babin, R-Texas, is seen on screen as he delivers an opening statement during a House Committee on Science, Space, and Technology hearing titled "America's Human Presence in Low-Earth Orbit" on Thursday, May 17, 2018 in the Rayburn House Office Building in Washington. Photo Credit: (NASA/Joel Kowsky)
2012-03-22
USC Team Members: SERC Research Council Dr. Abhi Deshmukh , Purdue Dr. Michael Griffin. U. Alabama-Huntsville Dr. Barry Horowitz, U. Virginia Dr...Areas ................................................. 34 3.2.1 Affordability, Agility, and Resilience (Barry Boehm and Abhi Deshmukh , Leads...statement was reinterpreted to involve the SERC Research Council (Drs. Deshmukh , Griffin, Horowitz, Rouse, and Wade, with Dr. Boehm as chair) in defining
ERIC Educational Resources Information Center
Yates, Eleanor Lee
2005-01-01
During the 1980s and into the '90s, HIV and AIDS primarily affected gay White men. The rates of HIV/AIDS stabilized in the 1990s in the United States, but today the numbers are soaring again. This time around, victims are more likely to be Black and heterosexual. Dr. Adaora Adimora, an HIV/AIDS researcher and associate professor of medicine at the…
2016 Health Care & Education Presidential Address: If DSME Were a Pill, Would You Prescribe It?
Powers, Margaret A
2016-12-01
This address was delivered by Margaret A. Powers, PhD, RD, CDE, President, Health Care & Education, of the American Diabetes Association (ADA), at the ADA's 76th Scientific Sessions in New Orleans, LA, on 11 June 2016. Dr. Powers conducts research and has a clinical practice as a registered dietitian and diabetes educator at the International Diabetes Center at Park Nicollet in Minneapolis. Her research focuses on improving diabetes outcomes including factors that affect the clinical, psychosocial, and behavioral aspects of diabetes. Dr. Powers has been an ADA volunteer for more than 25 years, including serving as a founding editor of Diabetes Spectrum She is the lead author of the 2015 joint Position Statement on Diabetes Self-management Education and Support published by the ADA, American Association of Diabetes Educators, and Academy of Nutrition and Dietetics. She is the recipient of the ADA's Outstanding Educator in Diabetes Award and has published research, authored numerous articles and chapters, published five books, and is an international presenter. Dr. Powers holds a doctorate in education with a focus on performance improvement from Capella University. She received her Master of Science from the University of Illinois at Chicago and her Bachelor of Science from Michigan State University. She completed her dietetic internship at Cook County Hospital in Chicago. © 2016 by the American Diabetes Association.
Epigenomic Susceptibility to the Social World: Plausible Paths to a "Newest Morbidity".
Boyce, W Thomas
2017-08-01
This article-presented on the celebratory occasion of Dr Robert Haggerty's 91st birthday-describes how a 1962 article by Dr Haggerty and his colleague Dr Roger Meyer launched a previously unexplored, pediatric research enterprise by asserting that: "There are little precise data to explain why one person becomes ill with an infecting agent and another not." Noting a prospective association between family stressors and the acquisition of β-hemolytic streptococcal infections, the article introduced a generation of young academic pediatricians-the author of the present article among them-to the possibility of causal linkages among children's adversity exposures, compromised immunological processes, and the development of immune-mediated, acute or chronic diseases of childhood. That research agenda has led, over the past 40 years, to the advent of psychoneuroimmunology as a field of study, to the recognition of childhood stress and adversity as potential etiologic agents among childhood morbidities, and to the discovery of differential susceptibility to social adversities within populations of children. Copyright © 2017 Academic Pediatric Association. Published by Elsevier Inc. All rights reserved.
Worta McCaskill-Stevens, MD, MS, Chief of the Community Oncology and Prevention Trials Research Group, NCI Division of Cancer Prevention, was named the recipient of the 2016 American Association for Cancer Research Jane Cooke Wright Memorial Lectureship. |
Postdoctoral Fellow | Center for Cancer Research
Dr. St. Croix’s laboratory at the Mouse Cancer Genetics Program (MCGP), National Cancer Institute, USA has an open postdoctoral position. We seek a highly motivated, creative and bright individual to participate in a collaborative project that involves the targeting of tumor-associated stroma using T-cells engineered to express chimeric antigen receptors (CARs). The laboratory focuses on the characterization and exploitation of molecules associated with tumor angiogenesis. The successful candidate would be involved in developing, producing and characterizing new therapeutic antibodies and CARs that recognize cancer cells or its associated stroma, and preclinical testing of these agents using mouse tumor models. The tumor angiogenesis lab is located at the National Cancer Institute in Frederick with access to state-of-the-art facilities for antibody engineering, genomic analysis, pathology, and small animal imaging, among others. Detailed information about Dr. St. Croix’s research and publications can be accessed at https://ccr.cancer.gov/Mouse-Cancer-Genetics-Program/brad-st-croix.
1996-01-01
Dr. Michael Wargo, program scientist for materials science at NASA headquarters, explains the math and physics principles associated with freefall research to attendees at the arnual conference of the National Council of Teachers of Mathematics.
1966-06-21
Dr. Joseph Randall, a laser expert at Marshall Space Flight Center (MSFC), explains one of the projects he is working on to a group composed of Federal Republic of Germany and MSFC officials. From left are: Dr. Randall; Minister for Scientific Research of Federal Republic of Germany, Dr. Gerhard Stolenberg; Director of MSFC Astrionics Lab, Dr. Walter Haeusserman; Head of Space Research Federal Republic of Germany, Max Mayer; MSFC Director Dr. von Braun; MSFC Deputy Director Dr. Elberhard Rees.
SIAM Data Mining Brings It’ to Annual Meeting
2017-02-24
address space) languages. Jose Moreira and Manoj Kumar from IBM presented the Graph Programming Interface (GPI) as well as a proposal for a common...Samsi (MIT), Dr. Manoj Kumar (IBM Research), Dr. Michel Kinsy (Boston University), and Dr. Shashank Yellapantula (GE Global Research). Dr. Gadepally...and Dr. Samsi discussed advances in data management technologies [22–25], and Dr. Kumar presented a brief overview of a graph-based API IBM is
White, Richard T; McGee-Collett, Martin
2016-10-01
The objective of this article is to provide a portrait of prefrontal lobotomy performed at the Royal Prince Alfred Hospital, Sydney by the Head of Neurosurgery Dr Rex Money and to describe Dr Money's role in the promotion of psychosurgery in Sydney. We draw attention to an oral presentation by Dr Rex Money in 1951, a journal article written by Money, archival information held at the Royal Prince Alfred Hospital, including Dr Money's accounts of his travels and his reports regarding neurosurgery - both internationally and in Australia. Dr Rex Money performed a series of 13 prefrontal lobotomies between 1945 and 1951, and presented the theoretical basis for his series, his operative procedures and the outcomes at the annual meeting of its medical officers' association. Notwithstanding various deficiencies in his clinical research, Money's descriptions give a relatively comprehensive account of one of the first series of prefrontal lobotomies performed in Australia. The current article also describes Dr Money's contributions to the promotion of psychosurgery in Sydney, and illustrates the participation of a senior neurosurgeon and of a major Sydney teaching hospital during the psychosurgery saga. © The Royal Australian and New Zealand College of Psychiatrists 2016.
Closeout Report: Experimental High Energy Physics Group at the University of South Alabama
DOE Office of Scientific and Technical Information (OSTI.GOV)
Jenkins, Charles M; Godang, Romulus
The High Energy Physics group at the University of South Alabama has been supported by this research grant (DE-FG02-96ER40970) since 1996. One researcher, Dr. Merrill Jenkins, has been supported on this grant during this time worked on fixed target experiments at the Fermi National Accelerator Laboratory, west of Chicago, Illinois. These experiments have been E-705, E-771, E-871 (HyperCP) and E-921 (CKM) before it was canceled for budgetary reasons. After the cancellation of CKM, Dr. Jenkins joined the Compact Muon Solenoid (CMS) experiment as an associate member via the High Energy Physics Group at the Florida State University. A second, recentlymore » tenured faculty member, Dr. Romulus Godang joined the group in 2009 and has been supported by this grant since then. Dr. Godang is working on the BaBaR experiment at SLAC and has joined the Belle-II experiment located in Japan at KEK. According to the instructions sent to us by our grant monitor, we are to concentrate on the activities over the last three years in this closeout report.« less
Delivery room continuous positive airway pressure and early pneumothorax in term newborn infants.
Clevenger, L; Britton, J R
2017-01-01
To assess the association between delivery room (DR) continuous positive airway pressure (CPAP) and pneumothorax (PT) in term newborns. Two studies performed in community hospitals used data extracted from computerized records of term newborns. Infants receiving positive pressure ventilation in the DR were excluded. Tabulated data included receipt of DR CPAP, PT on the day of birth, and gestational age (GA). In a case-control study from 2001-2013, infants with PT were compared to controls without PT but with respiratory distress or hypoxia persisting from birth for receipt of DR CPAP. In a cohort study from 2014-2016, infants receiving and not receiving DR CPAP were compared for the incidence of PT. In the case-control study, data were obtained for 169 cases and 850 controls. Compared to controls, PT infants were more likely to have received DR CPAP (16.8% vs. 40.2%, respectively, P < 0.001). Logistic regression revealed DR CPAP (Adjusted Odds Ratio [AOR] = 3.30, 95% confidence interval [CI] = 2.31, 4.72, P < 0.001) and GA (AOR = 1.21, 95% CI = 1.05, 1.39, P = 0.009) to be independent predictors of early PT.In the cohort study, PT was observed in 0.1% of 9255 control infants not receiving DR CPAP and 4.8% of 228 infants receiving DR CPAP (P < 0.001). In logistic regression analyses, DR CPAP significantly predicted PT (OR = 59.59, 95% CI = 23.34, 147.12, P < 0.001) and remained a significant predictor of PT after controlling for gestational age. Respiratory conditions treated with CPAP in delivery rooms are associated with increased risk of PT. A cause-and-effect relationship between CPAP and PT cannot be claimed in this study. Further research is needed to better understand this relationship.
Military Suicide Research Consortium
2015-10-01
physical and sexual abuse and lifetime number of suicide attempts: A persistent and theoretically important relationship. Behaviour Research & Therapy ...meeting of the Association of Behavioral and Cognitive Therapies , Chicago, IL. Norr, A. M., Allan, N. P., Macatee, R. J., Capron, D. W., & Schmidt, N. B...presentation to the annual Association for Behavioral and Cognitive Therapies conference, Chicago, IL. >>Dr. Craig Bryan had the following: Bryan, C.J
2003-08-20
KENNEDY SPACE CENTER, FLA. - KSC Director Jim Kennedy (left) and incoming KSC Deputy Director Woodrow Whitlow talk about One NASA during the rollout of the Agency initiative at KSC. They were joined at the IMAX Theater® by other NASA leaders James Jennings, NASA’s associate deputy administrator for institutions and asset management; Ed Weiler, associate administrator for Space Science; Kevin Peterson, Dryden Flight Research Center director; and implementation team lead Johnny Stevenson to explain how their respective centers contribute to One NASA. Glenn Research Center Director Dr. Julian Earls gave a motivational speech during the luncheon held at the Visitor Complex Debus Conference Center.
Appleyard, R
1996-01-01
This paper describes the six research monographs that were presented at the Emigration Dynamic Workshops in South Asia in September 1996. Research reports were presented by Associate Professor Nasra Shah on an overview of emigration dynamics, Dr. Godfrey Gunatilleke on the role of networks and community structures in migration from Sri Lanka, Dr. Raisul Awal Mahmood on illegal migration from Bangladesh to Singapore, Kuala Lumpur, Bangkok, and Delhi due to desperate poverty, Dr. Farooq-i-Azam on high and low labor-sending migration districts in Pakistan, Dr. Mahendra K. Premi on the impact of internal Indian migration on international migration, and Dr. P.R. Gopinathan Nair on emigration from Kerala, India, to the Middle East. Representatives of South Asian governments discussed the implications of the research findings. Pakistan's representative urged cooperation and joint strategies among labor-sending countries. He cautioned that income and remittance estimates were unstable and unrealistic for inclusion in economic development plans. The Indian representative noted that, although Indian emigration is low, it is highly visible in the press. He agreed with the suggestion for greater cooperation between sending countries. The Bangladesh representative stated that the country needed to locate new markets for Bangladeshi emigrants, to guarantee the rights of emigrant workers, and to prevent trafficking in illegal migrant workers. Three major topics were discussed in the workshop session on the implementation of programs based on research findings. Workshop participants recommended updated information on migration trends, updated information on labor markets in receiving countries, formal and regular policy dialogue between sending countries, and promotion of continuing research by the International Organization on Migration.
Breakup of Solid Ice Covers Due to Rapid Water Level Variations,
1982-02-01
Larsen, and Dr. Devinder S. Sodhi for their valuable comments and reviews of the report. He also thanks Dr. Ashton and Guenther E. Frankenstein for the...for wave periods larger than about 10 seconds. What are the minimum wave lengths that might be generated by discharge variations at a hydro- electric ...Canadian Electrical Association, Research and Development, Suite 580, One Westmount Square, Montreal, Canada. 2. Ashton, G.D. (1974a) Entrainment of ice
Introducing NASA's Solar System Exploration Research Virtual Institute
NASA Astrophysics Data System (ADS)
Pendleton, Yvonne
The Solar System Exploration Research Virtual Institute (SSERVI) is focused on the Moon, near Earth asteroids, and the moons of Mars. Comprised of competitively selected teams across the U.S., a growing number of international partnerships around the world, and a small central office located at NASA Ames Research Center, the institute advances collaborative research to bridge science and exploration goals. As a virtual institute, SSERVI brings unique skills and collaborative technologies for enhancing collaborative research between geographically disparate teams. SSERVI is jointly funded through the NASA Science Mission Directorate and the NASA Human Exploration and Operations Mission Directorate. Current U.S. teams include: Dr. Jennifer L. Heldmann, NASA Ames Research Center, Moffett Field, CA; Dr. William Farrell, NASA Goddard Space Flight Center, Greenbelt, MD; Prof. Carlé Pieters, Brown University, Providence, RI; Prof. Daniel Britt, University of Central Florida, Orlando, FL; Prof. Timothy Glotch, Stony Brook University, Stony Brook, NY; Dr. Mihaly Horanyi, University of Colorado, Boulder, CO; Dr. Ben Bussey, Johns Hopkins Univ. Applied Physics Laboratory, Laurel, MD; Dr. David A. Kring, Lunar and Planetary Institute, Houston, TX; and Dr. William Bottke, Southwest Research Institute, Boulder, CO. Interested in becoming part of SSERVI? SSERVI Cooperative Agreement Notice (CAN) awards are staggered every 2.5-3yrs, with award periods of five-years per team. SSERVI encourages those who wish to join the institute in the future to engage current teams and international partners regarding potential collaboration, and to participate in focus groups or current team activities now. Joining hand in hand with international partners is a winning strategy for raising the tide of Solar System science around the world. Non-U.S. science organizations can propose to become either Associate or Affiliate members on a no-exchange-of-funds basis. Current international partners include: Canada, Germany, Israel, Netherlands, Saudi Arabia, South Korea, and the United Kingdom. Discussions are ongoing to bring several more partners into the fold. These partnerships have impacted lunar science in a number of ways, resulting in such efforts and groups as the Pan-European Lunar Science Consortium and the Canadian Sudbury Field School. For more information visit sservi.nasa.gov
A wonderful laboratory and a great researcher
NASA Astrophysics Data System (ADS)
Sheikh, N. M.
2004-05-01
It was great to be associated with Prof. Dr. Karl Rawer. He devoted his life to make use of the wonderful laboratory of Nature, the Ionosphere. Through acquisition of the experimental data from AEROS satellites and embedding it with data from ground stations, it was possible to achieve a better empirical model, the International Reference Ionosphere. Prof. Dr. Karl Rawer has been as dynamic as the Ionosphere. His vision about the ionospheric data is exceptional and has helped the scientific and engineering community to make use of his vision in advancing the dimensions of empirical modelling. As a human being, Prof. Dr. Karl Rawer has all the traits of an angel from Heaven. In short he developed a large team of researchers forming a blooming tree from the parent node. Ionosphere still plays an important role in over the horizon HF Radar and GPs satellite data reduction.
Successes and Challenges of Vaccines to Prevent HPV-associated Cancers
Dr. John T. Schiller received his bachelor’s degree in Molecular Biology from the University of Wisconsin, Madison in 1975, and his master’s and PhD degrees in Microbiology from the University of Washington, Seattle, in 1978 and 1982, respectively. He is currently a NIH Distinguished Investigator and Section Chief in the Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute, Bethesda, MD. In his 35 years at the NCI, Dr. Schiller has studied various aspects of papillomavirus molecular biology, immunology, and epidemiology The laboratory headed by Dr. Schiller and Dr. Lowy led in the discovery, characterization, and clinical testing of virus-like particle (VLP) vaccines to prevent the HPV infections that cause cervical and other cancers. They have facilitated technology transfer to potential HPV vaccine manufactures in developing countries and provided leadership in promoting global public health issues related to the implementation of HPV vaccination. They have received numerous awards for this work including the 2007 Sabin Gold Medal Award, the 2014 National Medal of Technology and Innovation, and the 2017 Lasker~DeBakey Clinical Medical Research Award. Dr. Schiller’s current interests include basic studies of papillomavirus virion assembly and infection, the development of 2 generation HPV vaccines, and vaccines and therapies for other infectious diseases and cancers.
If DSME Were a Pill, Would You Prescribe It?
Powers, Margaret A
2017-02-01
EDITOR'S NOTE : This address was delivered by Margaret A. Powers, PhD, RD, CDE, President, Health Care & Education, of the American Diabetes Association (ADA), at the ADA's 76th Scientific Sessions in New Orleans, La., on 11 June 2016. Dr. Powers conducts research and has a clinical practice as a registered dietitian and diabetes educator at the International Diabetes Center at Park Nicollet in Minneapolis, Minn. Her research focuses on improving diabetes outcomes, including factors that affect the clinical, psychosocial, and behavioral aspects of diabetes. Dr. Powers has been an ADA volunteer for more than 25 years, including serving as a founding editor of Diabetes Spectrum . She is the lead author of the 2015 joint Position Statement on Diabetes Self-management Education and Support published by the ADA, American Association of Diabetes Educators, and Academy of Nutrition and Dietetics. She is the recipient of the ADA's Outstanding Educator in Diabetes Award and has published research, authored numerous articles and chapters, published five books, and is an international presenter. Dr. Powers holds a doctorate in education with a focus on performance improvement from Capella University. She received her Master of Science from the University of Illinois at Chicago and her Bachelor of Science from Michigan State University. She completed her dietetic internship at Cook County Hospital in Chicago.
If DSME Were a Pill, Would You Prescribe It?
2017-01-01
EDITOR’S NOTE: This address was delivered by Margaret A. Powers, PhD, RD, CDE, President, Health Care & Education, of the American Diabetes Association (ADA), at the ADA’s 76th Scientific Sessions in New Orleans, La., on 11 June 2016. Dr. Powers conducts research and has a clinical practice as a registered dietitian and diabetes educator at the International Diabetes Center at Park Nicollet in Minneapolis, Minn. Her research focuses on improving diabetes outcomes, including factors that affect the clinical, psychosocial, and behavioral aspects of diabetes. Dr. Powers has been an ADA volunteer for more than 25 years, including serving as a founding editor of Diabetes Spectrum. She is the lead author of the 2015 joint Position Statement on Diabetes Self-management Education and Support published by the ADA, American Association of Diabetes Educators, and Academy of Nutrition and Dietetics. She is the recipient of the ADA’s Outstanding Educator in Diabetes Award and has published research, authored numerous articles and chapters, published five books, and is an international presenter. Dr. Powers holds a doctorate in education with a focus on performance improvement from Capella University. She received her Master of Science from the University of Illinois at Chicago and her Bachelor of Science from Michigan State University. She completed her dietetic internship at Cook County Hospital in Chicago. PMID:28270715
Yang, Jack Y; Yang, Mary Qu; Arabnia, Hamid R; Deng, Youping
2008-09-16
Supported by National Science Foundation (NSF), International Society of Intelligent Biological Medicine (ISIBM), International Journal of Computational Biology and Drug Design and International Journal of Functional Informatics and Personalized Medicine, IEEE 7th Bioinformatics and Bioengineering attracted more than 600 papers and 500 researchers and medical doctors. It was the only synergistic inter/multidisciplinary IEEE conference with 24 Keynote Lectures, 7 Tutorials, 5 Cutting-Edge Research Workshops and 32 Scientific Sessions including 11 Special Research Interest Sessions that were designed dynamically at Harvard in response to the current research trends and advances. The committee was very grateful for the IEEE Plenary Keynote Lectures given by: Dr. A. Keith Dunker (Indiana), Dr. Jun Liu (Harvard), Dr. Brian Athey (Michigan), Dr. Mark Borodovsky (Georgia Tech and President of ISIBM), Dr. Hamid Arabnia (Georgia and Vice-President of ISIBM), Dr. Ruzena Bajcsy (Berkeley and Member of United States National Academy of Engineering and Member of United States Institute of Medicine of the National Academies), Dr. Mary Yang (United States National Institutes of Health and Oak Ridge, DOE), Dr. Chih-Ming Ho (UCLA and Member of United States National Academy of Engineering and Academician of Academia Sinica), Dr. Andy Baxevanis (United States National Institutes of Health), Dr. Arif Ghafoor (Purdue), Dr. John Quackenbush (Harvard), Dr. Eric Jakobsson (UIUC), Dr. Vladimir Uversky (Indiana), Dr. Laura Elnitski (United States National Institutes of Health) and other world-class scientific leaders. The Harvard meeting was a large academic event 100% full-sponsored by IEEE financially and academically. After a rigorous peer-review process, the committee selected 27 high-quality research papers from 600 submissions. The committee is grateful for contributions from keynote speakers Dr. Russ Altman (IEEE BIBM conference keynote lecturer on combining simulation and machine learning to recognize function in 4D), Dr. Mary Qu Yang (IEEE BIBM workshop keynote lecturer on new initiatives of detecting microscopic disease using machine learning and molecular biology, http://ieeexplore.ieee.org/servlet/opac?punumber=4425386) and Dr. Jack Y. Yang (IEEE BIBM workshop keynote lecturer on data mining and knowledge discovery in translational medicine) from the first IEEE Computer Society BioInformatics and BioMedicine (IEEE BIBM) international conference and workshops, November 2-4, 2007, Silicon Valley, California, USA.
2008-01-01
Supported by National Science Foundation (NSF), International Society of Intelligent Biological Medicine (ISIBM), International Journal of Computational Biology and Drug Design and International Journal of Functional Informatics and Personalized Medicine, IEEE 7th Bioinformatics and Bioengineering attracted more than 600 papers and 500 researchers and medical doctors. It was the only synergistic inter/multidisciplinary IEEE conference with 24 Keynote Lectures, 7 Tutorials, 5 Cutting-Edge Research Workshops and 32 Scientific Sessions including 11 Special Research Interest Sessions that were designed dynamically at Harvard in response to the current research trends and advances. The committee was very grateful for the IEEE Plenary Keynote Lectures given by: Dr. A. Keith Dunker (Indiana), Dr. Jun Liu (Harvard), Dr. Brian Athey (Michigan), Dr. Mark Borodovsky (Georgia Tech and President of ISIBM), Dr. Hamid Arabnia (Georgia and Vice-President of ISIBM), Dr. Ruzena Bajcsy (Berkeley and Member of United States National Academy of Engineering and Member of United States Institute of Medicine of the National Academies), Dr. Mary Yang (United States National Institutes of Health and Oak Ridge, DOE), Dr. Chih-Ming Ho (UCLA and Member of United States National Academy of Engineering and Academician of Academia Sinica), Dr. Andy Baxevanis (United States National Institutes of Health), Dr. Arif Ghafoor (Purdue), Dr. John Quackenbush (Harvard), Dr. Eric Jakobsson (UIUC), Dr. Vladimir Uversky (Indiana), Dr. Laura Elnitski (United States National Institutes of Health) and other world-class scientific leaders. The Harvard meeting was a large academic event 100% full-sponsored by IEEE financially and academically. After a rigorous peer-review process, the committee selected 27 high-quality research papers from 600 submissions. The committee is grateful for contributions from keynote speakers Dr. Russ Altman (IEEE BIBM conference keynote lecturer on combining simulation and machine learning to recognize function in 4D), Dr. Mary Qu Yang (IEEE BIBM workshop keynote lecturer on new initiatives of detecting microscopic disease using machine learning and molecular biology, http://ieeexplore.ieee.org/servlet/opac?punumber=4425386) and Dr. Jack Y. Yang (IEEE BIBM workshop keynote lecturer on data mining and knowledge discovery in translational medicine) from the first IEEE Computer Society BioInformatics and BioMedicine (IEEE BIBM) international conference and workshops, November 2-4, 2007, Silicon Valley, California, USA. PMID:18831773
Understanding anthocyanin: Researcher and educator Dr. Ron Wrolstad
USDA-ARS?s Scientific Manuscript database
This invited presentation is in honor of Dr. Ronald E. Wrolstad (Distinguished Professor Emeritus), recipient of the 2017 ACS AGFD Advancement of the Application of Agricultural and Food Chemistry Award. The talk will be a brief overview of Dr. Ronald E. Wrolstad’s research program and career; Dr. W...
Dr. Reginald Tucker-Seeley joined the faculty at the University of Southern California (USC) Leonard Davis School of Gerontology in June 2017. Prior to joining USC, Dr. Tucker-Seeley was an Assistant Professor at the Dana-Farber Cancer Institute (DFCI) and the Harvard T.H. Chan School of Public Health (HSPH). He completed master and doctoral degrees at HSPH and a postdoctoral fellowship in cancer prevention and control at HSPH and DFCI. Dr. Tucker-Seeley’s research focuses primarily on social determinants of health, such as the association between the neighborhood environment and health behavior; and on individual-level socioeconomic determinants of multi-morbidity, mortality, self-rated health, and health self-efficacy. His current work focuses on financial well-being across the cancer continuum, from prevention to end-of-life care. He has received R21 and K01 grants from the National Cancer Institute (NCI) to develop measures of financial well-being at two points along the cancer continuum: prevention and following diagnosis. He was also funded by the Academy Health/Aetna Foundation Scholars in Residence Fellowship Program to develop measures of neighborhood economic well-being. Dr. Tucker-Seeley’s research has been published in journals such as the American Journal of Public Health, Preventive Medicine, Journal of National Cancer Institute, Cancer Causes and Control, and the American Journal of Preventive Medicine. Dr. Tucker-Seeley is also committed to community service that targets the elimination of health disparities. He served for three years on the Rhode Island Commission for Health Advocacy and Equity. Based on his experience on this Commission, Dr. Tucker-Seeley developed a new course at HSPH called “Measuring and Reporting Health Disparities;” and in 2016, he received the HSPH teaching award for this course.
Dr. Prasun Desai Visit with UB
2017-07-18
Prasun Desai, deputy associate administrator for Management in NASA's Space Technology Mission Directorate, speaks to Exploration Research and Technology managers in the Space Station Processing Facility at the Kennedy Space Center in Florida.
Index of Oral Histories Relating to Naval Research and Development
1985-01-01
Repositories: NWC, DTNSRDC, NHC Individuals mentioned: Amlie, Dr. Thomas S. LaBerge , Dr. Walter McLean, Dr. William B. Parsons, RADM William S. Smith...future of R&D in the Navy. Repositories: NWC, DTNSRDC, NHC Individuals mentioned: Bennett, Dr. Ira Hollingsworth, Dr. Guilford L. LaBerge , Dr. Walter...DTNSRDC, NHC Individuals mentioned: Hunter, Dr. Hugh LaBerge . Dr. Walter McLean, Dr. William B. Brode, Dr. Wallace C. Sage, Dr. Bruce Wilson, Dr. Haskell
Seismology in South America; an interview with Alberto Giesecke
Spall, H.
1980-01-01
Dr. Alberto A. Giesecke is head of the Instituto Geofisico del Peru, in Lima, Peru, and Director of Centro Regional de Sismologia para America del Sur (CERESIS). The center is dedicated to the coordination and promotion of earthquake hazard mitigation. Dr. Giesecke was President of the National Research Council of Peru and currently is a member of the Board of Directors of the National Institute for Industrial Technological Research and Standards and of the National Institute for Research and Training in Telecommunications. He presided over the Organizing Committee for the General Assemblies of the International Association for Seismology and Physics of the Earth's interor and the International Union for Radio Science held in Lima, Peru, in 1973 and 1975, respectively.
United States comparative costs and absenteeism of diabetic ophthalmic conditions.
Brook, Richard A; Kleinman, Nathan L; Patel, Sunil; Smeeding, Jim E; Beren, Ian A; Turpcu, Adam
2015-06-01
This retrospective cohort study examined the impact of diabetic macular edema (DME), diabetic retinopathy (DR), or diabetes on annual health benefit costs and absenteeism in US employees. Claims data from 2001 to 2012 was extracted from the Human Capital Management Services Group Research Reference Database on annual direct/indirect health benefit costs and absences for employees aged ≥ 18 years. Employees with DME, DR, or diabetes were identified by International Classification of Diseases, Ninth Revision, Clinical Modification codes. Employees were divided into two groups, drivers or nondrivers, and examined in separate analyses. For drivers and nondrivers, the DME, DR, and diabetes cohorts were compared with their respective control groups (without diabetes). Two-part regression models controlled for demographics and job-related characteristics. A total of 39,702 driver and 426,549 nondriver employees were identified as having ≥ 1 year's continuous health plan enrollment. Direct medical costs for drivers with DME, DR, or diabetes were $6470, $8021, and $5102, respectively (>2.8 times higher and statistically significant compared with driver controls). Nondrivers with DME and DR incurred significantly higher sick leave and short-term disability costs compared with the nondrivers with diabetes and nondriver controls. In drivers with DME, the majority of days of absence were for short- and long-term disability (12.41 and 11.43 days, respectively). In drivers with DR, the majority of days of absence were for short-term disability (10.70 days). In nondrivers with DME and nondrivers with DR, the majority of days of absence were for sick leave (5.74 and 4.93 days, respectively) and short-term disability (5.08 and 4.93 days, respectively). DME and DR are associated with substantial direct medical cost and absenteeism in this real-world sample of medically insured employees. This research highlights the negative impact of DME and DR on annual costs and absenteeism and may assist employers in assessing the impact of these conditions on employees.
U.S. Army Medical Research Institute of Infectious Diseases Annual Report, Fiscal Year 1986
1986-10-01
determined. SUMMARY Strains of mice sensitive (A/J) and resistant (C3H/HeN) to C. burnetii were given varying doses of the phase 1, 9 Mile isolate...ASSOCIATE INVESTIGATORS: J. W. Ezzell , Ph.D. B. E. Ivins, Ph.D. As previously reported by Dr. Ezzell , a 93-kd extractable protein (EAI) is the principal...challenge. The following work has been carried out by Dr. Bruce Ivins in cooperation with Susan Welkos, Steve Little, John Ezzell , and Greg Knudson of
Estelle Brodman: Educator Extraordinaire
Lorenzi, Nancy M.
2008-01-01
Objective: The purpose of this article is to describe the educational contributions of Estelle Brodman PhD, to medical librarianship. Methods: The article is based on a comprehensive search of Dr. Brodman's articles, a review of her two Medical Library Association oral history interviews, and personal recollections. Findings: This article documents the educational contributions of Dr. Brodman, a librarian, researcher, and educator who had a significant and lasting impact on the education of medical librarians through more than fifty years of concentrated effort. PMID:18654645
United States Air Force Research Initiation Program. 1985 Technical Report. Volume 3.
1987-04-01
miners exposed to airborne radon (7). Thus the major health effect associated with radon is thought to be production of lung cancers by radon decay...Based Instruction: Effect Dr. Linda J. Buehner of Cognitive Style, Instructional Format, and Subject-Matter Content 160-OMG-085 9 Nonlinear Feedback...Instrumentation 760-OMG-042 16 Investigation of the Effects of Dr. David R. Cochran an Applied Electric Field on the InP Melt 760-OMG-014 17 Below-Melt
DOE Office of Scientific and Technical Information (OSTI.GOV)
Fisher-Hoch, Susan
Dr. Susan Fisher-Hoch, Virologist and Epidemiologist, will discuss her research and travels associated with viral hemorrhagic fevers. From the Ebola outbreak in Reston, Virginia to outbreaks of Crimean Congo Hemorrhagic Fever in South Africa, Senegal, and Saudi Arabia, Dr. Fisher-Hoch has studied and tracked the pathophysiology of these viral diseases. These studies have led her from the Center for Disease Control in the United States, to Lyon, France where she was instrumental in designing, constructing, and rendering operational a laboratory capable of containing some of the world's most dangerous diseases.
Meet EPA Scientist Betsy Smith, Ph.D.
Dr. Betsy Smith is Associate National Program Director for Systems Analysis within the Sustainable and Healthy Communities Research Program. Her work has focused on new methods to analyze spatial data on multiple problems.
2003-05-07
KENNEDY SPACE CENTER, FLA. - From left, Valerie Cassanto, Instrumentation Technology Associates, Inc., and Dr. Dennis Morrison, NASA Johnson Space Center, analyze one of the experiments carried on mission STS-107. Several experiments were found during the search for Columbia debris. Included in the Commercial ITA Biomedical Experiments payload on mission STS-107 are urokinase cancer research, microencapsulation of drugs, the Growth of Bacterial Biofilm on Surfaces during Spaceflight (GOBBSS), and tin crystal formation.
Edlich, Richard F
2005-01-01
Dr. Owen Wangensteen reminded Dr. Edlich that the chief responsibility of a teacher is to create an atmosphere friendly to learning. Dr Wangensteen indicated that the role of professor has been defined as that of teacher, clinician, and investigator. He then indicated that two more responsibilities must be added: (1) sideline cheerleader and (2) regimental water carrier. Above all those enumerated functions, he believed that the most important concern of a professor is to create an atmosphere friendly to learning. He/she must have the willingness to recognize every type of talent and ability and to encourage men/women of promise. He must be the professor of the open door, easily accessible to students, residents, and associates. The major goal of Dr. Edlich's comments, as he receives the Distinguished Medical Alumni Award from The Minneapolis Medical Alumni Association (Minneapolis, Minnesota, USA) is to acknowledge his distinguished colleagues and friends who have served as his teachers during his academic career. They include the following individuals: Theodore J. Edlich, III, President of Total Action Against Poverty; Elizabeth C. Edlic, Cofounder/Chairman and Chief Executive Officer of OneWorldLive; Richard F. Edlich, Jr., President of Edlich Realty; Rachel C. Edlich, Executive Vice President and Cofounder of OneWorldLive; William B. Long, III, MD, President and Medical Director of Trauma Specialists LLP; William P. Magee, MD, Cofounder and Director of Operation Smile; John Barrow, President of Coolibar Incorporated; Mary M. Barrow, Cofounder of Coolibar Incorporated; Kathryne L. Winters, Website Manager and Senior Research Assistant; Lise Borel, DDS, Independent Pharmaceutical/Biotechnical Consultant; Mary Jude Cox, MD, Board Certified Glaucoma Specialist, Teaching Staff at Wills Eye Hospital Glaucoma Service; John Wish, PhD, Member of the Board of The Association of Air Medical Services, Director of the Research Committee; and Dr. Andrew J. Gear, Plastic Surgical Resident, University of Minnesota Medical School.
Traveset, Alicia; Rubinat, Esther; Ortega, Emilio; Alcubierre, Nuria; Vazquez, Beatriz; Hernández, Marta; Jurjo, Carmen; Espinet, Ramon; Ezpeleta, Juan Antonio; Mauricio, Didac
2016-01-01
Aims. To assess the association of blood oxygen-transport capacity variables with the prevalence of diabetic retinopathy (DR), retinal ischemia, and macular oedema in patients with type 2 diabetes mellitus (T2DM). Methods. Cross-sectional, case-control study (N = 312) with T2DM: 153 individuals with DR and 159 individuals with no DR. Participants were classified according to the severity of DR and the presence of retinal ischemia or macular oedema. Hematological variables were collected by standardized methods. Three logistic models were adjusted to ascertain the association between hematologic variables with the severity of DR and the presence of retinal ischemia or macular oedema. Results. Individuals with severe DR showed significantly lower hemoglobin, hematocrit, and erythrocyte levels compared with those with mild disease and in individuals with retinal ischemia and macular oedema compared with those without these disorders. Hemoglobin was the only factor that showed a significant inverse association with the severity of DR [beta-coefficient = −0.52, P value = 0.003] and retinal ischemia [beta-coefficient = −0.49, P value = 0.001]. Lower erythrocyte level showed a marginally significant association with macular oedema [beta-coefficient = −0.86, P value = 0.055]. Conclusions. In patients with DR, low blood oxygen-transport capacity was associated with more severe DR and the presence of retinal ischemia. Low hemoglobin levels may have a key role in the development and progression of DR. PMID:27200379
Traveset, Alicia; Rubinat, Esther; Ortega, Emilio; Alcubierre, Nuria; Vazquez, Beatriz; Hernández, Marta; Jurjo, Carmen; Espinet, Ramon; Ezpeleta, Juan Antonio; Mauricio, Didac
2016-01-01
Aims. To assess the association of blood oxygen-transport capacity variables with the prevalence of diabetic retinopathy (DR), retinal ischemia, and macular oedema in patients with type 2 diabetes mellitus (T2DM). Methods. Cross-sectional, case-control study (N = 312) with T2DM: 153 individuals with DR and 159 individuals with no DR. Participants were classified according to the severity of DR and the presence of retinal ischemia or macular oedema. Hematological variables were collected by standardized methods. Three logistic models were adjusted to ascertain the association between hematologic variables with the severity of DR and the presence of retinal ischemia or macular oedema. Results. Individuals with severe DR showed significantly lower hemoglobin, hematocrit, and erythrocyte levels compared with those with mild disease and in individuals with retinal ischemia and macular oedema compared with those without these disorders. Hemoglobin was the only factor that showed a significant inverse association with the severity of DR [beta-coefficient = -0.52, P value = 0.003] and retinal ischemia [beta-coefficient = -0.49, P value = 0.001]. Lower erythrocyte level showed a marginally significant association with macular oedema [beta-coefficient = -0.86, P value = 0.055]. Conclusions. In patients with DR, low blood oxygen-transport capacity was associated with more severe DR and the presence of retinal ischemia. Low hemoglobin levels may have a key role in the development and progression of DR.
Global Prevalence and Major Risk Factors of Diabetic Retinopathy
Yau, Joanne W.Y.; Rogers, Sophie L.; Kawasaki, Ryo; Lamoureux, Ecosse L.; Kowalski, Jonathan W.; Bek, Toke; Chen, Shih-Jen; Dekker, Jacqueline M.; Fletcher, Astrid; Grauslund, Jakob; Haffner, Steven; Hamman, Richard F.; Ikram, M. Kamran; Kayama, Takamasa; Klein, Barbara E.K.; Klein, Ronald; Krishnaiah, Sannapaneni; Mayurasakorn, Korapat; O’Hare, Joseph P.; Orchard, Trevor J.; Porta, Massimo; Rema, Mohan; Roy, Monique S.; Sharma, Tarun; Shaw, Jonathan; Taylor, Hugh; Tielsch, James M.; Varma, Rohit; Wang, Jie Jin; Wang, Ningli; West, Sheila; Xu, Liang; Yasuda, Miho; Zhang, Xinzhi; Mitchell, Paul; Wong, Tien Y.
2012-01-01
OBJECTIVE To examine the global prevalence and major risk factors for diabetic retinopathy (DR) and vision-threatening diabetic retinopathy (VTDR) among people with diabetes. RESEARCH DESIGN AND METHODS A pooled analysis using individual participant data from population-based studies around the world was performed. A systematic literature review was conducted to identify all population-based studies in general populations or individuals with diabetes who had ascertained DR from retinal photographs. Studies provided data for DR end points, including any DR, proliferative DR, diabetic macular edema, and VTDR, and also major systemic risk factors. Pooled prevalence estimates were directly age-standardized to the 2010 World Diabetes Population aged 20–79 years. RESULTS A total of 35 studies (1980–2008) provided data from 22,896 individuals with diabetes. The overall prevalence was 34.6% (95% CI 34.5–34.8) for any DR, 6.96% (6.87–7.04) for proliferative DR, 6.81% (6.74–6.89) for diabetic macular edema, and 10.2% (10.1–10.3) for VTDR. All DR prevalence end points increased with diabetes duration, hemoglobin A1c, and blood pressure levels and were higher in people with type 1 compared with type 2 diabetes. CONCLUSIONS There are approximately 93 million people with DR, 17 million with proliferative DR, 21 million with diabetic macular edema, and 28 million with VTDR worldwide. Longer diabetes duration and poorer glycemic and blood pressure control are strongly associated with DR. These data highlight the substantial worldwide public health burden of DR and the importance of modifiable risk factors in its occurrence. This study is limited by data pooled from studies at different time points, with different methodologies and population characteristics. PMID:22301125
Cancer Prevention in the Precision Medicine Era
Dr. Rebbeck’s research focuses on the etiology and prevention of cancer, with an emphasis on cancers with a genetic etiology and those that are associated with disparities in incidence or mortality by race. He has directed multiple large molecular epidemiologic studies and international consortia that have been used to identify and characterize genes involved in cancer etiology, understand the relationship of allelic variation with biochemical or physiological traits, explore interactions of inherited and somatic genomic variation with epidemiological risk factors. His research also focuses on the roles of biological and social factors on prostate cancer disparities and prostate cancer in Africa through the Men of African Descent and Carcinoma of the Prostate (MADCaP) consortium. He has also led a number of consortia that study carriers of BRCA1 or BRCA2 mutations to understand breast, ovarian, and prostate cancer risk and precision prevention interventions that may reduce that risk. In addition to his research activities, Dr. Rebbeck leads a number of initiatives on the Harvard Campus. He serves as Associate Director for Equity and Engagement in the Dana-Farber / Harvard Cancer Center and Co-Director for the Collective Impact Program of Harvard Catalyst. In this role, he prioritizes the cancer research agenda to maximize disease prevention and risk reduction in Massachusetts. He also oversees a team charged with ensuring that this research engages with and positively impacts communities with the greatest disease burden. As Director of Global Oncology at the Dana Farber Cancer Institute, Dr. Rebbeck oversees formal and informal training and research partnerships between Dana Farber investigators and trainees with international partners.
Yang, Jack Y; Niemierko, Andrzej; Bajcsy, Ruzena; Xu, Dong; Athey, Brian D; Zhang, Aidong; Ersoy, Okan K; Li, Guo-Zheng; Borodovsky, Mark; Zhang, Joe C; Arabnia, Hamid R; Deng, Youping; Dunker, A Keith; Liu, Yunlong; Ghafoor, Arif
2010-12-01
Significant interest exists in establishing synergistic research in bioinformatics, systems biology and intelligent computing. Supported by the United States National Science Foundation (NSF), International Society of Intelligent Biological Medicine (http://www.ISIBM.org), International Journal of Computational Biology and Drug Design (IJCBDD) and International Journal of Functional Informatics and Personalized Medicine, the ISIBM International Joint Conferences on Bioinformatics, Systems Biology and Intelligent Computing (ISIBM IJCBS 2009) attracted more than 300 papers and 400 researchers and medical doctors world-wide. It was the only inter/multidisciplinary conference aimed to promote synergistic research and education in bioinformatics, systems biology and intelligent computing. The conference committee was very grateful for the valuable advice and suggestions from honorary chairs, steering committee members and scientific leaders including Dr. Michael S. Waterman (USC, Member of United States National Academy of Sciences), Dr. Chih-Ming Ho (UCLA, Member of United States National Academy of Engineering and Academician of Academia Sinica), Dr. Wing H. Wong (Stanford, Member of United States National Academy of Sciences), Dr. Ruzena Bajcsy (UC Berkeley, Member of United States National Academy of Engineering and Member of United States Institute of Medicine of the National Academies), Dr. Mary Qu Yang (United States National Institutes of Health and Oak Ridge, DOE), Dr. Andrzej Niemierko (Harvard), Dr. A. Keith Dunker (Indiana), Dr. Brian D. Athey (Michigan), Dr. Weida Tong (FDA, United States Department of Health and Human Services), Dr. Cathy H. Wu (Georgetown), Dr. Dong Xu (Missouri), Drs. Arif Ghafoor and Okan K Ersoy (Purdue), Dr. Mark Borodovsky (Georgia Tech, President of ISIBM), Dr. Hamid R. Arabnia (UGA, Vice-President of ISIBM), and other scientific leaders. The committee presented the 2009 ISIBM Outstanding Achievement Awards to Dr. Joydeep Ghosh (UT Austin), Dr. Aidong Zhang (Buffalo) and Dr. Zhi-Hua Zhou (Nanjing) for their significant contributions to the field of intelligent biological medicine.
2010-01-01
Significant interest exists in establishing synergistic research in bioinformatics, systems biology and intelligent computing. Supported by the United States National Science Foundation (NSF), International Society of Intelligent Biological Medicine (http://www.ISIBM.org), International Journal of Computational Biology and Drug Design (IJCBDD) and International Journal of Functional Informatics and Personalized Medicine, the ISIBM International Joint Conferences on Bioinformatics, Systems Biology and Intelligent Computing (ISIBM IJCBS 2009) attracted more than 300 papers and 400 researchers and medical doctors world-wide. It was the only inter/multidisciplinary conference aimed to promote synergistic research and education in bioinformatics, systems biology and intelligent computing. The conference committee was very grateful for the valuable advice and suggestions from honorary chairs, steering committee members and scientific leaders including Dr. Michael S. Waterman (USC, Member of United States National Academy of Sciences), Dr. Chih-Ming Ho (UCLA, Member of United States National Academy of Engineering and Academician of Academia Sinica), Dr. Wing H. Wong (Stanford, Member of United States National Academy of Sciences), Dr. Ruzena Bajcsy (UC Berkeley, Member of United States National Academy of Engineering and Member of United States Institute of Medicine of the National Academies), Dr. Mary Qu Yang (United States National Institutes of Health and Oak Ridge, DOE), Dr. Andrzej Niemierko (Harvard), Dr. A. Keith Dunker (Indiana), Dr. Brian D. Athey (Michigan), Dr. Weida Tong (FDA, United States Department of Health and Human Services), Dr. Cathy H. Wu (Georgetown), Dr. Dong Xu (Missouri), Drs. Arif Ghafoor and Okan K Ersoy (Purdue), Dr. Mark Borodovsky (Georgia Tech, President of ISIBM), Dr. Hamid R. Arabnia (UGA, Vice-President of ISIBM), and other scientific leaders. The committee presented the 2009 ISIBM Outstanding Achievement Awards to Dr. Joydeep Ghosh (UT Austin), Dr. Aidong Zhang (Buffalo) and Dr. Zhi-Hua Zhou (Nanjing) for their significant contributions to the field of intelligent biological medicine. PMID:21143775
2013-05-01
Dr. Charles Zeanah is the Mary K. Sellars-Polchow Chair in Psychiatry, Professor of Clinical Pediatrics and Vice Chair for Child and Adolescent Psychiatry in the Department of Psychiatry and Behavioral Sciences at Tulane University School of Medicine in New Orleans. He is also Executive Director of the Institute for Infant and Early Childhood Mental Health at Tulane. He is the recipient of multiple awards including the Irving Phillips Award for Prevention, (AACAP), the Presidential Citation for Distinguished Research and Leadership in Infant Mental Health (American Orthopsychiatric Association), the Sarah Haley Memorial Award for Clinical Excellence (International Society for Traumatic Stress Studies), the Blanche F. Ittelson Award for Research in Child Psychiatry (APA), and the Serge Lebovici Award for International Contributions in Infant Mental Health (World Association for Infant Mental Health). Dr. Zeanah is a Distinguished Fellow of AACAP, a Distinguished Fellow of the APA and a Board Member of Zero to Three. He is the Editor of Handbook of Infant Mental Health (3(rd) edition) considered as the state of the art textbook and standard reference in the field of Infant Mental Health.
Neto, Leonardo Vieira; Machado, Evelyn de O.; Luque, Raul M.; Taboada, Giselle F.; Marcondes, Jorge B.; Chimelli, Leila M. C.; Quintella, Leonardo Pereira; Niemeyer, Paulo; de Carvalho, Denise P.; Kineman, Rhonda D.; Gadelha, Mônica R.
2009-01-01
Context: Dopamine receptor (DR) and somatostatin receptor subtype expression in pituitary adenomas may predict the response to postsurgical therapies. Objectives: Our objectives were to assess and compare the mRNA levels of DR1-5 and somatostatin receptors 1–5 in normal pituitaries (NPs), nonfunctioning pituitary adenomas (NFPAs), and somatotropinomas. In addition, we determined whether the level of DR expression correlates with the in vivo response to octreotide-LAR in acromegalic patients. Design and Patients: Eight NPs, 30 NFPAs, and 39 somatotropinomas were analyzed for receptor mRNA levels by real-time RT-PCR. The DR2 short variant was estimated as the DR2 long/DR2 total (DR2T). The relationship between DR expression and the postsurgical response to octreotide-LAR was assessed in 19 of the acromegalic patients. Results: DR3 was not detected. The relationship between expression levels of DR subtypes in NPs and somatotropinomas was DR2T⋙DR4≫DR5>DR1, whereas in NFPAs, DR2T⋙DR4≫DR1>DR5. The DR2 short variant was the predominant DR2 variant in the majority of samples. In acromegalics treated with octreotide-LAR, DR1 was negatively correlated with percent GH reduction (3 months: r = −0.67, P = 0.002; and 6 months: r = −0.58, P = 0.009), and DR5 was positively correlated with percent IGF-I reduction (3 months: r = 0.55, P = 0.01; and 6 months: r = 0.47, P = 0.04). Conclusions: DR2 is the predominant DR subtype in NPs, NFPAs, and somatotropinomas. The fact that DR1, DR4, and DR5 are also expressed in many adenomas tested suggests that these receptors might also play a role in the therapeutic impact of postsurgical medical therapies in patients with NFPA and acromegaly. This was supported by the finding that the in vivo response to octreotide-LAR was negatively associated with DR1 and positively associated with DR5. PMID:19293270
2003-08-20
KENNEDY SPACE CENTER, FLA. - Dryden Flight Research Center Director Kevin Peterson talks about One NASA during the rollout of the Agency initiative at KSC. The event was held at the IMAX Theater® where NASA leaders discussed One NASA with selected employees. Explaining how their respective centers contribute to One NASA, along with Peterson, were KSC Director Jim Kennedy, James Jennings, NASA’s associate deputy administrator for institutions and asset management; Ed Weiler, associate administrator for Space Science; Kevin Peterson, Dryden Flight Research Center director; incoming KSC Deputy Director Woodrow Whitlow; and implementation team lead Johnny Stevenson. Glenn Research Center Director Dr. Julian Earls gave a motivational speech during the luncheon held at the Visitor Complex Debus Conference Center.
Dr. Irene Sänger-Bredt, a life for astronautics
NASA Astrophysics Data System (ADS)
Zaganescu, Nicolae-Florin
2004-12-01
Irene Bredt (b.1911 at Bonn) obtained her Doctorate in Physics in 1937; in the same year she became a scientific researcher at the German Research Center for Aviation at Trauen, led by Prof. Dr. Eugen Sänger. Soon, the young but efficient Dr. Irene Bredt became the first assistant of Dr. Sänger, who married her (1951). During 1973-1978, Dr. Bredt was in correspondence with Prof. Dr. Nikolae-Florin Zaganescu and helped him to familiarize the Romanian readers with Prof. Sänger's life and achievements. As for Dr. Bredt's life, she specified three main periods of her activity: 1937-1942, when she was researcher in charge of thermodynamic problems of liquid-fuelled rocket engines at Trauen 1942-1945, when she was Senior Researcher in charge of Ramjet in flight performances at Ainring, and also coauthored the Top Secret Technical report entitled 'A Rocket Engine for a Long-Range Bomber', which was finished in 1941 but edited only in 1944 the post world war II period, when she was Scientific Advisor or Director at various civil and military research institutes, universities, etc. Dr. Irene Sänger-Bredt helped her husband to develop many scientific theories like Ramjet thermodynamic theory, and photon rocket theory and also in establishing IAF and IAA. In 1970, Dr. Irene Sänger-Bredt was honored with 'Hermann Oberth Gold Medal' for her impressive scientific activity.
Harry Minti- a project for a book
NASA Astrophysics Data System (ADS)
Gaina, Alex
2011-08-01
A short biography and an account of scientific research of the Associated Professor of the Hebrew University in Jerusalem (Israel), Dr. Harry Minti (b. 1938, Bucharest) is given. His activity as translator was also mentioned.
Animal Models of Diabetic Retinopathy: Summary and Comparison
Lo, Amy C. Y.
2013-01-01
Diabetic retinopathy (DR) is a microvascular complication associated with chronic exposure to hyperglycemia and is a major cause of blindness worldwide. Although clinical assessment and retinal autopsy of diabetic patients provide information on the features and progression of DR, its underlying pathophysiological mechanism cannot be deduced. In order to have a better understanding of the development of DR at the molecular and cellular levels, a variety of animal models have been developed. They include pharmacological induction of hyperglycemia and spontaneous diabetic rodents as well as models of angiogenesis without diabetes (to compensate for the absence of proliferative DR symptoms). In this review, we summarize the existing protocols to induce diabetes using STZ. We also describe and compare the pathological presentations, in both morphological and functional aspects, of the currently available DR animal models. The advantages and disadvantages of using different animals, ranging from zebrafish, rodents to other higher-order mammals, are also discussed. Until now, there is no single model that displays all the clinical features of DR as seen in human. Yet, with the understanding of the pathological findings in these animal models, researchers can select the most suitable models for mechanistic studies or drug screening. PMID:24286086
Nanoscience and Technology at the Air Force Research Laboratory (AFRL)
2005-05-01
AIR FORCE RESEARCH LABORATORY ( AFRL ) Dr. Richard A. Vaia Dr. Daniel Miracle Dr. Thomas Cruse Air Force Research ...Technology At The Air Force Research Laboratory ( AFRL ) 5a. CONTRACT NUMBER 5b. GRANT NUMBER 5c. PROGRAM ELEMENT NUMBER 6. AUTHOR(S) 5d. PROJECT...98) Prescribed by ANSI Std Z39-18 AFRL NST Overview 2 AIR FORCE RESEARCH LABORATORY VISION We defend
Nanoscience and Technology at the Air Force Research Laboratory (AFRL)
2005-02-01
AIR FORCE RESEARCH LABORATORY ( AFRL ) Dr. Richard A. Vaia Dr. Daniel Miracle Dr. Thomas Cruse Air Force Research ...Technology At The Air Force Research Laboratory ( AFRL ) 5a. CONTRACT NUMBER 5b. GRANT NUMBER 5c. PROGRAM ELEMENT NUMBER 6. AUTHOR(S) 5d. PROJECT...98) Prescribed by ANSI Std Z39-18 AFRL NST Overview 2 AIR FORCE RESEARCH LABORATORY VISION We defend
2015-06-18
nanorods, while the second demonstrated long and skinny nanorods. This is demosntrated in Figure 20. The University of Dayton research group asked Dr...here and in other research carried out with this methodology. 5.4 Simulations 5.4.1 Experimental results. All of the simulations carried out in this...samples that Dr. Sarangan and Dr. Shah of the University of Dayton presented to Dr. Marciniak’s research group . The samples consisted of silver tilted
Dietary intake and diabetic retinopathy: A systematic review
Wong, Mark Y. Z.; Man, Ryan E. K.; Fenwick, Eva K.; Gupta, Preeti; Li, Ling-Jun; van Dam, Rob M.; Chong, Mary F.
2018-01-01
Introduction The evidence linking dietary intake with diabetic retinopathy (DR) is growing but unclear. We conducted a systematic review of the association between dietary intake and DR. Methods We systematically searched PubMed, Embase, Medline, and the Cochrane Central register of controlled trials, for publications between January 1967 and January 2017 using standardized criteria for diet and DR. Interventional and observational studies investigating micro- and macro-nutrient intakes; food and beverage consumptions; and dietary patterns were included. Study quality was evaluated using a modified Newcastle-Ottawa scale for observational studies, and the Cochrane collaboration tool for interventional studies. Results Of 4265 titles initially identified, 31 studies (3 interventional, 28 Observational) were retained. Higher intakes of dietary fibre, oily fish, and greater adherence to a Mediterranean diet were protective of DR. Conversely, high total caloric intake was associated with higher risk of DR. No significant associations of carbohydrate, vitamin D, and sodium intake with DR were found. Associations of antioxidants, fatty acids, proteins and alcohol with DR remain equivocal. Conclusions Dietary fibre, oily fish, a Mediterranean diet and a reduced caloric intake are associated with lower risk of DR. Longitudinal data and interventional models are warranted to confirm our findings and better inform clinical guidelines. PMID:29324740
Special issue dedicated in memory of Dr. Edward H. Ahrens, Jr.
Ahrens, Edward H
2002-01-01
This special issue of the "Cardiovascular Drug Reviews" is dedicated in memory of Dr. Edward H. Ahrens, Jr., who died on Dec. 9th, 2000 at the Princeton Medical Center in New Jersey at the age of 85. Dr. Ahrens was the Director of the Lipid Metabolism Laboratory at the Rockefeller University. Dr. Alexander Scriabine conceived the idea for the issue at the special memorial symposium held at the Rockefeller University on Feb. 05, 2002 under the auspices of The New York Lipid and Vascular Biology Research Club. Dr. Ahrens was the first president of the club. He started this club with Drs. Howard Eder and DeWitt Goodman. Dr. Eder thought that it would be a fitting attribute to honor one of the founding fathers of the club by hosting a memorial symposium. I, as the President of the club for that academic year, had no hesitation in accepting the proposal. This year will be the 40th anniversary of the club and its continued success provides a glimpse of the fine legacy left behind by Dr. Ahrens. Dr. Ahrens also played a pivotal role in the establishment of the Journal of Lipid Research. This is the 43rd year of the journal and in this commemorative issue we are reproducing a review he wrote for the 25th anniversary of the journal. I was never personally acquainted with Dr. Ahrens. However, I am honored that I got this opportunity to pay tribute to a great scientist whose work has contributed immensely to the progress of lipid research. He was a person who touched many lives and still continues to do so. My involvement in the remembrance of Dr. Ahrens shows that science not only impacts your contemporaries but also generations that follow you. Scientific research is a journey where you can leave your trails behind and be remembered for your work long after your departure from this world. Dr. Ahrens contributed immensely to the understanding of cholesterol metabolism. In the early stages of his career he showed that phospholipids solubilize fat in the blood. Now we know that a monolayer of phospholipids surrounds the neutral lipid core of cholesterol esters and triglycerides in lipoproteins. This monolayer contains proteins, called apolipoproteins, which play a major role in lipoprotein catabolism. Lipoproteins are the major vehicles that transport triglycerides and cholesterol in the plasma. He also described a new form of primary biliary cirrhosis characterized by the presence of xanthomas and hyperlipidemia with normal translucent plasma. Subsequently, his group at the Rockefeller Institute developed methods for the separation of lipids using silicic acid columns, isolated highly unsaturated long chain fish oil fatty acids using gas-liquid chromatography, standardized techniques to study sterol metabolism, and introduced the concept of using beta-sitosterolemia as an internal marker for cholesterol balance studies. These studies revealed that individuals show a reproducible response to a given regimen when studied over time. In contrast, different individuals may respond differently to the same regimen. Throughout his career, Dr. Ahrens championed metabolic studies in humans and has passionately argued for the continuation of such investigations. Dr. Ahrens also left behind trails of "graduates." Several of them are currently prominent scientists in their own fields. In this issue, Drs. Davignon and Samuel share their feelings for him in the form of "Remembrance" and "Curriculum Vitae." Dr. Salen has submitted a preview of his research progress towards the understanding of sitosterolemia. Dr. Hudgins and associates have acknowledged the efforts of Dr. Ahrens in binding LDL apheresis technique to the United States of America and have previewed the use of this procedure in the treatment of hypercholesterolemic patients. The contributions of these and other graduates will keep his legacy alive for a long time to come. We are truly grateful for this opportunity to pay homage to such a distinguished scientist.
2003-08-20
KENNEDY SPACE CENTER, FLA. - NASA’s Ed Weiler, associate administrator for Space Science, speaks to employees and guests during the rollout at KSC of the Agency initiative One NASA . The event was held at the IMAX Theater®. Explaining how their respective centers contribute to One NASA, along with Weiler, were KSC Director Jim Kennedy; James Jennings, NASA’s associate deputy administrator for institutions and asset management; Kevin Peterson, Dryden Flight Research Center director; incoming KSC Deputy Director Woodrow Whitlow; and implementation team lead Johnny Stevenson. Glenn Research Center Director Dr. Julian Earls gave a motivational speech during the luncheon held at the Visitor Complex Debus Conference Center.
NASA Technical Reports Server (NTRS)
Norsk, P.; Shelhamer, M.
2016-01-01
This panel will present NASA's plans for ongoing and future research to define the requirements for Artificial Gravity (AG) as a countermeasure against the negative health effects of long-duration weightlessness. AG could mitigate the gravity-sensitive effects of spaceflight across a host of physiological systems. Bringing gravity to space could mitigate the sensorimotor and neuro-vestibular disturbances induced by G-transitions upon reaching a planetary body, and the cardiovascular deconditioning and musculoskeletal weakness induced by weightlessness. Of particular interest for AG during deep-space missions is mitigation of the Visual Impairment Intracranial Pressure (VIIP) syndrome that the majority of astronauts exhibit in space to varying degrees, and which presumably is associated with weightlessness-induced fluid shift from lower to upper body segments. AG could be very effective for reversing the fluid shift and thus help prevent VIIP. The first presentation by Dr. Charles will summarize some of the ground-based and (very little) space-based research that has been conducted on AG by the various space programs. Dr. Paloski will address the use of AG during deep-space exploration-class missions and describe the different AG scenarios such as intra-vehicular, part-of-vehicle, or whole-vehicle centrifugations. Dr. Clement will discuss currently planned NASA research as well as how to coordinate future activities among NASA's international partners. Dr. Barr will describe some possible future plans for using space- and ground-based partial-G analogs to define the relationship between physiological responses and G levels between 0 and 1. Finally, Dr. Stenger will summarize how the human cardiovascular system could benefit from intermittent short-radius centrifugations during long-duration missions.
Science and Observation Recommendations for Future NASA Carbon Cycle Research
NASA Technical Reports Server (NTRS)
McClain, Charles R.; Collatz, G. J.; Kawa, S. R.; Gregg, W. W.; Gervin, J. C.; Abshire, J. B.; Andrews, A. E.; Behrenfeld, M. J.; Demaio, L. D.; Knox, R. G.
2002-01-01
Between October 2000 and June 2001, an Agency-wide planning, effort was organized by elements of NASA Goddard Space Flight Center (GSFC) to define future research and technology development activities. This planning effort was conducted at the request of the Associate Administrator of the Office of Earth Science (Code Y), Dr. Ghassem Asrar, at NASA Headquarters (HQ). The primary points of contact were Dr. Mary Cleave, Deputy Associate Administrator for Advanced Planning at NASA HQ (Headquarters) and Dr. Charles McClain of the Office of Global Carbon Studies (Code 970.2) at GSFC. During this period, GSFC hosted three workshops to define the science requirements and objectives, the observational and modeling requirements to meet the science objectives, the technology development requirements, and a cost plan for both the science program and new flight projects that will be needed for new observations beyond the present or currently planned. The plan definition process was very intensive as HQ required the final presentation package by mid-June 2001. This deadline was met and the recommendations were ultimately refined and folded into a broader program plan, which also included climate modeling, aerosol observations, and science computing technology development, for contributing to the President's Climate Change Research Initiative. This technical memorandum outlines the process and recommendations made for cross-cutting carbon cycle research as presented in June. A separate NASA document outlines the budget profiles or cost analyses conducted as part of the planning effort.
2018-01-01
As part of our interview editorial series, we bring forth a discussion with Dr. Glenn M. Hymel, the Founding Executive Editor of the International Journal of Therapeutic Massage and Bodywork. Dr. Hymel embodies the qualities set forth for the American Massage Therapy Association Dianne Polseno Lifetime Achievement Award, which he received in 2017. He has provided leadership and shown outstanding professionalism, and is a dedicated volunteer and a fervent advocate for research and education in the massage therapy profession. In this interview he discusses his massage therapy research, his interests, and his hopes for the future and the profession. PMID:29593841
Kennedy, Ann Blair
2018-03-01
As part of our interview editorial series, we bring forth a discussion with Dr. Glenn M. Hymel, the Founding Executive Editor of the International Journal of Therapeutic Massage and Bodywork . Dr. Hymel embodies the qualities set forth for the American Massage Therapy Association Dianne Polseno Lifetime Achievement Award, which he received in 2017. He has provided leadership and shown outstanding professionalism, and is a dedicated volunteer and a fervent advocate for research and education in the massage therapy profession. In this interview he discusses his massage therapy research, his interests, and his hopes for the future and the profession.
US Air Force 1989 Research Initiation Program. Volume 4.
1992-06-25
Kentucky University Specialty: Mechanical Engineering Svecialty: Analytical Chemistry 760-7MG-079 and 210-IOMG-095 Dr. Thomas Lalk Texas A&M University...Base) Dr. Peter Armendarez Mr. William Newbold (GSRP) Brescia College University of Florida Secialty: Physical Chemistry Specialty: Aerospace...Research Dr. Roger Bunting Dr. Steven Trogdon Illinois State University University of Minnesota-Duluth Specialty: Inorganic Chemistry Specialty
2008-10-20
Dr. Stephen Billings Dr. Leonard Pasion Sky Research, Inc) Laurens Beran UBC-GIF Approved for public release; distribution...Sites 5. FUNDING NUMBERS Contract # W912HQ-05-C-0018 6. AUTHOR(S) Dr. Stephen Billings, Dr. Leonard Pasion (Sky Research, Inc.) Laurens Beran...representative of the test datasets. ESTCP MM-0504: Additional Analysis of Camp Sibert Data Sky Research Inc October 2008 References [1] L.R. Pasion , N
Fenwick, Eva K; Xie, Jing; Man, Ryan Eyn Kidd; Lim, Lyndell L; Flood, Victoria M; Finger, Robert P; Wong, Tien Y; Lamoureux, Ecosse L
2015-01-01
To explore the association between alcohol consumption and the severity of diabetic retinopathy (DR). In this cross-sectional study, patients with type 2 diabetes answered questions on consumption of low and full-strength beer, white wine/champagne, red wine, fortified wines, and spirits. Never, moderate and high consumption of each alcoholic beverage, and overall alcoholic beverage consumption, were defined as <1, 1-14 and >14 standard drinks/week, respectively. DR was categorized into none; non vision-threatening DR (VTDR) and VTDR. Multivariable logistic regression determined the associations between alcohol consumption and DR. Of the 395 participants (mean age±SD [standard deviation] 65.9±10.4years; males=253), 188 (47.6%) consumed alcohol and 235 (59.5%) had any DR. Compared to no alcohol consumption, moderate alcohol consumption (overall) was significantly associated with reduced odds of any DR (OR=0.47, 95% CI [confidence interval] 0.26-0.85). Moderate consumption of white wine/champagne or fortified wine was also associated with reduced odds of any DR (OR=0.48, 95% CI 0.25-0.91, and OR=0.15, 95% CI 0.04-0.62, respectively). Similar results were observed for non-VTDR and VTDR. The amount and type of alcohol are associated with risk of DR in patients with type 2 diabetes. A longitudinal study is needed to assess the protective effect of alcohol consumption and DR. Copyright © 2015 Elsevier Inc. All rights reserved.
Diabetic Retinopathy: Vascular and Inflammatory Disease
Semeraro, F.; Cancarini, A.; dell'Omo, R.; Rezzola, S.; Romano, M. R.; Costagliola, C.
2015-01-01
Diabetic retinopathy (DR) is the leading cause of visual impairment in the working-age population of the Western world. The pathogenesis of DR is complex and several vascular, inflammatory, and neuronal mechanisms are involved. Inflammation mediates structural and molecular alterations associated with DR. However, the molecular mechanisms underlying the inflammatory pathways associated with DR are not completely characterized. Previous studies indicate that tissue hypoxia and dysregulation of immune responses associated with diabetes mellitus can induce increased expression of numerous vitreous mediators responsible for DR development. Thus, analysis of vitreous humor obtained from diabetic patients has made it possible to identify some of the mediators (cytokines, chemokines, and other factors) responsible for DR pathogenesis. Further studies are needed to better understand the relationship between inflammation and DR. Herein the main vitreous-related factors triggering the occurrence of retinal complication in diabetes are highlighted. PMID:26137497
An Economic Analysis of the Truth in Negotiations Act
2016-01-27
SPONSORED REPORT SERIES An Economic Analysis of the Truth in Negotiations Act 27 January 2016 Dr. Chong Wang, Associate Professor Dr. Rene G. Rendon...source) to submit “cost or pricing data” when they negotiate the price of a contract with the federal government. The contractors must certify that...SERIES An Economic Analysis of the Truth in Negotiations Act 27 January 2016 Dr. Chong Wang, Associate Professor Dr. Rene G. Rendon, Associate
Misplaced Priorities and Barrett’s Esophagus
Nicholas J. Shaheen, MD, MPH is the Bozymski-Heizer Distinguished Professor of Medicine at the University of North Carolina School of Medicine, and Chief of the Division of Gastroenterology and Hepatology at UNC. His research and clinical interests center on gastroesophageal reflux disease, and pre-cancerous and cancerous conditions of the esophagus. He has a clinical and research interest in early detection and treatment of cancerous and precancerous lesions of the esophagus. He has authored greater than 300 publications in these areas. Dr. Shaheen is author of multiple national guidelines in Barrett’s esophagus, GERD and eosinophilic esophagitis. He has served as senior associate editor for the American Journal of Gastroenterology, and on multiple other editorial boards. Dr. Shaheen receives research funding from the National Institutes of Health, multiple societies, and private and public foundations.
Role of ACE and PAI-1 Polymorphisms in the Development and Progression of Diabetic Retinopathy
Saleem, Saba; Azam, Aisha; Maqsood, Sundus Ijaz; Muslim, Irfan; Bashir, Shaheena; Fazal, Nosheen; Riaz, Moeen; Ali, Syeda Hafiza Benish; Niazi, Muhammad Khizar; Ishaq, Mazhar; Waheed, Nadia Khalida; Qamar, Raheel; Azam, Maleeha
2015-01-01
In the present study we determined the association of angiotensin converting enzyme (ACE) and plasminogen activator inhibitor-1 (PAI-1) gene polymorphisms with diabetic retinopathy (DR) and its sub-clinical classes in Pakistani type 2 diabetic patients. A total of 353 diabetic subjects including 160 DR and 193 diabetic non retinopathy (DNR) as well as 198 healthy controls were genotyped by allele specific polymerase chain reaction (PCR) for ACE Insertion/Deletion (ID) polymorphism, rs4646994 in intron 16 and PAI-1 4G/5G (deletion/insertion) polymorphism, rs1799768 in promoter region of the gene. To statistically assess the genotype-phenotype association, multivariate logistic regression analysis was applied to the genotype data of DR, DNR and control individuals as well as the subtypes of DR. The ACE genotype ID was found to be significantly associated with DR (p = 0.009, odds ratio (OR) 1.870 [95% confidence interval (CI) = 1.04–3.36]) and its sub-clinical class non-proliferative DR (NPDR) (p = 0.006, OR 2.250 [95% CI = 1.098–4.620]), while PAI polymorphism did not show any association with DR in the current cohort. In conclusion in Pakistani population the ACE ID polymorphism was observed to be significantly associated with DR and NPDR, but not with the severe form of the disease i.e. proliferative DR (PDR). PMID:26658948
Extending the Shoreline of Wonder through the Research Attic of J. Terry Gates
ERIC Educational Resources Information Center
Kuebel, Christa
2017-01-01
This article is a review of the Ohio Music Education Association Graduate Research Forum presentation from February 2017 in Cleveland. Each year, an expert in the field of music education is invited to the state conference to discuss research, practice, teaching, and learning. The presenter was Dr. J. Terry Gates of "The Hoenny Center for…
ERIC Educational Resources Information Center
Hawkins, B. Denise
2005-01-01
Dr. Shiriki K. Kumanyika, an authority in culturally specific weight-control and dietary change research, is taking an activist role in designing research to reduce the rates of obesity and its associated health risks in the Black community. She has convened AACORN--the African American Collaborative Obesity Research Network, all of whose members…
Dr. Henry Rodriguez, director of the Office of Cancer Clinical Proteomics Research, has been recognized as the recipient of the Chair’s Inspirational Award by the Mass Spectrometry and Separation Sciences for Laboratory Medicine Division (MSSS), American Association for Clinical Chemistry (AACC).
Assessment of Navy Contract Management Processes
2016-02-22
Assessment of Navy Contract Management Processes 22 February 2016 Dr. Rene G. Rendon, Associate Professor Graduate School of Business ...Know) for each survey item in each contract management process area. Acquisition Research Program Graduate School of Business ...management process . Figure 1. U.S. Navy CMMM Maturity Levels Acquisition Research Program Graduate School of Business
Federal Register 2010, 2011, 2012, 2013, 2014
2013-06-26
... questions than responses from the other group of stations.\\5\\ \\5\\ In the survey research literature this... appreciative of the survey design and evaluation guidance received from MMTC's volunteer peer reviewers--Dr... McGannon Communication Research Center; and Allen Hammond, Esq., Associate Dean for Faculty Development...
Fuel Performance Evaluation for the Solid-Fueled Ramjet
1984-10-01
Aeronautics W. DYER/ 2dL JOHN Dean of Science and Engineering NOTE: The Postdoctoral Research Associate Program (National Research Council...8. AFWAL/PORT 2 Wright-Patterson AFB, OH 45433 R. D. Stull 9. JHU/APL (Group AEO) 1 Dr. F. Billig 10. NAVSEA 1 SEA 62R2 Washington, DC 20361
Groundbreaking Investigator of Creativity: An Interview with James C. Kaufman
ERIC Educational Resources Information Center
Henshon, Suzanna E.
2010-01-01
This article presents an interview with James C. Kaufman, an associate professor of psychology at the California State University at San Bernardino, where he directs the Learning Research Institute. Kaufman received his PhD in cognitive psychology from Yale University in 2001. Dr. Kaufman's research broadly focuses on nurturing and encouraging…
NASA Astrophysics Data System (ADS)
James, George S.; Winter, Frank H.
Dr. Frank J. Malina, (1912-1981) is best known to members of the International Astronautical Federation and the International Academy of Astronautics for his deep commitment to, and active involvement in, both organizations; to his associates at UNESCO for his leadership in organizing the UNESCO Division of Scientific Research; to members of the art world for his kinetic paintings and editorship of the journal Leonardo; and to aerospace historians for his co-founding, with Dr. Theodore von Karman (1881-1963), of the Jet Propulsion Laboratory with its World War II development of rocket takeoff assist units for aircraft and, after WWII, America's first production sounding rocket, the WAC Corporal. However, Frank Malina has received little recognition from aerospace educators for his equally pioneering efforts on their behalf. This paper highlights Dr. Malina's efforts not only as an early participant in educator-supported student rocketry but also in helping establishing some of the guiding principles of this field of science motivation. As Dr. Malina noted in 1968, upon becoming one of the founding members of the Supervision of Youth Research Experiments (SYRE) subcommittee of the IAF's Education Committee, the fundamental safety and educational ground rules of: (A) qualified supervision, (B) proper safety facilities, and (C) professionally designed equipment, conceived almost fifty years ago, are equally valid to today's supervised youth rocketry space-related experiment educational programs.
Dr. Johney Green Jr. - Associate Laboratory Director for Mechanical and
Thermal Engineering Sciences | NREL Dr. Johney Green Jr. - Associate Laboratory Director for Mechanical and Thermal Engineering Sciences Dr. Johney Green Jr. - Associate Laboratory Director for Mechanical and Thermal Engineering Sciences A photo of Johney Green In his role, Johney Green oversees early
Wood, Marnie J; Gadd, Victoria L; Powell, Lawrie W; Ramm, Grant A; Clouston, Andrew D
2014-03-01
The development of portal fibrosis following the iron loading of hepatocytes is the first stage of fibrogenesis in hereditary hemochromatosis. In other chronic liver diseases it has been shown that a ductular reaction (DR) appears early, correlates with fibrosis progression, and is a consequence of activation of an alternative pathway of hepatocyte replication. This study was designed to investigate the presence of the DR in hemochromatosis and describe its associations. Liver biopsies from 63 C282Y homozygous patients were assessed for hepatic iron concentration (HIC) and graded for iron loading, fibrosis stage, steatosis, and inflammation. Immunostaining allowed quantification of the DR, hepatocyte senescence and proliferation, and analysis incorporated clinical data. Hepatocyte senescence was positively correlated with HIC, serum ferritin, and oxidative stress. A DR was demonstrated and occurred prior to histological fibrosis. HIC, age, hepatocyte senescence and proliferation, portal inflammation, and excessive alcohol consumption all had significant associations with the extent of the DR. In multivariate analysis, iron loading, hepatocyte replicative arrest, and portal inflammation remained independently and significantly associated with the DR. Of factors associated with fibrosis progression, the DR (odds ratio [OR] 10.86 P<0.0001) and the presence of portal inflammation (OR 4.31, P=0.028) remained significant after adjustment for cofactors. The extent of the DR regressed following therapeutic venesection. Iron loading of hepatocytes leads to impaired replication, stimulating the development of the DR in hemochromatosis and this correlates strongly with hepatic fibrosis. Portal inflammation occurs in hemochromatosis and is independently associated with the DR and fibrosis, and thus its role in this disease should be evaluated further. © 2014 by the American Association for the Study of Liver Diseases.
Adventures in Infectious Diseases
Fisher-Hoch, Susan [University of Texas School of Public Health
2018-04-25
Dr. Susan Fisher-Hoch, Virologist and Epidemiologist, will discuss her research and travels associated with viral hemorrhagic fevers. From the Ebola outbreak in Reston, Virginia to outbreaks of Crimean Congo Hemorrhagic Fever in South Africa, Senegal, and Saudi Arabia, Dr. Fisher-Hoch has studied and tracked the pathophysiology of these viral diseases. These studies have led her from the Center for Disease Control in the United States, to Lyon, France where she was instrumental in designing, constructing, and rendering operational a laboratory capable of containing some of the world's most dangerous diseases.
DR2DI: a powerful computational tool for predicting novel drug-disease associations
NASA Astrophysics Data System (ADS)
Lu, Lu; Yu, Hua
2018-05-01
Finding the new related candidate diseases for known drugs provides an effective method for fast-speed and low-risk drug development. However, experimental identification of drug-disease associations is expensive and time-consuming. This motivates the need for developing in silico computational methods that can infer true drug-disease pairs with high confidence. In this study, we presented a novel and powerful computational tool, DR2DI, for accurately uncovering the potential associations between drugs and diseases using high-dimensional and heterogeneous omics data as information sources. Based on a unified and extended similarity kernel framework, DR2DI inferred the unknown relationships between drugs and diseases using Regularized Kernel Classifier. Importantly, DR2DI employed a semi-supervised and global learning algorithm which can be applied to uncover the diseases (drugs) associated with known and novel drugs (diseases). In silico global validation experiments showed that DR2DI significantly outperforms recent two approaches for predicting drug-disease associations. Detailed case studies further demonstrated that the therapeutic indications and side effects of drugs predicted by DR2DI could be validated by existing database records and literature, suggesting that DR2DI can be served as a useful bioinformatic tool for identifying the potential drug-disease associations and guiding drug repositioning. Our software and comparison codes are freely available at https://github.com/huayu1111/DR2DI.
DR2DI: a powerful computational tool for predicting novel drug-disease associations
NASA Astrophysics Data System (ADS)
Lu, Lu; Yu, Hua
2018-04-01
Finding the new related candidate diseases for known drugs provides an effective method for fast-speed and low-risk drug development. However, experimental identification of drug-disease associations is expensive and time-consuming. This motivates the need for developing in silico computational methods that can infer true drug-disease pairs with high confidence. In this study, we presented a novel and powerful computational tool, DR2DI, for accurately uncovering the potential associations between drugs and diseases using high-dimensional and heterogeneous omics data as information sources. Based on a unified and extended similarity kernel framework, DR2DI inferred the unknown relationships between drugs and diseases using Regularized Kernel Classifier. Importantly, DR2DI employed a semi-supervised and global learning algorithm which can be applied to uncover the diseases (drugs) associated with known and novel drugs (diseases). In silico global validation experiments showed that DR2DI significantly outperforms recent two approaches for predicting drug-disease associations. Detailed case studies further demonstrated that the therapeutic indications and side effects of drugs predicted by DR2DI could be validated by existing database records and literature, suggesting that DR2DI can be served as a useful bioinformatic tool for identifying the potential drug-disease associations and guiding drug repositioning. Our software and comparison codes are freely available at https://github.com/huayu1111/DR2DI.
1990-03-23
Paciorek Dr. William B. Moniz Ultrasystems Defense and Space, Inc. Code 6120 16775 Von Karman Avenue Naval Research Laboratory Irvine, CA 92714 Washington...413h004 Dr. Les H. Sperling Dr. Richard S. Stein Materials Research Center #32 Polymer Research Institute Lehigh University University of Massachusetts
Dr. Ted Trimble: Why I Do Cancer Research
In a video, Dr. Ted Trimble talks about the importance of cancer research. World Cancer Research Day commemorates the important role research and cancer researchers play in reducing the global burden of cancer.
Dr. Rachel Bishop's Top Tips for Your Eyes | NIH MedlinePlus the Magazine
... hat to shield your eyes from ultraviolet light (sunlight), especially if you are a farmer, a fisherman, ... related cataract. Researchers are examining: The effect of sunlight exposure, which may be associated with an increased ...
Gupta, Aditi; Delhiwala, Kushal S; Raman, Rajiv P G; Sharma, Tarun; Srinivasan, Sangeetha; Kulothungan, Vaitheeswaran
2016-06-01
Insulin users have been reported to have a higher incidence of diabetic retinopathy (DR). The aim was to elucidate the factors associated with DR among insulin users, especially association between duration, prior to initiating insulin for Type 2 diabetes mellitus (DM) and developing DR. Retrospective cross-sectional observational study included 1414 subjects having Type 2 DM. Insulin users were defined as subjects using insulin for glycemic control, and insulin nonusers as those either not using any antidiabetic treatment or using diet control or oral medications. The duration before initiating insulin after diagnosis was calculated by subtracting the duration of insulin usage from the duration of DM. DR was clinically graded using Klein's classification. SPSS (version 9.0) was used for statistical analysis. Insulin users had more incidence of DR (52.9% vs. 16.3%, P < 0.0001) and sight threatening DR (19.1% vs. 2.4%, P < 0.0001) in comparison to insulin nonusers. Among insulin users, longer duration of DM (odds ratio [OR] 1.12, 95% confidence interval [CI] 1.00-1.25, P = 0.044) and abdominal obesity (OR 1.15, 95% CI 1.02-1.29, P = 0.021) was associated with DR. The presence of DR was significantly associated with longer duration (≥5 years) prior to initiating insulin therapy, overall (38.0% vs. 62.0%, P = 0.013), and in subjects with suboptimal glycemic control (32.5% vs. 67.5%, P = 0.022). The presence of DR is significantly associated with longer duration of diabetes (>5 years) and sub-optimal glycemic control (glycosylated hemoglobin <7.0%). Among insulin users, abdominal obesity was found to be a significant predictor of DR; DR is associated with longer duration prior to initiating insulin therapy in Type 2 DM subjects with suboptimal glycemic control.
2010-04-09
Netherlands Memorandum of Record (MOR) agreement signing and visit to the NASA Ames Research Center, Mofffett Field, California. At the table are left to right, Dr. Scott Sanford, NASA Ames, Dr Alexander Tielens, former NASA Civil Servant and former SOFIA Project Scientist, Dr Andrew Mattioda, NASA Ames, Dr. Louis B.J.Vertegaal, Director of Physical Sciences, Chemistry, and Advanced Chemical Technologies for Sustainability, of the Netherlands Organisation for Scientific Research (NWO)
The Malaysian Orthopaedic Association humanitarian mission to Indonesia and Sri Lanka.
Sharaf, I; Saw, A; Hyzan, Y; Sivananthan, K S
2005-07-01
The tsunami which occurred off the west coast of North Sumatra on December 26, 2004 devastated the coastal areas of North Sumatra, South-West Thailand, South-East India and Sri Lanka killing more than a quarter of a million people. The destruction was enormous with many coastal villages destroyed. The other countries affected were Malaysia, Myanmar, Maldives, Bangladesh, Somalia, Kenya, Tanzania and the Seychelles. In January 2005, volunteers went in weekly rotation to Banda Aceh in collaboration with Global Peace Mission. These were Dr Hyzan Yusof, Dr Suryasmi Duski, Dr Sharaf Ibrahim, Dr Saw Aik, Dr Kamariah Nor and Dr Nor Azlin. In Banda Aceh, the surgical procedures that we could do were limited to external fixation of open fractures and debriding infected wounds at the Indonesian Red Crescent field hospital. In February, a team comprising Dato Dr K S Sivananthan, Dr T Kumar and Dr S Vasan spent a week in Sri Lanka. In Sri Lanka, Dato Sivananthan and his team were able to perform elective orthopaedic operations in Dr Poonambalam Memorial Hospital. We appealed for national and international aid and received support from local hospitals and the orthopaedic industry. International aid bound for Banda Aceh arrived in Kuala Lumpur from the Philippine Orthopaedic Association, the Chiba Children's Hospital in Japan and the Chinese Orthopaedic Association. The COA donated 1.5 tons of orthopaedic equipments. A special handing over ceremony from the COA to the Indonesian Orthopaedic Association was held in Putrajaya in March. Malaysia Airlines flew in the donated equipment to Kuala Lumpur while the onward flight to Aceh was provided by the Royal Malaysian Air Force. In April, Dr Saw Aik and Dr Yong Su Mei joined the Tsu-Chi International Medical Association for volunteer services on Batam Island, Indonesia. The MOA acknowledges the many individuals and organizations, both governmental and non-governmental, for their contributions in the humanitarian efforts.
Thomas, Rebecca L; Distiller, Larry; Luzio, Stephen D; Chowdhury, Sharmistha Roy; Melville, Vanessa J; Kramer, Brian; Owens, David R
2013-02-01
To describe the prevalence and associated risk factors for diabetic retinopathy (DR) within a multiethnic population at presentation to a diabetes clinic in South Africa. Retinal photography was conducted using a nonmydriatic digital camera without mydriasis and graded by one of three senior graders. Logistic regression analyses were used to assess the association between any DR, referable DR, and clinical risk factors. A total of 1,537 persons with type 1 and 3,978 with type 2 diabetes were included. Prevalence of any DR in type 1 diabetes was 35.2% (background DR 26% and referable DR 9.2%) and in type 2 diabetes was 20.5% (14.1 and 6.4%, respectively). In type 1 diabetes, there was an increased risk of any DR in Asian Indians, whereas the risk of referable DR was increased for indigenous Africans compared with Caucasians. In type 2 diabetes, the risk was increased for all non-Caucasians compared with Caucasians. Longer duration of diabetes and elevated HbA(1c) were independently associated with any and referable DR in both type 1 and type 2 diabetes, with the addition of hypertension and smoking in type 1 diabetes when adjusted for age at diagnosis of diabetes, sex, and ethnicity. The prevalence of DR in this population from South Africa was similar to that reported globally; however, ethnic differences were observed. Increasing duration of diabetes and poor glycemic control were the strongest risk factors associated with any and referable DR in both type 1 and type 2 diabetes.
ROBOSIM Modeling of NASA and DoD Robotic Concepts
NASA Technical Reports Server (NTRS)
Fernandez, Kenneth R.
2005-01-01
Dr. Fernandez will discuss using ROBOSIM to model a robotic minesweeper for DoD and to model NASA's use of the Shuttle robot arm to examine shuttle tiles. He will show some of the actual robotic simulations that were developed, and provide some insight on solving the challenging issues involved with developing robotic simulations. Dr. Fernandez developed an earlier version of ROBOSIM with his Ph.D. advisor, Dr. George E. Cook, professor of Electrical Engineering at Vanderbilt University. After being honored as a NASA Administrator s Fellow, he chose Alabama A&M University as the location where he would do a year of teaching and a year of research, provided by the NASA Fellowship Grant. Dr. Trent Montgomery, Associate Dean of Engineering/Chairman Electrical Engineering Department, was his host for the NASA fellowship position at Alabama A&M. Mr. Lionel Macklin is a student at Alabama A&M University who developed the model of the minesweeper concept as his senior project.
DOE Office of Scientific and Technical Information (OSTI.GOV)
Judith C. Chow; John G. Watson; Howard J. Feldman
In the review, John D. Bachmann traces the regulatory history of U.S. air pollution from the beginning of the 20th century to the present. The review divides this progress into four segments: (1) 1900-1970, from smoke abatement to federal involvement and the establishment of air quality management (AQM) in the 1970 Clean Air Act (CAA); (2) 1971-1976, when the first National Ambient Air Quality Standards (NAAQS) were promulgated and implemented; (3) 1977-1993, which included the first NAAQS revisions, major CAA amendments, and the evolution of AQM; and (4) 1993-2006, the second and third waves of NAAQS revisions and their implementationmore » in the context of the 1990 CAA amendments. A discussant's commentary does not necessarily reflect the position of his or her respective organization. This Critical Review Discussion was compiled from written submissions and presentation transcripts. The invited discussants are as follows: Mr. Howard J. Feldman, director of regulatory and scientific affairs for the American Petroleum Institute; Ms. Janice E. Nolen, assistant vice president of national policy and advocacy for the American Lung Association; Dr. Barry Wallerstein, executive officer at the South Coast Air Quality Management District; Dr. John G. Watson, research professor in the Division of Atmospheric Sciences at the Desert Research Institute; Dr. George M. Hidy of Envair/Aerochem; Dr. Paul J. Lioy, Department of Environmental and Occupational Medicine; Robert Wood Johnson Medical School, University of Medicine and Dentistry, New Jersey; Dr. Herbert McKee, environmental consultant; Mr. David Mobley of the Atmospheric Modeling Division of the EPA's Office of Research and Development; and Mr. Keith Baugues, P.E., of air services for KERAMIDA Environmental. 127 refs.« less
Ashinne, Beteal; Rajalakshmi, Ramachandran; Anjana, Ranjit M; Venkat Narayan, K M; Jayashri, Ramamoorthy; Mohan, Viswanathan; Hendrick, Andrew M
2018-05-01
Vitamin D deficiency (VDD) is a condition that has been associated with diabetic retinopathy (DR) in various populations, but has not been studied in Asian Indians. To evaluate the association of serum 25-hydroxyvitamin D (25(OH)D) levels with presence and severity of DR among Asian Indians with type 2 diabetes. We collected information on individuals with type 2 diabetes that received care at a tertiary diabetes centre in India, between 2012 and 2015. Patients were 18 years of age or older, underwent retinal examinations with DR severity grading and had serum 25(OH)D measurements. Serum 25(OH)D levels were lower in patients with retinopathy compared to those without (11.9 ± 2.2 ng/ml vs. 13.7 ± 2.1 ng/ml, p < 0.001). Stratifying patients by DR grade, reduced geometric means of 25(OH)D levels were associated with increased retinopathy severity. After adjusting for six key covariates, VDD was associated with increased rates of proliferative DR (OR 2.05; 95% CI 1.35-3.11; p = 0.001). In Asian Indians with type 2 diabetes, lower serum 25(OH)D was associated with increased severity of DR and the presence of VDD was associated with a two-fold increased risk for proliferative DR. Copyright © 2018 Elsevier B.V. All rights reserved.
Special Spotlight: Levi A. Garraway, M.D., Ph.D.
Dr. Levi A. Garraway, a former CRCHD CURE trainee, received the prestigious Jane Cooke Wright Lectureship Award at the 2014 meeting of the American Association for Cancer Research and presented "The Cancer Genome in Biology, Therapy, and Drug Resistance.”
2010-06-09
2010 NASA Honor Awards Awards Group Achievement Award to VMS Space Shuttle Visual Database Development Team. Boris M. Rabin accepting. Presenters are on left Mr. Charles H. Scales, NASA Associate Deputy Administrator, on right Dr. S. Pete Worden, Director, NASA Ames Research Center.
Lukas, Rimas V; Wainwright, Derek A; Laterra, John J
2016-01-01
American Neurological Association Annual Meeting, Chicago, IL, USA, 27-29 September 2015 The American Neurological Association (ANA) held its annual meeting in Chicago, IL, USA on 27-29 September 2015. The Scientific Programming Advisory Committee was chaired by Dr. S Pleasure from the University of California-San Francisco (CA, USA). The Neuro-Oncology session, chaired by Dr. A Pruitt from the University of Pennsylvania (PA, USA) and cochaired by Dr. J Laterra from Johns Hopkins University (MD, USA), was held on 27 September 2015. Speakers included Dr. D Wainwright (Northwestern University, IL, USA), Dr. N Kolb (University of Utah, UT, USA), Dr. A Nath (NINDS/NIH, MD, USA), Dr. D Franz (Cincinnati Children's Hospital, OH, USA) and Dr. R Lukas (University of Chicago, IL, USA). A summary of key presentations from the Neuro-Oncology section of the 2015 American Neurological Association annual meeting is reported. Preclinical and clinical advances in the use of immunotherapies for the treatment of primary and metastatic CNS tumors are covered. Particular attention is paid to the enzyme indoleamine dioxygenase and the immune checkpoints CTLA4 and PD1 and their ligands. Specific nervous system toxicities associated with novel immunotherapies are also discussed. The recent success of targeting the mTOR pathway in the neurocutaneous syndrome tuberous sclerosis is detailed. Finally, important early steps in our understanding of the common toxicity of chemotherapy induced neuropathy are reviewed.
Lv, Zhiping; Li, Ying; Wu, Yongzhong; Qu, Yi
2016-08-01
To evaluate the association of intercellular cell-adhesion molecule 1 (ICAM-1) and high-mobility group A1 (HMGA1) gene variants with diabetic retinopathy (DR) in a Chinese type 2 diabetes mellitus (T2DM) cohort. A total of 792 patients with T2DM were enrolled and categorized into two groups: (1) the DR group consisted of 448 patients, which was further subclassified into the proliferative DR (PDR) group with 220 patients and the nonproliferative DR (NPDR) group with 228 patients; (2) the diabetes without retinopathy (DNR) group comprised 344 patients who had no signs of DR. The single-nucleotide polymorphism (SNP) rs5498 in ICAM-1 gene and IVS5-13insC variant in HMGA1 gene were genotyped. No evident association was found in the allele frequencies between SNP rs5498 in ICAM-1 gene and DR patients; the combined p values for the additive, dominant, and recessive models in genotype were greater than 0.05. No significant association was identified between the IVS5-13insC variant in HMGA1 gene and DR individuals. Our results revealed that SNP rs5498 in ICAM-1 gene and IVS5-13insC variant in HMGA1 gene were not associated with the susceptibility of DR in the Chinese T2DM cohort.
Obituary: Herbert Gursky, 1930-2006
NASA Astrophysics Data System (ADS)
Doschek, George; Dahlburg, Jill
2007-12-01
Dr. Herbert Gursky, Acting Associate Director of Research for the Naval Research Laboratory's (NRL's) Systems Directorate, and formerly Superintendent of the Space Science Division and Chief Scientist of the E. O. Hulburt Center for Space Research. Dr. Gursky died following a long illness on late Friday afternoon, December 1, 2006. Dr. Gursky was a great friend, valued colleague, and distinguished researcher who will be missed greatly. Dr. Gursky was born in Bronx, New York, on May 27, 1930. He was educated in secondary schools in Miami, Florida, and received a Bachelor's Degree from the University of Florida in 1951. He did graduate work in physics at Vanderbilt University (Master's degree in 1953) and Princeton University (Doctorate degree in 1959). His first professional position was at Columbia University as an instructor in the Physics Department from 1958 to 1961. In 1961, he joined American Science and Engineering, Inc. (AS&E) in Cambridge, Massachusetts, as a senior scientist and rose to the position of Vice President, Space Research in 1967. In 1973 he joined the Smithsonian Astrophysical Observatory (SAO) as a supervisory astrophysicist. In 1974, Dr. Gursky was appointed Professor in the Practice of Astronomy at Harvard University and in 1976 was named Associate Director of the Center for Astrophysics for the Division of Optical and Infrared Astronomy. In 1981, Dr. Gursky joined NRL as Superintendent of its Space Science Division and Chief Scientist of the E. O. Hulburt Center for Space Research. He moved to the position of Acting Associate Director of Research for NRL's Systems Directorate in 2006. Dr. Gursky's primary research interests were in the area of X-ray astronomy. He published more than 100 articles in this area and edited two books on the subject. Before arriving at NRL, he was the principal investigator for NASA-sponsored space programs on the Astronomical Netherlands Satellite (ANS) and the High Energy Astrophysics Observatory (HEAO)-1 satellite, and a co-investigator on numerous other rocket and satellite experiments. At AS&E, Dr. Gursky managed research activities encompassing solar physics and magnetospheric research, and at SAO, he managed programs of ground-based astronomy and infrared astronomy. At SAO, he oversaw the completion of the Multiple Mirror Telescope, a joint program of SAO and the University of Arizona, comprising a 4.5-meter (equivalent) telescope of novel design that is situated at Mount Hopkins in Arizona. Dr. Gursky's work at NRL involved direction of a broad-ranging research effort involving about fifty Ph.D. scientists conducting investigations in the areas of high-energy astronomy, solar physics, solar terrestrial effects and atmospheric science. NRL is the corporate research laboratory for the Navy and has the responsibility for assuring that future Navy systems take full advantage of all available technology and scientific understandings. Dr. Gursky had the ability to distill and seize the most important nuggets from any research program and envision its application to a variety of new problems and directions. In numerous areas of atmospheric, solar and space science technology, Dr. Gursky recognized key scientific issues and their potential DoD applications. In solar physics, he spurred the development of semi-empirical modeling to predict solar storms that has been successfully transitioned to operational systems. He also supported participation in all NASA and other agency Sun-Earth connection orbiting space programs which resulted in a succession of spectacularly successful experiments in solar physics such as the high resolution rocket spectrograph and its flight on the NASA Spacelab 2, the Solar Ultraviolet Spectral Irradiance Monitor (SUSIM) on the NASA Upper Atmosphere Research Satellite, the Bragg crystal spectrometer solar flare experiment on the Japanese Yohkoh spacecraft, and the Large Angle and Spectrometric Coronagraph Experiment (LASCO) and extreme ultraviolet imaging telescope (EIT) on the ESA/NASA Solar and Heliospheric Observatory. These experiments have shed considerable light on how solar activity affects the near-Earth environment with many potential space weather applications. In high-energy astronomy, Dr. Gursky made many contributions. He provided scientific oversight for the Advanced Research and Global Observation Satellite (ARGOS) Space Test Program spacecraft that contained five NRL instruments: the Unconventional Stellar Aspect (USA) experiment, the Global Imaging Monitor of the Ionosphere (GIMI), the High Resolution Airglow/Aurora Spectroscopy (HIRAAS) experiment, the Extreme Ultraviolet Imaging Photometer (EUVIP), and the Coherent Electromagnetic Radio Tomography (CERTO) instrument. He continued his interest in X-ray astronomy with the USA experiment, which obtained observations of many celestial sources such as galactic binary X-ray sources and pulsars. Always with an eye toward applications, Dr. Gursky was interested in using X-ray sources, specifically X-ray pulsars, as precise clocks to provide spacecraft with autonomous timing and navigation. Dr. Gursky also supported research in gamma ray astrophysics, such as the development of NRL's Oriented Scintillation Spectrometer Experiment (OSSE) for the NASA Compton Gamma Ray Observatory (CGRO) satellite, and analysis of solar flare gamma ray spectra obtained from the NASA Solar Maximum Mission. In atmospheric science, Dr. Gursky particularly encouraged practical applications of basic research. He recognized the importance of remote sensing for space weather, which resulted in the development at NRL of operational ultraviolet sensors on Defense Meteorological Satellite Program (DMSP) spacecraft that are now providing environmental data products to the Air Force Space Weather Agency. He initiated a program in middle atmosphere research that has been enormously successful and has spawned numerous experimental and theoretical advances, such as the Middle Atmosphere High Resolution Spectrograph Investigation (MAHRSI) to measure trace constituents in the middle atmosphere such as the hydroxyl radical (OH). Dr. Gursky supported the development of theoretical middle atmosphere models such as the Mountain Wave Forecast Model that was used to predict flight conditions for allied aircraft during operations Southern Watch, Enduring Freedom, and Iraqi Freedom, which has been a boon to stratospheric flight operations over mountainous terrain. He also supported the HIRAAS experiment on ARGOS. Dr. Gursky provided outstanding leadership in the continued development of the United States space program. Under his stewardship, the NRL Space Science Division substantially expanded its leadership role in understanding the space environment and its effects on military and civilian systems. The Laboratory and the world are now witnessing the newest results of his scientific acumen and sound decision-making as exemplified in the very recent successful completions and launches of these major Space Science Division instruments: Delivery of GLAST LAT (September 2006): Delivery of the collaborative NRL Large Area Telescope (LAT) for the NASA Gamma Ray Large Area Space Telescope (GLAST) satellite integration; when deployed, GLAST will measure the most energetic processes in the universe — from X-ray bursts, black holes, neutron stars, and solar flares — and has the potential to discover previously unknown relics of the Big Bang; Launch of SOLAR-B (September 2006): The Japan Aerospace Exploration Agency's Hinode (Japanese for Sunrise, formerly known as SOLAR-B) launched September 23 carrying NRL's collaborative Extreme-ultraviolet Imaging Spectrometer (EIS), which achieved first light on October 28. EIS is now observing emission lines produced by highly ionized elements in the solar coronal and upper transition region of the Sun's atmosphere. Space Science Division scientists expect much exciting science concerning the coupling of solar activity to the near-Earth space environment to be produced by the EIS instrument; and, Launch of STEREO (October 2006): NASA's Solar Terrestrial Relations Observatory (STEREO) launched 25 October, carrying the collaborative NRL Sun-Earth Connection Coronal and Heliospheric Investigation (SECCHI) instruments suite, which is currently successfully functioning in the pre-commissioning phase. The instruments onboard STEREO's twin spacecraft will make observations to help NRL researchers construct the first-ever three-dimensional views of coronal mass ejections, vital data — in complement with the long-operational NRL-built NASA LASCO — for understanding how the Sun creates space weather Perhaps Dr. Gursky's most personal research successes were as a member of the group that made the discovery of cosmic X-ray sources in 1961, his work with sounding rockets that culminated in the optical identification of the bright X-ray source Scorpius X1 in 1966, his work on clusters of galaxies and the diffuse X-ray background from the Uhuru Satellite and the discovery of X-ray bursters on the ANS satellite.
2003-08-20
KENNEDY SPACE CENTER, FLA. - KSC Director Jim Kennedy and Glenn Research Center Director Dr. Julian Earls share the stage during the rollout of the One NASA initiative at KSC. Earls gave a motivational speech during the luncheon held at the Visitor Complex Debus Conference Center. The event was held at the IMAX Theater® where NASA leaders discussed One NASA with selected employees. Explaining how their respective centers contribute to One NASA, along with Kennedy and Earls, were James Jennings, NASA’s associate deputy administrator for institutions and asset management; Ed Weiler, associate administrator for Space Science; Kevin Peterson, Dryden Flight Research Center director; incoming KSC Deputy Director Woodrow Whitlow; and implementation team lead Johnny Stevenson.
2003-08-20
KENNEDY SPACE CENTER, FLA. - At the rollout of the One NASA initiative at KSC, Glenn Research Center Director Dr. Julian Earls embraces implementation team lead Johnny Stevenson while KSC Director Jim Kennedy (left) applauds. Earls gave a motivational speech during the luncheon held at the Visitor Complex Debus Conference Center. The event was held at the IMAX Theater® where NASA leaders discussed One NASA with selected employees. Explaining how their respective centers contribute to One NASA, along with Kennedy and Earls, were James Jennings, NASA’s associate deputy administrator for institutions and asset management; Ed Weiler, associate administrator for Space Science; Kevin Peterson, Dryden Flight Research Center director; incoming KSC Deputy Director Woodrow Whitlow; and implementation team lead Johnny Stevenson.
2003-08-20
KENNEDY SPACE CENTER, FLA. - KSC’s incoming Deputy Director Woodrow Whitlow speaks to employees and guests during the rollout at KSC of the Agency initiative One NASA . The event was held at the IMAX Theater® where NASA leaders discussed One NASA with selected employees. Explaining how their respective centers contribute to One NASA, along with Whitlow, were KSC Director Jim Kennedy; James Jennings, NASA’s associate deputy administrator for institutions and asset management; Ed Weiler, associate administrator for Space Science; Kevin Peterson, Dryden Flight Research Center director; and implementation team lead Johnny Stevenson. Glenn Research Center Director Dr. Julian Earls gave a motivational speech during the luncheon held at the Visitor Complex Debus Conference Center.
The research contributions of Dr. Paul Van Deusen
Thomas B. Lynch; Francis A. Roesch; John Paul McTague; Jeffrey H. Gove; Gregory A. Reams; Aaron R. Weiskittel
2015-01-01
Dr. Paul Van Deusenâs recent passing concluded a rich 30+-year research career dedicated to development and implementation of quantitative methods for forestry and natural resources. Since the early part of his career as a biometrician with the USDA Forest Service Southern Research Station in the 1980s-1990s and continuing with his later employment at NCASI, Dr. Van...
A Solvable Self-Similar Model of the Sausage Instability in a Resistive Z-Pinch
1989-09-20
Ithaca, NY 14853 Dr. V. Nardi Dr. John C. Riordan Stevens Institute of Technology Physics International Co. Hoboken, NJ 07803 2700 Merced Street Dr...92122 Dr. Rick B. Spielman Dr. Frank C. Young Sandia National Laboratories Naval Research Laboratory P.O. Box 5800 Code 4770.1 Albuquerque, NM 87115
Association of HLA-DRB1 alleles and neuropsychological function in autism.
Chien, Yi-Ling; Wu, Yu-Yu; Chen, Chia-Hsiang; Gau, Susan Shur-Fen; Huang, Yu-Shu; Chien, Wei-Hsien; Hu, Fu-Chang; Chao, Yu-Lin
2012-02-01
Evidence suggests an association between autism and immune dysfunction. The associations between human lymphocyte antigen (HLA)-A2, B44, DRβ1*04 (DR4), C4B, and haplotype B44-SC30-DR4 and autism have been reported in western countries but there is a lack of such information in Asian population. This study aimed to assess the association between HLA-DRB1 allele frequencies and the clinical phenomenology of autism. The sample included 141 participants (male, 87.2%), who were diagnosed with autistic disorder based on clinical assessments and structured interviews using the Chinese version of the Autism Diagnostic Interview-Revised, and 156 healthy controls (male, 38.6%). The HLA-DRB1 alleles were determined by sequencing-based typing method. A subsample of patients (n=39) were assessed for intelligence and neuropsychological functions. The results showed that the pattern of DRB1 allele frequencies was significantly different between patients with autism and the controls (P=0.047). After adjusting for sex by haplotype regression, the frequencies of DR4, DR11, and DR14 were significantly different between patients with autism and healthy controls. In addition, patients with autism and DR4, DR11, or DR14 had different performance on intelligence and neuropsychology tests. Despite a relatively small sample size and a case-control association design, the findings suggest HLA-DRB1 gene might be associated with autism in Han Chinese. The true functional variants associated with autism in our samples remain to be further clarified. It warrants a replication study of a larger family sample and to validate the HLA genetic association with autism and its influence on neuropsychological function.
Hamza, Taye H; Zabetian, Cyrus P; Tenesa, Albert; Laederach, Alain; Montimurro, Jennifer; Yearout, Dora; Kay, Denise M; Doheny, Kimberly F; Paschall, Justin; Pugh, Elizabeth; Kusel, Victoria I; Collura, Randall; Roberts, John; Griffith, Alida; Samii, Ali; Scott, William K; Nutt, John; Factor, Stewart A; Payami, Haydeh
2010-01-01
Parkinson disease (PD) is a common disorder that leads to motor and cognitive disability. We performed a genome-wide association study (GWAS) with 2000 PD and 1986 control Caucasian subjects from NeuroGenetics Research Consortium.1–5 We confirmed SNCA2,6–8 and MAPT3,7–9; replicated GAK9 (PPankratz+NGRC=3.2×10−9); and detected a novel association with HLA (PNGRC=2.9×10−8) which replicated in two datasets (PMeta-analysis=1.9×10−10). We designate the new PD genes PARK17 (GAK) and PARK18 (HLA). PD-HLA association was uniform across genetic and environmental risk strata, and strong in sporadic (P=5.5×10−10) and late-onset (P=2.4×10−8) PD. The association peak was at rs3129882, a non-coding variant in HLA-DRA. Two studies suggested rs3129882 influences expression of HLA-DR and HLA-DQ.10,11 PD brains exhibit up-regulation of DR antigens and presence of DR-positive reactive microglia.12 Moreover, non-steroidal anti-inflammatory drugs (NSAID) reduce PD risk.4,13 The genetic association with HLA coalesces the evidence for involvement of the immune system and offers new targets for drug development and pharmacogenetics. PMID:20711177
Feature Extraction and Classification of Magnetic and EMI Data, San Luis Obispo, CA
2010-07-01
Stephen Billings Dr. Len Pasion Dr. Nicolas Lhomme Kevin Kingdon Jon Jacobson Sky Research, Inc. Dr. Douglas Oldenburg Dr. Lin Ping Song...Discrimination Strategies for Application to Live Sites W912HQ-05-C-0018 ESTCP 0504Dr. Stephen Billings, Dr. Len Pasion , Dr. Nicolas Lhomme, Kevin...e.g. Hart et al., 2001; Collins et al., 2001; Pasion & Oldenburg, 2001; Zhang et al., 2003a, 2003b; Billings, 2004). The most promising discrimination
Apostolova, Liana G; Morra, Jonathan H; Green, Amity E; Hwang, Kristy S; Avedissian, Christina; Woo, Ellen; Cummings, Jeffrey L; Toga, Arthur W; Jack, Clifford R; Weiner, Michael W; Thompson, Paul M
2010-05-15
We used a previously validated automated machine learning algorithm based on adaptive boosting to segment the hippocampi in baseline and 12-month follow-up 3D T1-weighted brain MRIs of 150 cognitively normal elderly (NC), 245 mild cognitive impairment (MCI) and 97 Dementia of the Alzheimer's type (DAT) ADNI subjects. Using the radial distance mapping technique, we examined the hippocampal correlates of delayed recall performance on three well-established verbal memory tests--ADAScog delayed recall (ADAScog-DR), the Rey Auditory Verbal Learning Test -DR (AVLT-DR) and Wechsler Logical Memory II-DR (LM II-DR). We observed no significant correlations between delayed recall performance and hippocampal radial distance on any of the three verbal memory measures in NC. All three measures were associated with hippocampal volumes and radial distance in the full sample and in the MCI group at baseline and at follow-up. In DAT we observed stronger left-sided associations between hippocampal radial distance, LM II-DR and ADAScog-DR both at baseline and at follow-up. The strongest linkage between memory performance and hippocampal atrophy in the MCI sample was observed with the most challenging verbal memory test-the AVLT-DR, as opposed to the DAT sample where the least challenging test the ADAScog-DR showed strongest associations with the hippocampal structure. After controlling for baseline hippocampal atrophy, memory performance showed regionally specific associations with hippocampal radial distance in predominantly CA1 but also in subicular distribution. Copyright (c) 2009 Elsevier Inc. All rights reserved.
Solid Propellant Combustion Mechanism Research 1975-1980.
1980-04-01
Roberto Office of Naval Research 1 AFSC Western Office Andrews AFB, Code DLFP 1030 East Green Street Washington, DC 20334 Pasadena, CA 91106 Attn: Mr...Office Atmospheric Sciences 495 Summer Street Bolling Air Force Base Boston, MA 02210 Washington, DC 20332 Attn: Dr. L. Peebles Dr. A. Wood Air Force... Bolling Air Force Base San Francisco, CA 94102 Washington, DC 20332 Attn: Dr. P. A. Miller Attn: Dr. L. H. Caveny F Defense-Technical Information 12 Anal
RDHWT/MARIAH II Hypersonic Wind Tunnel Research Program
2008-09-01
Diagnostics Dr. Gary Brown – Gas Dynamics Dr. Ihab Girgis – Modeling Dr. Dennis Mansfield – Experimental Ring Technical Services Dr. Leon Ring – Systems...wind tunnel (MSHWT) with Mach 8 to 15, true -temperature flight test capabilities. This research program was initiated in fiscal year (FY) 1998 and is...Force test capabilities that exist today. Performance goals of the MSHWT are true temperature, Mach 8 to 15, dynamic pressure of 500 to 2000 psf (24 to
Automated detection of diabetic retinopathy in retinal images.
Valverde, Carmen; Garcia, Maria; Hornero, Roberto; Lopez-Galvez, Maria I
2016-01-01
Diabetic retinopathy (DR) is a disease with an increasing prevalence and the main cause of blindness among working-age population. The risk of severe vision loss can be significantly reduced by timely diagnosis and treatment. Systematic screening for DR has been identified as a cost-effective way to save health services resources. Automatic retinal image analysis is emerging as an important screening tool for early DR detection, which can reduce the workload associated to manual grading as well as save diagnosis costs and time. Many research efforts in the last years have been devoted to developing automatic tools to help in the detection and evaluation of DR lesions. However, there is a large variability in the databases and evaluation criteria used in the literature, which hampers a direct comparison of the different studies. This work is aimed at summarizing the results of the available algorithms for the detection and classification of DR pathology. A detailed literature search was conducted using PubMed. Selected relevant studies in the last 10 years were scrutinized and included in the review. Furthermore, we will try to give an overview of the available commercial software for automatic retinal image analysis.
Low energy range dielectronic recombination of Fluorine-like Fe17+ at the CSRm
NASA Astrophysics Data System (ADS)
Khan, Nadir; Huang, Zhong-Kui; Wen, Wei-Qiang; Mahmood, Sultan; Dou, Li-Jun; Wang, Shu-Xing; Xu, Xin; Wang, Han-Bing; Chen, Chong-Yang; Chuai, Xiao-Ya; Zhu, Xiao-Long; Zhao, Dong-Mei; Mao, Li-Jun; Li, Jie; Yin, Da-Yu; Yang, Jian-Cheng; Yuan, You-Jin; Zhu, Lin-Fan; Ma, Xin-Wen
2018-05-01
The accuracy of dielectronic recombination (DR) data for astrophysics related ions plays a key role in astrophysical plasma modeling. The absolute DR rate coefficient of Fe17+ ions was measured at the main cooler storage ring at the Institute of Modern Physics, Lanzhou, China. The experimental electron-ion collision energy range covers the first Rydberg series up to n = 24 for the DR resonances associated with the {}2P1/2\\to {}2P3/2{{Δ }}n=0 core excitations. A theoretical calculation was performed by using FAC code and compared with the measured DR rate coefficient. Overall reasonable agreement was found between the experimental results and calculations. Moreover, the plasma rate coefficient was deduced from the experimental DR rate coefficient and compared with the available results from the literature. At the low energy range, significant discrepancies were found, and the measured resonances challenge state-of-the-art theory at low collision energies. Supported by the National Key R&D Program of China (2017YFA0402300), the National Natural Science Foundation of China through (11320101003, U1732133, 11611530684) and Key Research Program of Frontier Sciences, CAS (QYZDY-SSW-SLH006)
... International Symposium on Stem Cell Therapy and Cardiovascular Innovations in Madrid this month. Dr. Martin and his ... lab’s researchers. THI's Director of Electrophysiology Clinical Research & Innovations Dr. Mehdi Razavi and researchers at Rice University ...
EDN1 Lys198Asn is associated with diabetic retinopathy in type 2 diabetes
Li, Haitao; Louey, Janice W.C.; Choy, Kwong Wai; Liu, David T.L.; Chan, Wai Man; Chan, Yiu Man; Fung, Nicholas S.K.; Fan, Bao Jian; Baum, Larry; Chan, Juliana C.N.; Lam, Dennis S.C.
2008-01-01
Purpose We tested the hypothesis that genetic variants in vasoactive and angiogenic factors regulating the retina vasculature contribute to the development of diabetic retinopathy (DR). Methods A case-control study was performed to study the genetic association between DR and polymorphic variants of EDN1 (Lys198Asn), LTA (IVS1–80C>A, IVS1–206G>C, IVS1–252A>G), eNOS (Glu298Asp), and ITGA2 (BgI II) in a Chinese population with type 2 diabetes mellitus. A well defined population with type 2 diabetes, consisting of 127 controls and 216 DR patients, was recruited. Results A higher frequency of the Asn/Asn genotype of EDN1 was found in individuals with at least 10 years of diabetes and no retinopathy (controls) compared with DR patients with any duration of diabetes (DR: 2.3%; control: 11.0%; p=0.0002). The Asn allele was also more frequent in controls than DR patients (DR: 16.4%; control: 29.5%; p=0.007). Multiple logistic regression analysis showed that the Asn/Asn genotype was the factor most significantly associated with reduced risk of DR (odds ratio=0.19; 95% CI: 0.07-0.53; p=0.002) and with late onset of diabetes (Asn/Asn: 59 years; Lys/Lys + Lys/Asn: 53 years; p=0.02). Moreover, the Lys/Lys genotype was more common among patients with nonproliferative (75.7%) than proliferative DR (56.9%; p=0.008). The distributions of Lys198Asn alleles in hypertension did not differ from normotensive subjects. No associations between DR and polymorphisms of LTA, eNOS, or ITGA2 were detected, and there were no detectable gene-gene or gene-environmental interactions among the polymorphisms. Conclusions The Asn/Asn genotype of EDN1 was associated with a reduced risk of DR and with delayed onset of type 2 diabetes. PMID:18806884
2011 Presidential Early Career Awards for Scientists and Engineers: the PECASE Awards Ceremony
Poneman, Daniel
2018-05-31
The winners for 2011 of the DOE PECASE Awards were recognized in a ceremony held August 01, 2012. Dr. Bill Brinkman, Director of the Office of Science introduced the main speaker, DOE Deputy Secretary Daniel B. Poneman. Leaders from across the Department and the fields of energy research and technology presented the 2011 winners. They are: Dr. Stanley Atcitty (SNL); Dr. Jeffrey W. Banks (LLNL); Dr. Amy J. Clarke (LANL); Derek R. Gaston (INL); Dr. Christopher Hirata (California Institute of Technology); Dr. Heileen Hsu-Kim (Duke University); Dr. Thomas Francisco (Jaramillo Stanford University); Dr.Pablo Jarillo-Herrero (MIT); Dr. Peter Mueller (ANL); Dr. Daniel B. Sinars (SNL); Dr. Jesse Thaler (MIT); and Dr. Heather Whitley (LLNL).
2011 Presidential Early Career Awards for Scientists and Engineers: the PECASE Awards Ceremony
DOE Office of Scientific and Technical Information (OSTI.GOV)
Poneman, Daniel
2012-08-01
The winners for 2011 of the DOE PECASE Awards were recognized in a ceremony held August 01, 2012. Dr. Bill Brinkman, Director of the Office of Science introduced the main speaker, DOE Deputy Secretary Daniel B. Poneman. Leaders from across the Department and the fields of energy research and technology presented the 2011 winners. They are: Dr. Stanley Atcitty (SNL); Dr. Jeffrey W. Banks (LLNL); Dr. Amy J. Clarke (LANL); Derek R. Gaston (INL); Dr. Christopher Hirata (California Institute of Technology); Dr. Heileen Hsu-Kim (Duke University); Dr. Thomas Francisco (Jaramillo Stanford University); Dr.Pablo Jarillo-Herrero (MIT); Dr. Peter Mueller (ANL); Dr.more » Daniel B. Sinars (SNL); Dr. Jesse Thaler (MIT); and Dr. Heather Whitley (LLNL).« less
ERIC Educational Resources Information Center
Henderson, Nancy
2008-01-01
In this article, the author profiles Dr. Jack Kessler, chair of the Department of Neurology at Northwestern University Feinberg School of Medicine. Dr. Jack Kessler is a renowned stem cell expert and researcher. For years, Dr. Kessler had been researching ways to repair damage to the nervous system. It was not until his own daughter became…
Keller, Melissa R.; Haynes, Lynn D.; Jankowska-Gan, Ewa; Sullivan, Jeremy A.; Agashe, Vrushali V.; Burlingham, Scott R.; Burlingham, William J.
2013-01-01
Background IL-17-dependent cellular immune responses to the α1 chain of collagen type V are associated with development of bronchiolitis obliterans syndrome after lung transplantation, and with idiopathic pulmonary fibrosis and coronary artery disease, primary indications for lung or heart transplantation, respectively. Methodology/Principal Findings We found that 30% of the patients awaiting lung transplantation exhibited a strong cell-mediated immune response to col(V). Of these, 53% expressed HLA-DR15, compared to a 28% HLA-DR15 frequency in col(V) low-responders (p=0.02). After transplantation, patients with HLA-DR1 and -DR17, not -DR15, developed anti-col(V) responses most frequently (p=0.04 and 0.01 vs. controls, respectively). However, recipients of a lung from an HLA-DR15+ donor were at significantly elevated risk of developing anti-col(V) responses (p=0.02) and BOS (p=0.03). To determine the molecular basis of this unusual pattern of DR allele bias, a peptide library comprising the collagenous region of the α1(V) protein was screened for binding to HLA-DR0101, -DR1501, -DR0301 (DR17) or to HLA-DQ2 (DQA1*0501: DQB1*0201; in linkage disequilibrium with -DR17) and -DQ6 (DQA1*0102: DQB1*0602; linked to -DR15). Eight 15-mer peptides, six DR-binding and two DQ-binding, were identified. HLA-DR15 binding to two peptides yielded the highest binding scores: 650 (where 100 = positive control) for p799 (GIRGLKGTKGEKGED), and 193 for p1439 (LRGIPGPVGEQGLPG). These peptides, which also bound weakly to HLA-DR1, elicited responses in both HLA-DR1+ and -DR15+ col(V) reactive hosts, whereas binding and immunoreactivity of p1049 (KDGPPGLRGFPGDRG) was DR15-specific. Remarkably, a col(V)-reactive HLA-DR1+DR15neg lung transplant patient, whose donor was HLA-DR15+, responded not only to p799 and p1439, but also to p1049. Conclusions/Significance HLA-DR15 and IPF disease were independently associated with pre-transplant col(V) autoimmunity. The increased risk of de novo immunity to col(V) and BOS, associated with receiving a lung transplant from an HLA-DR15+ donor, may result from presentation by donor-derived HLA- DR15, of novel self-peptides to recipient T cells. PMID:24265781
Approximating Multivariate Normal Orthant Probabilities Using the Clark Algorithm.
1987-07-15
Kent Eaton Army Research Institute Dr. Hans Crombag 5001 Eisenhower Avenue University of Leyden Alexandria, VA 22333 Education Research Center...Boerhaavelaan 2 Dr. John M. Eddins 2334 EN Leyden University of Illinois The NETHERLANDS 252 Engineering Research Laboratory Mr. Timothy Davey 103 South...Education and Training Ms. Kathleen Moreno Naval Air Station Navy Personnel R&D Center Pensacola, FL 32508 Code 62 San Diego, CA 92152-6800 Dr. Gary Marco
Naval Health Research Center 1985 Annual Report
1985-01-01
research. While much of our earlier work addressed organizational issues within the shote -based health care delivery sytem, more recent efforts have focused...Laboratory, Groton, Connecticut, cn the Neurometric Program. Dr. Naitoh met with Dr. Charles Winget of NASA Amen Rasearch Center for a research consultation...lag in commercial aircrews. Collaborators on the project include LT COL R. Curtis Graeber from NASA -Ames, Dr. Hans-Martin Wegmann from the West German
Scientometric Analysis and Mapping of Scientific Articles on Diabetic Retinopathy.
Ramin, Shahrokh; Gharebaghi, Reza; Heidary, Fatemeh
2015-01-01
Diabetic retinopathy (DR) is the major cause of blindness among the working-age population globally. No systematic research has been previously performed to analyze the research published on DR, despite the need for it. This study aimed to analyze the scientific production on DR to draw overall roadmap of future research strategic planning in this field. A bibliometric method was used to obtain a view on the scientific production about DR by the data extracted from the Institute for Scientific Information (ISI). Articles about DR published in 1993-2013 were analyzed to obtain a view of the topic's structure, history, and to document relationships. The trends in the most influential publications and authors were analyzed. Most highly cited articles addressed epidemiologic and translational research topics in this field. During the past 3 years, there has been a trend toward biomarker discovery and more molecular translational research. Areas such as gene therapy and micro-RNAs are also among the recent hot topics. Through analyzing the characteristics of papers and the trends in scientific production, we performed the first scientometric report on DR. Most influential articles have addressed epidemiology and translational research subjects in this field, which reflects that globally, the earlier diagnosis and treatment of this devastating disease still has the highest global priority.
1984-09-01
1968-71 Dr. Francis S. L. Williamson, 1971-75 Dr. J. Kevin Sullivan, 1975-83 Dr. David L. Correll, 1983-84 B-I...BASIC RESEARCH (cont’d) SMITHSONIAN INSTITUTION Dr. I. Eugene Wallen, 1968-71 Dr. Francis S. L. Williamson, 1971-75 Dr. 3. Kevin Sullivan, 1975-83 Dr...MSX merical fishino and recrea- by increased distributions of waer sources fromsaltitru- the B E P predicted oysters tion industries and for the
Dr. Jennifer Temel is an Associate Professor of Medicine at Harvard Medical School and Director of the Cancer Outcomes Research Program at the Massachusetts General Hospital (MGH) Cancer Center. She is also the Clinical Director of Thoracic Oncology at the MGH Cancer Center and provides oncology care for patients with lung and esophageal cancer. Her research focuses on improving palliative, supportive and end of life care for patients with cancer and their families. She has received funding from the National Cancer Institute, the National Institute of Nursing Research, the Patient Centered Outcomes Research Institute, and the American Cancer Society to study novel methods of improving the care of cancer patients. One of the main focuses of Dr. Temel’s research involves studying the integration of palliative and oncology care in patients with advanced cancers. Her work in this area has been published in the New England Journal of Medicine, the Journal of Clinical Oncology, and JAMA. She was awarded a National Cancer Institute mid-career development award to mentor others in palliative and end of life care in oncology and serves as the co-Principal Investigator on a National Cancer Institute grant to conduct a workshop on methods in supportive oncology research for junior faculty. Dr. Temel recently received the American Academy of Hospice and Palliative Medicine Award for Excellence in Scientific Research, the American Cancer Society Pathfinder Award for her impact on the field of palliative care, and the American Psychosocial Oncology Society Award for Outstanding Education and Training.
Mission Critical STEM Partnership with the Air Force Office of Scientific Research
2015-04-06
Dr. Valerie Lundy-Wagner, Senior Research Associate, Community College Research Center Teachers College, Columbia University 29...composites. We were comparing our experiments vs. structural steel . Our project consisted of a 4x4 in square caste. The caste was fabricated by bonding...aluminum and stainless steel . The caste experiments varied from 3, 5, and 7 stainless steel rods embedded in the piece. We tested for tensile strength
Dr. von Braun Briefing Walt Disney
NASA Technical Reports Server (NTRS)
1965-01-01
Dr. von Braun began his association with Walt Disney in the 1950s when the rocket scientist appeared in three Disney television productions related to the exploration of space. Years later, Dr. von Braun invited Disney and his associates to tour the Marshall Space Flight Center (MSFC) in Huntsville, Alabama. This photograph is dated April 13, 1965. From left are R.J. Schwinghamer from the MSFC, Disney, B.J. Bernight, and Dr. von Braun.
Hooper, Scott L; Burstein, Helaine J
2015-03-28
Following the publication of this article [1] it was noticed that, due to an error on the part of the publisher, the 2nd round of comments submitted by Reviewer 1, Dr. López-García, were unintentionally omitted during the peer review process. As a consequence of this error, the authors were unable to reply to Dr. López-García's comments and subsequently revise their manuscript accordingly (where appropriate).In fairness to both the authors and reviewer, Dr. López-García's (Reviewer 1) 2nd round of comments are now included below and Scott L Hooper and Helaine J Burstein (author) were given the opportunity to reply. Any consequent amendments to the research article [1] are outlined in the author's replies.
DOE Office of Scientific and Technical Information (OSTI.GOV)
NONE
1995-08-01
This report is a transcript of an interview with Dr. Helen Vodopick by representatives of the US DOE Office of Human Radiation Experiments. Dr. Vodopick was chosen for this interview because of her involvement with the Oak Ridge Institute of Nuclear Studies (ORINS) and Oak Ridge Associated Universities (ORAU) experimental cancer-therapy program involving total-body irradiation. After a short biographical sketch Dr. Vodopick relates her remembrances of the Medium-Exposure-Rate Total Body Irradiator (METBI), ORINS radioisotope tracer studies, treatment of cancer patients with the METBI, radiation treatment for leukemia patients, bone marrow treatment of leukemia, the Low-Exposure-Rate Total Body Irradiation (LETBI), treatmentmore » of radiation accident victims at ORAU, research with radioactive phosphorus and sulfur, and public opinion issues.« less
Rudolf Hermann, wind tunnels and aerodynamics
NASA Astrophysics Data System (ADS)
Lundquist, Charles A.; Coleman, Anne M.
2008-04-01
Rudolf Hermann was born on December 15, 1904 in Leipzig, Germany. He studied at the University of Leipzig and at the Aachen Institute of Technology. His involvement with wind tunnels began in 1934 when Professor Carl Wieselsberger engaged him to work at Aachen on the development of a supersonic wind tunnel. On January 6, 1936, Dr. Wernher von Braun visited Dr. Hermann to arrange for use of the Aachen supersonic wind tunnel for Army problems. On April 1, 1937, Dr. Hermann became Director of the Supersonic Wind Tunnel at the Army installation at Peenemunde. Results from the Aachen and Peenemunde wind tunnels were crucial in achieving aerodynamic stability for the A-4 rocket, later designated as the V-2. Plans to build a Mach 10 'hypersonic' wind tunnel facility at Kochel were accelerated after the Allied air raid on Peenemunde on August 17, 1943. Dr. Hermann was director of the new facility. Ignoring destruction orders from Hitler as WWII approached an end in Europe, Dr. Hermann and his associates hid documents and preserved wind tunnel components that were acquired by the advancing American forces. Dr. Hermann became a consultant to the Air Force at its Wright Field in November 1945. In 1951, he was named professor of Aeronautical Engineering at the University of Minnesota. In 1962, Dr. Hermann became the first Director of the Research Institute at the University of Alabama in Huntsville (UAH), a position he held until he retired in 1970.
2009-01-01
Ste B-100 Directed Energy Bioeffects Division San Antonio, TX 78228 Optical Radiation Branch 2624 Louis Bauer Dr. Brooks City-Base, TX...S) Air Force Research Laboratory Human Effectiveness Directorate Directed Energy Bioeffects Division Optical Radiation Branch 2624 Louis Bauer Dr...Research Laboratory, 711th HPW, Optical Radiation Branch, 2624 Louis Bauer Dr., Brooks City-Base, Texas 78231 3Northrop Grumman, 4241 Woodcock Dr. Ste. B
Wuttke, Daniel; Connor, Richard; Vora, Chintan; Craig, Thomas; Li, Yang; Wood, Shona; Vasieva, Olga; Shmookler Reis, Robert; Tang, Fusheng; de Magalhães, João Pedro
2012-01-01
Dietary restriction (DR), limiting nutrient intake from diet without causing malnutrition, delays the aging process and extends lifespan in multiple organisms. The conserved life-extending effect of DR suggests the involvement of fundamental mechanisms, although these remain a subject of debate. To help decipher the life-extending mechanisms of DR, we first compiled a list of genes that if genetically altered disrupt or prevent the life-extending effects of DR. We called these DR–essential genes and identified more than 100 in model organisms such as yeast, worms, flies, and mice. In order for other researchers to benefit from this first curated list of genes essential for DR, we established an online database called GenDR (http://genomics.senescence.info/diet/). To dissect the interactions of DR–essential genes and discover the underlying lifespan-extending mechanisms, we then used a variety of network and systems biology approaches to analyze the gene network of DR. We show that DR–essential genes are more conserved at the molecular level and have more molecular interactions than expected by chance. Furthermore, we employed a guilt-by-association method to predict novel DR–essential genes. In budding yeast, we predicted nine genes related to vacuolar functions; we show experimentally that mutations deleting eight of those genes prevent the life-extending effects of DR. Three of these mutants (OPT2, FRE6, and RCR2) had extended lifespan under ad libitum, indicating that the lack of further longevity under DR is not caused by a general compromise of fitness. These results demonstrate how network analyses of DR using GenDR can be used to make phenotypically relevant predictions. Moreover, gene-regulatory circuits reveal that the DR–induced transcriptional signature in yeast involves nutrient-sensing, stress responses and meiotic transcription factors. Finally, comparing the influence of gene expression changes during DR on the interactomes of multiple organisms led us to suggest that DR commonly suppresses translation, while stimulating an ancient reproduction-related process. PMID:22912585
Ann O'Mara, PhD, RN, MPH | Division of Cancer Prevention
Dr. Ann O'Mara is Head of Palliative Research in the NCI Division of Cancer Prevention. She manages a portfolio of symptom management and palliative and end-of-life care research projects. The majority of these projects focus on the more common morbidities associated with cancer and its treatment, e.g., pain, chemotherapy induced neuropathy, fatigue, sleep disturbances, and
2001-02-08
At a groundbreaking ceremony, participants and guests get ready to dig in, signifying the start of construction on a new roadway through KSC. It is the start of a construction project that includes the Space Experiment Research & Processing Laboratory (SERPL). From left are Dr. Pamella J. Dana, from the executive office of Florida’s governor, Jeb Bush; Deputy Associate Administrator Michael Hawes, Space Station, NASA; Sen. George Kirkpatrick; Spaceport Florida Authority Executive Director Ed Gormel; Executive Director Dr. Samuel T. Durrance, Florida Space Research Institute; Florida’s Lt. Gov. Frank Brogan; Congressman Dave Weldon; Center Director Roy Bridges Jr.; SFA SERPL Program Manager Debra Holliday; KSC SERPL Program Manager Jan Heuser; District Manager Cheryl Harrison-Lee, Florida Department of Transportation; State Senator Jim Sebesta; and KSC Director JoAnn H. Morgan, External Relations and Business Development. The project is enabled by a partnership and collaboration between NASA and the State of Florida to create a vital resource for international and commercial space customers. SERPL is considered a magnet facility, and will support the development and processing of life sciences experiments destined for the International Space Station and accommodate NASA, industry and academic researchers performing associated biological research
Balasubbu, Suganthalakshmi; Sundaresan, Periasamy; Rajendran, Anand; Ramasamy, Kim; Govindarajan, Gowthaman; Perumalsamy, Namperumalsamy; Hejtmancik, J Fielding
2010-11-10
Diabetic retinopathy (DR) is classically defined as a microvasculopathy that primarily affects the small blood vessels of the inner retina as a complication of diabetes mellitus (DM).It is a multifactorial disease with a strong genetic component. The aim of this study is to investigate the association of a set of nine candidate genes with the development of diabetic retinopathy in a South Indian cohort who have type 2 diabetes mellitus (T2DM). Seven candidate genes (RAGE, PEDF, AKR1B1, EPO, HTRA1, ICAM and HFE) were chosen based on reported association with DR in the literature. Two more, CFH and ARMS2, were chosen based on their roles in biological pathways previously implicated in DR. Fourteen single nucleotide polymorphisms (SNPs) and one dinucleotide repeat polymorphism, previously reported to show association with DR or other related diseases, were genotyped in 345 DR and 356 diabetic patients without retinopathy (DNR). The genes which showed positive association in this screening set were tested further in additional sets of 100 DR and 90 DNR additional patients from the Aravind Eye Hospital. Those which showed association in the secondary screen were subjected to a combined analysis with the 100 DR and 100 DNR subjects previously recruited and genotyped through the Sankara Nethralaya Hospital, India. Genotypes were evaluated using a combination of direct sequencing, TaqMan SNP genotyping, RFLP analysis, and SNaPshot PCR assays. Chi-square and Fisher exact tests were used to analyze the genotype and allele frequencies. Among the nine loci (15 polymorphisms) screened, SNP rs2070600 (G82S) in the RAGE gene, showed significant association with DR (allelic P = 0.016, dominant model P = 0.012), compared to DNR. SNP rs2070600 further showed significant association with DR in the confirmation cohort (P = 0.035, dominant model P = 0.032). Combining the two cohorts gave an allelic P < 0.003 and dominant P = 0.0013). Combined analysis with the Sankara Nethralaya cohort gave an allelic P = 0.0003 and dominant P = 0.00011 with an OR = 0.49 (0.34 - 0.70) for the minor allele. In HTRA1, rs11200638 (G>A), showed marginal significance with DR (P = 0.055) while rs10490924 in LOC387715 gave a P = 0.07. No statistical significance was observed for SNPs in the other 7 genes studied. This study confirms significant association of one polymorphism only (rs2070600 in RAGE) with DR in an Indian population which had T2DM.
Man, Ryan Eyn Kidd; Sabanayagam, Charumathi; Chiang, Peggy Pei-Chia; Li, Ling-Jun; Noonan, Jonathan Edward; Wang, Jie Jin; Wong, Tien Yin; Cheung, Gemmy Chui-Ming; Tan, Gavin Siew Wei; Lamoureux, Ecosse L
2016-03-01
The association between obesity and diabetic retinopathy (DR) is equivocal, possibly owing to the strong interrelation between generalized and abdominal obesity leading to a mutually confounding effect. To our knowledge, no study in Asia has investigated the independent associations of these 2 parameters with DR to date. To investigate the associations of generalized (defined by body mass index [BMI], calculated as weight in kilograms divided by height in meters squared) and abdominal obesity (assessed by waist to hip ratio [WHR]) with DR in a clinical sample of Asian patients with type 2 diabetes mellitus. This cross-sectional clinic-based study was conducted at the Singapore National Eye Centre, a tertiary eye care institution in Singapore, from December 2010 to September 2013. We recruited 498 patients with diabetes. After exclusion of participants with ungradable retinal images and type 1 diabetes, 420 patients (mean [SD] age, 57.8 [7.5] years; 32.1% women) were included in the analyses. Body mass index and WHR as waist/hip circumference (in centimeters). The presence and severity of DR were graded from retinal images using the modified Airlie House Classification into none (n = 189), mild-moderate (Early Treatment Diabetic Retinopathy Study scale score, 20-41; n = 125), and severe DR (Early Treatment Diabetic Retinopathy Study scale score ≥53; n = 118). The associations of BMI and WHR with DR were assessed using multinomial logistic regression models adjusting for age, sex, traditional risk factors, and mutually for BMI and WHR. Among the total of 420 patients, the median (interquartile range) for BMI and WHR were 25.7 (5.7) and 0.94 (0.08), respectively. In multivariable models, BMI was inversely associated with mild-moderate and severe DR (odds ratio [OR], 0.90 [95% CI, 0.84-0.97] and OR, 0.92 [95% CI, 0.85-0.99] per 1-unit increase, respectively), while WHR was positively associated with mild-moderate and severe DR (OR, 3.49 [95% CI, 1.50-8.10] and OR, 2.68 [95% CI, 1.28-5.62] per 0.1-unit increase, respectively) in women (P for interaction = .006). No sex-specific associations were found between BMI and DR (P for interaction >.10). In Asian patients with type 2 diabetes, a higher BMI appeared to confer a protective effect on DR, while higher WHR was associated with the presence and severity of DR in women. Our results may inform future clinical trials to determine whether WHR is a more clinically relevant risk marker than BMI for individuals with type 2 diabetes.
Friedewald, Vincent E; Kornman, Kenneth S; Beck, James D; Genco, Robert; Goldfine, Allison; Libby, Peter; Offenbacher, Steven; Ridker, Paul M; Van Dyke, Thomas E; Roberts, William C
2009-07-01
This Editors' Consensus is supported by an educational grant from Colgate-Palmolive, Inc., New York, New York, and is based on a meeting of the authors held in Boston, Massachusetts, on January 9, 2009. Dr. Friedewald has received honoraria for speaking from Novartis, East Hanover, New Jersey. Dr. Kornman is a full-time employee and shareholder of Interleukin Genetics, Waltham, Massachusetts, which owns patents on genetic biomarkers for chronic inflammatory diseases. Dr. Genco is a consultant to Merck, Whitehouse Station, New Jersey. Dr. Ridker has received research support from AstraZeneca, Wilmington, Delaware; Novartis; Pfizer, New York, New York; Roche, Nutley, New Jersey; Sanofi-Aventis, Bridgewater, New Jersey; and Abbott Laboratories, Abbott Park, Illinois. Dr. Ridker has received non-financial research support from Amgen, Thousand Oaks, California. Dr. Ridker is a co-inventor on patents held by Brigham and Women's Hospital that relate to the use of inflammatory biomarkers in cardiovascular disease. Dr. Ridker is a research consultant for Schering-Plough, Kenilworth, New Jersey; Sanofi-Aventis; AstraZeneca; Isis, Carlsbad, California; Novartis; and Vascular Biogenics, Tel Aviv, Israel. Dr. Van Dyke is a co-inventor on patents held by Boston University, Boston, Massachusetts, that relate to inflammation control, including consulting fees. Dr. Roberts has received honoraria for speaking from Merck, Schering-Plough, AstraZeneca, and Novartis. All other individuals in a position to control content disclosed no relevant financial relationships.
A Diagnostic Approach to Building Collaborative Capacity in an Interagency Context
2006-09-25
School. She received an EdD at Arizona State University in Business and Education in 1986. She currently teaches strategic communication in the MBA...Provost The Acquisition Chair, Graduate School of Business & Public Policy, Naval Postgraduate School supported the funding of the research...Thomas, Associate Professor Graduate School of Business & Public Policy ________________________________ Dr. Susan Page Hocevar, Associate
ERIC Educational Resources Information Center
Wardlow, George W.
2014-01-01
Dr. George W. Wardlow presented the 2013 AAAE Distinguished Lecture at the Annual Meeting of the American Association for Agricultural Education in Columbus, Ohio in May, 2013. While the focus of the article is on the importance of research to the profession, it is intended as a philosophical work.
Polar Science: From the Field to the Classroom (Invited)
NASA Astrophysics Data System (ADS)
O'Neill, M.; O'Brien, K.
2010-12-01
The ARMADA Project was a National Science Foundation Project organized by the Office of Marine Programs of the University of Rhode Island. ARMADA connected scientists and teachers to conduct field research together and share directly with the classroom. In addition to the field research, ARMADA teachers mentored new science teachers to assist in teacher retention and presented at National Science Teachers’ Association National Conventions. As an ARMADA teacher, I participated in two polar research experiences. In 2007, I worked with scientists from the University of Barcelona, Spain in the Arctic off the coast of Svalbard conducting seafloor mapping and sediment core sampling. My second research experience was to Antarctica in 2009 with Dr. Kristin O’Brien and her team studying Antarctic Ice Fish and their tolerance to temperature change. Sharing ship time with Dr. O’Brien was a team of scientists from Duke University studying humpback whales and their feeding behaviors. I was able to join both research teams and share the information with students, colleagues and the community. Connecting directly with scientists in the field has not only increased my personal knowledge of polar science, but has been invaluable to my teaching efforts. While in the Arctic, I was able to conduct a telephone conference with my students and the lead scientist via the satellite phone. From Antarctica I connected with several classes from Fairhope High School in a “Live from Antarctica” video conference. I was able to take them on a “virtual tour” of Palmer Station and Dr. O’Brien and Dr. Crockett answered student questions about Antarctic Fish. During both expeditions, I maintained a daily blog that enable my students to follow along with my research experience. Being able to bring the most current scientific research into the classroom with these expeditions has been inspiring for the students, colleagues and community.
capr-contact us | Center for Cancer Research
CAPR Contacts: Dr. Shyam Sharan, Director; Dr. Zoe Weaver Ohler, Preclinical Team Leader; Dr. Serguei Kozlov, Technology Optimization Team Leader; Ken Miller, Project Manager; Chris Hester, Administrative Assistant
Sesquinaries, Magnetics and Atmospheres: Studies of the Terrestrial Moons and Exoplanets
2016-12-01
support provided by Red Sky Research, LLC. Computational support was provided by the NASA Ames Mission Design Division (Code RD) for research...Systems Branch (Code SST), NASA Ames Research Center, provided supercomputer access and computational resources for the work in Chapter 5. I owe a...huge debt of gratitude to Dr. Pete Worden, Dr. Steve Zornetzer, Dr. Alan Weston ( NASA ), and Col. Carol Welsch, Lt. Col Joe Nance and Lt. Col Brian
NASA Technical Reports Server (NTRS)
Tao, W.-K.; Adler, R.; Braun, S.; Einaudi, F.; Ferrier, B.; Halverson, J.; Heymsfield, G.; Kummerow, C.; Negri, A.; Kakar, R.;
2000-01-01
A symposium celebrating the first 50 years of Dr. Joanne Simpson's career took place at the NASA/Goddard Space Flight Center from December 1 - 3, 1999. This symposium consisted of presentations that focused on: historical and personal points of view concerning Dr. Simpson's research career, her interactions with the American Meteorological Society, and her leadership in TRMM; scientific interactions with Dr. Simpson that influenced personal research; research related to observations and modeling of clouds, cloud systems and hurricanes; and research related to the Tropical Rainfall Measuring Mission (TRMM). There were a total of 36 presentations and 103 participants from the US, Japan and Australia. The specific presentations during the symposium are summarized in this paper.
Improving Decision Making for Advanced Heart Failure Patients and Caregivers.
McIlvennan, Colleen K
2017-04-01
In this month's Magnet® Perspectives column, Colleen K. McIlvennan, DNP, ANP, lead nurse practitioner, Advanced Heart Failure and Transplantation at the University of Colorado, discusses her groundbreaking research encompassing patients' and caregivers' emotional, rational, and fundamental beliefs when considering a left ventricular assist device (LVAD). Results have led to the development of 2 innovative decision aids that are currently in use by LVAD programs across the United States and Canada. Dr McIlvennan's efforts led to a $2 million grant from the Patient-Centered Outcomes Research Institute, as well as national recognition from the American Heart Association and the Heart Failure Society of America. Last year, she received the 2016 National Magnet Nurse of the Year® Award in the Empirical Outcomes category. In addition to sharing her findings, Dr McIlvennan examines the value of performing research in a Magnet-recognized organization.
Annotated Bibliography of Dr Salmani Nodoushan's Research on Education and Language Teaching
ERIC Educational Resources Information Center
Etemadfar Kashani, Abbas Ali
2016-01-01
This is an annotated bibliography of the research conducted on education and language teaching and assessment by Dr. Mohammad Ali Salmani Nodoushan in the past 25 years. This bibliography is a precise picture of the current state of education and language teaching and assessment in Iran. Dr. Salmani Nodoushan is the most distinguished Iranian…
A dangerous movie? Hollywood does psychoanalysis.
Ferrell, Donald R; Silverman, Martin A
2014-12-01
After the appearance of David Cronenberg's film A Dangerous Method in 2011, dealing with the relationships of Sigmund Freud, C. G. Jung and Sabina Spielrein, Dr. Donald Ferrell published: A Dangerous Method, A Film Directed by David Cronenberg: An Extended Review (Ferrell 2012) in the Journal of Religion and Health. Upon its publication, Dr. Ferrell's article was nominated for a Gradiva Award by the National Association for the Advancement of Psychoanalysis. On November 1, 2013, the Association for the Psychoanalysis of Culture and Society held its annual conference at Rutgers University, New Brunswick, NJ. Dr. Billie Pivnick, a member at large of the Board of Directors of the APCS and also on the Editorial Board of the Journal of Religion and Health, persuaded the 2013 Conference Program Committee that Cronenberg's film would make an interesting subject for discussion for conference participants. To that end, Dr. Pivnick invited Dr. Ferrell, C. G. Jung Institute of New York, Dr. Steven Reisner, Coalition for an Ethical Psychology, and Dr. Martin Silverman, Training and Supervising Analyst and Supervising Child Analyst at the Institute for Psychoanalytic Education, NYU College of Medicine, Training and Supervising Analyst at the Center for Psychotherapy and Psychoanalysis of New Jersey, and Associate Editor of The Psychoanalytic Quarterly to serve as panel members to discuss: A Dangerous Movie? Hollywood does Psychoanalysis. Presentations on Cronenberg's film and the early history of psychoanalysis were given by Drs. Ferrell and Reisner, followed by a response to their presentations by Dr. Silverman. Dr. Pivnick chaired the session. The articles presented here were given originally at the APCS conference by Dr. Ferrell and Dr. Silverman. Dr. Reisner declined the invitation to submit his presentation for publication. Dr. Silverman's remarks were based not only on the presentation given by Dr. Ferrell at the session on A Dangerous Movie?, but also on his close and careful reading of the extended review of Cronenberg's film Dr. Ferrell published in the Journal of Religion and Health, as well as Dr. Reisner's presentation. It was appropriate for Dr. Silverman to serve in his capacity as discussant since he had earlier published a critical review of A Secret Symmetry. Sabina Spielrein Between Jung and Freud by Aldo Carotenuto (Silverman 1985).
Dietary restriction alters fine motor function in rats.
Smith, Lori K; Metz, Gerlinde A
2005-08-07
A number of standard behavioral tasks in animal research utilize food rewards for positive reinforcement. In order to enhance the motivation to participate in these tasks, animals are usually placed on a restricted diet. While dietary restriction (DR) has been shown to have beneficial effects on recovery after brain injury, life span and aging processes, it might also represent a stressor. Since stress can influence a broad range of behaviors, the purpose of this study was to assess whether DR may have similar effects on skilled movement. Adult male Long-Evans rats were trained and tested in a skilled reaching task both prior to and during a mild food restriction regimen that maintained their body weights at 90-95% of baseline weight for eight days. The observations revealed that DR decreased reaching success and increased the number of attempts to grasp a single food pellet. The animals appeared to be more frantic when attempting to reach for food pellets, and the time taken to reach for 20 pellets decreased following the onset of DR. A second experiment investigating behaviors that do not require food rewards, including a ladder rung walking task and an open field test, confirmed that rats on DR display deficits in skilled movements and are hyperactive. These findings suggest that results obtained in motor tasks using food rewards need to be interpreted with caution. The findings are discussed with respect to stress associated with DR.
Increased Burden of Cerebral Small Vessel Disease in Patients With Type 2 Diabetes and Retinopathy.
Sanahuja, Jordi; Alonso, Núria; Diez, Javier; Ortega, Emilio; Rubinat, Esther; Traveset, Alícia; Alcubierre, Núria; Betriu, Àngels; Castelblanco, Esmeralda; Hernández, Marta; Purroy, Francisco; Arcidiacono, Maria Vittoria; Jurjo, Carmen; Fernández, Elvira; Puig-Domingo, Manuel; Groop, Per-Henrik; Mauricio, Dídac
2016-09-01
We sought to examine the presence and severity of brain small vessel disease (SVD) in patients with type 2 diabetes and diabetic retinopathy (DR) compared with those without DR. We evaluated 312 patients with type 2 diabetes without previous cardiovascular disease (men 51%; mean age 57 years; age range 40-75 years); 153 patients (49%) had DR. MRI was performed to evaluate the presence and severity (age-related white matter changes scale) of white matter lesions (WMLs) and lacunes, and transcranial Doppler ultrasound was used to measure the Gosling pulsatility index (PI) of the middle cerebral artery (MCA). The prevalence of lesions of cerebral SVD (WML and/or lacunes) was higher in patients with DR (40.2% vs. 30.1% without DR, P = 0.04). Age (P < 0.01) and systolic blood pressure (P = 0.02) were associated with the presence of SVD. The severity of SVD was associated with age and the presence of DR (P < 0.01 and P = 0.01, respectively). Patients with DR showed a higher MCA PI compared with those without DR (P < 0.01). Age, systolic and diastolic blood pressure, and retinopathy and its severity were associated with an increased MCA PI (P < 0.01 for all variables). A positive correlation was found between MCA PI values and the presence and severity of SVD (P < 0.01 for both variables). Patients with type 2 diabetes who have DR have an increased burden of cerebral SVD compared with those without DR. Our findings suggest that the brain is a target organ for microangiopathy, similar to other classic target organs, like the retina. © 2016 by the American Diabetes Association.
Dyslipidemia and Diabetic Retinopathy
Chang, Yo-Chen; Wu, Wen-Chuan
2013-01-01
Diabetic retinopathy (DR) is one of the major microvascular complications of diabetes. In developed countries, it is the most common cause of preventable blindness in diabetic adults. Dyslipidemia, a major systemic disorder, is one of the most important risk factors for cardiovascular disease. Patients with diabetes have an increased risk of suffering from dyslipidemia concurrently. The aim of this article is to review the association between diabetic retinopathy (DR) and traditional/nontraditional lipid markers, possible mechanisms involving lipid metabolism and diabetic retinopathy, and the effect of lipid-lowering therapies on diabetic retinopathy. For traditional lipid markers, evidence is available that total cholesterol and low-density lipoprotein cholesterol are associated with the presence of hard exudates in patients with DR. The study of nontraditional lipid markers is advancing only in recently years. The severity of DR is inversely associated with apolipoprotein A1 (ApoA1), whereas ApoB and the ApoB-to-ApoA1 ratio are positively associated with DR. The role of lipid-lowering medication is to work as adjunctive therapy for better control of diabetes-related complications including DR. PMID:24380088
Bilbao, J R; Calvo, B; Aransay, A M; Martin-Pagola, A; Perez de Nanclares, G; Aly, T A; Rica, I; Vitoria, J C; Gaztambide, S; Noble, J; Fain, P R; Awdeh, Z L; Alper, C A; Castaño, L
2006-10-01
The major susceptibility locus for type 1 diabetes mellitus (T1D) maps to the human lymphocyte antigen (HLA) class II region in the major histocompatibility complex on chromosome 6p21. In southern European populations, like the Basques, the greatest risk to T1D is associated with DR3 homo- and heterozygosity and is comparable to that of DR3/DR4, the highest risk genotype in northern European populations. Celiac disease (CD) is another DR3-associated autoimmune disorder showing certain overlap with T1D that has been explained by the involvement of common genetic determinants, a situation more frequent in DR3-rich populations, like the Basques. As both T1D- and CD-associated HLA alleles are part of conserved extended haplotypes (CEH), we compared DR3-homozygous T1D and CD patients to determine whether CEHs were equally distributed between both disorders or there was a differential contribution of different haplotypes. We observed a very pronounced distribution bias (P<10(-5)) of the two major DR3 CEHs, with DR3-B18 predominating in T1D and DR3-B8 in CD. Additionally, high-density single nucleotide polymorphism (SNP) analysis of the complete CEH [A*30-B*18-MICA*4-F1C30-DRB1*0301-DQB1*0201-DPB1*0202] revealed extraordinary conservation throughout the 4.9 Mbp analyzed supporting the existence of additional diabetogenic variants (other than HLA-DRB1*0301-DQB1*0201), conserved within the DR3-B18 CEH (but not in other DR3 haplotypes) that could explain its enhanced diabetogenicity.
Sahli, Michelle W; Mares, Julie A; Meyers, Kristin J; Klein, Ronald; Brady, William E; Klein, Barbara E K; Ochs-Balcom, Heather M; Donahue, Richard P; Millen, Amy E
2016-01-01
We tested the hypothesis that dietary intake of lutein is inversely associated with prevalence of diabetic retinopathy (DR) due to its antioxidant and anti-inflammatory properties and location within the retina. We used logistic regression to examine the association between prevalent DR and energy-adjusted lutein intake by quartile (Q) using data collected from 1430 Atherosclerosis Risk in Communities Study (ARIC) participants with diabetes (n = 994 white, n = 508 black). DR was assessed from 45° non-mydriatic retinal photographs of one randomly chosen eye taken at visit 3 (1993-1995). Dietary lutein intake was estimated using a 66-item food frequency questionnaire at visit 1 (1987-1989). Median estimated daily lutein intake was 1370 µg/1000 kcals and prevalence of DR was ~21%. We found a crude association between lutein and DR (odds ratio, OR, 2.11, 95% confidence interval, CI, 1.45-3.09 for Q4, high intake, vs. Q1, low intake; p for trend <0.0001), which was attenuated after adjustment for ethnicity, duration of diabetes, glycosylated hemoglobin levels, field center and energy intake (OR 1.41, 95% CI 0.87-2.28; p for trend = 0.01). In analyses limited to persons with short diabetes duration (<6 years), the association no longer persisted (OR 0.94, 95% CI 0.31-2.16; p for trend =0.72) compared to the association in those with longer diabetes duration (≥6 years; OR 1.58, 95% CI 0.91-2.75; p for trend = 0.01). Contrary to our hypothesis, we found that the odds of higher lutein intake were greater among those with DR than those without DR. However, after adjusting for confounders, intake of lutein was not associated with DR.
Ma, Jinlan; Li, Yan; Zhou, Fang; Xu, Xiaoyi; Guo, Gang; Qu, Yi
2012-01-01
The Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 (PPARγ2) gene is reported to be associated with diabetes. However, the gene's association with diabetic retinopathy (DR) in type 2 diabetes mellitus (T2DM) has been investigated in numerous epidemiologic studies with controversial results. This meta-analysis aimed to collectively assess the association of the Pro12Ala polymorphism with DR in T2DM. An electronic literature search was conducted on PubMed, ISI Web of Knowledge, EMBASE, and the China National Knowledge Internet. A dominant model [(Pro/Ala +Ala/Ala) versus Pro/Pro] was used to ensure adequate statistical power. Crude odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using the fixed effect model. Potential sources of heterogeneity and bias were explored. This meta-analysis included genotype data from 2,720 cases with DR and 2,450 controls free of DR from eight eligible publications. The results showed the Ala allele had a protective effect on DR in T2DM (OR=0.81; 95% CI: 0.68-0.98, p=0.03). There was no significant evidence against homogeneity (I(2)=46%, P(heterogeneity)=0.07). The sensitivity analysis showed a robust association of the Pro12Ala polymorphism with DR in T2DM after a study involving Caucasians that presented a big effect on heterogeneity (OR=0.75; 95% CI: 0.62-0.91, p=0.003) was excluded. Possible ethnic differences in the association of the Pro12Ala single nucleotide polymorphism and DR were demonstrated; a significant association was illustrated in the Caucasian subgroup (OR=0.74; 95% CI: 0.59-0.94, p=0.01) but was not found in the Asian subgroup (OR=0.77; 95% CI: 0.55-1.07, p=0.12). No publication bias was observed. This meta-analysis suggested a significant association exists between the Pro12Ala polymorphism and DR in T2DM with ethnic differences. The Ala allele had a significant protective effect against DR in T2DM.
Computerized Biophysical Data Acquisition System for Motion Sickness Studies.
1984-12-01
biofeedback in Autogenic Feedback Training (AFT). Dr. Patricia Cowings of 1- 1 NASA-Ames Research Center has also successfully used AFT in her studies (7...analysis can be completed. Summary of Current Knowledge Researchers have approached the problem of motion sick- ness in several ways. One approach is to...that the technique is not "black magic" (17). Despite apparent successes by Dr. Levy and others, notably Dr. Patricia Cowings of the NASA-Ames Research
Raum, Philipp; Lamparter, Julia; Ponto, Katharina A; Peto, Tunde; Hoehn, René; Schulz, Andreas; Schneider, Astrid; Wild, Philipp S; Pfeiffer, Norbert; Mirshahi, Alireza
2015-01-01
Diabetic retinopathy (DR) is the leading cause of blindness in people of working age. The purpose of this paper is to report the prevalence and cardiovascular associations of diabetic retinopathy and maculopathy (DMac) in Germany. The Gutenberg Health Study (GHS) is a population-based study with 15,010 participants aged between 35 at 74 years from the city of Mainz and the district of Mainz-Bingen. We determined the weighted prevalence of DR and DMac by assessing fundus photographs of persons with diabetes from the GHS data base. Diabetes was defined as HbA1c ≥ 6.5%, known diagnosis diabetes mellitus or known diabetes medication. Furthermore, we analysed the association between DR and cardiovascular risk factors and diseases. Overall, 7.5% (1,124/15,010) of the GHS cohort had diabetes. Of these, 27.7% were unaware of their disease and thus were newly diagnosed by their participation in the GHS. The prevalence of DR and DMac was 21.7% and 2.3%, respectively among patients with diabetes. Vision-threatening disease was present in 5% of the diabetic cohort. In the multivariable analysis DR (all types) was associated with age (Odds Ratio [95% confidence interval]: 0.97 [0.955-0.992]; p = 0.006) arterial hypertension (1.90 [1.190-3.044]; p = 0.0072) and vision-threatening DR with obesity (3.29 [1.504-7.206]; p = 0.0029). DR (all stages) and vision-threatening DR were associated with duration of diabetes (1.09 [1.068-1.114]; p<0.0001 and 1.18 [1.137-1.222]; p<0.0001, respectively). Our calculations suggest that approximately 142 000 persons aged between 35 and 74 years have vision threatening diabetic retinal disease in Germany [corrected].Prevalence of DR was lower in the GHS compared to East-Asian studies. Associations were found with age, arterial hypertension, obesity, and duration of diabetes mellitus.
Tang, Huilin; Li, Guangyao; Zhao, Ying; Wang, Fei; Gower, Emily W; Shi, Luwen; Wang, Tiansheng
2018-05-01
To assess the comparative effects of glucose-lowering drugs (GLDs) on the risk of diabetic retinopathy (DR) in patients with type 2 diabetes mellitus (T2DM). We systematically searched Cochrane Central Register of Controlled Trials, PUBMED and EMBASE from inception to January 17, 2017 to identify randomized controlled trials (RCTs) that reported DR events among T2DM patients receiving any GLD. Random-effects pairwise and network meta-analyses were performed to calculate odds ratios (ORs) with 95% confidence intervals (CIs). A total of 37 independent RCTs with 1806 DR events among 100 928 patients with T2DM were included. The mean duration of diabetes was 8.7 years and mean baseline HbA1c was 8.2% (SD, 0.5%). Our network meta-analysis found that DPP-4i (OR, 1.20; 95% CI, 0.87-1.65), GLP-1RA (OR, 1.19; 95% CI, 0.94-1.52) and SGLT2 inhibitors (OR, 0.79; 95% CI, 0.49-1.28) were not associated with a higher risk of DR than placebo; however, a significantly increased risk of DR was associated with DPP-4i in the pairwise meta-analysis (OR, 1.27; 95% CI, 1.05-1.53). Sulfonylureas, on the other hand, were associated with a significantly increased risk of DR compared to placebo (OR, 1.67; 95% CI, 1.01-2.76). Current evidence indicates that the association between DPP-4i, GLP-1RA or SGLT2 inhibitors and risk of DR remains uncertain in patients with T2DM. Some evidence suggests that sulfonylureas may be associated with increased risk of DR. However, given that DR events were not systematically assessed, these effects should be explored further in large-scale, well-designed studies. © 2018 John Wiley & Sons Ltd.
ERIC Educational Resources Information Center
Breunig, H. Latham
1990-01-01
This article describes the family of Alexander Graham Bell, including research and therapeutic work in speech and hearing impairments spanning three generations. Bell's life and discoveries are discussed, including the formation of the American Association for the Promotion of Teaching of Speech to the Deaf, whose history and organization are…
Energy-Efficient High-Performance Routers
2012-02-01
award, the PI Dr. Sartaj Sahni, AFRL research scientist Dr. Gunasekaran Seetharaman, and University of Florida Ph.D. student Ms. Tania Banerjee...Sartaj Sahni, AFRL research scientist Dr. Gunasekaran Seetharaman, and University of Florida Ph.D. student Ms. Tania Banerjee-Mishra...Searching and Shift Redundancy Architecture, IJSSC, 40, 1, Jan 2005, 245-253. PC-DUOS+: A TCAM Architecture for Packet Classifiers Tania Banerjee
DOE Office of Scientific and Technical Information (OSTI.GOV)
Jacob, C.O.; Fronek, Z.; Koo, M.
1990-02-01
The authors report on the production of tumor necrosis factor (TNF)-{alpha} and TNF-{beta} by mitogen-activated peripheral blood lymphocytes or enriched monocyte subpopulations from human leukocyte antigen (HLA)-typed healthy subjects. The results indicate that HLA-DR2- and DQw1-positive donors frequently exhibit low production of TNF-{alpha}, whereas DR3- and DR4-positive subjects show high levels of TNF-{alpha} production. No correlation between TNF-{alpha} levels and HLA-A, -B, and -C genotype was found. The relevance of this quantitative polymorphism to the genetic predisposition to lupus nephritis in systemic lupus erythematosus (SLE) patients was investigated. DR2, DQw1-positive SLE patients show low levels of TNF-{alpha} inducibility; this genotypemore » is also associated with an increased incidence of lupus nephritis. DR3-positive SLE patients, on the other hand, are not predisposed to nephritis, and these patients have high TNF-{alpha} production. DR4 haplotype is associated with high TNF-{alpha} inducibility and is negatively correlated with lupus nephritis. These data may help explain the strong association between HLA-DR2, DQw1 in SLE patients and their susceptibility to nephritis.« less
HLA-DR2-associated DRB1 and DRB5 alleles and haplotypes in Koreans.
Song, E Y; Kang, S J; Lee, Y J; Park, M H
2000-09-01
There are considerable racial differences in the distribution of HLA-DR2-associated DRB1 and DRB5 alleles and the characteristics of linkage disequilibrium between these alleles. In this study, the frequencies of DR2-associated DRB1 and DRB5 alleles and related haplotypes were analyzed in 186 DR2-positive individuals out of 800 normal Koreans registered for unrelated bone marrow donors. HLA class I antigen typing was performed by the serological method and DRB1 and DRB5 genotyping by the PCR-single strand conformational polymorphism method. Only 3 alleles were detected for DR2-associated DRB1 and DRB5 genes, respectively: DRB1(*)1501 (gene frequency 8.0%), (*)1502 (3.2%), (*)1602 (0.9%); DRB5(*)0101 (8.0%), (*)0102 (3.2%), and (*)0202 (0.9%). DRB1-DRB5 haplotype analysis showed an exclusive association between these alleles: DRB1*1501-DRB5*0101 (haplotype frequency 8.0%), DRB1(*)1502-DRB5(*)0102 (3.2%), and DRB1(*)1602-DRB5(*)0202 (0.9%). The 5 most common DR2-associated A-B-DRB1 haplotypes occurring at frequencies of > or = 0.5% were A24-B52-DRB1(*)1502 (1.8%), A2-B62-DRB1(*)1501, A2-B54-DRB1(*)1501, A26-B61-DRB1(*)1501, and A24-B51-DRB1(*)1501. The remarkable homogeneity in the haplotypic associations between DR2-associated DRB1 and DRB5 alleles in Koreans would be advantageous for organ transplantation compared with other ethnic groups showing considerable heterogeneity in the distribution of DRB1-DRB5 haplotypes.
Prostate Cancer Research Training in Health Disparities for Minority Undergraduates
2014-04-01
dentistry , one is already in a graduate program, and one more is in the process of applying to dental school. Two of our interns now hold research...23 Research Ethics Dr. C. Freund Introduction to Biostatistics Mr. Tan Ding Digital Library Ms. A. Whitehead Informatics Dr. F. Barnes...Training Mr. Cedric Harville Introduction to Biostatistics Dr. Vincent Agboto Mentors’ Laboratory Management of Cancer Dr. L. Dent
Transatlantic Roots of Prostate Cancer Disparities in Black Men: The CaPTC Program
Dr. Odedina is Professor in the Colleges of Pharmacy and Medicine at the University of Florida. She is also the PI and Program Director for the NCI-funded (P20 award) Florida Minority Cancer Research & Training (MiCaRT) Center as well as the PI and Founder of the NCI-EGRP supported Prostate Cancer Transatlantic Consortium (CaPTC). She leads the Research Core of the Florida Health Equity Research Institute, a Florida Board of Governors-approved institute. Dr. Odedina’s research program, primarily funded by NIH and Department of Defense, focuses on the predictors of health disparities and cost-effective, community-based behavioral interventions to improve the health of minority populations, especially Black men. She has directed over 30 research projects, including genetic-environmental determinants of prostate cancer disparity studies. Her NCI EGRP-supported consortium, CaPTC, facilitates and supports recruitment and retention of minorities in biomedical research and biobanking for Black men’s research globally. Her contribution to Health Equity in Florida dates back to 1997 and has resulted in multiple accomplishments and recognitions. As far back as 2009, her leadership in health disparities was recognized by the American Society of Health-Systems Pharmacy and the Association of Black Health-System Pharmacists with the Inaugural (1st) Leadership Award for Health Disparities. Due to her extensive experiences in prostate cancer disparity research, she was selected by the US Congressionally Directed Medical Research Programs to give the inaugural Dr. Barbara Terry-Koroma Health Disparity Legacy Lecture in 2013. Her efforts in training underrepresented minorities for over two decades was recognized through the INSIGHT Into Diversity 2016 Inspiring Women in STEM Award. Her most recent awards include the Living Legend Award for innovations with health/economic impact from the Africa Clinical Trial Summit in 2017 and the 2017 Williams Award for Innovation in Cancer care in Africa from the African Organization for Research & Training in Cancer (AORTIC). Her outstanding contributions have also been recognized at University of Florida with her selection as UF Term Professor twice (2015-2017; 2018-2020). Dr. Odedina is personally and professionally committed to eliminating cancer disparities, especially in ethnically diverse Black populations.
VIP group in hangar during AirSAR 2004 Mesoamerica campaign
2004-03-03
VIP group in hangar during AirSAR 2004 Mesoamerica campaign, L-R: Dr. Gahssem Asrar, NASA Associate Administrator for Earth Science Enterprises; Fernando Gutierrez, Costa Rican Minister of Science and Technology(MICIT); Jorge Andres Diaz, Director of the Costa Rican National Hangar for Airborne Research division of the National Center for High Technology(CENAT); Dr. Pedro Leon, General Director for the Costa Rican National Center for High Technology(CENAT); NASA Administrator Sean O'Keefe; Dr. Sonia Marta Mora, President of the Costa Rican National Rector’s Council(CONARE); Mr. John Danilovich, US Ambassador to Costa Rica; and unknown. AirSAR 2004 Mesoamerica is a three-week expedition by an international team of scientists that will use an all-weather imaging tool, called the Airborne Synthetic Aperture Radar (AirSAR), in a mission ranging from the tropical rain forests of Central America to frigid Antarctica.
ACHP | Q&A | The ACHP Interview: Dr. Julia King, associate professor of
specific nav links Home arrow The ACHP Interview: Dr. Julia King, associate professor of archaeology and anthropology at St. MaryÂs College of Maryland, expert member ACHP The ACHP Interview: Dr. Julia King With the recent Society for Historical Archaeology conference concluded, and former chairman John Nau
Hydrodynamic Analyses and Evaluation of New Fluid Film Bearing Concepts
NASA Technical Reports Server (NTRS)
Keith, Theo G., Jr.; Dimofte, Florin
1998-01-01
Over the past several years, numerical and experimental investigations have been performed on a waved journal bearing. The research work was undertaken by Dr. Florin Dimofte, a Senior Research Associate in the Mechanical Engineering Department at the University of Toledo. Dr. Theo Keith, Distinguished University Professor in the Mechanical Engineering Department was the Technical Coordinator of the project. The wave journal bearing is a bearing with a slight but precise variation in its circular profile such that a waved profile is circumscribed on the inner bearing diameter. The profile has a wave amplitude that is equal to a fraction of the bearing clearance. Prior to this period of research on the wave bearing, computer codes were written and an experimental facility was established. During this period of research considerable effort was directed towards the study of the bearing's stability. The previously developed computer codes and the experimental facility were of critical importance in performing this stability research. A collection of papers and reports were written to describe the results of this work. The attached captures that effort and represents the research output during the grant period.
Quantum Chemical Investigations of the Mechanism of Cationic Polymerization.
1980-10-15
of Naval Research I Code 260 Code AFRPL MKPA Arlingon, VA 22217 Edwards AFB, CA 93523 Attn: Mr. D. Siegel Attn: Dr. F. Roberto Office of Naval...495 Summer Street Bolling Air Force BaseBoston, MA 02210 Washington, DC 20332 Attn: Dr. L. Peebles Dr. A. Wood Air Force Office of 1~Scientific...Research 4 Office of Naval Research 1 Directorate of Aero- San Francisco Area Office space Sciences One HaITidie Plaza Suite 601 Bolling Air Force Base San
Research Associate | Center for Cancer Research
PROGRAM DESCRIPTION The Basic Science Program (BSP) pursues independent, multidisciplinary research in basic and applied molecular biology, immunology, retrovirology, cancer biology, and human genetics. Research efforts and support are an integral part of the Center for Cancer Research (CCR) at the Frederick National Laboratory for Cancer Research (FNLCR). KEY ROLES/RESPONSIBILITIES - Research Associate III Dr. Zbigniew Dauter is the head investigator of the Synchrotron Radiation Research Section (SRRS) of CCR’s Macromolecular Crystallography Laboratory. The Synchrotron Radiation Research Section is located at Argonne National Laboratory, Argonne, Illinois; this is the site of the largest U.S. synchrotron facility. The SRRS uses X-ray diffraction technique to solve crystal structures of various proteins and nucleic acids of biological and medical relevance. The section is also specializing in analyzing crystal structures at extremely high resolution and accuracy and in developing methods of effective diffraction data collection and in using weak anomalous dispersion effects to solve structures of macromolecules. The areas of expertise are: Structural and molecular biology Macromolecular crystallography Diffraction data collection Dr. Dauter requires research support in these areas, and the individual will engage in the purification and preparation of samples, crystallize proteins using various techniques, and derivatize them with heavy atoms/anomalous scatterers, and establish conditions for cryogenic freezing. Individual will also participate in diffraction data collection at the Advanced Photon Source. In addition, the candidate will perform spectroscopic and chromatographic analyses of protein and nucleic acid samples in the context of their purity, oligomeric state and photophysical properties.
An Interview with Professor Melquíades de Dios Leyva, December 2008
NASA Astrophysics Data System (ADS)
Arias de Fuentes, Olimpia
When writing about the history of physics in Cuba, this remarkable professor of quantum mechanics must be mentioned, for he embodies a most genuine example of the turn taken by national educational policy after 1959: Education for all, at all levels, with no discrimination or elitism. The following is an interview granted by Dr. Melquíades de Dios Leyva, Outstanding Full Professor of the Physics Faculty of the University of Havana, to Dr. Olimpia Arias de Fuentes, Associate Professor at the same, and Senior Researcher of the Institute of Materials Science and Technology (IMRE) of the University of Havana.
Pan, Chen-Wei; Wang, Shan; Wang, Pei; Xu, Cai-Lian; Song, E
2018-05-08
We aim to describe the impact of diabetic retinopathy (DR) on health-related quality of life (HRQOL) among community-dwelling Chinese adults who had been previously diagnosed with type 2 diabetes mellitus (T2DM). A community-based survey including 913 patients with T2DM was conducted in Suzhou, China. Retinopathy lesions were graded according to the Airlie House classification system of the Early Treatment Diabetic Retinopathy Study. The HRQOL was measured by the Chinese version of the EuroQol Group's five-level EuroQol five-dimensional questionnaire (EQ-5D-5L). A Gamma distribution with log link was incorporated into linear regression models to assess the associations between DR and EQ-5D-5L health utility score. The mean EQ-5D-5L index scores were 0.971 ± 0.082 among individuals with unilateral DR and 0.970 ± 0.145 among those with bilateral DR, which were lower compared with those without DR (0.986 ± 0.045, P = 0.02). In multivariate analysis adjusting for confounders, people with bilateral DR reported lower the EQ-5D index scores compared with those without DR. The presence of DR was significantly associated with problems in usual activities (odds ratio [OR] = 0.16, P = 0.02, comparing participants with unilateral vs. no DR; OR = 0.11; P = 0.01, comparing participants with bilateral vs. no DR). No significant variations in EQ-5D-5L index scores as well as different domains of health problems between individuals with unilateral and bilateral DR were observed (P > 0.05). Chinese T2DM patients with bilateral DR tend to report lower HRQOL scores compared with those without DR, especially in health problems associated with usual activities.
The Influence of Emerging Leadership in Nursing: An Interview With Dr Casey Shillam.
Adams, Jeffrey M
2016-11-01
This department highlights emerging nursing leaders who have demonstrated leadership in advancing innovation and patient care in practice, policy, research, education, and theory. This interview profiles Casey Shillam, PhD, RN, associate dean for baccalaureate education, University of Portland School of Nursing, Oregon.
ERIC Educational Resources Information Center
Diverse: Issues in Higher Education, 2012
2012-01-01
This article presents a list of the top 100 producers of associate, bachelor's and graduate degrees awarded to minority students based on research conducted by Dr. Victor M.H. Borden, professor of educational leadership and policy students at the Indiana University Bloomington. For the year 2012, the listings focus on Hispanic students. Data for…
This testing is available only after mandatory prior consultation with Dr. Jeff Lifson (lifsonj@mail.nih.gov) of the Quantitative Molecular Diagnostics Core (QMDC). This assay is performed by the QMDC for measuring levels of cell- or t
The Top Theological Degree Producers
ERIC Educational Resources Information Center
Diverse: Issues in Higher Education, 2012
2012-01-01
Each year, "Diverse: Issues in Higher Education" publishes a list of the Top 100 producers of associate, bachelor's and graduate degrees awarded to minority students based on research conducted by Dr. Victor M. H. Borden, professor of educational leadership and policy studies at Indiana University Bloomington. This year, for the first…
The Top 50 Communication, Journalism and Related Degrees Conferred
ERIC Educational Resources Information Center
Diverse: Issues in Higher Education, 2012
2012-01-01
Each year, "Diverse: Issues In Higher Education" publishes lists of the Top 100 producers of associate, bachelor's, and graduate degrees awarded to minority students based on research conducted by Dr. Victor M. H. Borden, professor of educational leadership and policy studies at Indiana University Bloomington. This article presents a…
The Top American Indian Degree Producers
ERIC Educational Resources Information Center
Diverse: Issues in Higher Education, 2012
2012-01-01
Each year, "Diverse: Issues In Higher Education" publishes lists of the Top 100 producers of associate, bachelor's and graduate degrees awarded to minority students based on research conducted by Dr. Victor M.H. Borden, professor of educational leadership and policy studies at the Indiana University Bloomington. This year, Diverse staff…
Development of the Meharry Medical College Prostate Cancer Research Program
2007-03-01
Immunology Jul;62 Suppl 1:73-83, 2005. Marshall D, Sabek O, Fraga D, Kotb M and Gaber AO. Examination of the molecular signature associated...Sabek OM, Marshall DR, Minoru O, Fraga DW, Gaber AO. Gene expression profile of nonfunctional human pancreatic islets:predictors of transplant
Genetic Factors in Breast Cancer: Center for Interdisciplinary Biobehavioral Research
2006-10-01
Hypnosis Intervention, Dr. Guy Montgomery, Associate Professor, Oncological Sciences 12/14/2005 Patient Navigation for CRC Screening with Low Income...Attending Psychologist Psychiatry and Behavioral Sciences Memorial Sloan-Kettering Cancer Center 4/20/2006 "It’s all in your head: The use of MRI in
2000-11-03
The Honorable George P. Schultz during a Visit and tour of Ames Research Center. Shown here from left to right are in the background Bill Berry, Ames Deputy Director, Dr. Tom Edwards, Chief, Aviation Systems Division, Front row, Dr. Sidney Drell, Staford University, former U S Secretary of State George Schultz, Dr Richard Haines, Senior Research Csientist, FFC at the Future Flight Central Simulator facility.
Binaural Processing of Multiple Sound Sources
2016-08-18
Sound Source Localization Identification, and Sound Source Localization When Listeners Move. The CI research was also supported by an NIH grant...8217Cochlear Implant Performance in Realistic Listening Environments,’ Dr. Michael Dorman, Principal Investigator, Dr. William Yost unpaid advisor. The other... Listeners Move. The CI research was also supported by an NIH grant (“Cochlear Implant Performance in Realistic Listening Environments,” Dr. Michael Dorman
Clinical Investigation Program Annual Progress Report
1989-10-01
Investigators: Linda K. Kullama, Ph.D., Dr. Kenneth T. Nakamura,MD; Dr. Venkataraman Balaraman, MD, Wayne M. Ichimura, Biomedical Engineer. Department/Section...Investigators: John R. Claybaugh, Ph.D.; Kenneth T. Nakamura, MD; Dr. Venkataraman Balaraman, M.D. Department/Section: Clinical Investigation/Physiology Key...Pigs and Rats Principal ’Investigator: Linda K. Kullama, Ph.D.; John R. Claybaugh, Ph.D. Associate Investigators: Dr. Venkataraman Balaraman, M.D.; Dr
Ross, I L; Babu, S; Armstrong, T; Zhang, L; Schatz, D; Pugliese, A; Eisenbarth, G; Baker Ii, P
2014-10-01
Genetic similarities between patients from the United States and South African (SA) Addison's Disease (AD) strengthen evidence for genetic association. SA-AD (n = 73), SA healthy controls (N = 78), and US-AD patients (N = 83) were genotyped for DQA1, DQB1, DRB1, and HLA-B alleles. Serum was tested for the quantity of 21OH-AA and IFNα-AA at the Barbara Davis Center. Although not as profound as in US-AD, in SA-AD 21OH-AA + subjects the predominantly associated risk haplotypes were DRB1*0301-DQB1*0201 (DR3), DRB1*04xx-DQB1*0302 (DR4), and the combined DR3/4 genotype. DQB1*0302 associated DRB1*04xx haplotypes conferred higher risk than those DRB1*04xx haplotypes associated with other DQB1 alleles. We found negative association in 21OH-AA + SA-AD for DQA1*0201-DQB1*0202 and DQA1*0101-DQB1*0501 vs SA controls, and positive association for DQA1*0401-DQB1*0402 vs US-AD. Apart from the class II DR3 haplotype, HLA-B8 did not have an independent effect; however together DR3 and HLA-B8 conferred the highest risk vs 21OH-AA negative SA-AD and SA-controls. HLA-B7 (often with DR4) conferred novel risk in 21OH-AA + SA-AD vs controls. This study represents the first comparison between South African and United States AD populations utilizing genotyping and serology performed at the same center. SA-AD and US-AD 21OH-AA + patients share common HLA risk haplotypes including DR4 (with HLA-B7) and DR3 (with HLA-B8), strengthening previously described HLA associations and implicating similar genetic etiology. © 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Postdoctoral Fellow | Center for Cancer Research
A postdoctoral research position is available in the laboratory of Dr. Natasha Caplen in the Genetics Branch, National Cancer Institute, Center for Cancer Research. Dr. Caplen’s Laboratory conducts multidisciplinary and interdisciplinary research that uses RNAi and other DNA or RNA-based functional genomic technologies to interrogate specific aspects of the genetic,
Dirani, Mohamed; Xie, Jing; Fenwick, Eva; Benarous, Rehab; Rees, Gwyneth; Wong, Tien Yin; Lamoureux, Ecosse L
2011-06-22
To investigate the relationship between anthropometric parameters and diabetic retinopathy (DR) in adults with diabetes. Five hundred participants with diabetes were recruited prospectively from ophthalmology clinics in Melbourne, Australia. Each underwent an eye examination, anthropometric measurements, and standardized interview-administered questionnaires, and fasting blood glucose and serum lipids were analyzed. Two-field fundus photographs were taken and graded for DR. Height; weight; body mass index (BMI); waist, hip, neck, and head circumferences; and skinfold measurements were recorded. A total of 492 patients (325 men, 66.1%) aged between 26 and 90 years (median, 65) were included in the analysis: 171 (34.8%), 187 (38.0%), and 134 (27.2%) with no DR, nonproliferative DR (NPDR), and proliferative DR (PDR), respectively. After multiple adjustments, higher BMI (odds ratio [OR], 1.06; 95% confidence interval [CI],1.01-1.11; P = 0.02) was significantly associated with any DR. Obese people were 6.5 times more likely to have PDR than were those with normal weight (OR, 6.52; 95% CI, 1.49-28.6; P = 0.013). Neck circumference (OR, 1.05; 95% CI, 1.00-1.10; P = 0.03) and waist circumference (OR, 1.12; 95% CI, 1.03-1.22; P = 0.01) were significantly associated with any DR. BMI (OR, 1.04; 95% CI, 1.00-1.08; P = 0.04) and neck circumference (OR, 1.04 95% CI, 1.01-1.08; P = 0.04) were also positively associated with increasing severity levels of DR. Persons with diabetes with higher BMI and larger neck circumference are more likely to have DR and more severe stages of DR. These data suggest that obesity is an independent risk factor for DR.
Association Of Serum Total Bilirubin Level With Diabetic Retinopathy In Type 2 Diabetes Mellitus.
Ghaffar, Tahir; Marwat, Zahid Irfan; Ullah, Fahim; Khan, Salman; Hassan Aamir, Aziz Ul
2016-01-01
Serum bilirubin has anti-inflammatory, antioxidant and immunological properties. It is considered a protective substance against atherosclerotic and microvascular complications of diabetes mellitus (DM). This study was designed to find the association between total serum bilirubin concentration and diabetic retinopathy (DR). This case control study was conducted in the Department of Endocrinology, Diabetes and Metabolic Diseases, Hayatabad Medical Complex, Peshawar. Type-2 DM patients more than 18 years of age of either gender with duration of T2DM more than 6 months were included and sub categorized in two groups. Cases (DM with DR) and Controls (DM without DR) while patients with acute and chronic liver diseases, haemolytic anaemia, history of chronic alcohol consumption, use of hepatotoxic drugs (anti-tuberculous, anti-epileptic), women on oral contraceptive pills were excluded. All participants underwent ophthalmic examination at diabetic retinopathy screening clinic followed by pre designed set of investigations. A total of 152 patients, 76 cases and 76 controls were included. Serum bilirubin concentration was found inversely and independently (p 0.000) associated and inversely co related (r -0.345and p 0.000) with prevalence of DR. Cases were concentrated in the lower quartiles of serum bilirubin concentration and vice versa. Low haemoglobin (p 0.00) and longer duration of DM (0.003) were independently and directly associated with prevalence of DR. Serum bilirubin concentration is inversely and independently associated and inversely correlated with the prevalence of DR and may predict progression of DR over time.
A TRIBUTE TO DR. WILLIAM PENN WATKINSON
Dr. William Penn Watkinson (known to colleagues as "Penn") of EPA¿s health research lab (National Health and Environmental Research Laboratory) of Research Triangle Park, North Carolina, died Wednesday, December 13 after a battle with lung cancer. He was a member of the Pulmonar...
C-reactive protein and diabetic retinopathy in Chinese patients with type 2 diabetes mellitus.
Yang, Xiu-Fen; Deng, Yu; Gu, Hong; Lim, Apiradee; Snellingen, Torkel; Liu, Xi-Pu; Wang, Ning-Li; Domalpally, Amitha; Danis, Ronald; Liu, Ning-Pu
2016-01-01
To investigate the relationship between C-reactive protein (CRP) and diabetic retinopathy (DR) in a cohort of Chinese patients with type 2 diabetes mellitus (T2DM). Community-based observational cohort study. There were 1131 participants recruited from November 2009 to September 2011 in Desheng community in urban Beijing. Patients diagnosed T2DM were recruited and underwent a standardized evaluation consisting of a questionnaire, ocular and anthropometric examinations and laboratory investigation. The presence and severity of DR were assessed by seven fields 30° color fundus photographs. Subjects were then classified into groups with no DR, any DR, or vision-threatening DR. CRP was analyzed from serum of study subjects. A total of 1007 patients with T2DM were included for analysis, including 408 (40.5%) men and 599 (59.5%) women. The median CRP level was 1.5 mg/L for women and 1.1 mg/L for men (P=0.004, OR 0.37, 95% CI 0.18-0.74). After adjusting for possible covariates, higher levels of CRP were associated with lower prevalence of any DR (P=0.02, OR 0.55, 95% CI 0.35-0.89), but not associated with vision-threatening DR (P=0.62, OR 0.78, 95% CI 0.28-2.14). After stratification by sex, the inverse association between CRP and DR was found to be statistically significant in men (P=0.006, OR 0.35, 95% CI 0.16-0.73), but not in women (P=0.58, OR 0.88, 95% CI 0.29-1.16). The data drawn from a Chinese population with T2DM suggest that increasing CRP levels may be inversely associated with development of DR.
Carbonell, Marc; Castelblanco, Esmeralda; Valldeperas, Xavier; Betriu, Àngels; Traveset, Alícia; Granado-Casas, Minerva; Hernández, Marta; Vázquez, Federico; Martín, Mariona; Rubinat, Esther; Lecube, Albert; Franch-Nadal, Josep; Fernández, Elvira; Puig-Domingo, Manel; Avogaro, Angelo; Alonso, Núria; Mauricio, Dídac
2018-05-04
Cardiovascular (CV) disease due to atherosclerosis is a major cause of morbidity and mortality in adult patients with diabetes, either type 1 or type 2 diabetes. The aim of the study was to assess the association of the frequency and the burden of subclinical carotid atherosclerotic disease in patients with type 1 diabetes according to the presence and severity of diabetic retinopathy (DR). A cross-sectional study was conducted in 340 patients with type 1 diabetes (41.5% with DR), and in 304 non-diabetic individuals. All participants were free from previous CV disease and chronic kidney disease (CKD). B-mode carotid ultrasound imaging was performed in all the study subjects. Patients with type 1 diabetes underwent a full eye examination, and DR patients were divided into two groups: mild disease and advanced disease. In the group of patients with type 1 diabetes, the percentage of patients with carotid plaques was higher in those with DR compared with those without DR (44.7% vs. 24.1%, p < 0.001). Patients with DR also presented a higher incidence of ≥ 2 carotid plaques (25.5% vs. 11.1%, p < 0.001). Apart from other traditional cardiovascular risk factors, the presence of advanced stages of DR was independently associated with the presence (p = 0.044) and the burden (≥ 2 carotid plaques; p = 0.009) of subclinical carotid atherosclerosis. In patients with type 1 diabetes without previous CV disease or established CKD, the presence of advanced stages of DR is associated with a higher atherosclerotic burden in the carotid arteries. The presence of DR identifies patients at risk for carotid atherosclerotic disease.
Raman, Rajiv; Ganesan, Suganeswari; Pal, Swakshyar Saumya; Gella, Laxmi; Kulothungan, Vaitheeswaran; Sharma, Tarun
2017-10-01
To evaluate the 4-year incidence and progression of and risk factors for diabetic retinopathy (DR) in an Indian population. From a cross-sectional study of 1425 subjects with diabetes, 911 (63.9%) returned for 4-year follow-up. After excluding 21 with ungradable retinal images, data from 890 subjects were analyzed. Participants underwent examinations based on a standard protocol, which included grading of retinal photographs. The incidences of DR, diabetic macular edema (DME), and sight-threatening diabetic retinopathy (STDR) were 9.2%, 2.6%, and 5.0%, respectively. In subjects with DR at baseline, the incidence of DME and STDR had increased (11.5% and 22.7%, respectively). 1-step and 2-step progressions of DR were seen in 30.2% and 12.6% of participants, respectively, and 1-step and 2-step regressions were seen in 12.0% and 1.8%, respectively. Incident DR, DME, and STDR were associated with higher systolic blood pressure (odds ratio, OR, 1.21, 2.11 and 1.72, respectively, for every 10 mmHg increase). Incident DR and DME were associated with increasing duration of diabetes (OR 2.29 and 4.77, respectively, for every 10-year increase) and presence of anemia (OR 1.96 and 10.14, respectively). Incident DR was also associated with higher hemoglobin A1c (OR 1.16 for every 1% increase). Variables associated with 1-step progression were every 10 mg/dL increase in serum total cholesterol (OR 15.65) as a risk factor, and 10 mg/dL increase in serum triglyceride (OR 0.52) as a protective factor. The incidences of STDR and DME were higher in people with pre-existing DR than in those without DR at baseline.
Sunita, Mohan; Singh, Arvind Kumar; Rogye, Ashwini; Sonawane, Manish; Gaonkar, Ravina; Srinivasan, Radhika; Natarajan, Sundaram; Stevens, Fred C J; Scherpbier, A J J A; Kumaramanickavel, Govindasamy; McCarty, Catherine
2017-10-01
The aims of the study were to estimate the prevalence of diabetic retinopathy (DR) and enumerate history-based risk factors in the urban slums of Western India. The population-based study was conducted in seven wards of Mumbai urban slums, where we screened 6569 subjects of ≥ 40 years age, with a response rate of 98.4%, for type 2 diabetes mellitus (T2DM) based on American Diabetes Association criteria. All subjects with T2DM underwent dilated 30° seven-field stereo-fundus-photography for DR severity grading based on modified Airlie House classification. A multivariate logistic regression model was used to assess the correlation of DR with the history-based risk factors. The prevalence of DR in the general population of Mumbai urban slums was 1.41% (95% CI 0.59-2.23) and in the T2DM population it was 15.37% (95% CI 8.87-21.87). The positive associations with DR were the longer duration of DM (≥ 11 years: OR, 12.77; 95% CI 2.93-55.61) and male gender (OR, 2.05; 95% CI 1.08-3.89); increasing severity of retinopathy was also significantly associated with longer duration of DM (p < 0.001). However, history of hypertension, family history of DM, consanguineous marriage and migration status were not associated with DR in the study population. The prevalence of DR in the general population and T2DM subjects were 1.41% and 15.37% respectively in Mumbai urban slums. Duration of DM and male gender were significantly associated with DR. The slums in Western India show the trends of urban lifestyle influences similar to the rest of urban India.
Threshold Tear Strength of some Molecular Networks.
1981-04-03
Attn: Dr. F. Roberto Office of Naval Research 1 AFSC Western Office Andrews AFB, Code DLFP 1030 East Green Street Washington, DC 20334 Pasadena, CA...of Chemical & Office Atmospheric Sciences 495 Summer Street Bolling Air Force Base Boston, MA 02210 Washington, DC 20332 Attn: Dr. L. Peebles Dr. A...Plaza Suite 601 Bolling Air Force Base San Francisco, CA 94102 Washington, DC 20332 Attn: Dr. P. A. Miller Attn: Dr. L. H. Caveny Defense Technical
United States Air Force Summer Faculty Research Program - Management Report - 1985.
1985-12-01
Properties and Processing of a Dr. Vernon R. Allen Perfluorinated Polyalkylene Linked Polyimide 4 Quantifying Experience in the Cost Dr. Jihad A. Alsadek...Dr. Terrill D. Smith Compounds 127 Studies on Combustion of Liquid Fuel Dr. Siavash H. Sohrab Sprays in Stagnation Flows 128 Monitoring Environmental...Trafton Various Dinitrotoluenes and the Synthesis of Azo Compounds . 125 e 0 Ka 140 A Comparison of Measured and Calculated Dr. Larry Vardiman
United States Air Force Research Initiation Program for 1988. Volume 2
1990-04-01
Specialty: Modeling and Simulation ENGINEERING AND SERVICES CENTER (Tyndall Air Force Base) Dr. Wayne A. Charlie Dr. Peter Jeffers (1987) Colorado State...Michael Sydor University of New Hampshire University of Minnesota Specialty: Systems Modeling & Controls Specialty: Optics, Material Science Dr. John...9MG-025 4 Modeling and Simulation on Micro- Dr. Joseph J. Feeley (1987) computers, 1989 760-7MG-070 5 Two Dimensional MHD Simulation of Dr. Manuel A
Long Cycle Life Secondary Lithium Cells Utilizing Tetrahydrofuran.
1984-04-01
Rosenwasser) Code RD-I Washington, D.C. 20360 Washington, D.C. 20380 Naval Civil Engineering Laboratory 1 Dean William Tolles Attn: Dr. R. W. Drisko...Ocean Systems Center 11 apel Street San Diego, California 92152 wton, Massachusetts 02158 Dr. J. J. Auborn Dr. Adam Heller Bell Laboratories Bell...University Research Triangle Park, NC 27709 Evanston, Illinois 60201 Dr. William Ayers Dr. Aaron Fletcher ECD Inc. Naval Weapons Center P.O. Box 5357 Code
Physical Studies of Brown Dwarfs and Extrasolar Planets
NASA Technical Reports Server (NTRS)
Noll, Keith
2004-01-01
The main purpose of this grant proposal was to fund the ongoing work on brown dwarfs by Denise Stephens during her tenure at STScI as a postdoctoral researcher. We have completed approximately half of the three-year grant period. Dr. Stephens has now assumed to role of senior research associate at Johns Hopkins University and in this position is eligible to be PI of grants. Because the bulk of the work and funds under this grant have been and will continue to be for the purposes of supporting Dr. Stephens, we are transferring control of the grant to her at JHU. This closeout is a formality to allow that transfer. The largest project was the completion of a major work on the infrared photometry of L and T dwarfs. The paper was published in January 2004.
Hay, Phillipa; Chinn, David; Forbes, David; Madden, Sloane; Newton, Richard; Sugenor, Lois; Touyz, Stephen; Ward, Warren
2014-11-01
This clinical practice guideline for treatment of DSM-5 feeding and eating disorders was conducted as part of the Royal Australian and New Zealand College of Psychiatrists (RANZCP) Clinical Practice Guidelines (CPG) Project 2013-2014. The CPG was developed in accordance with best practice according to the National Health and Medical Research Council of Australia. Literature of evidence for treatments of anorexia nervosa (AN), bulimia nervosa (BN), binge eating disorder (BED), other specified and unspecified eating disorders and avoidant restrictive food intake disorder (ARFID) was sourced from the previous RANZCP CPG reviews (dated to 2009) and updated with a systematic review (dated 2008-2013). A multidisciplinary working group wrote the draft CPG, which then underwent expert, community and stakeholder consultation, during which process additional evidence was identified. In AN the CPG recommends treatment as an outpatient or day patient in most instances (i.e. in the least restrictive environment), with hospital admission for those at risk of medical and/or psychological compromise. A multi-axial and collaborative approach is recommended, including consideration of nutritional, medical and psychological aspects, the use of family based therapies in younger people and specialist therapist-led manualised based psychological therapies in all age groups and that include longer-term follow-up. A harm minimisation approach is recommended in chronic AN. In BN and BED the CPG recommends an individual psychological therapy for which the best evidence is for therapist-led cognitive behavioural therapy (CBT). There is also a role for CBT adapted for internet delivery, or CBT in a non-specialist guided self-help form. Medications that may be helpful either as an adjunctive or alternative treatment option include an antidepressant, topiramate, or orlistat (the last for people with comorbid obesity). No specific treatment is recommended for ARFID as there are no trials to guide practice. Specific evidence based psychological and pharmacological treatments are recommended for most eating disorders but more trials are needed for specific therapies in AN, and research is urgently needed for all aspects of ARFID assessment and management. Associate Professor Susan Byrne, Dr Angelica Claudino, Dr Anthea Fursland, Associate Professor Jennifer Gaudiani, Dr Susan Hart, Ms Gabriella Heruc, Associate Professor Michael Kohn, Dr Rick Kausman, Dr Sarah Maguire, Ms Peta Marks, Professor Janet Treasure and Mr Andrew Wallis. © The Royal Australian and New Zealand College of Psychiatrists 2014.
Meet EPA Exposure Scientist and National Program Director Dr. Tina Bahadori
Dr. Tina Bahadori leads EPA's Chemical Safety for Sustainability research program. She is an exposure scientist with extensive expertise developing and managing research programs that integrate exposure with health sciences.
UPR/Mayaguez High Energy Physics
DOE Office of Scientific and Technical Information (OSTI.GOV)
Mendez, Hector
This year the University of Puerto Rico at Mayaguez (UPRM) High Energy Physics (HEP) group continued with the ongoing research program outlined in the grant proposal. The program is centered on the Compact Muon Solenoid (CMS) experiment at the proton-proton (pp) collisions at the Large Hadron Collider (LHC) at CERN in Geneva, Switzerland. The main research focus is on data analysis and on the preparation for the High Luminosity (HL) LHC or experiment detector upgrade. The physics data analysis included Higgs Doublet Search and measurement of the (1) Λ 0 b branching fraction, (2) B meson mass, and (3) hyperonmore » θ - b lifetime. The detector upgrade included work on the preparations for the Forward Pixel (FPIX) detector Silicon Sensor Testing in a production run at Fermilab. In addition, the group has taken responsibilities on the Software Release through our former research associate Dr. Eric Brownson who acted until last December as a Level Two Offline Manager for the CMS Upgrade. In support of the CMS data analysis activities carried out locally, the UPRM group has built and maintains an excellent Tier3 analysis center in Mayaguez. This allowed us to analyze large data samples and to continue the development of algorithms for the upgrade tracking robustness we started several years ago, and we plan to resume in the near future. This project involves computer simulation of the radiation damage to be suffered at the higher luminosities of the upgraded LHC. This year we continued to serve as a source of outstanding students for the field of high energy physics. Three of our graduate students finished their MS work in May, 2014, Their theses research were on data analysis of heavy quark b-physics. All of them are currently enrolled at Ph.D. physics program across the nation. One of them (Hector Moreno) at New Mexico University (Hector Moreno), one at University of New Hampshire (Sandra Santiesteban) and one at University of Puerto Rico-Rio Piedras (Carlos Malca). The students H. Moreno and C. Malca has been directly supervised by Dr. Mendez and S. Santiesteban supervised by Dr. Ramirez. During the last 13 years, our group have graduated 23 MS students on experimental High Energy Physics data analysis and applied hardware techniques. Most of the students have been supported by DOE grants, included this grant. Since 2001, Dr. Mendez have directly supervised eleven students, Dr. Ramirez three students and the former PI (Dr. Lopez) nine students. These theses work are fully documented in the group web page (http://charma.uprm.edu). The High Energy Physics group at Mayaguez is small and presently consists of three Physics faculty members, the Senior Investigators Dr. Hector Mendez (Professor) and Dr. Juan Eduardo Ramirez (Professor), and Dr. Sudhir Malik who was just hired in July 2014. Dr. Ramirez is in charge of the UPRM Tier-3 computing and will be building the network bandwidth infrastructure for the campus, while Dr. Mendez will continues his effort in finishing the heavy quark physics data analysis and moving to work on SUSY analysis for the 2015 data. Our last grant application in 2012 was awarded only for 2013-2014. As a result our postdoc position was lost last month of March. Since then, we have hired Dr. Malik as a new faculty in order to reinforce the group and to continue our efforts with the CMS experiment. Our plan is to hire another junior faculty in the next two years to strengthen the HEP group even further. Dr. Mendez continues with QuarkNet activities involving an ever larger group of high school physics teachers from all around Puerto Rico.« less
1988-04-12
Res. Minneapolis Dr P Klocek Texas Instruments, Dallas Dr D N Lewis Naval Research Lab Dr S Musikant General Electric Co, Philadelphia Dr D Perry US...by utilising only a small fraction of the available reactants. Not only is this wasteful, limiting the method to reactants that are comparatively
ARC Accomplishments and Collaborations Pursuing Challenges with Vision and Focus
2010-05-10
Navistar Defense LLC – Dr. Joe Lin, Eaton – Dr. Young Jae Kim, GM Hybrid Powertrain Eng. – Dr. Bin Wu, Mercedes - Benz Hybrid LLC – Dr. Vasilios Tsourapas...Fellows: 3 SAE, 4 ASME, 1 AAAS,1 IACM, 3 IEEE • 8 external Research and Educational Awards • 8 University Awards • 2 Young Scientists/Young Innovator
1993-05-07
Dongen, P., 80 Blouin, S . E., 140, 146 Maestas , F. A., 211, 215 van Doormaal, J.C.A.M., 200 Bryant, L. M., 241 Majka, R. J., 332 Verhagen, A. H., 158...Applied Research Associates, Inc. Albuquerque, New Mexico, U. S . A. Dr. Frank A. Maestas , Applied Research Associates, Inc. Albuquerque, New Mexico, U...76 DTIC S ELECTE Proceedings FEB22: of the ASixth International Symposium onteraction ofof Nonnuclear Munitions with Structures Thi
2012-02-20
The Ohio State University Vice President for Research Dr. Caroline Whitacre, standing right, moderates the first panel discussion during NASA's Future Forum with NASA Associate Administrator for Science Mission Directorate John Grunsfeld, left, Ohio State University Graduate Research Associate Vijay Gadepally, Sen. John Glenn, NASA Administrator Charles Bolden, and NASA 2009 Astronaut Candidate and Flight Surgeon Serena Auñón, seated right, at The Ohio State University on Monday, Feb. 20, 2012, in Columbus, Ohio. Monday marked the 50th anniversary of Glenn's historic flight as the first American to orbit Earth. Photo Credit: (NASA/Bill Ingalls)
Moran, Elizabeth P.; Wang, Zhongxiao; Chen, Jing; Sapieha, Przemyslaw; Smith, Lois E. H.
2016-01-01
Diabetic retinopathy (DR) is the leading cause of blindness in the working-age population in developed countries, and its prevalence will increase as the global incidence of diabetes grows exponentially. DR begins with an early nonproliferative stage in which retinal blood vessels and neurons degenerate as a consequence of chronic hyperglycemia, resulting in vasoregression and persistent retinal ischemia, metabolic disequilibrium, and inflammation. This is conducive to overcompensatory pathological neovascularization associated with advanced proliferative DR. Although DR is considered a microvascular complication, the retinal microvasculature is intimately associated with and governed by neurons and glia; neurodegeneration, neuroinflammation, and dysregulation of neurovascular cross talk are responsible in part for vascular abnormalities in both early nonproliferative DR and advanced proliferative DR. Neuronal activity directly regulates microvascular dilation and blood flow in the process of neurovascular coupling. Retinal neurons also secrete guidance cues in response to injury, ischemia, or metabolic stress that may either promote or suppress vascular outgrowth, either alleviating or exacerbating DR, contingent on the stage of disease and retinal microenvironment. Neurodegeneration, impaired neurovascular coupling, and dysregulation of neuronal guidance cues are key events in the pathogenesis of DR, and correcting these events may prevent or delay development of advanced DR. The review discusses the mechanisms of neurovascular cross talk and its dysregulation in DR, and their potential therapeutic implications. PMID:27473938
Globalization and the Diplomacy of Science
ERIC Educational Resources Information Center
Makhema, Joseph
2010-01-01
The closing keynote address given by Dr. Joseph Makhema highlights the important issues that need to be understood in international research collaborations. Dr. Makhema uses his extensive experience in international research collaborations to illustrate the various challenges that collaborating partners in international research may face. He…
Air and Space Power Journal. Volume 30, Number 2, Summer 2016
2016-01-01
Nicholas J. Thomas, USAF, PE Features Thinking beyond the Books ❙ 15 Sociological Biases of Our Military Institutions Ben Zweibelson Institutional ...Retired Editor, Strategic Studies Quarterly Air Force Research Institute Dr. Grant T. Hammond USAF Center for Strategy and Technology Dr. Dale L...Hayden Air Force Research Institute Col S. Clinton Hinote Military Fellow Council on Foreign Relations Dr. Thomas Hughes USAF School of Advanced Air and
USAF Summer Faculty Research Program. 1981 Research Reports. Volume I.
1981-10-01
Kent, OH 44242 (216) 672-2816 Dr. Martin D. Altschuler Degree: PhD, Physics and Astronomy, 1964 Associate Professor Specialty: Robot Vision, Surface...line inspection and control, computer- aided manufacturing, robot vision, mapping of machine parts and castings, etc. The technique we developed...posture, reduced healing time and bacteria level, and improved capacity for work endurance and efficiency. 1 ,2 Federal agencies, such as the FDA and
United States Air Force Research Initiation Program. 1985 Technical Report. Volume 1
1987-04-01
Classification) USAF Research Initiation Program Volume 1 12. PERSONAL AUTHOR(S) Program Director Rodney C. Darrah 13a. TYPE OF...Maximum Voluntary +land Grip Torque for Circular Electrical Connectors 760-0MG-068 Temperature Dependence of Ion- Molecule Association Reactions...Foster 30 Photothermal and Photochemical Properties of Melanin and Their Role in Light Induced Degrad- ation of the Retina 760-0MG-106 Dr. James
Sarilumab for the treatment of rheumatoid arthritis.
Cooper, Simon
2016-01-01
Simon Cooper has >18 years of global experience in the pharmaceutical industry. He joined Sanofi in July 2014 as the Vice President, Global Project Head. In his current position at Sanofi, Dr Cooper is responsible for the clinical development of sarilumab and the worldwide submission in rheumatoid arthritis. He joined Sanofi after serving as the Global Program Medical Director at Novartis since 2012. In this role, Dr Cooper acted as the clinical lead for secukinumab psoriasis submission. Prior to Novartis, Dr Cooper held various posts at Human Genome Sciences, USA, including Executive Director of Clinical Research, Senior Director of Clinical Research and Director of Clinical Research. During his tenure at Human Genome Sciences, USA, Dr Cooper was involved in the submission of belimumab leading to its approval for SLE, and was responsible for its subsequent clinical development program. Dr Cooper has also previously held positions at MedImmune Ltd, UK, Roche, Napp Pharmaceutical Research Ltd, Wyeth Research and Medeval Ltd. In these roles, his responsibilities ranged from medical oversight of clinical trials to medical support for commercial, medical affairs and business development. He received a Bachelor of Medicine and Bachelor of Surgery from University of Newcastle upon Tyne Medical School.
Demand Response Advanced Controls Framework and Assessment of Enabling Technology Costs
DOE Office of Scientific and Technical Information (OSTI.GOV)
Potter, Jennifer; Cappers, Peter
The Demand Response Advanced Controls Framework and Assessment of Enabling Technology Costs research describe a variety of DR opportunities and the various bulk power system services they can provide. The bulk power system services are mapped to a generalized taxonomy of DR “service types”, which allows us to discuss DR opportunities and bulk power system services in fewer yet broader categories that share similar technological requirements which mainly drive DR enablement costs. The research presents a framework for the costs to automate DR and provides descriptions of the various elements that drive enablement costs. The report introduces the various DRmore » enabling technologies and end-uses, identifies the various services that each can provide to the grid and provides the cost assessment for each enabling technology. In addition to a report, this research includes a Demand Response Advanced Controls Database and User Manual. They are intended to provide users with the data that underlies this research and instructions for how to use that database more effectively and efficiently.« less
Ma, Jinlan; Li, Yan; Zhou, Fang; Xu, Xiaoyi; Guo, Gang
2012-01-01
Purpose The Pro12Ala polymorphism of the peroxisome proliferator–activated receptor-γ2 (PPARγ2) gene is reported to be associated with diabetes. However, the gene’s association with diabetic retinopathy (DR) in type 2 diabetes mellitus (T2DM) has been investigated in numerous epidemiologic studies with controversial results. This meta-analysis aimed to collectively assess the association of the Pro12Ala polymorphism with DR in T2DM. Methods An electronic literature search was conducted on PubMed, ISI Web of Knowledge, EMBASE, and the China National Knowledge Internet. A dominant model [(Pro/Ala +Ala/Ala) versus Pro/Pro] was used to ensure adequate statistical power. Crude odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using the fixed effect model. Potential sources of heterogeneity and bias were explored. Results This meta-analysis included genotype data from 2,720 cases with DR and 2,450 controls free of DR from eight eligible publications. The results showed the Ala allele had a protective effect on DR in T2DM (OR=0.81; 95% CI: 0.68–0.98, p=0.03). There was no significant evidence against homogeneity (I2=46%, Pheterogeneity=0.07). The sensitivity analysis showed a robust association of the Pro12Ala polymorphism with DR in T2DM after a study involving Caucasians that presented a big effect on heterogeneity (OR=0.75; 95% CI: 0.62–0.91, p=0.003) was excluded. Possible ethnic differences in the association of the Pro12Ala single nucleotide polymorphism and DR were demonstrated; a significant association was illustrated in the Caucasian subgroup (OR=0.74; 95% CI: 0.59–0.94, p=0.01) but was not found in the Asian subgroup (OR=0.77; 95% CI: 0.55–1.07, p=0.12). No publication bias was observed. Conclusions This meta-analysis suggested a significant association exists between the Pro12Ala polymorphism and DR in T2DM with ethnic differences. The Ala allele had a significant protective effect against DR in T2DM. PMID:22993484
78 FR 12092 - John V. Scalera; Decision and Order
Federal Register 2010, 2011, 2012, 2013, 2014
2013-02-21
... from both Dr. C. and Dr. M. Tr. 259-64. According to Respondent, Dr. C. is an orthopedic surgeon who... professional practice or research.''). \\14\\ It is also noted that Respondent has not been convicted of an...
2010-03-16
L TO R: DR. FRANCIS CHIARAMONTE, PROGRAM EXECUTIVE FOR PHYSICAL SCIENCES, ISS RESEARCH PROJECT, NASA HEADQUARTERS; DR. RAYMOND CLINTON, ACTING MANAGER FOR SCIENCE AND MISSION SYSTEMS OFFICE, NASA MARSHALL; DR. FRANK SZOFRAN, MICROGRAVITY MATERIALS SCIENCE PROJECT MANAGER AND DISCIPLINE SCIENTIST MATERIALS AND PROCESSES LABORATORY AT MSFC.
Validation of Biomarkers for Prostate Cancer Prognosis
2013-10-01
prostate cancer research community for testing candidate biomarkers. Groups using the resource include Dr. Jeremy Squire, Dr. Gustavo Ayala, and Dr...Ferrari, Javier Hernandez , Antonio Hurtado-Coll, Kyle Kuchinsky, Janet Liew, Rosario Mendez-Meza, Elizabeth Smith, Imelda Tenggarra, Xiaotun Zhang
Sharon Savage Appointed DCEG Clinical Director
Dr. Sharon Savage has been named as the new Clinical Director for DCEG, responsible for patient safety, research integrity, and responsible stewardship of research funding for all DCEG clinical activities. Learn more about Dr. Savage’s appointment
PREFACE: 7th EEIGM International Conference on Advanced Materials Research
NASA Astrophysics Data System (ADS)
Joffe, Roberts
2013-12-01
The 7th EEIGM Conference on Advanced Materials Research (AMR 2013) was held at Luleå University of Technology on the 21-22 March 2013 in Luleå, SWEDEN. This conference is intended as a meeting place for researchers involved in the EEIGM programme, in the 'Erasmus Mundus' Advanced Materials Science and Engineering Master programme (AMASE) and the 'Erasmus Mundus' Doctoral Programme in Materials Science and Engineering (DocMASE). This is great opportunity to present their on-going research in the various fields of Materials Science and Engineering, exchange ideas, strengthen co-operation as well as establish new contacts. More than 60 participants representing six countries attended the meeting, in total 26 oral talks and 19 posters were presented during two days. This issue of IOP Conference Series: Materials Science and Engineering presents a selection of articles from EEIGM-7 conference. Following tradition from previous EEIGM conferences, it represents the interdisciplinary nature of Materials Science and Engineering. The papers presented in this issue deal not only with basic research but also with applied problems of materials science. The presented topics include theoretical and experimental investigations on polymer composite materials (synthetic and bio-based), metallic materials and ceramics, as well as nano-materials of different kind. Special thanks should be directed to the senior staff of Division of Materials Science at LTU who agreed to review submitted papers and thus ensured high scientific level of content of this collection of papers. The following colleagues participated in the review process: Professor Lennart Walström, Professor Roberts Joffe, Professor Janis Varna, Associate Professor Marta-Lena Antti, Dr Esa Vuorinen, Professor Aji Mathew, Professor Alexander Soldatov, Dr Andrejs Purpurs, Dr Yvonne Aitomäki, Dr Robert Pederson. Roberts Joffe October 2013, Luleå Conference photograph EEIGM7 conference participants, 22 March 2013 The PDF contains the book of abstracts.
Decision regret in men undergoing dose-escalated radiation therapy for prostate cancer.
Steer, Anna N; Aherne, Noel J; Gorzynska, Karen; Hoffman, Matthew; Last, Andrew; Hill, Jacques; Shakespeare, Thomas P
2013-07-15
Decision regret (DR) is a negative emotion associated with medical treatment decisions, and it is an important patient-centered outcome after therapy for localized prostate cancer. DR has been found to occur in up to 53% of patients treated for localized prostate cancer, and it may vary depending on treatment modality. DR after modern dose-escalated radiation therapy (DE-RT) has not been investigated previously, to our knowledge. Our primary aim was to evaluate DR in a cohort of patients treated with DE-RT. We surveyed 257 consecutive patients with localized prostate cancer who had previously received DE-RT, by means of a validated questionnaire. There were 220 responses (85.6% response rate). Image-guided intensity modulated radiation therapy was given in 85.0% of patients and 3-dimensional conformal radiation therapy in 15.0%. Doses received included 73.8 Gy (34.5% patients), 74 Gy (53.6%), and 76 Gy (10.9%). Neoadjuvant androgen deprivation (AD) was given in 51.8% of patients and both neoadjuvant and adjuvant AD in 34.5%. The median follow-up time was 23 months (range, 12-67 months). In all, 3.8% of patients expressed DR for their choice of treatment. When asked whether they would choose DE-RT or AD again, only 0.5% probably or definitely would not choose DE-RT again, compared with 8.4% for AD (P<.01). Few patients treated with modern DE-RT express DR, with regret appearing to be lower than in previously published reports of patients treated with radical prostatectomy or older radiation therapy techniques. Patients experienced more regret with the AD component of treatment than with the radiation therapy component, with implications for informed consent. Further research should investigate regret associated with individual components of modern therapy, including AD, radiation therapy and surgery. Crown Copyright © 2013. Published by Elsevier Inc. All rights reserved.
Decision Regret in Men Undergoing Dose-Escalated Radiation Therapy for Prostate Cancer
DOE Office of Scientific and Technical Information (OSTI.GOV)
Steer, Anna N.; Aherne, Noel J., E-mail: noel.aherne@ncahs.health.nsw.gov.au; Rural Clinical School Faculty of Medicine, University of New South Wales, Coffs Harbour
2013-07-15
Purpose: Decision regret (DR) is a negative emotion associated with medical treatment decisions, and it is an important patient-centered outcome after therapy for localized prostate cancer. DR has been found to occur in up to 53% of patients treated for localized prostate cancer, and it may vary depending on treatment modality. DR after modern dose-escalated radiation therapy (DE-RT) has not been investigated previously, to our knowledge. Our primary aim was to evaluate DR in a cohort of patients treated with DE-RT. Methods and Materials: We surveyed 257 consecutive patients with localized prostate cancer who had previously received DE-RT, by meansmore » of a validated questionnaire. Results: There were 220 responses (85.6% response rate). Image-guided intensity modulated radiation therapy was given in 85.0% of patients and 3-dimensional conformal radiation therapy in 15.0%. Doses received included 73.8 Gy (34.5% patients), 74 Gy (53.6%), and 76 Gy (10.9%). Neoadjuvant androgen deprivation (AD) was given in 51.8% of patients and both neoadjuvant and adjuvant AD in 34.5%. The median follow-up time was 23 months (range, 12-67 months). In all, 3.8% of patients expressed DR for their choice of treatment. When asked whether they would choose DE-RT or AD again, only 0.5% probably or definitely would not choose DE-RT again, compared with 8.4% for AD (P<.01). Conclusion: Few patients treated with modern DE-RT express DR, with regret appearing to be lower than in previously published reports of patients treated with radical prostatectomy or older radiation therapy techniques. Patients experienced more regret with the AD component of treatment than with the radiation therapy component, with implications for informed consent. Further research should investigate regret associated with individual components of modern therapy, including AD, radiation therapy and surgery.« less
1988-03-01
32264. Technical Monitors were Dr. John Bushman and Mr. David P. Buelow, OCE, and Mr. Dave Mathis, Water Resources Support Center, Fort Belvoir, Va. The...Manager for EIRP was Dr. Roger T. Saucier. Dr. John Harrison was Chief, EL. The report was written by Dr. Smardon, Dr. Palmer, Mr. Knopf, Ms. Grinde...Riverfront area will continue. Historic Mill District projects and establishment of the Riverside Parkway System will further unify S the Riverfront
High Performance Embedded Computing Software Initiative (HPEC-SI)
2004-08-20
models , methodologies, and standards i i i i i i i i i l i i i i l , l i , Slide-5 www.hpec-si.org MITRE AFRLMIT Lincoln...Linderman AFRL Dr. Richard Games MITRE Mr. John Grosh OSD Mr. Bob Graybill DARPA/ITO Dr. Keith Bromley SPAWAR Dr. Mark Richards GTRI Dr. Jeremy Kepner...Capt. Bergmann AFRL Dr. Tony Skjellum MPISoft ... Advanced Research Mr. Bob Graybill DARPA • Partnership with ODUSD(S&T), Government Labs, FFRDCs
DOE Office of Scientific and Technical Information (OSTI.GOV)
Dizier, M.H.; Eliaou, J.F.; Babron, M.C.
In order to investigate the HLA component involved in rheumatoid arthritis (RA), the authors tested genetic models by the marker association-segregation [chi][sup 2] (MASC) method, using the HLA genotypic distribution observed in a sample of 97 RA patients. First they tested models assuming the involvement of a susceptibility gene linked to the DR locus. They showed that the present data are compatible with a simple model assuming the effect of a recessive allele of a biallelic locus linked to the DR locus and without any assumption of synergistic effect. Then they considered models assuming the direct involvement of the DRmore » allele products, and tested the unifying-shared-epitope hypothesis, which has been proposed. Under this hypothesis the DR alleles are assumed to be directly involved in the susceptibility to the disease because of the presence of similar or identical amino acid sequences in position 70-74 of the third hypervariable region of the DRBI molecules, shared by the RA-associated DR alleles DR4Dw4, DR4Dw14, and DR1. This hypothesis was strongly rejected with the present data. In the case of the direct involvement of the DR alleles, hypotheses more complex that the unifying-shared-epitope hypothesis would have to be considered. 28 refs., 2 tabs.« less
Marine Biotoxins: Laboratory Culture and Molecular Structure
1989-10-18
associated with the human fish intoxication known as ciguatera , ciguatoxin and umitotoxin. and with palytoxin. Each of the three toxins presents a different...B. Current Status 1. Ciguatoxin The PI reviewed the status of ciguatera research at the Mycotoxins and Phycotoxins Symposium "n August, 1988 in...CITED BOMBER. J.W.. RUBIO. G.G. and NORRIS. D.R. (1989) Epiphytism of dinoflagellates associated with the disease ciguatera : substrate specificity and
Xiao, Di; Vignarajan, Janardhan; Chen, Tingting; Ye, Tiantian; Xiao, Baixiang; Congdon, Nathan; Kanagasingam, Yogessan
2017-12-01
We have developed a new telemedicine system for comprehensive eye examination, diabetic retinopathy (DR) screening, and eye disease diagnosis and treatment. The novel points of the system include a tablet application for facilitating doctor's examination and diagnosis process, a comprehensive eye examination component, and integrated treatment planning and recording. The system provided a new service model through one ophthalmological center linking with multiple remote and rural hospitals for eye care in Guangdong province, China. The early stage of the project study also undertook the responsibility of educations for remote-area doctors and image graders for DR grading and glaucoma grading and research on the effectiveness of short message service (SMS) reminder for patient revisit. Some other research, such as the comparison of the accuracy of graders' DR grading with the gold standard, and doctor's tentative diagnosis with final diagnosis and related statistical information, has been implemented in the system. In the preliminary practice, we summarized the outcomes related to presenting system performance and made an initial analysis. From the practice, the project has shown the telemedicine system and associated contents have satisfied our initial goal and demonstrated their effectiveness and efficiency.
Editor's note: notice of retraction.
Shafer, Steven L
2014-11-01
In 2009, Joachim Boldt published an article in Anesthesia & Analgesia comparing albumin and hydroxyethyl starch priming cardiopulmonary bypass. The study was retracted in December 2010 for lack of IRB approval. A subsequent investigation by Klinikum Ludwigshafen determined that the study was fabricated. Based on the finding by Landesärztekammer Rheinland-Pfalz, the State Medical Association of Rheinland-Pfalz, that the studies were conducted without IRB approval, Anesthesia & Analgesia retracted 22 papers by Dr. Boldt in 2011 for unethical conduct of research. A subsequent investigation by Klinikum Ludwigshafen found that Boldt’s studies "failed to meet required standards," included "false data" in at least 10 studies, and found "clear evidence of procedural irregularities and research misconduct on the part of Dr. Joachim Boldt." In light of these concerns, Justus-Liebig Universität Giessen undertook an investigation of Dr. Boldt’s work from that institution. This investigation cast doubt on the veracity of Boldt J, Heesen M, Müller M, Pabsdorf M, Hempelmann G. The effects of albumin versus hydroxyethyl starch solution on cardiorespiratory and circulatory variables in critically ill patient. Anesth Analg 1996;83: 254–61. Based on evidence of data manipulation reported by Justus-Liebig Universität Giessen to the journal, this paper is hereby retracted.
DOE Office of Scientific and Technical Information (OSTI.GOV)
Samios,N.P.
The ninth evaluation of the RIKEN BNL Research Center (RBRC) took place on Nov. 17-18, 2008, at Brookhaven National Laboratory. The members of the Scientific Review Committee (SRC) were Dr. Dr. Wit Busza (Chair), Dr. Miklos Gyulassy, Dr. Akira Masaike, Dr. Richard Milner, Dr. Alfred Mueller, and Dr. Akira Ukawa. We are pleased that Dr. Yasushige Yano, the Director of the Nishina Institute of RIKEN, Japan participated in this meeting both in informing the committee of the activities of the Nishina Institute and the role of RBRC and as an observer of this review. In order to illustrate the breadthmore » and scope of the RBRC program, each member of the Center made a presentation on his/her research efforts. This encompassed three major areas of investigation, theoretical, experimental and computational physics. In addition the committee met privately with the fellows and postdocs to ascertain their opinions and concerns. Although the main purpose of this review is a report to RIKEN Management (Dr. Ryoji Noyori, RIKEN President) on the health, scientific value, management and future prospects of the Center, the RBRC management felt that a compendium of the scientific presentations are of sufficient quality and interest that they warrant a wider distribution. Therefore we have made this compilation and present it to the community for its information and enlightenment.« less
Study of Vibrational Energy Transfer at a Surface by a Time-of-Flight Method.
1983-07-31
82174* - *-. L7 .i.&. I- I OD(D SOI x O 1 6/81 INIT DISTRIBUTION LIST July 31, 1983 No. Copies No. Copies Dr. L.V. Schmidt 1 Dr. F. Roberto 1 Assistant...of Scientific Dr. A.L. Slafkosky 1Research Scientific Advisor Directorate of Aerospace Sciences Commandant of the Marine Corps Bolling Air Force Base...Research Research Code 432 Directorate of Chemical Sciences Arlington, VA 22217 Bolling Air Force Base Washington, D.C. 20332Mr. David SiegelI Office of
Clinical Investigation Program, Reports Control Symbol MED-300(R1), Fiscal Year 1988
1988-10-01
Dr. Venkataraman Balaraman, M.D. Department/Section: Clinical Investigation Key Words: arginine vasopressin (AVP); vascular smooth muscle responses...Kullama, Ph.D. Associate Investigators: Dr. Venkataraman Balaraman, M.D.; Dr. Kenneth T. Nakamura, M.D.; John R. Claybaugh, Ph.D. Department/Section...Harrison Hassell, MC Associate Investigators: John R. Claybaugh, Ph.D.; Arnold Siemsen, MD; Jon Streltzer, MD Department/Section: Medicine/ Nephrology
Associations between sleep duration, sleep quality and diabetic retinopathy.
Tan, Nicholas Y Q; Chew, Merwyn; Tham, Yih-Chung; Nguyen, Quang Duc; Yasuda, Masayuki; Cheng, Ching-Yu; Wong, Tien Yin; Sabanayagam, Charumathi
2018-01-01
Abnormal durations of sleep have been associated with risk of diabetes. However, it is not clear if sleep duration is associated with diabetic retinopathy (DR). In a cross-sectional study, we included 1,231 (Malay, n = 395; Indian, n = 836) adults (mean age 64.4 ± 9.0 years, 50.4% female) with diabetes from the second visit of two independent population-based cohort studies (2011-15) in Singapore. Self-reported habitual sleep duration was categorized as short (<6 h), normal (6≤ h <8), and long (≥8 h). Questionnaires were administered to detect risk of obstructive sleep apnea (OSA), excessive daytime sleepiness, and insomnia, all of which may indicate poor quality of sleep. The associations between sleep-related characteristics with moderate DR and vision-threatening DR (VTDR) were analysed using logistic regression models adjusted for potential confounders. Prevalence of moderate DR and VTDR in the study population were 10.5% and 6.3% respectively. The mean duration of sleep was 6.4 ± 1.5 h. Compared to normal sleep duration, both short and long sleep durations were associated with moderate DR with multivariable odds ratio (95% confidence interval) of 1.73 (1.03-2.89) and 2.17 (1.28-3.66) respectively. Long sleep duration (2.37 [1.16-4.89]), high risk of OSA (2.24 [1.09-4.75]), and excessive daytime sleepiness (3.27 [1.02-10.30]) were separately associated with VTDR. Sleep duration had a U-shaped association with moderate DR; long sleep duration, excessive daytime sleepiness and high risk of OSA were positively associated with VTDR.
Dr. Stefan Ambs: Increasing Diversity in Cancer Research: One Lab at a Time
As part of the series “Increasing Diversity in Cancer Research,” CRCHD interviewed Dr. Stefan Ambs, an investigator at NCI’s Center for Cancer Research, who is using novel approaches to discover gene differences in the tumors of African American patients.
2013-10-01
Velozo’s research focus is on the development of functional outcome measures using Rasch measurement theory. Dr. Velozo’s research team has...functional outcome measures using Rasch measurement theory. Dr. Velozo’s research team has developed computerized adaptive measurement of physical
Interdisciplinary Research Training in Breast Cancer
2006-07-01
McCorkle and Knobf, the study was published in Journal of Medical Internet Research . • Dr. LaCoursiere had begun an ongoing collaboration with Dr...patients’ self-reported attitudes about the Internet. Journal of Medical Internet Research , 7(3), e22. • LaCoursiere, S. P., & Sarkar, M. (2004
Nadarajan, Balasubramanian; Krishna, Ramesh Babu; Lakshminarayanan, Subitha
2017-01-01
Introduction There is limited information on prevalence of Diabetic Retinopathy (DR) among diabetic subjects and its associated factors in a rural setting in developing countries including India. The information will be useful for initiating early screening strategies for this group in the community. Aim To assess the prevalence and certain associated factors of DR among diabetic subjects in a rural area of Tamil Nadu, India. Materials and Methods This cross-sectional study was conducted among 105 Type 2 diabetic subjects in Pakkam and Mandagapattu sub-center area of Kondur Primary Health Center in Villupuram district of Tamil Nadu, India. Data on associated factors which include sociodemographic factors, duration of disease, family history, and frequency of blood test, treatment regularity, hypertension, visual acuity and cataract were collected. Detailed eye examination including visual acuity, direct ophthalmoscope and Non Mydriatic Fundus Camera was done. Data was analysed by univariate analysis and described in proportion or percentages. Results The mean age of the study population was 56.69 years. About 47 (44.8%) of the subjects were more than 60 years of age followed by 44 subjects (41.9%) in age group 45-59 years. Fundus examination in at least one eye was seen in 83 people (79.0%). Prevalence of DR in any eye and both the eye was 32.53% (27/83) and 31.58% (24/76) respectively. Severity of DR was moderate (51.9%) followed by mild (44.4%) and severe (3.7%). DR prevalence was more among >60 years age group (p=0.032) and lesser education level (p=0.057). There was no association of DR with duration of disease, family history of diabetes, treatment regularity, presence of hypertension, visual acuity and cataract (p>0.05) Conclusion The prevalence of DR was inferred to be high and further larger follow up studies will explore the role of associated factors and its quantification in the causation of DR. PMID:28892938
Nadarajan, Balasubramanian; Saya, Ganesh Kumar; Krishna, Ramesh Babu; Lakshminarayanan, Subitha
2017-07-01
There is limited information on prevalence of Diabetic Retinopathy (DR) among diabetic subjects and its associated factors in a rural setting in developing countries including India. The information will be useful for initiating early screening strategies for this group in the community. To assess the prevalence and certain associated factors of DR among diabetic subjects in a rural area of Tamil Nadu, India. This cross-sectional study was conducted among 105 Type 2 diabetic subjects in Pakkam and Mandagapattu sub-center area of Kondur Primary Health Center in Villupuram district of Tamil Nadu, India. Data on associated factors which include sociodemographic factors, duration of disease, family history, and frequency of blood test, treatment regularity, hypertension, visual acuity and cataract were collected. Detailed eye examination including visual acuity, direct ophthalmoscope and Non Mydriatic Fundus Camera was done. Data was analysed by univariate analysis and described in proportion or percentages. The mean age of the study population was 56.69 years. About 47 (44.8%) of the subjects were more than 60 years of age followed by 44 subjects (41.9%) in age group 45-59 years. Fundus examination in at least one eye was seen in 83 people (79.0%). Prevalence of DR in any eye and both the eye was 32.53% (27/83) and 31.58% (24/76) respectively. Severity of DR was moderate (51.9%) followed by mild (44.4%) and severe (3.7%). DR prevalence was more among >60 years age group (p=0.032) and lesser education level (p=0.057). There was no association of DR with duration of disease, family history of diabetes, treatment regularity, presence of hypertension, visual acuity and cataract (p>0.05). The prevalence of DR was inferred to be high and further larger follow up studies will explore the role of associated factors and its quantification in the causation of DR.
Chambers, A F
1999-02-01
The Metastasis Research Society (MRS) has held its International Congress every two years since 1986, and alternates between European and North American meeting venues. The next MRS International Congress will be held in London, UK in the year 2000, and will be hosted by the current MRS President, Dr. Suzanne Eccles (Institute of Cancer Research, Sutton, UK). Dr. Eccles took over from the out-going President, Dr. William Stetler-Stevenson (National Institutes of Health, Bethesda, MD, USA), at the San Diego meeting. Information on joining the Metastasis Research Society, which includes a subscription to the Society's journal, Clinical and Experimental Metastasis, can be obtained from Dr. Eccles (suzan@icr.ac.uk) or from the newly-elected Secretary/Treasurer Dr. Danny Welch (Hershey, PA, USA; drw9@psu.edu). The meeting was organized by Darwin Medical Communications Ltd (Gill Heaton, Oxford, UK), who have placed the full program on the meeting web site (http:@www.sparks.co.uk/mrs). It is envisaged that full abstracts of all the presentations will be placed on the Metastasis Research Society web site, which is currently under construction. Corporate sponsors for the San Diego meeting included Agouron Pharmaceuticals, Becton Dickinson & Co, Zeneca Pharma SA, Schering AG, AntiCancer Inc, Oncogene Research Products, Daiichi Seiyaku Co Ltd and Novartis Pharma AG.
Noble, Janelle A.; Martin, Adelle; Valdes, Ana M.; Lane, Julie A.; Galgani, Andrea; Petrone, Antonio; Lorini, Renata; Pozzilli, Paolo; Buzzetti, Raffaella; Erlich, Henry A.
2008-01-01
Patients with high-risk HLA-DR-DQ genotypes for type 1 diabetes (T1D) were compared to HLA-matched controls to evaluate T1D risk for other HLA loci, including HLA-A, -B, -Cw, and DPB1. Patients (n=133) with high-risk genotypes (DR3/DR3, DR3/DR4, DR4/DR4) were selected from the Lazio (Rome) region of Italy. Screening of more than 9000 subjects from the Lazio region and northern Italy yielded 162 controls with high- T1D-risk haplotypes. Although the overall distributions were not significantly different, allele frequency differences were discovered between the controls from Lazio and those from Northern Italy for some alleles previously shown to affect T1D risk, such as A*3002, DPB1*0301, and DPB1*0402. Therefore, Lazio patient data were compared both to the Lazio subset of controls (n=53) and to the entire group of controls for association analyses. Significant allele frequency differences between patients and DR-DQ-matched controls were found for specific alleles at all loci. Data for the DR3/DR3 subset of patients and controls showed an increase of Cw*0702 in patients. Reduced patient, compared to control, frequencies were seen for several alleles, including A*0101, B*0801, and Cw*0701, all found on the highly-conserved, extended DR3 haplotype known as 8.1 in DR3/DR3, but not DR3/DR4, subgroup. DPB1*0101, often found on 8.1 haplotypes, was also less frequent in DR3/DR3 patients than controls. Analysis of family-based data from the HBDI repository was consistent with the observed results from the Italian subjects, suggesting the presence of a T1D-protective locus at or near A*0101 and a second T1D-protective locus at or near DPB1*0101. These data suggest that T1D risk conferred by the 8.1 haplotype is genotype dependent. PMID:18486765
HbA1c, systolic blood pressure variability and diabetic retinopathy in Asian type 2 diabetics.
Foo, Valencia; Quah, Joanne; Cheung, Gemmy; Tan, Ngiap Chun; Ma Zar, Kyi Lin; Chan, Choi Mun; Lamoureux, Ecosse; Tien Yin, Wong; Tan, Gavin; Sabanayagam, Charumathi
2017-02-01
The aim of the present study was to examine the association between variability in HbA1c or systolic blood pressure (SBP) and diabetes-specific moderate retinopathy in Asians with type 2 diabetes (T2D). A retrospective study was conducted of 172 cases of moderate diabetic retinopathy (DR) cases and 226 controls without DR, matched for age, sex, and ethnicity. Serial HbA1c and SBP (range 3-6 readings) over the 2 years prior to photographic screening of DR were collected. Intrapersonal mean and SD values for HbA1c (iM-HbA1c and iSD-HbA1c) and SBP (iM-SBP and iSD-SBP) were derived. Moderate DR was assessed from digital retinal photographs and defined as levels >43 using the Early Treatment Diabetic Retinopathy Study scale. Cases of moderate DR had higher iM-HbA1c (8.2 % vs 7.3 %; P = 0.001), iSD-HbA1c (1.22 vs 0.64; P = 0.001), iM-SBP (136.8 vs 129.6 mmHg; P = 0.001) and iSD-SBP (13.3 vs 11.1; P = 0.002) than controls. In the multivariate regression model adjusted for age, gender, ethnicity, duration of diabetes, SBP, and HbA1c, iM-HbA1c and iM-SBP were significantly associated with moderate DR (odds ratio [OR] 1.80, 95 % confidence interval [CI] 1.37-2.36; and OR 1.03, 95 % CI 1.01-1.05, respectively). Neither iSD-HbA1c nor iSD-SBP were associated with moderate DR. When stratified by HbA1c <7 %, only iSD-SBP remained significantly associated with moderate DR (OR 1.11, 95 % CI 1.01-1.21). In a cohort of Asian patients with T2D, both higher mean HbA1c levels and SBP, but not their variability, were associated with moderate DR. Among those with good glycemic control, wider variability of SBP is associated with moderate DR. © 2016 Ruijin Hospital, Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd.
Klein, Ronald; Lee, Kristine E; Danforth, Lorraine; Tsai, Michael Y; Gangnon, Ronald E; Meuer, Stacy E; Wong, Tien Y; Cheung, Carol Y; Klein, Barbara E K
2018-05-17
To examine the relationships of retinal vessel geometric characteristics (RVGCs) to the incidence and progression of diabetic retinopathy (DR). Observational, prospective cohort study. Nine hundred ninety-six persons with type 1 diabetes mellitus (T1DM) and 1370 persons with type 2 diabetes mellitus (T2DM) seen at a baseline examination who were eligible for follow-up examinations at subsequent 5-year intervals. A total of 3846 person-interval data from these follow-up examinations are the basis for the analyses. Diabetic retinopathy and macular edema were assessed by grading of 30° stereoscopic color fundus photographs. Retinal vessel geometric characteristics were assessed using the Singapore I Vessel Assessment program from a digitized copy of 1 of the field 1 fundus photographs obtained at baseline and follow-up. The 5-year incidence of any DR, progression of DR, and incidence of proliferative diabetic retinopathy (PDR) and clinically significant macular edema (CSME) in right eyes. Incident DR occurred in 45%, progression in 32%, PDR in 10%, and CSME in 5%. While adjusting for glycated hemoglobin, duration of diabetes, and other factors, retinal arteriolar simple tortuosity was associated significantly with the incidence of any DR (odds ratio [OR], 1.17; 95% confidence interval [CI], 1.01-1.35). Retinal venular branching angle was associated significantly with progression of DR (OR, 1.18; 95% CI, 1.03-1.36), retinal venular curvature tortuosity was associated significantly with the incidence of PDR (OR, 1.15; 95% CI, 1.01-1.30), and retinal venular branching angle (OR, 1.41; 95% CI, 1.10-1.82) was associated significantly with the incidence of CSME. There were no significant associations of other RVGCs with any of the DR outcomes in the full multivariate model. Inclusion of all possible RVGCs did not improve the predictive value of the models that already included retinal vessel diameter and baseline DR severity level. Retinal vessel geometric characteristics of the retinal venules were associated with progression of DR; however, most of the RVGCs measured from digitized fundus photographs added little to the assessment of risk of incidence and progression of DR when other risk factors were considered in T1DM and T2DM. Copyright © 2018 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
Myopia and/or longer axial length are protective against diabetic retinopathy: a meta-analysis.
Fu, Yu; Geng, Dengfeng; Liu, Hua; Che, Huixin
2016-06-01
To evaluate the current evidence of the relationship between myopia, together with its structural and refractive component, and diabetic retinopathy (DR) risk. A systematic search was performed up to April, 2015. Summary odds ratios (ORs) and 95% confidence intervals (CIs) were calculated employing random-effects models. Three models were used to assess the association between myopia and risk of DR: axial length (AL) (per millimetre increase) and DR; myopia (myopia versus non-myopia) and DR; refractive error (RE) (per D decrease) and DR. Publication bias of the literature was evaluated using Begg's funnel plots and Egger's test. A total of 11 studies that met the predefined criteria were included in this meta-analysis. Overall, longer AL (per millimetre increase) was associa-ted with a significantly decreased risk of DR (combined OR, 0.75; 95% CI, 0.65-0.86; p < 0.001); myopic eyes (myopia versus non-myopia) showed a lower risk of DR (combined OR, 0.70; 95% CI, 0.58-0.85; p < 0.001). A greater degree of myopic RE (per D decrease) also revealed a significantly decreased risk of DR (combined OR, 0.89; 95% CI, 0.85-0.93; p < 0.001). The sensitivity analyses and cumulative meta-analysis showed similar results. No publication bias was detected in any of the three models. This meta-analysis suggests that both myopic refraction and longer AL are associated with a lower risk of DR. Further studies are needed to determine exact mechanisms underpinning the protective effect of myopia against DR. © 2015 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.
Dr. Nancy Krieger is Professor of Social Epidemiology, in the Department of Social and Behavioral Sciences at the Harvard T.H. Chan School of Public Health and Director of the HSPH Interdisciplinary Concentration on Women, Gender, and Health. She is an internationally recognized social epidemiologist, with a background in biochemistry, philosophy of science, and the history of public health, combined with over 30 years of activism linking issues involving social justice, science, and health. In 2004, she became an ISI highly cited scientist (reaffirmed: 2015 ISI update), a group comprising “less than one-half of one percent of all publishing researchers,” and in 2013 was the recipient of the Wade Hampton Frost Award from the Epidemiology Section of the American Public Health Association; in 2015, she was awarded the American Cancer Society Clinical Research Professorship. Dr. Krieger’s work addresses three topics: (1) conceptual frameworks to understand, analyze, and improve the people’s health, including the ecosocial theory of disease distribution she has been developing since 1994 and its focus on embodiment and equity; (2) etiologic research on societal determinants of population health and health inequities; and (3) methodologic research on improving monitoring of health inequities. She is author of Epidemiology and The People’s Health: Theory and Context (Oxford University Press, 2011), editor of Embodying Inequality: Epidemiologic Perspectives (Baywood Press, 2004) and co-editor, with Glen Margo, of AIDS: The Politics of Survival (Baywood Publishers, 1994), and, with Elizabeth Fee, of Women’s Health, Politics, and Power: Essays on Sex/Gender, Medicine, and Public Health (Baywood Publishers, 1994). In 1994, she co-founded, and still chairs, the Spirit of 1848 Caucus of the American Public Health Association, which is concerned with the links between social justice and public health. Dr. Krieger received her PhD in Epidemiology from the University of California at Berkeley in 1989.
Interview with Janet Woodcock.
Woodcock, Janet
2010-09-01
Dr Janet Woodcock is the Director of the US FDA's Center for Drug Evaluation and Research. Dr Woodcock has held various positions within the FDA's Office of the Commissioner from October 2003 until 1 April 2008, as Deputy Commissioner and Chief Medical Officer, Deputy Commissioner for Operations and Chief Operating Officer and Director of the Critical Path Programs. She oversaw scientific and medical regulatory operations for the FDA. Dr Woodcock served as Director of the Center for Drug Evaluation and Research at the FDA from 1994 to 2005. She previously served in other positions at the FDA, including Director of the Office of Therapeutics Research and Review and Acting Deputy Director of the Center for Biologics Evaluation and Research. Dr Woodcock received her MD from Northwestern Medical School (IL, USA), and completed further training and held teaching appointments at the Pennsylvania State University (PA, USA) and the University of California in San Francisco (CA, USA). She joined the FDA in 1986.
Drug-resistant tuberculosis clinical trials: proposed core research definitions in adults.
Furin, J; Alirol, E; Allen, E; Fielding, K; Merle, C; Abubakar, I; Andersen, J; Davies, G; Dheda, K; Diacon, A; Dooley, K E; Dravnice, G; Eisenach, K; Everitt, D; Ferstenberg, D; Goolam-Mahomed, A; Grobusch, M P; Gupta, R; Harausz, E; Harrington, M; Horsburgh, C R; Lienhardt, C; McNeeley, D; Mitnick, C D; Nachman, S; Nahid, P; Nunn, A J; Phillips, P; Rodriguez, C; Shah, S; Wells, C; Thomas-Nyang'wa, B; du Cros, P
2016-03-01
Drug-resistant tuberculosis (DR-TB) is a growing public health problem, and for the first time in decades, new drugs for the treatment of this disease have been developed. These new drugs have prompted strengthened efforts in DR-TB clinical trials research, and there are now multiple ongoing and planned DR-TB clinical trials. To facilitate comparability and maximise policy impact, a common set of core research definitions is needed, and this paper presents a core set of efficacy and safety definitions as well as other important considerations in DR-TB clinical trials work. To elaborate these definitions, a search of clinical trials registries, published manuscripts and conference proceedings was undertaken to identify groups conducting trials of new regimens for the treatment of DR-TB. Individuals from these groups developed the core set of definitions presented here. Further work is needed to validate and assess the utility of these definitions but they represent an important first step to ensure there is comparability in clinical trials on multidrug-resistant TB.
Causality: School Libraries and Student Success (CLASS). White Paper
ERIC Educational Resources Information Center
American Association of School Librarians, 2014
2014-01-01
On April 11 and 12, 2014, the American Association of School Librarians (AASL) held "Causality: School Libraries and Student Success" (CLASS), an IMLS-funded national forum. Dr. Thomas Cook, one of the most influential methodologists in education research, and a five member panel of expert scholars and practitioners led 50 established…
Postdoctoral Fellow | Center for Cancer Research
Dr. St. Croix’s laboratory at the Mouse Cancer Genetics Program (MCGP), National Cancer Institute, USA has an open postdoctoral position. We seek a highly motivated, creative and bright individual to participate in a collaborative project that involves the targeting of tumor-associated stroma using T-cells engineered to express chimeric antigen receptors (CARs). The laboratory
Nutrition Frontiers - Spring 2018 | Division of Cancer Prevention
Dear Colleague, The spring issue of Nutrition Frontiers showcases the association of gut microbial communities in premenopausal women, how high-fat, high-calorie-diet-induced obesity may increase pancreatic cancer, and the effects of calorie restriction protocols on pro-inflammatory cytokines. Meet our spotlight investigator, Dr. Purnima Kumar, and her research on black
The Top 100 Communication, Journalism, and Related Degrees Conferred
ERIC Educational Resources Information Center
Diverse: Issues in Higher Education, 2011
2011-01-01
Each year, "Diverse: Issues In Higher Education" publishes lists of the Top 100 producers of associate, bachelor's and graduate degrees awarded to minority students based on research conducted by Dr. Victor M. H. Borden, professor of educational leadership and policy studies at Indiana University Bloomington. This article presents a listing of the…
Navy-ASEE Summer Faculty Research Program. Navy-ASEE Sabbatical Leave Program.
1994-09-01
University Arnall Physical Therapy N. Arizona Univ. I Azimi-Sadjadi Elec. Eng. Colorado St. Univ. Baird Chem. Univ. of Alabama in Huntsville I Bandy Mech...provide the framework for the analysis of data in magneto -optics and on tunneling structures for a number of years. Dr. Bilal M. Ayyub Associate
Healthcare reform in the Middle East and the USA.
Younis, Mustafa Z
2017-01-01
Mustafa Z Younis speaks to Laura Dormer, Commissioning Editor: Dr Mustafa Z Younis is an internationally recognized scholar and was a member of the Executive Committee of the International Society for Research of Healthcare Financial Management. Dr Younis has authored and published over 200 articles, abstracts and presentations in refereed journals and meetings, and has presented at national and international conferences. Dr Younis has administrative experience as Senior Adviser for the President at Zirve University, Turkey and as Chair of the Department of Health Policy and Management at Florida International University (FL, USA) where he led the accreditation efforts for the Healthcare Management Program. Dr Younis has a history of playing visible roles on the editorial boards of journals as Chief Editor, Guest Editor and Editorial board member of leading journals such as Journal of International Medical Research, Journal of Health Care Finance, Inquiry, Journal of Health and Human Services Administration, Journal of Public Budgeting, Accounting and Financial Management. Dr Younis is a frequent speaker for both academic and professional audiences. His talks often feature his latest research and work in progress as well as cross-industry trends and strategy implications. He has provided workshops and presentation for wide organizations. His research and findings applied to for-profit, non-profit settings, and government. Dr Younis has consulted with several organizations on healthcare finance, and economics. Dr Younis is often invited to speak about the challenges in the healthcare industry and other related topics to health economics, finance, and research. He has presented topics such as, healthcare reform, ownership structure, profitability, unit cost, payment system and efficiency in management, at a variety of forums and conferences in Europe, Asia and Middle East.
2003-05-07
KENNEDY SPACE CENTER, FLA. - From left, Barry Perlman, Pembroke Pines Charter Middle School in Florida; Valerie Cassanto, Instrumentation Technology Associates, Inc.; and Dr. Dennis Morrison, NASA Johnson Space Center, process one of the experiments carried on mission STS-107. Several experiments were found during the search for Columbia debris. Included in the Commercial ITA Biomedical Experiments payload on mission STS-107 are urokinase cancer research, microencapsulation of drugs, the Growth of Bacterial Biofilm on Surfaces during Spaceflight (GOBBSS), and tin crystal formation. The latter was sponsored by the Pembroke Pines Charter Middle School.
Research in Energetic Compounds.
1980-01-01
Copies No. Copies Dr. L.V. Schmidt 1 [r. F. Roberto Assistant Secretary of the Navy Code AFRPL HKPA (R,E, and S) Room 5E 731 Edwards AF6, CA 93523...Force Office of Sciertific Dr. Richard S. Miller 10 Research Office of Naval Research Directorate of Chemical Sciences Arlington, VA 22217 Bolling Air
Dr. Dinah Singer: Increasing Diversity in Cancer Research: One Lab at a Time
As part of the series “Increasing Diversity in Cancer Research,” CRCHD spoke with Dr. Dinah Singer, Director of NCI’s Division of Cancer Biology, about training and mentorship, and the role it plays in attracting and retaining students and investigators underrepresented in cancer research.
The Logic of the Theoretical and Practical Products of Design Research
ERIC Educational Resources Information Center
Easterday, Matthew W.; Rees Lewis, Daniel G.; Gerber, Elizabeth M.
2016-01-01
Design research (DR) promises to simultaneously solve practical problems of education and develop theory to guide future interventions. However, educational DR remains paradigmatically underdeveloped, making it difficult to train new researchers, to agree upon what makes a theoretical contribution, and to promise clear outputs to funders--all of…
Adult Brain and Spine Tumor Research - Facebook Live Event
Chief, Dr. Mark Gilbert and Senior Investigator, Dr. Terri Armstrong, of the NCI Center for Cancer Research, Neuro-Oncology Branch, will be joined by moderator and Chief Executive Officer, David Arons of the National Brain Tumor Society led a discussion on adult brain and spine tumor research and treatment.
Adult Brain and Spine Tumor Research and Development
Chief, Dr. Mark Gilbert and Senior Investigator, Dr. Terri Armstrong, of the NCI Center for Cancer Research, Neuro-Oncology Branch, will be joined by moderator and Chief Executive Officer, David Arons of the National Brain Tumor Society led a discussion on adult brain and spine tumor research and treatment.
McLaughlin, Kerry A; Gulati, Kavita; Richardson, Carolyn C; Morgan, Diana; Bodansky, H Jonathan; Feltbower, Richard G; Christie, Michael R
2014-11-01
Autoantibodies to IA-2 in type 1 diabetes are associated with HLA-DR4, suggesting influences of HLA-DR4-restricted T cells on IA-2-specific B cell responses. The aim of this study was to investigate possible T-B cell collaboration by determining whether autoantibodies to IA-2 epitopes are associated with T cell responses to IA-2 peptides presented by DR4. T cells secreting the cytokines IFN-γ and IL-10 in response to seven peptides known to elicit T cell responses in type 1 diabetes were quantified by cytokine ELISPOT in HLA-typed patients characterized for Abs to IA-2 epitopes. T cell responses were detected to all peptides tested, but only IL-10 responses to 841-860 and 853-872 peptides were associated with DR4. Phenotyping by RT-PCR of FACS-sorted CD45RO(hi) T cells secreting IL-10 in response to these two peptides indicated that these expressed GATA-3 or T-bet, but not FOXP3, consistent with these being Th2 or Th1 memory T cells rather than of regulatory phenotype. T cell responses to the same two peptides were also associated with specific Abs: those to 841-860 peptide with Abs to juxtamembrane epitopes, which appear early in prediabetes, and those to peptide 853-872 with Abs to an epitope located in the 831-862 central region of the IA-2 tyrosine phosphatase domain. Abs to juxtamembrane and central region constructs were both DR4 associated. This study identifies a region of focus for B and T cell responses to IA-2 in HLA-DR4 diabetic patients that may explain HLA associations of IA-2 autoantibodies, and this region may provide a target for future immune intervention to prevent disease. Copyright © 2014 by The American Association of Immunologists, Inc.
Setting Priorities for Diabetic Retinopathy Clinical Research and Identifying Evidence Gaps.
Le, Jimmy T; Hutfless, Susan; Li, Tianjing; Bressler, Neil M; Heyward, James; Bittner, Ava K; Glassman, Adam; Dickersin, Kay
2017-01-01
Prioritizing comparative effectiveness research may contribute to obtaining answers that clinicians perceive they need and may minimize research that could be considered wasteful. Our objective was to identify evidence gaps and set priorities for new systematic reviews and randomized controlled trials for managing diabetic retinopathy (DR), including diabetic macular edema (DME). Cross-sectional study. Diabetic Retinopathy Clinical Research Network (DRCR.net) investigators. We provided recommendations from the American Academy of Ophthalmology's 2012 Preferred Practice Patterns for Diabetic Retinopathy as 91 answerable clinical research questions about intervention effectiveness to 410 DRCR.net investigators to rate each question's importance from 0 (not important) to 10 (very important) using a 2-round Delphi survey and to suggest additional questions. We considered questions as high priority if at least 75% of respondents to both rounds assigned an importance rating of 5 or more in round 2. We also extracted outcome measures relevant to DR and asked respondents to identify those that must be measured in all studies. We mapped Cochrane reviews published up to March 2016 to high-priority clinical research questions. Ranking of importance of each clinical question. Thirty-two individuals completed rounds 1 and 2 and suggested 15 questions. Among the final list of 106 clinical research questions, 22 questions met our definition of high priority: 9 of 22 concerned the effectiveness of anti-VEGF therapy, and 13 of 22 focused on how often patients should be followed up (re-examination) and treatment effectiveness in patients with specific characteristics (e.g., DME). Outcomes that 75% or more of respondents marked as "must be measured in all studies" included visual acuity and visual loss, death of participants, and intraocular pressure. Only 1 prioritized question was associated with conclusive evidence from a Cochrane systematic review. A limited response rate among DRCR.net members identified 22 comparative effectiveness research questions as high priority for the management of DR, including DME, but few were associated with Cochrane reviews. These results support the need of systematic reviews and randomized controlled trials to address evidence gaps.
Associative learning and regional white matter deficits in mild cognitive impairment.
Boespflug, Erin L; Eliassen, James; Welge, Jeffrey; Krikorian, Robert
2014-01-01
While diagnostic criteria for Alzheimer's disease (AD) include neuroimaging biomarkers, there remains no definitive biomarker of mild cognitive impairment (MCI). MCI is a risk factor for AD that may be amenable to early intervention. Early decline in white matter (WM) integrity identified by diffusion tensor imaging (DTI) is a predictor of future progression of neurodegeneration. Identify regionally specific WM differences between individuals with MCI and those with age-associated memory impairment (AAMI) and relationships with specific memory decrements. DTI and neuropsychological data were acquired from 38 participants (23 MCI and 15 AAMI). A region of interest approach was used to evaluate regional differences between groups and correlative relationships with performance on memory tasks. Fornix WM had higher mean (MD), radial (DR), and axial (DA) diffusivity in MCI participants relative to AAMI. Temporal stem (TS) WM had higher MD and DR in MCI than in AAMI. In MCI, TS MD and DR varied, while fornix MD and DR was uniformly high, and in AAMI, TS MD and DR were uniformly low and fornix MD and DR varied. In MCI, TS MD and DA were inversely associated with associative learning but not list learning. In addition to supporting prior evidence implicating the fornix in early AD pathology, these data implicate a profile of neurodegeneration associated with early MCI. Further, they suggest that associative learning tasks are more sensitive to early neurodegeneration and may be useful in identifying individuals at risk for AD.
A Comparison of the Effects of Random Versus Fixed Order of Item Presentation Via the Computer
1989-02-01
Copies) Dr. Hans Crombag Dr. Stephen Dunbar University of Leyden Lindquist Center Education Research Center for Measurement Boerhaavelaan 2 University of...Iowa 2334 EN Leyden Iowa City, IA 52242 The NETHERLANDS Dr. James A. Earles Dr. Timothy Davey Air Force Human Resources Lab Educational Testing...Montague 4401 Ford Avenue NPRDC Code 13 P.O. Box 16268 San Diego, CA 92152-6800 Alexandria, VA 22302-0268 Ms. Kathleen Moreno Dr..William L. Maloy
Guidon-Watch: A Graphic Interface for Viewing a Knowledge-Based System.
1985-08-01
Research Center Department of the Navy University of Illinois Boerhaavelaan 2 Washington, DO 20350-1000 Department of Cmpuer Science2334 EN Leyden 1304...Dr. William L. Maloy 270 Crown Street Pittsburgh, PA 15213 Chief of Naval Education New Haven, CT 06510 and Training Dr. Kathleen IaPiana Naval Air...Mclean, VA 22102 1250 West 6th Street Campus Box 345 San Diego, CA 92101 Boulder, CO 8D302 Dr. Aan M. lesgoldlearning M.D Center Dr. Kathleen McKeown Dr
Effects of Whole and Partial Body Exposure to Dry Heat on Certain Performance Measures.
1981-05-01
Robert Bachert who assisted with the statistical analyses; and he acknowledges the support of the Lite Mr. George C. Frost for his advice on the...of the study and interpretation of data: Dr. Arthur L Dudycha, Dr. Barry H. Kantowitz, Dr. N. M. Downie, Dr. Ernest J. McCormick, and Dr. Robert D...D., Summers, W. C., & Smedley , D. C., November 1974, Evaluation of a water- cooled helmet liner (AMRL-TR-74-135). Aerospace Medical Research
Successful Education Research: Guidelines for Getting Going, Getting Funded and Getting Published
ERIC Educational Resources Information Center
Deacon, Roger; Parker, Ben
2009-01-01
As part of the Teacher Education Research and Development Programme (TEP), a project focusing on "Stimulation of practice-based teacher education research", was undertaken by Dr. Roger Deacon and Dr. Ben Parker, in conjunction with the Centre for Education Policy Development (CEPD). As part of the project, a set of research guidelines…
STS-99 / Endeavour Mission Overview
NASA Technical Reports Server (NTRS)
2000-01-01
The primary objective of the STS-99 mission was to complete high resolution mapping of large sections of the Earth's surface using the Shuttle Radar Topography Mission (SRTM). This radar system will produce unrivaled 3-D images of the Earth's Surface. This videotape presents a mission overview press briefing. The panel members are Dr. Ghassem Asrar, NASA Associate Administrator Earth Sciences; General James C. King, Director National Imagery and Mapping Agency (NIMA); Professor Achim Bachem, Member of the Executive Board, Deutschen Zentrum fur Luft- und Raumfahrt (DLR), the German National Aerospace Research Center; and Professor Sergio Deiulio, President of the Italian Space Agency. Dr. Asrar opened with a summary of the history of Earth Observations from space, relating the SRTM to this history. This mission, due to cost and complexity, required partnership with other agencies and nations, and the active participation of the astronauts. General King spoke to the expectations of NIMA, and the use of the Synthetic Aperture Radar to produce the high resolution topographic images. Dr. Achim Bachem spoke about the international cooperation that this mission required, and some of the commercial applications and companies that will use this data. Dr Deiulio spoke of future plans to improve knowledge of the Earth using satellites. Questions from the press concerned use of the information for military actions, the reason for the restriction on access to the higher resolution data, the mechanism to acquire that data for scientific research, and the cost sharing from the mission's partners. There was also discussion about the mission's length.
Dr.LiTHO: a development and research lithography simulator
NASA Astrophysics Data System (ADS)
Fühner, Tim; Schnattinger, Thomas; Ardelean, Gheorghe; Erdmann, Andreas
2007-03-01
This paper introduces Dr.LiTHO, a research and development oriented lithography simulation environment developed at Fraunhofer IISB to flexibly integrate our simulation models into one coherent platform. We propose a light-weight approach to a lithography simulation environment: The use of a scripting (batch) language as an integration platform. Out of the great variety of different scripting languages, Python proved superior in many ways: It exhibits a good-natured learning-curve, it is efficient, available on virtually any platform, and provides sophisticated integration mechanisms for existing programs. In this paper, we will describe the steps, required to provide Python bindings for existing programs and to finally generate an integrated simulation environment. In addition, we will give a short introduction into selected software design demands associated with the development of such a framework. We will especially focus on testing and (both technical and user-oriented) documentation issues. Dr.LiTHO Python files contain not only all simulation parameter settings but also the simulation flow, providing maximum flexibility. In addition to relatively simple batch jobs, repetitive tasks can be pooled in libraries. And as Python is a full-blown programming language, users can add virtually any functionality, which is especially useful in the scope of simulation studies or optimization tasks, that often require masses of evaluations. Furthermore, we will give a short overview of the numerous existing Python packages. Several examples demonstrate the feasibility and productiveness of integrating Python packages into custom Dr.LiTHO scripts.
A life with horses: it's been a great ride!
Antczak, Douglas F
2012-07-15
In 2010 Doug Antczak was the recipient of the Distinguished Veterinary Immunologist Award of the Veterinary Immunology Committee of the International Union of Immunological Societies. Dr. Antczak is the Dorothy Havemeyer McConville Professor of Equine Medicine at the Baker Institute for Animal Health in the College of Veterinary Medicine at Cornell University. His research focuses on immunological and genetic aspects of the fetal-maternal relationship in the horse. This includes studies of major histocompatibility complex (MHC) genes and molecules, the regulation of their expression in the placenta, the composition and function of uterine lymphocytes, and alterations in maternal immune reactivity during pregnancy. For this research Dr. Antczak developed a herd of purpose-bred horses selected for homozygosity at the MHC. These horses are a unique genetic resource in equine immunology. During his career Dr. Antczak has mentored over 20 graduate students and post-doctoral fellows, many of whom have gone on to independent careers in immunology research. Dr. Antczak has made contributions to equine immunology, genetics, and reproduction, and collaborated widely with scientists in each of these disciplines. Through his relationship with the Havemeyer Foundation, Dr. Antczak has been a catalyst for cooperative research through a series of Havemeyer Foundation Workshops initiated over 25 years ago. Since 1995 he has been a principal participant in the international Horse Genome Project collaboration furthering his equine immunology research through genomic applications. In 2009 Dr. Antczak was inducted into the University of Kentucky's Equine Research Hall of Fame. Copyright © 2012 Elsevier B.V. All rights reserved.
At NCI, Supporting the Best Science
Yesterday, at the AACR annual meeting, Dr. Doug Lowy spoke directly to the research community about his goals as NCI Acting Director. Dr. Lowy said that he plans to continue many of the programs launched by his predecessor, Dr. Harold Varmus, and to sharp
1965-04-13
Dr. von Braun began his association with Walt Disney in the 1950s when the rocket scientist appeared in three Disney television productions related to the exploration of space. Years later, Dr. von Braun invited Disney and his associates to tour the Marshall Space Flight Center (MSFC) in Huntsville, Alabama. This photograph is dated April 13, 1965. From left are R.J. Schwinghamer from the MSFC, Disney, B.J. Bennight, and Dr. von Braun.
An interview with Mark G. Hans
Bolognese, Ana Maria; Palomo, Juan Martin; Miyashita, Kunihiko; Nojima, Lincoln Issamu; Nojima, Matilde da Cunha Gonçalves
2014-01-01
It is a great honor to conduct an interview with Professor Mark G. Hans, after following his outstanding work ahead of the Bolton-Brush Growth Study Center and the Department of Orthodontics at the prestigious Case Western Reserve School of Dental Medicine (CWRU) in Cleveland, Ohio. Born in Berea, Ohio, Professor Mark Hans attended Yale University in New Haven, CT, and earned his Bachelor of Science Degree in Chemistry. Upon graduation, Dr. Hans received his DDS and Masters Degree of Science in Dentistry with specialty certification in Orthodontics at Case Western Reserve University. During his education, Dr. Hans' Master's Thesis won the Harry Sicher Award for Best Research by an Orthodontic Student and being granted a Presidential Teaching Fellowship. As one of the youngest doctors ever certified by the American Board of Orthodontics, Dr. Hans continues to maintain his board certification. He has worked through academics on a variety of research interests, that includes the demographics of orthodontic practice, digital radiographic data, dental and craniofacial genetics, as obstructive sleep apnea syndrome, with selected publications in these fields. One of his noteworthy contributions to the orthodontic literature came along with Dr. Donald Enlow on the pages of "Essentials of Facial Growth", being reference on the study of craniofacial growth and development. Dr. Mark Hans's academic career is linked to CWRU, recognized as the renowned birthplace of research on craniofacial growth and development, where the classic Bolton-Brush Growth Study was historically set. Today, Dr. Hans is the Director of The Bolton-Brush Growth Study Center, performing, with great skill and dedication, the handling of the larger longitudinal sample of bone growth study. He is Associate Dean for Graduate Studies, Professor and Chairman of the Department of Orthodontics, working in clinical and theoretical activities with students of the Undergraduate Course from the School of Dental Medicine and residents in the Department of Orthodontics at CWRU. Part of his clinical practice at the university is devoted to the treatment of craniofacial anomalies and to special needs patients. Prof. Mark Hans has been wisely conducting the Joint Cephalometric Experts Group (JCEG) since 2008, held at the School of Dental Medicine (CWRU). He coordinates a team composed of American, Asian, Brazilian and European researchers and clinicians, working on the transition from 2D cephalometrics to 3D cone beam imaging as well as 3D models for diagnosis, treatment planning and assessment of orthodontic outcomes. Dr. Hans travels to different countries to give lectures on his fields of interest. Besides, he still maintains a clinical orthodontic practice at his private office. In every respect, Dr. Hans coordinates all activities with particular skill and performance. Married to Susan, they have two sons, Thomas and Jack and one daughter, Sarah and he enjoys playing jazz guitar for family and friends. Matilde da Cunha Gonçalves Nojima PMID:25162563
An interview with Mark G. Hans.
Hans, Mark G; Nojima, Matilde da Cunha Gonçalves
2014-01-01
It is a great honor to conduct an interview with Professor Mark G. Hans, after following his outstanding work ahead of the Bolton-Brush Growth Study Center and the Department of Orthodontics at the prestigious Case Western Reserve School of Dental Medicine (CWRU) in Cleveland, Ohio. Born in Berea, Ohio, Professor Mark Hans attended Yale University in New Haven, CT, and earned his Bachelor of Science Degree in Chemistry. Upon graduation, Dr. Hans received his DDS and Masters Degree of Science in Dentistry with specialty certification in Orthodontics at Case Western Reserve University. During his education, Dr. Hans’ Master’s Thesis won the Harry Sicher Award for Best Research by an Orthodontic Student and being granted a Presidential Teaching Fellowship. As one of the youngest doctors ever certified by the American Board of Orthodontics, Dr. Hans continues to maintain his board certification. He has worked through academics on a variety of research interests, that includes the demographics of orthodontic practice, digital radiographic data, dental and craniofacial genetics, as obstructive sleep apnea syndrome, with selected publications in these fields. One of his noteworthy contributions to the orthodontic literature came along with Dr. Donald Enlow on the pages of “Essentials of Facial Growth”, being reference on the study of craniofacial growth and development. Dr. Mark Hans’s academic career is linked to CWRU, recognized as the renowned birthplace of research on craniofacial growth and development, where the classic Bolton-Brush Growth Study was historically set. Today, Dr. Hans is the Director of The Bolton-Brush Growth Study Center, performing, with great skill and dedication, the handling of the larger longitudinal sample of bone growth study. He is Associate Dean for Graduate Studies, Professor and Chairman of the Department of Orthodontics, working in clinical and theoretical activities with students of the Undergraduate Course from the School of Dental Medicine and residents in the Department of Orthodontics at CWRU. Part of his clinical practice at the university is devoted to the treatment of craniofacial anomalies and to special needs patients. Prof. Mark Hans has been wisely conducting the Joint Cephalometric Experts Group (JCEG) since 2008, held at the School of Dental Medicine (CWRU). He coordinates a team composed of American, Asian, Brazilian and European researchers and clinicians, working on the transition from 2D cephalometrics to 3D cone beam imaging as well as 3D models for diagnosis, treatment planning and assessment of orthodontic outcomes. Dr. Hans travels to different countries to give lectures on his fields of interest. Besides, he still maintains a clinical orthodontic practice at his private office. In every respect, Dr. Hans coordinates all activities with particular skill and performance. Married to Susan, they have two sons Thomas and Jack, and one daughter Sarah, and he enjoys playing jazz guitar for family and friends.
Maximizing the Prospects for Progress Against Cancer
The 2018 American Society of Clinical Oncology annual meeting featured numerous, potentially practice changing research findings, according to NCI Director Dr. Norman Sharpless. In this Cancer Currents post, Dr. Sharpless discusses the rapid pace of progress in cancer research.
SpaceX CRS-10 "What's On Board" Science Briefing
2017-02-17
Dr. Melissa Kacena, associate professor of orthopedic surgery at Indiana University, left, and Dr. Rasha Hammamieh, director of Integrative Systems Biology for the US Army Medical Research and Materiel Command at Fort Detrick, Maryland, speak to members of social media in the Kennedy Space Center’s Press Site auditorium. The briefing focused on studies on the effects of microgravity on tissue regeneration planned for the International Space Station following the arrival of a Dragon spacecraft. The Dragon is scheduled to be launched from Kennedy’s Launch Complex 39A on Feb. 18 atop a SpaceX Falcon 9 rocket on the company's 10th Commercial Resupply Services mission to the space station.
Huang, Olivia S; Tay, Wan Ting; Ong, Peng Guan; Sabanayagam, Charumathi; Cheng, Ching-Yu; Tan, Gavin S; Cheung, Gemmy C M; Lamoureux, Ecosse L; Wong, Tien Y
2015-12-01
To determine the prevalence and risk factors of undiagnosed diabetic retinopathy (DR), in particular vision-threatening DR (VTDR) in a multiethnic Asian cohort. A population-based survey of 3353 Chinese, 3280 Malays and 3400 Indians (73.6% response) aged 40-80 years residing in Singapore. Diabetes mellitus (DM) was defined as random glucose ≥11.1 mmol/L, use of diabetic medication or a previous physician diagnosis. DR severity was graded from retinal photographs following the modified Airlie House classification. VTDR was defined as the presence of severe non-proliferative DR (NPDR), proliferative DR (PDR) or clinically significant macular oedema (CSMO), using the Eye Diseases Prevalence Research Group definition. Participants were deemed 'undiagnosed' if they reported no prior physician diagnosis in structured interviews, in those with the condition. Of 10 033 participants, 2376 had DM (23.7%), of which 805 (33.9%) had DR. Among 2376 with DM, 11.1% (n=263) were undiagnosed. Among 805 with DR, 671 (83.3%) were undiagnosed. Among 212 with VTDR, 59 (27.3%) were undiagnosed. In multivariate models, factors associated with undiagnosed VTDR were higher low-density lipoprotein (LDL) cholesterol (OR=1.53, 95% CI 0.99 to 2.35, p=0.05) and absence of visual impairment or blindness in any eye in terms of best-corrected vision OR=3.00, 95% CI 1.47 to 6.11, p=0.003). In this community, a quarter with VTDR is undiagnosed, and 8 in 10 with any DR are undiagnosed, compared with only 1 in 10 with DM undiagnosed. These findings suggest that screening for diabetes is successful, while screening for DR is currently inadequate in our population. Public health strategies to aid early diagnosis of DR in Singapore are urgently warranted to reduce blindness due to diabetes. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
NASA Technical Reports Server (NTRS)
1975-01-01
Dr. David R. Scott was appointed Director of NASA's Flight Research Center on April 18, 1975. From August 1973 he served as Deputy Director of FRC and was appointed acting director in January 1975. He is retired from the U.S. Air Force where he held the rank of Colonel. Dave left the NASA Dryden Flight Research Center on October 30, 1977 after the Center had been renamed in honor of Hugh L. Dryden. As a NASA astronaut, Scott flew on Gemini 8, Apollo 9 and was spacecraft commander of Apollo 15. When he left the astronaut corps in 1972, Scott was named Technical Assistant to the Apollo Program Manager at Johnson Space Center in Houston. Later he served as Special Assistant for Mission Operations and Government Funded Equipment. Dave earned a Bachelor of Science Degree from the United States Military Academy in 1954, standing fifth in a class of 633, and the degrees of Bachelor and Master of Science in Aeronautics and Astronautics from the Massachusetts Institute of Technology (MIT) in 1962. He was awarded an Honorary Doctorate of Astronautical Science from the University of Michigan in 1971. Dave has graduated from the Air Force Experimental Test Pilot School and Aerospace Research Pilot School. He has over 5,600 hours flying time along with 20 hours of extra vehicular activity (EVA) time. Dr. Scott is a Fellow of the American Astronautical Society; Associate Fellow of the American Institute of Aeronautics and Astronautics; a member of the Society of Experimental Test Pilots, Tau Beta Pi, Sigma Xi, and Sigma Gamma Tau. Among Dr. Scott's special honors are two NASA Distinguished Service Medals, the NASA Exceptional Service Medal, two Air Force Distinguished Service Medals, the Air Force Distinguished Flying Cross, the Air Force Association's David C. Schilling Trophy, and the Robert J. Collier Trophy for 1971.
Brewer, Nathan R
2006-01-01
In recognition of Dr. Nathan Brewer's many years of dedicated service to AALAS and the community of research animal care specialists, the premier issue of JAALAS includes the following compilation of Dr. Brewer's essays on rabbit anatomy and physiology. These essays were originally published in the ASLAP newsletter (formerly called Synapse), and are reprinted here with the permission and endorsement of that organization. I would like to thank Nina Hahn, Jane Lacher, and Nancy Austin for assistance in compiling these essays. Publishing this information in JAALAS allows Dr. Brewer's work to become part of the searchable literature for laboratory animal science and medicine and also assures that the literature references and information he compiled will not be lost to posterity. However, readers should note that this material has undergone only minor editing for style, has not been edited for content, and, most importantly, has not undergone peer review. With the agreement of the associate editors and the AALAS leadership, I elected to forego peer review of this work, in contradiction to standard JAALAS policy, based on the status of this material as pre-published information from an affiliate organization that holds the copyright and on the esteem in which we hold for Dr. Brewer as a founding father of our organization.
Oswald Hall, PhD: Pioneer Canadian Sociologist; 1924–1976
Brown, Douglas M.
2006-01-01
At ninety-eight (2006), Oswald Hall is Canada’s senior, distinguished sociologist. For several decades Dr. Hall’s colleagues have acknowledged his abiding “contributions to the growth of sociology in Canada and his loyalty to the profession.”1 The prime purpose of this paper is to document Dr. Hall’s legacy. It begins by briefly looking at Dr. Hall’s origins and early training. Then it investigates his graduate and postgraduate education and delves into his varied roles as a teacher, researcher, civil servant, and administrator, as well as his appointments to various advisory bodies, enquiries, boards and associations and concludes with a commentary on Oswald Hall’s accomplishments. Throughout the paper, Dr. Hall’s major publications are reviewed chronologically. This study does not include Hall’s twenty-seven year involvement with the chiropractic profession (1976 to 1998) because that era has been covered extensively in the December 2005 issue of the JCCA.2 Much of the article is based on testimony from colleagues and friends, as well as quotes from some of Hall’s unpublished writings and manuscripts. Unpublished Hall quotes are identified in the references by their titles and/or dates. PMID:17549188
Veterinary Research Manpower Development for Defense
2008-09-01
Geographic Risk Factors for Disease Transmission between Livestock and Elephants in Chitwan, Nepal Philip Gerwin V’11 Dr. Mann The Role of...loss for the farmer, but also has negative impact on livelihoods. Using the Rose Bengal Agglutination Test, this study tested 163 goats to determine...and Mycobacterium avium in captive elephants in Nepal Trainee: Tierra Wilson Mentors: Dr. Gretchen Kaufman, Dr. Jean Mukherjee and Dr. Donna
Targeting Neuropilin-1 in Prostate Cancer Bone Metastasis
2011-04-01
USA; Dr. Leland W. K. Chung (Email: Leland.Chung@cshs.org), Uro -Oncology Research Program, Cedars-Sinai Medical Center, Los Angeles, CA, USA...Association for Cancer Research Annual Meeting, Los Angeles, CA, 2007. 25 Zhang S, Zhau HE, Iqbal S, Chung LWK, Wu D. Vascular endothelial growth...15. Pedersen LO , Hansen AS, Olsen AC, et al. The interaction between h2-microglobulin (h2m) and puri- fied class-I major histocompatibility (MHC
1993-05-01
RESEARCH Code 1001 Dr. T. Coffey ASSOCIATE DIRECTORS OF RESEARCH OFFICE FOR STRATEGIC PLANNING Code 1003 Or W.M Tolles II I I/.... I BUSINESS GENERAL...of its strategic vision, we agreed that together towards NRL’s strength lies in its broad, multi- the best solution. " disciplinary character and the...peace, crisis or war, American leaders can continue to contribute in several have always turned to the Sea Services areas as America’s corporate
ERIC Educational Resources Information Center
Intercultural Development Research Association, 2015
2015-01-01
English language learners make up the fastest growing segment of the student population, but they are one of the lowest academically performing groups of students and the achievement gap widens as students progress through school. Dr. Oscar Jimenez-Castellanos, the Intercultural Development Research Association's (IDRA's) inaugural Jose A.…
Martha N. Hill: transformational leader.
Coombs, V J
1998-01-01
Martha N. Hill, PhD, RN, FAAN, is a world-renowned researcher, educator, and nursing leader. Her election as president of the American Heart Association, effective June 1997, places her in one of the highest regarded positions in the field of cardiology. Despite her success on a national and international level, Dr. Hill has managed to continue to mentor and conduct clinical research with her nursing colleagues and students at The Johns Hopkins University in Baltimore, Maryland.
Analytic and Computational Studies on Micro-Propulsion and Micro-detonics
2006-08-22
Professor. • Dr. Aslan Kasimov, PostDoctoral Research Associate (Stewart), May 2004- June 2005. • Mr. Aslan Kasimov, Graduate Student (Stewart...Short continuing as his Ph.D. advisor. 2. Research completed with AFOSR support (a ) Reseach summary: Prof. D.S. Stewart (1) A.R. Kasimov and D.S...Theory of Instability and Nonlinear Evolution of Self-Sustained Detonation Waves”. Ph.D., Spring 2004. • Mr. Dave Kessler, Graduate Student (Short
Directory of Aircraft Survivability Specialists and Their Affiliations
1980-12-01
AnalysisOps Research WILLIAMS RESEARCH CORP 2280 West Maple Rd Walled Lake, MT 48088 SCHNYDER, Sidney A. (313) 624-5200 Gas turbine droneSupervisor of...AAWP-3 (513) 255-5076 reduction PELTON , Dr. Edward AV 785-5076 Radar cross section AFWAL/AAWP-3 (513) 255-5076 Reduction technology SANDERSON, Dr...Aberdeen Proving Gd, MD 21005 AV 927-3902 AV 283-4643 (804) 878-3902 (301) 278-4643 PELTON , Dr. Edward PARKER, Preston L. AFWAL/AAWP-3 AD/SESS Air
Application of Component Scoring to a Complicated Cognitive Domain
1985-05-15
Command (N-5) NAS Pensacola, FL 32508 Dr. John M. Eddins S..""*University of IllinoisDr. Hans Crombag 252 Engineering Research University of Leyden ...Laboratory Education Research Center 103 South Mathews Street Boerhaavelaan 2 Urbana, IL 61801 2334 EN Leyden The NETHERLANDS V.- University of Illinois...Naval Air Station Pensacola, FL 32508 Ms. Kathleen Moreno Navy Personnel R&D Center Dr. Gary Marco Code 62 Stop 31-E San Diego, CA 92152 Educational
ERIC Educational Resources Information Center
Foster, Charles W., Ed.; Esau, Dwight B., Ed.
This publication presents a comprehensive record of the 62nd Annual Meeting of the Association of School Business Officials, which was held in October 1976 in Boston. Included are transcripts of the meeting's three general sessions, including keynote addresses by Dr. Paul Salmon and Senator Edward Kennedy, as well as reports summarizing the…
Special Issue on Global Health Disparities Focus on Cancer.
Lee, Haeok
2016-01-01
Haeok Lee, PhD, RN, FAAN who is a Korean-American nurse scientist, received her doctor al degree from the Nursing Physiology Department, College of Nursing, University of California, San Francisco (UCSF), in 1993, and her post doctor al training from College of Medicine, UCSF. Dr. Lee worked at Case Western Reserve University and University of Colorado Health Sciences Center. She has worked at the UMass Boston since 2008. Dr. Lee has established a long-term commitment to minority health, especially Asian American Pacific Islanders, as a community leader, community health educator, and community researcher, and all these services have become a foundation for her community-based participatory research. Dr. Lee's research addresses current health problems framed in the context of social, political, and economic settings, and her studies have improved racial and ethnic data and developed national health policies to address health disparities in hepatitis B virus (HBV) infections and liver cancer among minorities. Dr. Lee's research, which is noteworthy for its theoretical base, is clearly filling the gap. Especially, Dr. Lee's research is beginning to have a favorable impact on national and international health policies and continuing education programs directed toward the global elimination of cervical and liver cancer-related health disparities in underserved and understudied populations.
2010-04-09
Netherlands Memorandum of Record (MOR) agreement signing the NASA Ames Research Center, Mofffett Field, California. Signing the MOR are on left Dr. Louis B.J.Vertegaal, Director of Physical Sciences, Chemistry, and Advanced Chemical Technologies for Sustainability, of the Netherlands Organisation for Scientific Research (NWO) and on right Dr. S. Pete Worden, Director NASA Ames Research Center
7, 2018, LA Times) Dr. Jason Siegel to chair IEEE Technical Committee on Automotive Controls (Feb 2018, IEEE) Dr. Anna Stefanopoulou on research of sustainable vehicle technologies (Jan 24, 2018, WEMU ) Stefanopoulou plenary at IEEE 56th CDC (Jan 17, 2018, ME) ARC Researchers at IEEE 56th Conf. Decision and
The history of Patuxent: America’s wildlife research story
Perry, Matthew C.
2017-01-18
This report, based on a symposium held on October 13, 2011, at the National Wildlife Visitor Center at the Patuxent Research Refuge in Laurel, MD, documents the history of the Patuxent Research Refuge and the Patuxent Wildlife Research Center, collectively known as Patuxent. The symposium was one of the many activities occurring at that time to celebrate the 75th anniversary of the creation of the Patuxent Research Refuge in 1936. The Patuxent Wildlife Research Center is located at the refuge, and the research center director, Dr. Gregory J. Smith, with great enthusiasm, personally supervised all aspects of the celebration. The symposium was coordinated by Dr. Matthew C. Perry, the editor of this report, with Dr. Smith’s strong support. The refuge and the research center have been essentially synonymous for the almost 80 years of their history.
Salvarani, C.; Boiardi, L.; Mantovani, V.; Ranzi, A.; Cantini, F.; Olivieri, I.; Bragliani, M.; Collina, E.; Macchioni, P.
1999-01-01
OBJECTIVE—To examine the association of HLA-DRB1 alleles with polymyalgia rheumatica (PMR) in a Mediterranean country and to explore the role of HLA-DRB1 genes in determining disease severity. METHODS—A five year prospective follow up study of 92 consecutive PMR patients diagnosed by the secondary referral centre of rheumatology of Reggio Emilia, Italy was conducted. HLA-DRB1 alleles were determined in the 92 patients, in 29 DR4 positive rheumatoid arthritis (RA) patients, and in 148 controls from the same geographical area by polymerase chain reaction amplification and oligonucleotide hybridisation. RESULTS—No significant differences were observed in the frequencies of HLA-DRB1 types and in the expression of HLA-DRB 70-74 shared motif between PMR and controls. The frequency of the patients with double dose of epitope was low and not significantly different in PMR and in controls. No significant differences in the distribution of HLA-DR4 subtypes were observed between DR4+ PMR, DR+ RA, and DR4+ controls. Results of the univariate analysis indicated that an erythrocyte sedimentation rate (ESR) at diagnosis > 72 mm 1st h, the presence of HLA-DR1, DR10, rheumatoid epitope, and the type of rheumatoid epitope were significant risk factors associated with relapse/recurrence. Cox proportional hazards modelling identified two variables that independently increased the risk of relapse/recurrence: ESR at diagnosis > 72 mm 1st h (RR=1.5) and type 2 (encoded by a non-DR4 allele) rheumatoid epitope (RR=2.7). CONCLUSION—These data from a Mediterranean country showed no association of rheumatoid epitope with PMR in northern Italian patients. A high ESR at diagnosis and the presence of rheumatoid epitope encoded by a non-DR4 allele are independent valuable markers of disease severity. PMID:10225816
Contributions of vitamin D response elements and HLA promoters to multiple sclerosis risk.
Nolan, David; Castley, Alison; Tschochner, Monika; James, Ian; Qiu, Wei; Sayer, David; Christiansen, Frank T; Witt, Campbell; Mastaglia, Frank; Carroll, William; Kermode, Allan
2012-08-07
The identification of a vitamin D-responsive (VDRE) motif within the HLA-DRB1*15:01 promoter region provides an attractive explanation for the combined effects of HLA-DR inheritance and vitamin D exposure on multiple sclerosis (MS) risk. We therefore sought to incorporate HLA-DRB1 promoter variation, including the VDRE motif, in an assessment of HLA-DRB1-associated MS risk. We utilized 32 homozygous HLA cell lines (covering 17 DRB1 alleles) and 53 heterozygote MS samples (20 DRB1 alleles) for HLA-DRB1 promoter sequencing. The influence of HLA-DRB1 variation on MS risk was then assessed among 466 MS cases and 498 controls. The majority of HLA*DRB1 alleles (including HLA-DRB1*15:01) express the functional VDRE motif, apart from HLA-DRB1*04, *07, and *09 alleles that comprise the HLA-DR53 serologic group. Allele-specific variation within functional X-box and Y-box motifs was also associated with serologically defined HLA-DR haplotypes. Incorporating these results in an analysis of MS risk, we identified a strong protective effect of HLA-DRB1*04, *07, and *09 (DR53) alleles (p = 10(-12)) and elevated risk associated with DRB1*15 and *16 (DR51) and *08 (DR8) alleles (p < 10(-18)). HLA-DRB1 groups corresponding to serologic HLA-DR profiles as well as promoter polymorphism haplotypes effectively stratified MS risk over an 11-fold range, suggesting functional relationships between risk-modifying HLA-DRB1 alleles. An independent contribution of VDRE motif variation to increase MS risk was not discernible, although vitamin D-dependent regulation of HLA-DR expression may still play an important role given that HLA-DRB1*04/*07/*09 (DR53) alleles that express the "nonresponsive" VDRE motif were associated with significantly reduced risk of MS.
Antennas and Electromagnetics Instrumentation for Research and Education
2016-06-01
Antennas and Electromagnetics Instrumentation for Research and Education The objective of this proposal is to enhance the instrumentation of FIU’s... ElectroMagnetics Lab (EMLab) directed by Dr. Georgakopoulos and create a state-of-the art lab that will support the following: (a) Dr. Georgakopoulos...funded research on reconfigurable antennas and wireless power transfer, (b) other research on advanced electromagnetic technologies that support
LDRD 2013 Annual Report: Laboratory Directed Research and Development Program Activities
DOE Office of Scientific and Technical Information (OSTI.GOV)
Bookless, W.
This LDRD project establishes a research program led by Jingguang Chen, who has started a new position as a Joint Appointee between BNL and Columbia University as of FY2013. Under this project, Dr. Chen will establish a new program in catalysis science at BNL and Columbia University. The LDRD program will provide initial research funding to start research at both BNL and Columbia. At BNL, Dr. Chen will initiate laboratory research, including hiring research staff, and will collaborate with the existing BNL catalysis and electrocatalysis research groups. At Columbia, a subcontract to Dr. Chen will provide startup funding for hismore » laboratory research, including initial graduate student costs. The research efforts will be linked under a common Catalysis Program in Sustainable Fuels. The overall impact of this project will be to strengthen the BNL catalysis science program through new linked research thrusts and the addition of an internationally distinguished catalysis scientist.« less
Sehgal, Manika; Singh, Tiratha Raj
2014-04-01
We present DR-GAS(1), a unique, consolidated and comprehensive DNA repair genetic association studies database of human DNA repair system. It presents information on repair genes, assorted mechanisms of DNA repair, linkage disequilibrium, haplotype blocks, nsSNPs, phosphorylation sites, associated diseases, and pathways involved in repair systems. DNA repair is an intricate process which plays an essential role in maintaining the integrity of the genome by eradicating the damaging effect of internal and external changes in the genome. Hence, it is crucial to extensively understand the intact process of DNA repair, genes involved, non-synonymous SNPs which perhaps affect the function, phosphorylated residues and other related genetic parameters. All the corresponding entries for DNA repair genes, such as proteins, OMIM IDs, literature references and pathways are cross-referenced to their respective primary databases. DNA repair genes and their associated parameters are either represented in tabular or in graphical form through images elucidated by computational and statistical analyses. It is believed that the database will assist molecular biologists, biotechnologists, therapeutic developers and other scientific community to encounter biologically meaningful information, and meticulous contribution of genetic level information towards treacherous diseases in human DNA repair systems. DR-GAS is freely available for academic and research purposes at: http://www.bioinfoindia.org/drgas. Copyright © 2014 Elsevier B.V. All rights reserved.
Performance Envelopes and Optimal Appropriateness Measurement.
1984-12-01
20370 Dr. Hans Crombag University of Leyden Mr. Raymond E. Christal Education Research Center AFHRL/MOE Boerhaavelaan 2 Brooks AFB, TX 78235 2334 EN... Leyden The NETHERLANDS Dr. Norman Cliff Department of Psychology CTB/McGraw-Hill Library Univ. of So. California 2500 Garden Road University Park...Psychology Dr William Montague University of Western Australia NPRDC Code 13 Nedlands W.A. 6009 San Diego, CA 92152 AUSTRALIA Ms. Kathleen Moreno Dr
1992-04-01
Instituuts Advies R2ad PML Prof. dr. U.A.Th. Brinkanl~ 36. Direactur van het Medisch Biologisch Laboratorium TNO Prof.Dr. W.R.F. Notten 37. Directeur...Grootsdialige Rampenbestrijdcing Ministerie van Binnenlandsc Zaken Drs. H. Evers 9. Adviseur van het Prins Maurits Laboratorium TWO Prot. Dr. J.M. van...Rossum, 10. Adyisew, van het Prins Maurits Laboratorium TWO Chernisdie Research Prof.Dr. G. Dijkstra 11. H~ur. NBC DMKIJOMAT/KIO Ir. AAM. Slagveer 12
Making Aggressive Prostate Cancer Quiescent by Abrogating Cholesterol Esterification
2016-10-01
team has been assembled , with expertise in spectroscopic imaging & nanomedicine (Dr. J. X. Cheng, PI), biochemistry (Dr. X. Liu, co-PI), and prostate...was approved in 2004 as the first- line cytotoxic chemotherapy owing to a modest increase in overall survival compared to mitoxantrone. Since 2010...interdisciplinary research team has been assembled , with expertise in spectroscopic imaging & nanomedicine (Dr. J. X. Cheng, PI), biochemistry (Dr. X. Liu, co-PI
Lake, A J; Rees, G; Speight, J
2018-05-24
Young adults with type 2 diabetes (T2D, 18-39 years) experience early-onset and rapid progression of diabetic retinopathy (DR), the leading cause of vision loss for working age adults. Despite this, uptake of retinal screening, the crucial first step in preventing vision loss from DR, is low. The aim of this review is to summarize the clinical and psychosocial factors affecting uptake of retinal screening. Barriers include lack of diabetes-related symptoms, low personal DR risk perception, high rates of depression and diabetes-related distress, fatalism about inevitability of complications, time and financial constraints, disengagement with existing diabetes self-management services, and perceived stigma due to having a condition associated with older adults. Young adults with T2D are an under-researched population who face an accumulation of barriers to retinal screening. Tailored interventions that address the needs, characteristics, and priorities of young adults with T2D are warranted.
[Uriel García Cáceres, prominent leader and teacher of public health in Peru].
Ugarte Ubilluz, Oscar
2014-01-01
Dr. Uriel García Cáceres, prominent physician, researcher and Peruvian historian, was born in the city of Cusco in 1922. He studied medicine at Universidad Nacional Mayor de San Marcos (1942-1950). He was influenced by Dr. Pedro Weiss and as a result he worked in the field of Pathological Anatomy, where he made substantial discoveries such as the description of kidney nodules associated with the verrucous stage of bartonellosis or Carrions disease. His most important contributions are in the paleopathology field, in which he helped create a better understanding of Peruvian ancient pathology. Dr. García Cáceres also participated in the political arena; he was Peru's Minister of Health, a position in which he served selflessly and always working for the good of the health of all Peruvians. At 91 years old, he is always tenacious and cheerful, and above all, he is a teacher with a readiness to learn.
A tribute to Dr. Gordon Hisashi Sato (December 24, 1927-March 31, 2017).
Sato, J Denry; Okamoto, Tetsuji; Barnes, David; Hayashi, Jun; Serrero, Ginette; McKeehan, Wallace L
2018-03-01
Gordon H. Sato, an innovator in mammalian tissue culture and integrated cellular physiology, passed away in 2017. In tribute to Dr. Sato, In Vitro Cellular and Developmental Biology-Animal presents a collection of invited remembrances from six colleagues whose associations with Dr. Sato spanned more than 40 years. Dr. Sato was a past president of the Tissue Culture Association (now the Society for In Vitro Biology), editor-in-chief of In Vitro Cellular and Developmental Biology (1987-1991), and the recipient of the lifetime achievement award from the Society for In Vitro Biology (2002). He was elected to the US National Academy of Sciences in 1984.
NASA Technical Reports Server (NTRS)
1999-01-01
Shown viewing the Apollo telescope mockup are, from left to right, Charles Donlan, deputy associate administrator for manned space flight; Dr. Wernher Von Braun, Marshall Space Flight Center director; William Horton, astrionics lab; Dr. Thomas Paine, NASA deputy administrator; Warner Kuers, director of the ME lab.
Axial length and proliferative diabetic retinopathy.
Yang, Ko-Jen; Sun, Chi-Chin; Ku, Wan-Chen; Chuang, Lan-Hsin; Ng, Soh Ching; Chou, Kuei-Mei; Kuo, Sheng-Fong; Yeung, Ling
2012-04-01
To determine the correlation between axial length and diabetic retinopathy (DR) in patients with diabetes mellitus for 10 years or more. This study was a prospective, observational, cross-sectional study. Patients with diabetes for 10 years or more were included. We excluded eyes with any other significant ocular disease or any prior intraocular surgery, except uncomplicated cataract surgery. Only one eye of each patient was included as the study eye. The severity of DR was graded as no DR, non-proliferative DR (NPDR), or proliferative DR (PDR). Axial length was measured by A-scan ultrasound (10 MHz Transducer, AL-2000 Biometer/Pachymeter; Tomey, Phoenix, AZ). Univariate logistic regression models were used to evaluate the relationship between the dependent variables (any DR, PDR) and all potential risk factors. Axial length and other factors with p value <0.1 were included in multivariate logistic regression models. Backward selection based on the likelihood ratio statistic was used to select the final models. We included 166 eyes from 166 patients (93 female and 73 male; mean age, 68.8 years). The mean diabetes duration was 15.4 years. Fifty-four (32.5%) eyes had no DR, 72 (43.4%) eyes had NPDR, and 40 (24.1%) eyes had PDR. In univariate analysis, hypertension (p = 0.009), renal impairment (p = 0.079), and insulin use (p = 0.009) were associated with developing any DR. Hypertension (p = 0.042), renal impairment (p = 0.014), insulin use (p = 0.040), pseudophakia (p = 0.019), and axial length (p = 0.076) were associated with developing PDR. In multivariate analysis, hypertension (p = 0.005) and insulin use (p = 0.010) were associated with developing any DR. Hypertension (p = 0.020), renal impairment (p = 0.025), pseudophakia (p = 0.006), and axial length (p = 0.024) were associated with developing PDR. This observational study suggests an inverse relationship between axial length and the development of PDR in patients with diabetes for 10 years or more. No relationship was found between axial length and the development of any DR.
1989-01-01
Abbatte’ Ministre de la Sante ernmost part of the Horn of Africa. Its inhabitants publique : Dr Albert; WHO, Djibouti: Dr Wassef; H6pital belong to...Research Unit No. 3, FPO, New York, NY entreprise : Dr Said; Cabinet Medical: Dr Rodier" and Mr 09527-1600, USA. Adel; Dispensaire de Randa: Dr Qufz&k...41 at the Service Medical Inter- entreprise , at the Nation- hospital patients with a disease compatible with al Army Health Centre, at the Service
1966-05-09
S66-32629 (1966) --- Left to right are Dr. Charles A. Berry, MSC Medical Director; Dr. Donald K. (Deke) Slayton, Director of Flight Crew Operations; Eugene F. Kranz, Flight Director; Charles W. Mathews, Gemini Program Manager, Manned Spacecraft Center; William C. Schneider, Gemini Mission Manager, NASA Headquarters; General Leighton Davis; Dr. Robert R. Gilruth, MSC Director; and Dr. George E. Mueller, Associate Administrator for Manned Space Flight, NASA Headquarters.
Analytical Representations of Blast Damage for Several Types of Targets
1978-10-01
Office Box 195 Washington, D.C. Oak Ridge, Tennessee 37830 Mr. Eugene Kopf (1) Dr. Richard Garwin (1) Defense Advanced Research Projects IBM Fellow...Ridge National Laboratory Center for Planning & Research, Inc. Post Office Box X 750 Welch Road Oak Ridge, Tennessee 37830 Palo Alto, California 94304 Dr...Dr. Conrad V. Chester(i Oak Ridge National Laboratory Building 450C-S, Roan S-24o0 Post Office Box E O •k Ridge, Tennessee 37830 Institute for Defense
Threshold Tear Strength of Elastomers.
1982-04-01
O 0 0 C~j C-J C7,) 0DY 122 DISTRIBUTION LIST No. Cooes No. Cooies Dr. L.V. Schmidt I Dr. F. Roberto 1 ’Assistant Secretary of the Navy Code AFRPL MKPA...Research Scientific Advisor Directorate of Aerospace Sciences Commandant of the Marine Corps Bolling Air Force Base Code RD-i Washington, D.C. 20332...Directorate of Chemical Sciences Arlington, VA 22217 Bolling Air Force Base Washington, D.C. 20332 Mr. David Siegel D Office of Naval Research Dr. John S
Directory of Researchers for Manpower, Personnel, Training, and Human Factors
1998-03-01
Cambridge, MA Bohres, G Naval Surface Warfare Center - Dahlgren Div 904-234-4184 Panama City, FL DSN:436-4184 Bowers, Clint A Dr Univ of Central...Research 703-696-4318 Arlington, VA DSN:426-4318 Clevenger, J Evans and Sutherland Computer Corp 801-588-1518 Salt Lake City, UT Clingerman, B Space and...Drew W. CAPT Bergondy, M Bilazarian, P Bowers, Clint A Dr Bradley, S Breaux, R Mr Burke, J Burns, Christopher M Mr Burns, J Cannon-Bowers, Janis A Dr
Mazighi, Mikael; Meseguer, Elena; Labreuche, Julien; Serfaty, Jean-Michel; Laissy, Jean-Pierre; Lavallée, Philippa C; Cabrejo, Lucie; Guidoux, Céline; Lapergue, Bertrand; Klein, Isabelle F; Olivot, Jean-Marc; Rouchaud, Aymeric; Desilles, Jean-Philippe; Schouman-Claeys, Elisabeth; Amarenco, Pierre
2012-11-01
Dramatic recovery (DR) is a predictor of stroke outcome among others. However, after successful recanalization, systematic favorable outcome is not the rule. We sought to analyze the impact of recanalization on DR in patients with acute ischemic stroke eligible for any revascularization strategies (either intravenous or endovascular). We analyzed data collected between April 2007 and May 2011 in our prospective clinical registry. All patients with acute ischemic stroke with National Institutes of Health Stroke Scale≥10 at admission and an identification of arterial status before treatment were included. DR was defined as National Institutes of Health Stroke Scale≤3 at 24 hours or a decrease of ≥10 points within 24 hours. DR occurred in 75 of 255 patients with acute ischemic stroke (29.4%). Patients with persistent occlusion had a low DR rate (11.1%) than those with no documented occlusion (36.5%) and those with occlusion followed by recanalization (35.3%; both P<0.001). Among patients with recanalization monitored by angiography, DR was higher among patients with complete recanalization than among those with partial recanalization (46.8% versus 14.3%; P<0.001) and increased with tertiles of time to recanalization (Ptrend=0.002). In multivariable logistic regression analysis, grade and time to recanalization appeared independently associated with DR; the adjusted ORs were 4.17 (95% CI, 1.61-10.77) for complete recanalization and 1.24 (95% CI, 1.04-1.48) for each 30-minute time decrease. Patients with versus without DR more frequently had modified Rankin Scale≤1 (67.6% versus 9.0%; P<0.001) and less frequently had hemorrhage (17.3% versus 33.9%; P=0.024). DR is strongly associated with favorable clinical outcome and is dependent on complete recanalization and time to recanalization.
Ferreira, Fábio Netto; Crispim, Daisy; Canani, Luís Henrique; Gross, Jorge Luiz; dos Santos, Kátia Gonçalves
2013-10-01
Diabetic retinopathy (DR) is a common chronic complication of diabetes and remains the leading cause of blindness in working-aged people. Hyperglycemia increases glucose flux through the polyol pathway, in which aldose reductase converts glucose into intracellular sorbitol, which is subsequently converted to fructose by sorbitol dehydrogenase (SDH). The accelerated polyol pathway triggers a cascade of events leading to retinal vascular endothelial dysfunction and the eventual development of DR. Polymorphisms in the gene encoding aldose reductase have been consistently associated with DR. However, only two studies have analyzed the relationship between polymorphisms in the gene encoding SDH (SORD) and DR. In this case-control study, we investigated whether the -888G > C polymorphism (rs3759890) in the SORD gene is associated with the presence or severity of DR in 446 Caucasian-Brazilians with type 2 diabetes (241 subjects with and 205 subjects without DR). The -888G > C polymorphism was also examined in 105 healthy Caucasian blood donors, and the genotyping of this polymorphism was carried out by real-time PCR. The genotype and allele frequencies of the -888G > C polymorphism in patients with type 2 diabetes were similar to those of blood donors (G allele frequency = 0.16 in both groups of subjects). Similarly, the genotype and allele frequencies in patients with DR or the proliferative form of DR were similar to those of patients without this complication (P > 0.05 for all comparisons). Thus, our findings suggest that the -888G > C polymorphism in the SORD gene is not involved in the pathogenesis of DR in type 2 diabetes. Copyright © 2013 Elsevier Ltd. All rights reserved.
PREFACE: National Seminar on Current Trends in Materials Science (CTMS-2011)
NASA Astrophysics Data System (ADS)
Jayakrishnan, R.; Vijayakumar, K. P.; Unnikrishnan, N. V.
2013-05-01
India is going through an era of many changes in its higher education system. Emphasis is being given to research and development initiatives at Universities and colleges. The teaching community is faced with the challenge of coping with both regular academic activities and research initiatives. The teaching faculties need to keep in step with the momentous research output being generated globally. To mold young talent that will be sought after, teachers need to undertake challenging initiatives. Research in emerging areas like nanotechnology, meta materials, functional materials and structures is being pursued vigorously in Universities and colleges in the state of Kerala. Awareness of the impact of integrating teaching and research in basic science has inspired the teaching faculty. The number of seminars and conferences is not commensurate with the amount of research being conducted in this state. The state lags behind in the number of institutes with state of the art facilities and human resource with cutting edge knowledge. The national seminar on Current Trends in Materials Science (CTMS-2011) is organized by the Department of Physics, Christian College, Chengannur. It is a continuation of the initiatives of the Department to bridge the haitus between teaching and research. Current Trends in Materials Science (CTMS-2007) was successfully conducted with over 80 research paper presentations and participation of delegates from the states of Karnataka, Andhrapradesh, Tamilnadu and Kerala. CTMS-2011 is a sequel envisaged to serve as an effective platform for teachers to interact with eminent scientists and share their knowledge and experience. Papers were invited from the subject area comprising glasses and ceramics, crystal growth, nanotechnology, semiconductors thin films and polymers. We are delighted that after a peer review process of the papers we have selected ten of the best papers presented at the seminar for publication in IOP Conference Series: Materials Science and Engineering. This initiative is in pursuit of the vision of the department to establish itself as a part of the global scientific community. The department is striving to establish itself as a centre of excellence in teaching and research. We sincerely hope that the papers published in this journal will contribute to the advancement of knowledge in the respective fields. We present this volume of papers to the scientific community for their valuable feedback by way of suggestions and collaborative research. Acknowledgment The Department of Physics, Christian College Chengannur acknowledges the efforts of Dr Jacob George who was inspirational in organizing this seminar. His vision and perseverance made it possible for us to organize this event. The seminar was graciously funded by University Grants Commission (UGC), New Delhi, India and Kerala State Council for Science Technology and Environment (KSCSTE), Thiruvananthapuram, Kerala, India. The department wishes to thank both organizations for their support for the event. The management of the college provided great assistance by providing all the infrastructural help required for the event. The department is weighed in gratitude for this gesture and encouragement. Ammini Solar Pvt. Ltd, and Hind High Vacuum Pvt. Ltd, sponsored the best paper award and best poster award respectively. We thank them for this token of their support for the event. The event will be remembered for the participants who arrived from various parts India and the students who made it memorable. The Department acknowledges the efforts of the 2010-2012 and 2009-2011post graduate students who ran the show behind the scenes. National Advisory Board Professor (Dr) K L Chopra (Padamshree) (Former Director, Indian Institute of Technology, Kharagpur) Professor A K Barua (Padamshree) Project Director, MNES/DST project on a-Si Solar cell Professor C Vijayan IIT, Madras Dr M K Jayaraj, Cochin University of Science and technology Dr P Kurian, S B College, Chengannaserry Dr Daisy Philip, Mar Ivanous College,Thiruvananthapuram Local Organizing Committee Patron: Rt Rev Dr Zacharias Mar Theophillus Saffragan Metropolitan Chairman: Dr Jacob George, Principal Vice Chairman: Professor Beena Racheal Thomas, HOD Convenor: Dr Vinoy Thomas Joint Convenor: Dr Sunila Abraham Dr Ligi Cherian, Sri Hysen Thomas, Sri A Abraham, Dr Tiju Joseph Mthew, Smt Agee Susan, Dr Ajit Verghese George, Dr Johnson Baby, Sri Lalu Varghese, Sri Biji Abraham Editorial Committee Editor: Dr R Jayakrishnan Editorial Consultants: Professor K P Vijayakumar, Department of Physics, CUSAT, Cochin, India Professor N V Unnikrishnan, Director, SPAP, MG University, Kottayam, India
ERIC Educational Resources Information Center
Diverse: Issues in Higher Education, 2011
2011-01-01
Each year, "Diverse: Issues In Higher Education" publishes lists of the Top 100 producers of associate, bachelor's and graduate degrees awarded to minority students based on research conducted by Dr. Victor M. H. Borden, professor of educational leadership and policy studies at Indiana University Bloomington. This article presents lists of the top…
Managing the U.S. Economy in a Post-Attack Environment. A System Dynamics Model of Viability.
1979-11-01
RATE (NET SUPPLIES - PIPELINE) IPPPW - PRODUCTIVITY PER INTERMEDIATE PRODUCTS W 0 Rl R*E I PPPW. K=. ’PWN* PPM, K 14, A IPPPW - PRODUCTIVITY PER...Drive, S.E. University Research Park Mr. Bjorn Pederson Albuquerque, New Mexico 87106 International Association of Chiefs of Police Dr. William W
Miyamoto, Suzanne; Adams, Jeffrey M
2015-09-01
This department highlights emerging nursing leaders who have demonstrated great potential in advancing innovation and patient care leadership in practice, policy, research, education, and theory. This interview profiles Suzanne Miyamoto, PhD, RN, Senior Director of Government Affairs and Health Policy at the American Association of Colleges of Nursing.
Reflections on an Evolving View of Giftedness and Talent: An Interview with Rena Subotnik
ERIC Educational Resources Information Center
Henshon, Suzanna E.
2005-01-01
This article presents an interview with Dr. Rena F. Subotnik, a director of the Center for Gifted Education Policy at the American Psychological Association (APA). The Center's mission is to generate public awareness, advocacy, clinical applications, and cutting-edge research ideas that will enhance the achievement and performance of children and…
Comparing a Cognitive Model and Phototherapy in the Treatment of Seasonal Affective Disorder.
ERIC Educational Resources Information Center
Krantz, Sandra
Seasonal affective disorder (SAD) is characterized by recurrent major depression or bipolar disorder that occurs annually, usually later in fall as the daylight hours decrease, and that alternates with euthymic or hypomanic moods in the spring and summer. Pioneering research by Dr. Norman Rosenthal and associates has found phototherapy to be…
Lorna H. McNeill, PhD, MPH, is Chair and Associate Professor in the Department of Health Disparities at the University of Texas MD Anderson Cancer Center. Dr. McNeill's research is on the elimination of cancer-related health disparities in minority populations. Her research has particular emphasis on understanding the influence of social contextual determinants of cancer in minorities, with a special focus of the role of physical activity as a key preventive behavior and obesity as a major cancer determinant. Her research takes place in minority and underserved communities such as public housing developments, black churches, community-based clinics and low-income neighborhoods-communities with excess cancer death rates. She has been continuously funded, receiving grants from various funding agencies (i.e., National Institutes of Health, Robert Wood Johnson Foundation, etc.), to better understand and design innovative solutions to address obesity in racial/ethnic minority communities. Dr. McNeill is PI of several community-based studies, primarily working with African American churches. One is a called Project CHURCH, an academic-faith-based partnership established to: 1) identify underlying reasons for health disparities in cancer and cancer risk factors (e.g., screening, diet) among AAs using a cohort study (N=2400), 2) engage AAs as partners in the research process, and 3) to ultimately eliminate disparities among AAs. In 2014 Dr. McNeill furthered her partnership through the Faith, Health, and Family (FHF) Collaborative. The goals of FHF are to enhance the Project CHURCH partnership to address family obesity in African Americans, strengthen the partnership by developing a larger coalition of organizations and stakeholders to address the problem, assess church and community interest in family obesity and develop an agenda to address obesity in faith settings. To date we have 50 churches as members. Dr. McNeill is also director of the Center for Community-Engaged Translational Research (CCETR) at MD Anderson. CCETR works with MD Anderson faculty to develop collaborations with underserved communities with a focus on conducting high-quality, relevant cancer prevention research.
Servin, Alain L
2014-10-01
The pathogenicity and clinical pertinence of diffusely adhering Escherichia coli expressing the Afa/Dr adhesins (Afa/Dr DAEC) in urinary tract infections (UTIs) and pregnancy complications are well established. In contrast, the implication of intestinal Afa/Dr DAEC in diarrhea is still under debate. These strains are age dependently involved in diarrhea in children, are apparently not involved in diarrhea in adults, and can also be asymptomatic intestinal microbiota strains in children and adult. This comprehensive review analyzes the epidemiology and diagnosis and highlights recent progress which has improved the understanding of Afa/Dr DAEC pathogenesis. Here, I summarize the roles of Afa/Dr DAEC virulence factors, including Afa/Dr adhesins, flagella, Sat toxin, and pks island products, in the development of specific mechanisms of pathogenicity. In intestinal epithelial polarized cells, the Afa/Dr adhesins trigger cell membrane receptor clustering and activation of the linked cell signaling pathways, promote structural and functional cell lesions and injuries in intestinal barrier, induce proinflammatory responses, create angiogenesis, instigate epithelial-mesenchymal transition-like events, and lead to pks-dependent DNA damage. UTI-associated Afa/Dr DAEC strains, following adhesin-membrane receptor cell interactions and activation of associated lipid raft-dependent cell signaling pathways, internalize in a microtubule-dependent manner within urinary tract epithelial cells, develop a particular intracellular lifestyle, and trigger a toxin-dependent cell detachment. In response to Afa/Dr DAEC infection, the host epithelial cells generate antibacterial defense responses. Finally, I discuss a hypothetical role of intestinal Afa/Dr DAEC strains that can act as "silent pathogens" with the capacity to emerge as "pathobionts" for the development of inflammatory bowel disease and intestinal carcinogenesis. Copyright © 2014, American Society for Microbiology. All Rights Reserved.
2014-01-01
SUMMARY The pathogenicity and clinical pertinence of diffusely adhering Escherichia coli expressing the Afa/Dr adhesins (Afa/Dr DAEC) in urinary tract infections (UTIs) and pregnancy complications are well established. In contrast, the implication of intestinal Afa/Dr DAEC in diarrhea is still under debate. These strains are age dependently involved in diarrhea in children, are apparently not involved in diarrhea in adults, and can also be asymptomatic intestinal microbiota strains in children and adult. This comprehensive review analyzes the epidemiology and diagnosis and highlights recent progress which has improved the understanding of Afa/Dr DAEC pathogenesis. Here, I summarize the roles of Afa/Dr DAEC virulence factors, including Afa/Dr adhesins, flagella, Sat toxin, and pks island products, in the development of specific mechanisms of pathogenicity. In intestinal epithelial polarized cells, the Afa/Dr adhesins trigger cell membrane receptor clustering and activation of the linked cell signaling pathways, promote structural and functional cell lesions and injuries in intestinal barrier, induce proinflammatory responses, create angiogenesis, instigate epithelial-mesenchymal transition-like events, and lead to pks-dependent DNA damage. UTI-associated Afa/Dr DAEC strains, following adhesin-membrane receptor cell interactions and activation of associated lipid raft-dependent cell signaling pathways, internalize in a microtubule-dependent manner within urinary tract epithelial cells, develop a particular intracellular lifestyle, and trigger a toxin-dependent cell detachment. In response to Afa/Dr DAEC infection, the host epithelial cells generate antibacterial defense responses. Finally, I discuss a hypothetical role of intestinal Afa/Dr DAEC strains that can act as “silent pathogens” with the capacity to emerge as “pathobionts” for the development of inflammatory bowel disease and intestinal carcinogenesis. PMID:25278576
... Elizabeth Wilcox, Archives & Special Collections, Columbia University Health Sciences Library Dr. Apgar's advice to mothers is summarized in ... more about Dr. Apgar through the Profiles in Science program of the National Library of Medicine and through the NLM exhibit Changing ...
Huang, Chao; Fisher, Kiera P; Hammer, Sandra S; Navitskaya, Svetlana; Blanchard, Gary J; Busik, Julia V
2018-06-04
Diabetic Retinopathy (DR) is a micro-vascular complication of diabetes and is the leading cause of vision loss in working-age adults. Recent studies have implicated the complement system as an emerging player in development of vascular damage and progression of DR. However, the role and activation of the complement system in DR is not well understood. Exosomes, small vesicles that are secreted into the extracellular environment, have a cargo of complement proteins in plasma suggesting that they can participate in causing vascular damage associated with DR. We demonstrate that IgG-laden exosomes in plasma activate the classical complement pathway, and that the quantity of these exosomes is increased in diabetes. Moreover, we show that lack of IgG in exosomes results in a reduction of retinal vascular damage in diabetic mice. Together, the results of this study demonstrate that complement activation by IgG-laden plasma exosomes could contribute to the development of DR. © 2018 by the American Diabetes Association.
Qiao, Yong-Chao; Wang, Min; Pan, Yan-Hong; Zhang, Xiao-Xi; Tian, Fang; Chen, Yin-Ling; Zhao, Hai-Lu
2018-01-01
This study aims to investigate the association between renin-angiotensin system gene polymorphism and diabetic retinopathy (DR) in Chinese patients with type 2 diabetes. We consecutively included 1491 patients for the assessment of ACE I/D and AGT M/T gene polymorphisms in 345 DR cases and 1146 patients without retinopathy (DNR). Albuminuria was defined by urine albumin creatinine ratio and albumin excretion rate. Compared with the NDR patients, the DR cases displayed a higher proportion of diabetic nephropathy (32.68% vs. 6.52%, χ 2 = 150.713, p < 0.001). The DR cases and DNR individuals did not differ in the frequency of genotypes and alleles of ACE I/D and AGT M/T (all p > 0.05). Intriguingly, DR patients with obesity showed higher frequency of DD (χ 2 = 4.181, p = 0.041), but no significant difference exists in the other stratified BMI and hypertension analyses (all p > 0.05). Binary logistic regression displays that the association of the ACE and AGT gene polymorphisms in DR patients is not significant after adjusting for confounding covariates in all the comparisons. The ACE and AGT gene polymorphisms are not associated with the progress of diabetes developing into retinopathy in Chinese patients with type 2 diabetes. However, more investigations are needed to further prove the association.
Mobility Research and Development (Briefing charts)
2016-03-17
Mobility Research & Development Dr. Paramsothy Jayakumar, STE, Analytics Tank Automotive Research, Development and Engineering Center Research...Mobility Model (NRMM) • Dr. M. G. Bekker of TARDEC is the “Father of Terrain-Vehicle Systems ” • NRMM was developed in 1960-70 by TARDEC and ERDC...Blocks: Scaled Experiments Particle Image Velocimetry Pressure – Sinkage Test Direct Shear Test Simulations Single Wheel Test Plate width = 50 mm
Hadley, David; Hagopian, William; Liu, Edwin; She, Jin-Xiong; Simell, Olli; Akolkar, Beena; Ziegler, Anette-G; Rewers, Marian; Krischer, Jeffrey P; Chen, Wei-Min; Onengut-Gumuscu, Suna; Bugawan, Teodorica L; Rich, Stephen S; Erlich, Henry; Agardh, Daniel
2015-06-01
Tissue transglutaminase autoantibodies (tTGAs) represent the first evidence of celiac disease (CD) development. Associations of HLA-DR3-DQA1*05:01-DQB1*02:01 (i.e., DR3-DQ2) and, to a lesser extent, DR4-DQA1*03:01-DQB1*03:02 (i.e., DR4-DQ8) with the risk of CD differ by country, consistent with additional genetic heterogeneity that further refines risk. Therefore, we examined human leukocyte antigen (HLA) factors other than DR3-DQ2 for their contribution to developing tTGAs. The Environmental Determinants of Diabetes in the Young (TEDDY) study enrolled 8,676 infants at an increased HLA-DR-DQ risk for type 1 diabetes and CD into a 15-year prospective surveillance follow-up. Of those followed up, 21% (n=1,813) carried DR3-DQ2/DR3-DQ2, 39% (n=3,359) carried DR3-DQ2/DR4-DQ8, 20% (n=1701) carried DR4-DQ8/DR4-DQ8, and 17% (n=1,493) carried DR4-DQ8/DQ4. Within TEDDY, a nested case-control design of 248 children with CD autoimmunity (CDA) and 248 matched control children were genotyped for HLA-B, -DRB3, -DRB4, -DPA1, and -DPB1 genes, and the entire cohort was genotyped for single-nucleotide polymorphisms (SNPs) using the Illumina ImmunoChip. CDA was defined as a positive tTGA test at two consecutive clinic visits, whereas matching in those with no evidence of tTGAs was based on the presence of HLA-DQ2, country, and sex. After adjustment for DR3-DQ2 and restriction to allele frequency (AF) ≥5%, HLA-DPB1*04:01 was inversely associated with CDA by conditional logistic regression (AF=44%, odds ratio=0.71, 95% confidence interval (CI)=0.53-0.96, P=0.025). This association of time to CDA and HLA-DPB1*04:01 was replicated with statistical significance in the remainder of the cohort using imputation for specific HLA alleles based on SNP genotyping (hazard ratio=0.84, 95% CI=0.73-0.96, P=0.013). HLA-DPB1*04:01 may reduce the risk of tTGAs, an early marker of CD, among DR3-DQ2 children, confirming that additional variants in the HLA region influence the risk for CDA.
Manuel Stein's Five Decades of Structural Mechanics Contributions (1944-1988)
NASA Technical Reports Server (NTRS)
Mikulas, Martin M.; Card, Michael F.; Peterson, Jim P.; Starnes, James H., Jr.
1998-01-01
Manuel Stein went to work for NACA (National Advisory Committee for Aeronautics) in 1944 and left in 1988. His research contributions spanned five decades of extremely defining times for the aerospace industry. Problems arising from the analysis and design of efficient thin plate and shell aerospace structures have stimulated research over the past half century. The primary structural technology drivers during Dr. Stein's career included 1940's aluminum aircraft, 1950's jet aircraft, 1960's launch vehicles and advanced spacecraft, 1970's reusable launch vehicles and commercial aircraft, and 1980's composite aircraft. Dr. Stein's research was driven by these areas and he made lasting contributions for each. Dr. Stein's research can be characterized by a judicious mixture of physical insight into the problem, understanding of the basic mechanisms, mathematical modeling of the observed phenomena, and extraordinary analytical and numerical solution methodologies of the resulting mathematical models. This paper summarizes Dr. Stein's life and his contributions to the technical community.
Food and Drug Administration workshop on indirect mechanisms of carcinogenesis.
Poirier, L A
1996-01-01
A workshop sponsored by the Food and Drug Administration (FDA) was held on March 4-5, 1996, at the Lister Hill Auditorium of the National Institutes of Health (NIH) Campus in Bethesda, Maryland. The workshop considered both the scientific aspects and the regulatory implications of indirect-acting carcinogens. A wide variety of agents and of prospective mechanisms was discussed. The organizing committee for the workshop consisted of Drs. James Farrelly and Joseph DeGeorge of the Center for Drug Evaluation and Research (CDER), Ronald J. Lorentzen and Sidney Green of the Center for Food Safety and Applied Nutrition (CFSAN), Martin D. Green of the Center for Biologics, Evaluation and Research (CBER), C. Darnell Jackson and Lionel A. Poirier of the National Center for Toxicological Research (NCTR). Rosalie K. Elespuru of the Center for Devices and Radiological Health (CDRH), and David G. Longfellow of the National Cancer Institute (NCI). Following an introduction by Dr. Poirier, who provided a description of indirect carcinogens, the major talks were grouped into three formal sessions: indirect-acting compounds and agents of FDA interest, biological and biochemical endpoints commonly seen with indirect agents, and specific problems associated with the indirect-acting compounds. A panel discussion followed and the concluding remarks were made by Dr. Bernard A. Schwetz, Associate Commissioner for Science, FDA.
Patty, Lauren; Wu, Cathy; Torres, Mina; Azen, Stanley; Varma, Rohit
2012-09-01
To examine the validity of self-reported eye disease, including cataract, age-related macular degeneration (AMD), glaucoma, and diabetic retinopathy (DR), and self-reported surgical treatment for cataract and DR in the Los Angeles Latino Eye Study (LALES). Population-based, cross-sectional study. A total of 6357 Latinos aged 40+ years from the LALES. Participants underwent a detailed interview, including survey questions about ocular health, diagnoses, and timing of last eye examination, and a standardized clinical examination. Self-report was compared with examination to determine sensitivity and specificity by length of time since last eye examination. Stepwise logistic regression was used to determine factors associated with inaccurate self-report. Sensitivity and specificity were calculated for 4 self-reported eye diseases (cataract, AMD, glaucoma, and DR) and for surgical treatment of cataract and DR. Odds ratios (ORs) were determined for factors associated with inaccurate self-report underestimating eye disease and treatment. For each disease, sensitivity and specificity in those who reported their last eye examination as <1 year ago were 36.8% and 92.5% for cataract, 37.7% and 96.3% for glaucoma, 5.1% and 98.9% for AMD, and 25.7% and 94.2% for DR, respectively. Self-report was less accurate with increasing time since last eye examination. Inaccurate self-report was independently associated with better visual acuity (OR, 2.4), <2 comorbidities (OR, 1.7), last eye examination/visit 1 to 5 years ago and ≥ 5 years ago (OR, 2.3 and 4.9, respectively), and less education (OR, 1.3 for 7-12 years and 1.7 for <7 years). Of 88 participants surgically treated for cataract who reported an eye examination <1 year ago, sensitivity and specificity of self-reported surgical history were 90.9% and 99.9%, respectively. Of the 31 participants treated for DR (laser/surgery) and reporting an eye examination <1 year ago, sensitivity and specificity of self-reported surgical history were 19.4% and 99.6%, respectively. Among Latinos, self-reporting of eye disease and surgical history provides a significant underestimate of the disease burden. This may lead to significant misclassification in vision research if self-report alone is used to identify persons with eye disease. Copyright © 2012 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
Patty, Lauren; Wu, Cathy; Torres, Mina; Azen, Stanley; Varma, Rohit
2012-01-01
Purpose To examine the validity of self-reported eye disease, including cataract, age-related macular degeneration (AMD), glaucoma, and diabetic retinopathy (DR), and self-reported surgical treatment for cataract and DR in the Los Angeles Latino Eye Study (LALES). Design Population-based cross-sectional study Participants 6357 Latinos age 40+ years from the LALES Methods Participants underwent a detailed interview, including survey questions about ocular health, diagnoses and timing of last eye examination, and a standardized clinical examination. Self report was compared to examination to determine sensitivity and specificity by length of time since last eye examination. Stepwise logistic regression was used to determine factors associated with inaccurate self report. Main Outcome Measures Sensitivity and specificity were calculated for four self reported eye diseases (cataract, AMD, glaucoma, DR) and for surgical treatment of cataract and DR. Odds ratios (OR) were determined for factors associated with inaccurate self report underestimating eye disease and treatment. Results For each disease, sensitivity and specificity in those who reported their last eye examination as <1 year ago were: 36.8%, 92.5% for cataract; 37.7%, 96.3% for glaucoma; 5.1%, 98.9% for AMD; and 25.7%, 94.2% for DR. Self report was less accurate with increasing time since last eye examination. Inaccurate self report was independently associated with better visual acuity (OR=2.4), <2 comorbidities (OR=1.7), last eye exam/visit 1–5 years ago and ≥5 years ago (OR=2.3 and 4.9, respectively), and less education (OR=1.3 for 7–12 years and 1.7 for <7 years). Of 88 participants surgically treated for cataract who reported an eye examination <1 year ago, sensitivity and specificity of self-reported surgical history were 90.9% and 99.9%. Of the 31 participants treated for DR (laser/surgery) and reporting an eye examination <1 year ago, sensitivity and specificity of self-reported surgical history were 19.4% and 99.6%. Conclusions Among Latinos, self reporting of eye disease and surgical history provides a significant underestimate of the disease burden. This may lead to significant misclassification in vision research if self report alone is used to identify persons with eye disease. PMID:22537615
Operational Intelligence and Operational Design: Thinking about Operational Art
2011-06-01
undersigned certify that this thesis meets masters-level standards of research, argumentation, and expression. DR. HAROLD R . WINTON (Date) DR...Studies (SAASS) to study and think about matters important to our national security. I will be forever grateful to Dr. Harold R . Winton, my thesis...thankful for the assistance of Mrs. Sandhya Malladi and Dr. Mary Ruwell. To the faculty and staff of SAASS, thank you for your commitment to our
Effects of Temperature and Environment on Creep Behavior of an Oxide-Oxide Ceramic Matrix Composite
2007-03-01
Zelina, Dr. Ruth Sikorski, and Dr. Ron Kerans, whose sponsorship made my research possible; Dr. Robert Canfield and Dr. Som Soni, for their membership...on my thesis committee and discerning comments; Lt Joseph Broeckert, Lt Christina Falcone, Capt Christine Ladrido, and LT Robert Salvia, whose...Society for Testing and Materials (1997). 54. Raymer , D.P. Aircraft Design: A Conceptual Approach, 3rd Edition. Reston, VA: American Institute of
1992-12-01
cm 2 heat flux which must be transferred by the buoyancy-induced gas flow. A survey of electronic cooling literature can easily demonstrate how large...Toward Implementation of a Certification Framework for Reusable Dr. Allen S. Parrish Software Modules 15 Data Association Problems in Multisensor Data...next section and the reader is referred to [5] for additional details of the analysis. Then the method is applied to a dipole element with straight
Kawasaki, Ryo; Konta, Tsuneo; Nishida, Kohji
2018-05-22
Fenofibrate and statins reduced the risk of diabetic retinopathy (DR) related treatment in clinical trials. We aimed to determine whether lipid-lowering medication use reduce the risk of DR and its treatments in patients with type 2 diabetes using a real-world health claims database. This was an observational analysis using a nation-wide health claims database of the Japan Medical Data Center (JMDC). Type 2 diabetes was defined by the ICD-10 codes with glucose-lowering medication use. Lipid-lowering medication use at least one year was confirmed by the Anatomical Therapeutic Chemical Classification System. DR and diabetic macular edema (DME) were determined by ICD-10; DR related treatments were determined by health insurance claims. A propensity score for lipid-lowering medication use was estimated, and a doubly robust estimator using the inverse probability weighting model with regression adjustment was obtained to estimate odds ratios (OR) with 95% confidence interval (95%CI) for cumulative incidence of DR and its treatments over 3 years. There were 69,070 persons with type 2 diabetes at baseline. DR developed in 5,687 persons over 3 years. Lipid-lowering medication use was associated with decreased risk of incidence of DR (OR 0.772, 95%CI 0.720-0.827; p<0.001). Lipid-lowering medication use was also associated with decreased incidence of DME, any treatments for DR, laser photocoagulation, and vitrectomy in patients with DR at baseline. In a population of patients with type 2 diabetes with a variety of risk profile, lipid-lowering medication use reduced the risk of DR and its treatments of laser photocoagulation and vitrectomy. This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.
Interaction of older donor age and survival after weight-matched pediatric heart transplantation.
Westbrook, Thomas C; Morales, David L S; Khan, Muhammad S; Bryant, Roosevelt; Castleberry, Chesney; Chin, Clifford; Zafar, Farhan
2017-05-01
Donors are matched for weight in pediatric heart transplantation (PHT), yet age differences are not considered in this decision. In this study we attempt to identify the effect of age differences in weight-matched patients and the effect these differences have on post-transplant survival. The United Network of Organ Sharing (UNOS) database was queried for the period from October 1987 to March 2014 for all pediatric heart transplant patients. Transplants with donor-to-recipient (D-R) weight ratios of 0.8 to 1.5 were identified (weight-matched). D-R age differences were categorized as: donors 5 years younger than recipients (D
Ozdemir, Fatma Nurhan; Sezer, Siren; Akcay, Ali; Arat, Zubeyde; Turan, Munire; Gulmus, Sale; Kulah, Eyup; Haberal, Mehmet
2004-01-01
Pre- and post-renal transplantation panel reactive antibody (PRA) screening is associated with increased incidence of hyperacute or acute graft rejection and graft loss. This study was designed to find any relationship PRA sensitization and associated human leukocyte antigen (HLA)-specific antibodies in Turkish renal transplant candidates. We included 340 patients who were in the renal transplantation waiting list in the study. We determined PRA sensitization ratio and the associated anti-HLA IgG antibody distribution of the patient group. The PRA testing was currently performed and levels above 30% were accepted to be positive. The PRA class I positivity was determined in 24 (7%) and class II in 34 (10%) of the patients. The most frequent HLA antibodies for class I were B56, A2, A34, A1, A23, A24 and B61; and for class II were DR11, DR14, DQ7, DR10, DQ5, DR1 and DR7, respectively. From these, the increase of the numbers of anti-HLA class II antibodies was significantly correlated with the increase of PRA sensitization ratio. In conclusion, the identification of the associated HLA-specific antibodies and correlation with the Turkish population HLA antigen distribution will identify the high-risk patients who are candidates for transplantation.
Factors Associated with Nursing Activities in Humanitarian Aid and Disaster Relief
Noguchi, Norihito; Inoue, Satoshi; Shimanoe, Chisato; Shibayama, Kaoru; Shinchi, Koichi
2016-01-01
Background Although nurses play an important role in humanitarian aid and disaster relief (HA/DR), little is known about the nursing activities that are performed in HA/DR. We aimed to clarify the nursing activities performed by Japanese nurses in HA/DR and to examine the factors associated with the frequency of nursing activities. Methods A self-administered questionnaire survey was completed by 147 nurses with HA/DR experience. The survey extracted information on demographic characteristics, past experience (e.g., disaster medical training experience, HA/DR experience), circumstances surrounding their dispatched to HA/DR (e.g., team size, disaster type, post-disaster phase, mission term), and the frequency of nursing activities performed under HA/DR. The frequency of nursing activities was rated on a 5-point Likert scale. Evaluation of nursing activities was conducted based on the “nursing activity score”, which represents the frequency of each nursing activity. Factors related to the nursing activity score were evaluated by multiple logistic regression analysis. Results Nurses were involved in 27 nursing activities in HA/DR, 10 of which were performed frequently. On analysis, factors significantly associated with nursing activity score were nursing license as a registered nurse (OR 7.79, 95% CI 2.95–20.57), two or more experiences with disaster medical training (OR 2.90 95%, CI 1.12–7.49) and a post-disaster phase of three weeks or longer (OR 8.77, 95% CI 2.59–29.67). Conclusions These results will contribute to the design of evidence-based disaster medical training that improves the quality of nursing activities. PMID:26959351
Dr. Goddard and a 1918 version of 'Bazooka'
NASA Technical Reports Server (NTRS)
2004-01-01
Dr. Robert H. Goddard loading a 1918 version of the Bazooka of World War II. From 1930 to 1941, Dr. Goddard made substantial progress in the development of progressively larger rockets, which attained altitudes of 2400 meters, and refined his equipment for guidance and control, his techniques of welding, and his insulation, pumps, and other associated equipment. In many respects, Dr. Goddard laid the essential foundations of practical rocket technology
Genetic engineering of a mouse: Dr. Frank Ruddle and somatic cell genetics.
Jones, Dennis
2011-06-01
Genetic engineering is the process of modifying an organism's genetic composition by adding foreign genes to produce desired traits or evaluate function. Dr. Jon W. Gordon and Sterling Professor Emeritus at Yale Dr. Frank H. Ruddle were pioneers in mammalian gene transfer research. Their research resulted in production of the first transgenic animals, which contained foreign DNA that was passed on to offspring. Transgenic mice have revolutionized biology, medicine, and biotechnology in the 21st century. In brief, this review revisits their creation of transgenic mice and discusses a few evolving applications of their transgenic technology used in biomedical research.
Research Area 3: Mathematics (3.1 Modeling of Complex Systems)
2017-10-31
RESEARCH AREA 3: MATHEMATICS (3.1 Modeling of Complex Systems). Proposal should be directed to Dr. John Lavery The views, opinions and/or findings...so designated by other documentation. 9. SPONSORING/MONITORING AGENCY NAME(S) AND ADDRESS (ES) U.S. Army Research Office P.O. Box 12211 Research ...Title: RESEARCH AREA 3: MATHEMATICS (3.1 Modeling of Complex Systems). Proposal should be directed to Dr. John Lavery Report Term: 0-Other Email
Air Pollution Exposure Modeling for Health Studies | Science ...
Dr. Michael Breen is leading the development of air pollution exposure models, integrated with novel personal sensor technologies, to improve exposure and risk assessments for individuals in health studies. He is co-investigator for multiple health studies assessing the exposure and effects of air pollutants. These health studies include participants with asthma, diabetes, and coronary artery disease living in various U.S. cities. He has developed, evaluated, and applied novel exposure modeling and time-activity tools, which includes the Exposure Model for Individuals (EMI), GPS-based Microenvironment Tracker (MicroTrac) and Exposure Tracker models. At this seminar, Dr. Breen will present the development and application of these models to predict individual-level personal exposures to particulate matter (PM) for two health studies in central North Carolina. These health studies examine the association between PM and adverse health outcomes for susceptible individuals. During Dr. Breen’s visit, he will also have the opportunity to establish additional collaborations with researchers at Harvard University that may benefit from the use of exposure models for cohort health studies. These research projects that link air pollution exposure with adverse health outcomes benefit EPA by developing model-predicted exposure-dose metrics for individuals in health studies to improve the understanding of exposure-response behavior of air pollutants, and to reduce participant
Final report for Utah State's SciDAC CEMM contribution
DOE Office of Scientific and Technical Information (OSTI.GOV)
Dr. Eric Held
2008-05-13
This document represents a summary of work carried out at Utah State University in conjunction with the Center for Extended Magnetohyrodynamic Modeling (CEMM). The principal investigator, Dr. Eric Held, was aided in this work by two former graduate students, Drs. John James and Michael Addae-Kagyah, who completed their PhD's while being partially funded by CEMM monies. In addtion, Dr. Jeong-Young Ji, a postdoctoral researcher and Mukta Sharma, a graduate student were supported. The work associated with this grant focused on developing an efficient, hybrid fluid/kinetic model for fusion plasmas. Specifically, expressions for the parallel heat fluxes and stresses in magnetizedmore » plasmas were implemented and exercised in the NIMROD plasma fluid code.« less
Dr. Tamaro Hudson is currently an Assistant Professor at Howard University in the Department of Pharmacology and holds an appointment as a Health Research Specialist at the Washington VA Medical Center. Dr. Hudson received his Bachelor of Science from Iowa State University in Biology in 1994 and went on to receive a Master of Science in Preventive Medicine from Ohio State University in 2007. Afterwards, he received a Ph.D. from Ohio State University in 2002 where he focused on evaluating the functional differences among isothiocyanates in the rat esophageal tumor model. Following his Ph.D., Dr. Hudson was selected to complete a prestigious Cancer Prevention Fellowship Program at the National Institute of Health, National Cancer Institute, where he focused on utilizing in vitro and in vivo cancer models to assess the biological activity of bioactive compounds on prostate cancer molecular pathways. Concurrently, he completed a Master of Public Health degree from George Washington University in 2003 where he focused on assessing the degree of agreement between a food frequency questionnaire and a 4-day food record as it related to dietary fiber intake. Upon completion of his MPH and Fellowship, he was recruited by Howard University Cancer Center in 2007 as an Assistant Professor. Since joining the Howard faculty, Dr. Hudson has integrated his research focus by identifying novel signature biomarkers – that could have a significant impact on both the diagnosis and targeted treatment of prostate cancer – with the evaluation of new chemopreventive strategies, which have been evaluated in Phase I and Phase II clinical trials. Dr. Hudson received the first five-year VA-HBCU Research, Scientist, and Training grant that focuses on developing a biomarker-based risk prediction model for prostate cancer. Dr. Hudson serves on several Howard University committees and has many peer-reviewed publications. Dr. Hudson's research interests continue to expand as he tries to build collaborations across broad disciplines to make an impact in translational research.
Modeling Incorrect Responses to Multiple-Choice Items with Multilinear Formula Score Theory.
1987-08-01
Eisenhower Avenue University of Leyden Alexandria, VA 22333 Education Research Center Boerhaavelaan 2 Dr. John M. Eddins 2334 EN Leyden University of...22302-0268 Dr. William Montague NPRDC Code 13 Dr. William L. Maloy San Diego, CA 92152-6800 Chief of Naval Education and Training Ms. Kathleen Moreno
When Diversity Training Isn’t Enough: The Case for Inclusive Leadership
2013-08-06
professionals with disabilities . Professional Psychology: Research and Practice, 40, 201–205. Day, R., & Allen, T. D. (2004). The relationship between...DIRECTORATE OF RESEARCH DEVELOPMENT AND STRATEGIC INITIATIVES Dr. Richard Oliver Hope Human Relations Research Center Directed by Dr. Daniel P. McDonald...believes diversity leads to increased conflict and decreased cohesion. Indeed, research over the past several decades has often been contradictory. On
Modeling Item Responses When Different Subjects Employ Different Solution Strategies.
1987-10-01
Crombag Dr. Stephen Dunbar University of Leyden Lindquist Center Education Research l-enter for Measurement Boerhaavelaan 2 University of Iowa 2334 EN... Leyden Iowa City, IA 52242 The NEFHlPLANDS Dr. James A. F.arles Mr. Iimothy Davey Air Force Human Resources Lab iJniversity of Illinois Brooks AFB, TX...Education and Training Dr. William Montague Naval Air Station NPRDC Code 13 Pensacola, fL 32508 San Diego, CA 92152-6800 Dr. Gary Marco Ms. Kathleen Moreno
United States Air Force Summer Faculty Research Program. 1985 Technical Report. Volume 2.
1985-12-01
Voluntary Hand Grip Torque for Dr. Samuel Adams Circular Electrical Connectors 3 Properties and Processing of a Dr. Vernon R. Allen Perfluorinated ...Neutral Particle Beam at Low Energies in the Mark I Aerospace Chamber 126 Preparation of Non-Flammable Model Dr. Terrill D. Smith Compounds 127 Studies on...Synthesis of Azo Compounds F xi 140 A Comparison of Measured and Calculated Dr. Larry Vardiman Attenuation of 28 GHZ Beacon Signals in Three California
Tapered Wiggler Analysis of High Gain Free Electron Laser Oscillators.
1987-12-12
Vladislav Bevc Livermore, CA 94550 Synergy Research Institute P.O. Box 561 Dr. H. Brandt San Ramon , CA 94583 Department of the Army Harry Diamond...800 N. Quincy Street 3011 Malibu Canyon Road Arlington, VA 22217 Malibu, CA 90265 Dr. B. Robinson Dr. Antonio Sanchez Boeing Aerospace Company...Walsh, Jr. Dr. R. Whitefield Bell Laboratories 15260 Dickens Ave. 600 Mountain Avenue San Jose , CA 95124 Room I-D 332 Murray Hill, NJ 07974 Ms
United States Air Force Summer Faculty Research Program 1989. Program Technical Report. Volume 2
1989-12-01
of an Osmotically Dr. Juin Yu Driven Thermal Transfer Cycle 114 The Influence of Viscoelastically Dr. Lawrence Zavodney Damped Members on the Dynamic...Hormones Effect Upon Dr. Rex Moyer Chlamydomonas Phototaxis 166 Influence of Radio Frequency Dr. Raymond Quock Radiation on Psychotropic Drug Effects 167...systems do not cover. Therefore, the use of SHG for creating coherent light at twice the frequency of an- other laser is one way to extend the range
Miersch, Claudia; Döring, Frank
2013-07-02
The metabolic and health-promoting effects of dietary restriction (DR) have been extensively studied in several species. The response to DR with respect to sex is essentially unknown. To address this question, we used the model organism Caenorhabditis elegans to analyze body composition and gene expression in males and hermaphrodites in response to DR. Unexpectedly, DR increased the fat-to-fat-free mass ratio and enlarged lipid droplets in both sexes to a similar extent. These effects were linked to a downregulation of the lipase-like 5 (lipl-5) gene in both sexes at two developmental stages. By contrast, the reductions in body size, protein content, and total RNA content in response to DR were more pronounced in hermaphrodites than in males. Functional enrichment analysis of gene expression data showed a DR-induced downregulation of several embryogenesis-associated genes concomitant with an ongoing expression of sperm-associated genes in hermaphrodites. In conclusion, DR increases fat stores in both sexes of C. elegans in the form of large and possibly lipolysis-resistant lipid droplets and markedly alters the reproductive program in hermaphrodites but not in males.
USAF/SCEEE Summer Faculty Research Program (1982). Research Reports. Volume 2.
1982-10-01
Engineering (802) 658-3330 Assigned: RADC/Griffiss Dr. Milton J. Alexander Degree: D.B.A., Management , 1968 Professor Specialty: Management ...Information Auburn University Systems, Operational Management Department Research Auburn, AL 36830 Assigned: LMC (205) 826-4730 Dr. Gary L. Allen Degree: Ph.D...Ph.D., Industrial Professor Engineering, 1951 Oklahoma State University Specialty: Project Management , Industrial Engineering & Management Dept
Disparities in Intratumoral Steroidogenesis
2017-12-01
was a Health Disparity Prostate Cancer Research Award originally to Dr. Keith Solomon at Boston Children’s Hospital. In 2015, Dr. Solomon lost the rest... Research and Materiel Command Fort Detrick, Maryland 21702-5012 DISTRIBUTION STATEMENT: Approved for Public Release; Distribution Unlimited The...AND ADDRESS(ES) 10. SPONSOR/MONITOR’S ACRONYM(S) U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland 21702-5012 11. SPONSOR
DOE Office of Scientific and Technical Information (OSTI.GOV)
Kashima, K.; Wilkowski, G.M.
1988-03-01
The third in a series of international Leak-Before-Break (LBB) Seminars supported in part by the US Nuclear Regulatory Commission was held at TEPCO Hall in the Tokyo Electric Power Company's (TEPCO) Electric Power Museum on May 14 and 15, 1987. The seminar updated the international policies and supporting research on LBB. Attendees included representatives from regulatory agencies, electric utility representatives, fabricators of nuclear power plants, research organizations, and university professors. Regulatory policy was the subject of presentations by Mr. G. Arlotto (US NRC, USA), Dr. H. Schultz (GRS, W. Germany), Dr. P. Milella (ENEA-DISP, Italy), Dr. C. Faidy, P. Jamet,more » and S. Bhandari (EDF/Septen, CEA/CEN, and Framatome, France), and Mr. T. Fukuzawa (MITI, Japan). Dr. F. Nilsson presented revised nondestructive inspection requirements relative to LBB in Sweden. In addition, several papers on the supporting research programs discussed regulatory policy. Questions following the presentations of the papers focused on the impact of various LBB policies or the impact of research findings. Supporting research programs were reviewed on the first and second day by several participants from the US, Japan, Germany, Canada, Italy, Sweden, England, and France.« less
Massey Award Given to Harvey Tananbaum
NASA Astrophysics Data System (ADS)
2010-06-01
Dr. Harvey Tananbaum, director of the Chandra X-ray Center, has been selected as the recipient of the 2010 Massey Award for his career accomplishments in high-energy astrophysics in space. The Massey Award is given by the Royal Society of London and the Committee of Space Research (COSPAR) in memory of Sir Harrie Massey, past Physical Secretary of the Society and member of the COSPAR Bureau. The prestigious award recognizes outstanding contributions to the development of space research in which a leadership role is of particular importance. Dr. Harvey Tananbaum began his career at American Science and Engineering and has been an astrophysicist at the Smithsonian Astrophysical Observatory since 1973. He was involved with pioneering X-ray astronomy missions including UHURU and the Einstein Observatory. Beginning in 1976, Dr. Tananbaum, along with Nobel Prize winner Dr. Riccardo Giacconi, led the team that proposed to NASA to study and design a large X-ray telescope. This project was launched 23 years later in 1999 as the Chandra X-ray Observatory, becoming NASA's flagship X-ray telescope. Dr. Tananbaum has served as the director of the Chandra X-ray Center since 1991. Dr. Tananbaum has received numerous awards from NASA as well as from other agencies and institutions, including the American Astronomical Society's Bruno Rossi Award in 2004 along with Chandra Project Scientist Martin Weisskopf. He is a fellow of the American Association for the Advancement of Science, and in 2005 was elected as a member of the United States National Academy of Science. The presentation of the Massey Award, along with the gold medal that accompanies it, will be made at the upcoming 2010 COSPAR meeting in Bremen, Germany in July. NASA's Marshall Space Flight Center in Huntsville, Ala., manages the Chandra program for NASA's Science Mission Directorate in Washington. The Smithsonian Astrophysical Observatory controls Chandra's science and flight operations from Cambridge, Mass. A complete list of previous award recipients may be found at: http://cosparhq.cnes.fr/Awards/awards.htm More information on Chandra can be found at: http://chandra.harvard.edu and http://chandra.nasa.gov
1980-03-28
Dr. F. Roberto Lt. S. Clift Naval Weapons Center 3 Mr. ;. Geisler Chi•a Lakre, CA 93555 4a Attn: Dr. A. Amsrer, Code 385 U.S. Army Research Office I...Research Naval: Weapons Center 1 Directorate of Chemical Sciences China Lake, CA 93555 Bolling Air Force Base Attn: Mr. H. Richter, Code 3858
2012-03-08
members past and present, including Dr. David Krantz, Dr. Mark Ettenhofer, Dr. Cara Olsen and Dr. Neil Grunberg. Additionally, I want to express my...version of the HPQ, referred to as “the absenteeism and presenteeism questions of the Heath and Work Performance Questionnaire,” (Kessler, et al...were carefully chosen for their reliability in other studies. For instance, the absenteeism and presenteeism questions of the Heath and Work
DOE Office of Scientific and Technical Information (OSTI.GOV)
NONE
1995-06-01
Dr. Earl R. Miller was interviewed by representatives of US DOE Office of Human Radiation Research (OHRE). The interview covers Dr. Miller`s involvement with the Manhattan Engineer District, with total body irradiation, and heavy-ion therapy. Dr. Miller`s remembrances include wartime work on radiation exposure, Joe Hamilton, Neutron Therapy research, means of obtaining isotopes, consent forms, infinite laminograms, invention of a baby holder to alleviate exposure of radiological technicians in diagnostic procedures involving infants, and several personages.
Cehofski, Lasse Jørgensen; Honoré, Bent; Vorum, Henrik
2017-04-28
Retinal artery occlusion (RAO), retinal vein occlusion (RVO), diabetic retinopathy (DR) and age-related macular degeneration (AMD) are frequent ocular diseases with potentially sight-threatening outcomes. In the present review we discuss major findings of proteomic studies of RAO, RVO, DR and AMD, including an overview of ocular proteome changes associated with anti-vascular endothelial growth factor (VEGF) treatments. Despite the severe outcomes of RAO, the proteome of the disease remains largely unstudied. There is also limited knowledge about the proteome of RVO, but proteomic studies suggest that RVO is associated with remodeling of the extracellular matrix and adhesion processes. Proteomic studies of DR have resulted in the identification of potential therapeutic targets such as carbonic anhydrase-I. Proliferative diabetic retinopathy is the most intensively studied stage of DR. Proteomic studies have established VEGF, pigment epithelium-derived factor (PEDF) and complement components as key factors associated with AMD. The aim of this review is to highlight the major milestones in proteomics in RAO, RVO, DR and AMD. Through large-scale protein analyses, proteomics is bringing new important insights into these complex pathological conditions.
The portrayal of J. Marion Sims' controversial surgical legacy.
Spettel, Sara; White, Mark Donald
2011-06-01
In the mid 1800s Dr. J. Marion Sims reported the successful repair of vesicovaginal fistulas with a technique he developed by performing multiple operations on female slaves. A venerated physician in his time, the legacy of Dr. Sims is controversial and represents a significant chapter in the mistreatment of African-Americans by the medical establishment. This review compares the modern debate surrounding his legacy with the presentation of his operation in widely consulted urological texts and journals. A literature review was performed of medical, sociological and periodical sources (1851 to the present) regarding J. Marion Sims and vesicovaginal fistula repair. During the last several decades, while the controversy around Dr. Sims' surgical development has produced a steady stream of articles in the historical and popular literature, relatively little mention is found in standard urology textbooks or journals. With increased public attention, some have debated the removal or modification of public tributes to Dr. Sims. This move has been countered by arguments against the validity of judging a 19th century physician by modern standards. While historians, ethicists and the popular press have debated Dr. Sims' legacy, medical sources have continued to portray him unquestionably as a great figure in medical history. This division keeps the medical profession uninformed and detached from the public debate on his legacy and, thus, the larger issues of ethical treatment of surgical patients. Copyright © 2011 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.
Acculturation and gestational weight gain in a predominantly Puerto Rican population.
Tovar, Alison; Chasan-Taber, Lisa; Bermudez, Odilia I; Hyatt, Raymond R; Must, Aviva
2012-11-21
Identifying risk factors that affect excess weight gain during pregnancy is critical, especially among women who are at a higher risk for obesity. The goal of this study was to determine if acculturation, a possible risk factor, was associated with gestational weight gain in a predominantly Puerto Rican population. We utilized data from Proyecto Buena Salud, a prospective cohort study of Hispanic women in Western Massachusetts, United States. Height, weight and gestational age were abstracted from medical records among participants with full-term pregnancies (n=952). Gestational weight gain was calculated as the difference between delivery and prepregnancy weight. Acculturation (measured via a psychological acculturation scale, generation in the US, place of birth and spoken language preference) was assessed in early pregnancy. Adjusting for age, parity, perceived stress, gestational age, and prepregnancy weight, women who had at least one parent born in Puerto Rico/Dominican Republic (PR/DR) and both grandparents born in PR/DR had a significantly higher mean total gestational weight gain (0.9 kg for at least one parent born in PR/DR and 2.2 kg for grandparents born in PR/DR) and rate of weight gain (0.03 kg/wk for at least one parent born in PR/DR and 0.06 kg/wk for grandparents born in PR/DR) vs. women who were of PR/DR born. Similarly, women born in the US had significantly higher mean total gestational weight gain (1.0 kg) and rate of weight gain (0.03 kg/wk) vs. women who were PR/ DR born. Spoken language preference and psychological acculturation were not significantly associated with total or rate of pregnancy weight gain. We found that psychological acculturation was not associated with gestational weight gain while place of birth and higher generation in the US were significantly associated with higher gestational weight gain. We interpret these findings to suggest the potential importance of the US "obesogenic" environment in influencing unhealthy pregnancy weight gains over specific aspects of psychological acculturation.
Singh, Kanhaiya; Kant, Shri; Singh, Vivek Kumar; Agrawal, Neeraj K.; Gupta, Sanjeev K.
2014-01-01
Purpose Persistent inflammation and impaired neovascularization in type 2 diabetes mellitus (T2DM) patients may lead to development of macro- and microvascular complications. Diabetic retinopathy (DR) is one of the secondary microvascular complications of T2DM. Improper activation of the innate immune system may be an important contributor in the pathophysiology of DR. Toll-like receptor 4 (TLR4) is an important mediator of innate immunity, and genetic alterations in TLR4 support inflammation in the hyperglycemic condition. The present work was designed to investigate whether the TLR4 single nucleotide polymorphisms (SNPs) rs4986790, rs4986791, rs10759931, rs1927911, and rs1927914 are associated with DR in a north Indian population. Methods The study group of 698 individuals (128 DR, 250 T2DM, 320 controls) was genotyped by PCR-RFLP. Haplotype and linkage disequilibrium between SNPs were determined using Haploview software. Results Combined risk genotypes of TLR4 SNPs rs10759931 (odds ratio [OR] 1.50, p = 0.05) and rs1927914 (OR 1.48, p = 0.05) were found to be significantly associated with pathogenesis of DR. A total of 14 haplotypes with frequency >1% were obtained using Haploview software. Haplotypes ACATC (37.5%) and ACATT (14.8%) were the two most common haplotypes obtained. Conclusions Results of the present case-control study that included 698 north Indian subjects suggested that TLR4 SNPs rs10759931 and rs1927914 modulate the risk of DR in T2DM cases. Association analysis using haplotypes showed none of the haplotypes were associated with either susceptibility or resistance to DR in a north Indian population. PMID:24883015
Report on the 2011 Critical Assessment of Function Annotation (CAFA) meeting
DOE Office of Scientific and Technical Information (OSTI.GOV)
Friedberg, Iddo
2015-01-21
The Critical Assessment of Function Annotation meeting was held July 14-15, 2011 at the Austria Conference Center in Vienna, Austria. There were 73 registered delegates at the meeting. We thank the DOE for this award. It helped us organize and support a scientific meeting AFP 2011 as a special interest group (SIG) meeting associated with the ISMB 2011 conference. The conference was held in Vienna, Austria, in July 2011. The AFP SIG was held on July 15-16, 2011 (immediately preceding the conference). The meeting consisted of two components, the first being a series of talks (invited and contributed) and discussionmore » sections dedicated to protein function research, with an emphasis on the theory and practice of computational methods utilized in functional annotation. The second component provided a large-scale assessment of computational methods through participation in the Critical Assessment of Functional Annotation (CAFA). The meeting was exciting and, based on feedback, quite successful. There were 73 registered participants. The schedule was only slightly different from the one proposed, due to two cancellations. Dr. Olga Troyanskaya has canceled and we invited Dr. David Jones instead. Similarly, instead of Dr. Richard Roberts, Dr. Simon Kasif gave a closing keynote. The remaining invited speakers were Janet Thornton (EBI) and Amos Bairoch (University of Geneva).« less
Interview: from Down's syndrome to basic epigenetics and back again.
Lawrence, Jeanne; Telfer, Caroline
2013-12-01
Dr Jeanne Lawrence talks to Caroline Telfer, Commissioning Editor. Dr Jeanne Lawrence is an internationally recognized leader in the study of chromosome regulation by noncoding RNA and nuclear and genome organization. Her research bridges fundamental questions about genome regulation with clinical implications of recent advances in epigenetics. Her interest in chromosome structure and regulation has been a theme throughout her career and she has been honored for her work developing sensitive FISH technology for the detection of single copy genes, as well as RNAs. Her laboratory's publications include the initial demonstration of cell type-specific gene organization with nuclear subdomains; the novel biology of a noncoding RNA, XIST, which coats a whole X-chromosome to induce its silencing; and a new architectural role for a large noncoding RNA to scaffold a nuclear body. Her laboratory's work on epigenetic chromosome regulation in stem cells led to recent studies regarding unanticipated roles of repeat sequences in normal chromosome regulation and deregulation in cancer. Most recently, her laboratory has demonstrated a new approach to translate the basic mechanism of X-chromosome inactivation to correct a chromosomal dosage imbalance in patient-derived cells with trisomy 21 (Down's syndrome). Dr Lawrence has received awards from numerous agencies, including a Research Career Development Award from the National Center for Human Genome Research, career awards from the American Society of Cell Biology, the German Society for Biochemistry, the Muscular Dystrophy Association and a John Merck Fund Translational Research Award. She has served on the NIH National Advisory Council for Human Genome Research, numerous study sections and is currently a monitoring editor for the Journal of Cell Biology. Dr Lawrence has a BA in Biology and Music from Stephens College (MO, USA), a MS in Human Genetics and Genetic Counseling from Rutgers University (NJ, USA) and a PhD in Developmental Biology from Brown University (RI, USA). She is currently a Professor and Interim Chair of the Department of Cell and Developmental Biology at the University of Massachusetts Medical School (MA, USA).
A Nonparametric Multidimensional IRT Approach with Applications to Ability Estimation and Test Bias.
1988-04-01
VA 22314 800 N. Quincy Street Attn: TC Arlington, VA 22217-5000 (12 Copies) Dr. Hans Crombag Dr. Stephen Dunbar University of Leyden Lindquist...CenterEducation Research Center for Measurement Boerhaavelaan 2 University of Iowa 2334 EN Leyden Iowa City, IA 52242 The NETHERLANDS Dr. James A. Earles Mr...William Montague Naval Air Station NPRDC Code 13 Pensacola, FL 32508 San Diego, CA 92152-6800 Dr. Gary Marco Ms. Kathleen Moreno Stop 31-E Navy Personnel R
Physical Properties of Polymers (Ultrastructure Processing of Polymers)
1982-09-30
vinyl benzene Network-Diluent Systems". 17. J . Appl. Polym. Sci. 28, 219-224 (1983) (with R. Vukovic and W.J. MacKnight) "Compatibility of Some...Temperature of Polymer Networks by Dil uents". 23. J . Appl. Polym. Sci. 28, 1379-1389 (1983) (with R. Vukovic , V. Kuresevic, N. Segudovic, and W.J...AFOSR 80-0101 IV. DATES: 1 January 1980 - 30 September 1982 V. SENIOR RESEARCH PERSONNEL*: Dr. C. Crosby Dr. G. ten Brinke Dr. T. Ellis Dr. R. Vukovic
Ultrastructure Processing and Characterization of Polymers
1988-01-01
Eur. Polym. J . 24, 123-127 (1988) (with R. Vukovic , G. Bogdanic, V. Kuresevic, and W.J. MacKnight) "Miscibility and Phase Behavior in Poly (2,6...Month, Day) |I5 fAGE U d FINAL FROM TO j -"_ 16. SUPPLEMENTARY NOTATION 17. COSATI CODES 18. SUBJECT TERMS (Continue on reverse if necessary and...Lee Dr. J . Obrzut Dr. D. Rice Dr. J . Schlenoff Dr. J . Shim V. JUNIOR RESEARCH PERSONNEL: M. Bishop R. Gregorius M. Lux J . Machado M. Masse R
The SME (Structure-Mapping Engine) User’s Manual (SME Version 2E)
1988-12-30
It is prior to this step that one might want to think about wether to modify any system parameters (e.g., print the match hypotheses, print only the...Wshington, DC 20390 Department of Psychology Carnegie-Mellon University Dr. Judith Orsanu Schenley Park Dr. Harold P. O’Neil, Jr. Basic Research Office...Pinker Baltimore, MD 21201 Department of Psychology ElO-018 Dr. Judith W. Segal MIT Dr. J. Wesley Regian OERI Cambridge, MA 02139 AFHRL/IDI 556 New
2015-10-25
Graduation Requirements Advisors: Dr . Gregory F. Intoccia and Dr . Patricia Lessane Maxwell Air Force Base, Alabama 25 October 2015 DISTRIBUTION A...support while I was diverting much of my free time and attention to this graduate program. I appreciate my research advisors Dr . Greg Intoccia and Dr ...underutilized USAJOBS, the federal government job search engine, as compare to LinkedIn , Career Builders and Monster. Only 8.8 percent of the
2009-04-01
individuals who helped me in many ways throughout my research and thesis writing process. First and foremost, my sincere thanks go to my advisor, Dr... go to Professor John Akin who helped me in the technical areas of Finite Element programming. Thank you for your time and efforts beyond the...classroom. Thank you to Dr. Enrique Barrera and Dr. Jun Lou for serving on my thesis committee. Many thanks go to Dr. Jan Hewitt as well for volunteering
Soraisham, Amuchou Singh; Lodha, Abhay Kumar; Singhal, Nalini; Aziz, Khalid; Yang, Junmin; Lee, Shoo K; Shah, Prakesh S
2014-02-01
To examine the neonatal mortality and morbidity of infants born at <33 weeks gestational age (GA) who received extensive delivery room cardiopulmonary resuscitation (DR-CPR) immediately after birth. In this retrospective cohort study, we performed secondary analyses of data from infants born at <33 weeks GA and admitted to participating NICUs in the Canadian Neonatal Network between January 2010 and December 2011. Infants were divided into two groups based on birth weight (<1000 g and ≥1000 g) and neonatal morbidity and mortality compared using bivariate and multivariate analyses. Of the 8033 eligible infants, 419 (5.2%) received DR-CPR. For infants weighing <1000 g at birth, 10.9% (outborn: 21.6%, inborn: 7.6%) received DR-CPR, whereas 3.4% (outborn: 9.6%, inborn: 2.2%) of those weighing ≥1000 g received DR-CPR. If infants received DR-CPR there was increased risk of mortality, bronchopulmonary dysplasia (BPD) and severe brain injury. Logistic regression analysis showed DR-CPR was associated with increased mortality (adjusted odds ratio [aOR]: 2.09, 95% CI [1.39, 3.14]) in infants born weighing <1000 g. Among infants born weighing ≥1000 g, DR-CPR was associated with increased mortality (aOR: 7.16, 95% CI [3.88, 13.2]), severe brain injury (aOR: 3.08, 95% CI [1.82, 5.22]), BPD (aOR: 2.14, 95% CI [1.25, 3.65]), pneumothorax (aOR: 3.11, 95% CI [1.53, 6.31]) and intestinal perforation (aOR: 3.47, 95% CI [1.46, 8.24]). DR-CPR is associated with increased risk of mortality and morbidity especially in preterm infants born weighing ≥1000 g. Long-term neurodevelopmental follow up is warranted for these infants.
ERIC Educational Resources Information Center
Morin, Courtnie; Stanley, Candace
2017-01-01
Building upon Kuh's (2008) research on high-impact educational practices, the authors interviewed Dr. Aaron Thompson to discuss effective implementation of these teaching and learning initiatives and the advancement of faculty development programming to support them. Dr. Thompson is the Interim President of Kentucky State University and Council on…
1993-12-01
dr. U.A. Th. Brinkmnan 31* Directeur van het Medisch Biologisch Laboratorium TNO Prof. dr. W.R.F. Notten 32 PML-TNO, Directeur; daarna reserve 33 PML...Generaal Personeel Ministerie van Defensie 8* Adviseur van het Prins Maurits Laboratorium TNO Chemnische Research Prof. dr. G. Dijkstra 9* lid van de
Back-of-the-Envelope Problems.
1987-07-01
S D This researh was ’rdd by the Office of Naval Research with Ccntract N00014-5-K-0095. i roiect NR e67-544. Approved for public release...NY 10027 Dr Gary Aston-Jones Dr. R. Darrell Bock Dr. Patricia A. Butler Deot. of Biology , N.Y.U. University of Chicago, NORC OERI 10C9 Main Bldg
Valero Cedeño, Nereida Josefina
2014-12-01
The Instituto de Investigaciones Clínicas "Dr. Américo Negrette" belongs to the Faculty of Medicine at University of Zulia in Maracaibo, Zulia State, Venezuela. It was created on December 4, 1959 by Dr. Américo Negrette. Today, with 55 years of existence, the Institute seeks to fulfill the mission that characterizes it, based on the values instilled by its founder and maintained by subsequent generations, whose research projects are implemented through seven research sections: Biochemistry, Hematologic Research, Neuropharmacology and Neuroscience, Immunology and Cell Biology, Clinical Neurochemistry, Parasitology and Virology. The research originated in these laboratories have become national and international points of reference, despite the current economic situation with budget deficits that put at risk the quality and originality of their projects with negative consequences on the productivity and applications for health population, reasons of biomedical research.
Celebrating 40 Years of the Midwest Nursing Research Society.
Hershberger, Patricia E; Wynd, Christine A; Glass, Laurie K; O'Connell, Karen M; Fitzpatrick, Joyce J; Bergstrom, Nancy; Lusk, Sally Lechlitner
2017-05-01
The Midwest Nursing Research Society (MNRS) recently held its 40th annual conference and celebrated four decades of nursing research in the Midwest. MNRS continues to be one of the largest nursing research societies in the United States. Over the years, a vast majority of programmatic initiatives included education and tangible support for novice and experienced nurse researchers. In this article, the background for development of MNRS is reviewed with examination of driving forces that led to its creation. Three past presidents, Dr. Joyce Fitzpatrick, the first President of MNRS (1980-1981); Dr. Nancy Bergstrom, the eighth President (1993-1995); and Dr. Sally Lusk, the 14th President (2005-2007), discuss challenges, opportunities, and the exceptional progress made toward fostering excellence in nursing research for the Midwest and contributing to nursing science on a national and global scale. Lessons from the past as well as opportunities for the future are addressed.
Modifying the Human-Machine Interface Based on Quantitative Measurements of the Level of Awareness
NASA Technical Reports Server (NTRS)
Freund, Louis E.; Knapp, Benjamin
1999-01-01
This project got underway without funding approved during the summer of 1998. The initial project steps were to identify previously published work in the fields of error classification systems, physiological measurements of awareness, and related topics. This agenda was modified at the request of NASA Ames in August, 1998 to include supporting the new Cargo Air Association (CAA) evaluation of the Human Factors related to the ADS-B technology. Additional funding was promised to fully support both efforts. Work on library research ended in the late Fall, 1998 when the SJSU project directors were informed that NASA would not be adding to the initial funding of the research project as had been initially committed. However, NASA did provide additional funding for the CAA project activity. NASA elected to leave the research grant in place to provide a pathway for the CAA project funding to SJSU (San Jose State University) to support Dr. Freund's work on the CAA tasks. Dr. Knapp essentially terminated his involvement with the project at this time.
quantifying and Predicting Reactive Transport
DOE Office of Scientific and Technical Information (OSTI.GOV)
Peter C. Burns, Department of Civil Engineering and Geological Sciences, University of Notre Dame
2009-12-04
This project was led by Dr. Jiamin Wan at Lawrence Berkeley National Laboratory. Peter Burns provided expertise in uranium mineralogy and in identification of uranium minerals in test materials. Dr. Wan conducted column tests regarding uranium transport at LBNL, and samples of the resulting columns were sent to Dr. Burns for analysis. Samples were analyzed for uranium mineralogy by X-ray powder diffraction and by scanning electron microscopy, and results were provided to Dr. Wan for inclusion in the modeling effort. Full details of the project can be found in Dr. Wan's final reports for the associated effort at LBNL.
ERIC Educational Resources Information Center
Banerji, Shilpa
2005-01-01
Harvard psychologist Dr. Mahzarin R. Banaji is helping explore the world of subconscious bias with the Implicit Association Test (IAT). Banaji teamed up with fellow psychology professors Dr. Anthony Greenwald of the University of Washington and Dr. Brian Nosek of the University of Virginia to develop the IAT. The IAT was created as a tool to…
Amendola, R; Martinez, R; Negroni, A; Venturelli, D; Tanno, B; Calabretta, B; Raschellà, G
2001-01-01
Nm23 gene family has been associated with metastasis suppression and differentiation. We studied DR-nm23 during neuroblastoma cells differentiation. DR-nm23 expression increased after retinoic acid induction of differentiation in human cell lines SK-N-SH and LAN-5. In several cell lines, overexpression of DR-nm23 was associated with more differentiated phenotypes. SK-N-SH cells increased vimentin expression, increased deposition of collagen type IV, modulated integrin expression, and underwent growth arrest; the murine neuroblastoma cell line N1E-115 showed neurite outgrowth and a striking enhancement of beta1 integrin expression. Up-regulation of beta1 integrin was specifically responsible for the increase in the adhesion to collagen type I-coated plates. Finally, cells overexpressing DR-nm23 were unable to growth in soft agar. In conclusion, DR-nm23 expression is directly involved in differentiation of neuroblastoma cells, and its ability to affects the adhesion to extracellular substrates and to inhibit growth in soft agar suggests an involvement in the metastatic potential of neuroblastoma.
Prion protein is essential for diabetic retinopathy-associated neovascularization.
Zhu, Lingyan; Xu, Jixiong; Liu, Ying; Gong, Tian; Liu, Jianying; Huang, Qiong; Fischbach, Shane; Zou, Wenquan; Xiao, Xiangwei
2018-05-30
Diabetic retinopathy (DR), a major complication of diabetes caused by vascular damage and pathological proliferation of retinal vessels, often progresses to vision loss. Vascular endothelial growth factor (VEGF) signaling plays a pivotal role in the development of DR, but the exact underlying molecular mechanisms remain ill-defined. Cellular prion protein (PrP c ) is a surface protein expressed by vascular endothelial cells, and the increased expression of PrP c is associated with physiological and pathological vascularization. Nevertheless, a role for PrP c in the development of DR has not been appreciated. Here, we addressed this question. We found that the development of streptozocin (STZ)-induced DR, but not the STZ-induced hyperglycemia/diabetes itself, was significantly attenuated in PrP c -KO mice, compared to control wildtype (WT) mice, evident by measurement of retinal vascular leakage, retinal neovascularization, a retinopathy score and visual acuity assessment. Moreover, the attenuation of DR severity seemingly resulted from attenuation of retinal neovascularization via VEGF/ras/rac signaling. Together, our study suggests a previously unappreciated role for PrP c in the development of DR.
Measuring Equilibrium Binding Affinity of Biological Macromolecules in Solution by Thermophoresis
2015-05-18
SECURITY CLASSIFICATION OF: The primary research focus of the San Diego State University (SDSU) Structural Biochemistry Laboratory led by Dr. Tom...U.S. Army Research Office P.O. Box 12211 Research Triangle Park, NC 27709-2211 Biochemistry , Biophysics, Fluorescence, IkappaB Kinase...University (SDSU) Structural Biochemistry Laboratory led by Dr. Tom Huxford is to understand how the assembly of macromolecular complexes gives rise
A Successful Application of Latent Trait Theory to Tailored Achievement Testing.
1980-02-01
strategy for achieve- ment test batteries (Research Report 77-6). Minneapolis: University of Minnesota, Department of Psychology , Psychometric Methods...trait models to tailored testing (Research Report 79-1). Columbia: Uni- versity of Missouri, Department of Educational Psychology , 1979. Lord, F. M. A... Psychology Psychometric Research Group Kawauchi, Sendai 980 Educational Testing Service JAPAN Princeton, NJ 08541 Dr. Edwin Shirkey 1 Dr. Kikui
Modeling the Acoustic Channel for Simulation Studies
2012-09-30
Michele Zorzi (PI), Prof. Gianfranco Pierobon (co-PI), Dr. Paolo Casari (post-doctoral researchers ) and Dr. Beatrice Tomasi (PhD student until 12/31...2011 and then post-doctoral researcher ), Mr. Daniele Munaretto (PhD student ), Mr. Giovanni Toso (engineer) and Mr. Matteo Lazzarin (MS student ...approach, are reported in [TWC2012]. DISSEMINATION ACTIVITIES The results obtained in the conducted reseach have been disseminated to the research
Ma, Qinghua; Chen, Dandan; Sun, Hong-Peng; Yan, Ning; Xu, Yong; Pan, Chen-Wei
2015-01-01
Objective. To determine the association between regular Chinese green tea consumption and the risk of diabetic retinopathy (DR) in diabetic patients in China. Methods. 100 DR patients and 100 age-sex-matched diabetic controls without retinopathy were recruited in a clinic-based, case-control study. DR was defined from retinal photographs and detailed information on Chinese green tea consumption of the participants was collected through a face-to-face interview. Results. The crude odds ratio [OR] of Chinese green tea consumption for DR was 0.49 (95% confidence interval: 0.26–0.90). When stratified by sex, the protective effect of Chinese green tea consumption on DR was statistically significant in women (P = 0.01) but not in men (P = 0.63). After adjusting for age, sex, and other confounders, DR was significantly associated with Chinese green tea consumption (OR = 0.48; P = 0.04), higher systolic blood pressure (OR = 1.02; P = 0.05), longer duration of diabetes (OR = 1.07; P = 0.02), and the presence of family history of diabetes (OR = 2.35; P = 0.04). Conclusions. Diabetic patients who had regularly drunk Chinese green tea every week for at least one year in their lives had a DR risk reduction of about 50% compared with those who had not. Regular Chinese green tea consumption may be a novel approach for the prevention of DR. PMID:26539551
Ma, Qinghua; Chen, Dandan; Sun, Hong-Peng; Yan, Ning; Xu, Yong; Pan, Chen-Wei
2015-01-01
To determine the association between regular Chinese green tea consumption and the risk of diabetic retinopathy (DR) in diabetic patients in China. 100 DR patients and 100 age-sex-matched diabetic controls without retinopathy were recruited in a clinic-based, case-control study. DR was defined from retinal photographs and detailed information on Chinese green tea consumption of the participants was collected through a face-to-face interview. The crude odds ratio [OR] of Chinese green tea consumption for DR was 0.49 (95% confidence interval: 0.26-0.90). When stratified by sex, the protective effect of Chinese green tea consumption on DR was statistically significant in women (P = 0.01) but not in men (P = 0.63). After adjusting for age, sex, and other confounders, DR was significantly associated with Chinese green tea consumption (OR = 0.48; P = 0.04), higher systolic blood pressure (OR = 1.02; P = 0.05), longer duration of diabetes (OR = 1.07; P = 0.02), and the presence of family history of diabetes (OR = 2.35; P = 0.04). Diabetic patients who had regularly drunk Chinese green tea every week for at least one year in their lives had a DR risk reduction of about 50% compared with those who had not. Regular Chinese green tea consumption may be a novel approach for the prevention of DR.
2016 AMS Mario J. Molina Symposium
DOE Office of Scientific and Technical Information (OSTI.GOV)
Zhang, Renyi
A named symposium to honor Dr. Mario J. Molina was held 10–14 January 2016, as part of the 96th American Meteorological Society (AMS) Annual Meeting in New Orleans, Louisiana. Dr. Molina first demonstrated that industrially produced chlorofluorocarbons (CFCs) decompose in the stratosphere and release chlorine atoms, leading to catalytic ozone destruction. His research in stratospheric chemistry was instrumental to the establishment of the 1987 United Nations Montreal Protocol to ban ozone-depleting substances worldwide. Dr. Molina’s contributions to preserving the planet Earth not only save the atmospheric ozone layer, but also protect the climate by reducing the emissions of greenhouse gases.more » He was awarded the 1995 Nobel Prize in Chemistry for his pioneering research in understanding the stratospheric ozone loss mechanism. In 2013, President Barack Obama announced Dr. Molina as a recipient of the Presidential Medal of Freedom. The 2016 AMS Molina Symposium honored Dr. Molina’s distinguished contributions to research related to atmospheric chemistry. The symposium contained an integrated theme related to atmospheric chemistry, climate, and policy. Dr. Molina delivered a keynote speech at the Symposium. The conference included invited keynote speeches and invited and contributed oral and poster sessions, and a banquet was held on Tuesday January 12, 2016. The symposium covered all aspects of atmospheric chemistry, with topics including (1) Stratospheric chemistry, (2) Tropospheric chemistry, (3) Aerosol nucleation, growth, and transformation, (4) Aerosol properties, (5) Megacity air pollution, and (6) Atmospheric chemistry laboratory, field, and modeling studies. This DOE project supported 14 scientists, including graduate students, post docs, junior research scientists, and non-tenured assistant professors to attend this symposium.« less
Lian, JinXiao; McGhee, Sarah M; Gangwani, Rita A; Lam, Cindy L K; Yap, Maurice K H; Wong, David S H
2018-04-13
To assess the association between awareness of diabetic retinopathy (DR) and actual attendance for DR screening. Cross-sectional study. Two public general outpatient clinics. The subjects were people with diabetes mellitus (DM) who participated in a randomised controlled trial, set up in 2008, to test the impact of a copayment on attendance for DR screening. The subjects' awareness of DR was evaluated using a structured questionnaire conducted via a telephone interview. The attendance for screening was from the actual attendance data. Association between awareness and attendance for screening was determined using multivariate logistic regression model and was reported as ORs. A total of 2593 participants completed the questionnaire. A total of 42.9% (1113/2593) said they would worry if they had any vision loss and 79.6% (2063/2593) knew that DM could cause blindness. Only 17.5% (453/2593) knew that treatment was available for DR and 11.5% (297/2593) knew that early DR could be asymptomatic. The importance of having a regular eye examination was acknowledged by 75.7% (1964/2593), but 34% (881/2593) did not know how frequently their eyes should be examined. Worry about vision loss (OR=1.72, P<0.001), awareness of the importance of regular eye examination (OR=1.83, P=0.002) and awareness of the frequency of eye examinations ('every year' (OR=2.64, P<0.001) or 'every 6 months' (OR=3.27, P<0.001)) were the most significant factors associated with attendance. Deficits in knowledge of DR and screening were found among subjects with DM, and three awareness factors were associated with attendance for screening. These factors could be targeted for future interventions. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Bryant, Alex K; Moore, David J; Burdo, Tricia H; Lakritz, Jessica R; Gouaux, Ben; Soontornniyomkij, Virawudh; Achim, Cristian L; Masliah, Eliezer; Grant, Igor; Levine, Andrew J; Ellis, Ronald J
2017-04-24
Higher plasma soluble cluster of differentiation (CD)163 (sCD163), shed by monocytes and macrophages, correlates with neurocognitive impairment in HIV infection. We hypothesized that higher antemortem plasma or cerebrospinal fluid (CSF) sCD163 would be associated with greater postmortem neurodegeneration and/or microgliosis. Retrospective, postmortem observational study. We measured sCD163 levels in antemortem plasma (n = 54) and CSF (n = 32) samples from 74 HIV-seropositive participants (median 5 months before death) who donated their brains to research at autopsy. Postmortem, we quantified markers of synaptodendritic damage (microtubule-associated protein 2, synaptophysin), microgliosis [human leukocyte antigen DR (HLA-DR), ionized calcium-binding adaptor molecule 1], astrocytosis (glial fibrillary acidic protein), and impaired protein clearance (β-amyloid) in frontal cortex, hippocampus, putamen, and internal capsule. Multivariable least-squares regression was used to evaluate the association between plasma or CSF sCD163 and histological measures, correcting for multiple comparisons. Higher plasma sCD163 was associated with lower microtubule-associated protein 2 in frontal cortex [B = -0.23, 95% confidence interval (CI) -0.41 to -0.06, P = 0.04], putamen (B = 0.32, 95% CI -0.52 to -0.12, P = 0.02), and hippocampus (B = -0.23, 95% CI -0.35 to -0.10, P = 0.01), and with lower synaptophysin in hippocampus (B = -0.25, 95% CI -0.42 to -0.03, P = 0.02) but not putamen or frontal cortex (P > 0.05). Higher plasma sCD163 was associated with higher HLA-DR in putamen (B = 0.17, 95% CI 0.08 to 0.26, P = 0.008). CSF sCD163 was not associated with any histological measure (P > 0.05). Higher plasma sCD163 in life is associated with greater synaptodendritic damage and microglial activation in cortical and subcortical brain regions.
DOE Office of Scientific and Technical Information (OSTI.GOV)
Johnson, James H.
Abstract In 1994 the Department of Energy established the DOE Chair of Excellence Professorship in Environmental Disciplines Program. In 2004, the Massie Chair of Excellence Professor at Howard University transitioned from Dr. Edward Martin to Dr. James H. Johnson, Jr. At the time of his appointment Dr. Johnson served as professor of civil engineering and Dean of the College of Engineering, Architecture and Computer Sciences. Program activities under Dr. Johnson were in the following areas: • Increase the institution’s capacity to conduct scientific research and technical investigations at the cutting-edge. • Promote interactions, collaborations and partnerships between the private sector,more » Federal agencies, majority research institutes and other HBCUs. • Assist other HBCUs in reaching parity in engineering and related fields. • Mentor young investigators and be a role model for students.« less
The Manifest and Latent Functions of Differential Response in Child Welfare
ERIC Educational Resources Information Center
Ji, Daniel; Sullivan, Richard
2016-01-01
Although previous research has explored the efficacy of differential response (DR) programs in child welfare, there have been no studies to date about coding decisions between designations by child protection service agencies. Research has explored client satisfaction with DR as well as rates of recidivism and removal/placement but with limited…
Static Scheduler for Hard Real-Time Tasks on Multiprocessor Systems
1992-09-01
Foundation of Computer Science, 1980 . [SIM83] Simons, B., "Multiprocessor Scheduling of Unit-Time Jobs with Arbitrary Release Times and Deadlines", SIAM...Research Office Attn: Dr. David Hislop P. O. Box 12211 Research Triangle Park, NC 27709-2211 31. Persistent Data Systems 75 W. Chapel Ridge Road Attn: Dr
College Student Experiences Questionnaire: Norms for the Fourth Edition
ERIC Educational Resources Information Center
Gonyea, Robert M.; Kish, Kelly A.; Kuh, George D.; Muthiah, Richard N.; Thomas, Auden D.
2003-01-01
The College Student Experiences Questionnaire (CSEQ) was developed by UCLA Professor Emeritus Dr. C. Robert Pace in the 1970s. First administered by Dr. Pace in 1979, the CSEQ Research Program formally moved its operations to Indiana University's Center for Postsecondary Research and Planning in 1994, under the direction of Chancellor's Professor…
2009-03-01
like to extend our appreciation to our research sponsor Dr. Janet Miller from the Air Force Research Labs, and her colleague Dr. Cheryl Batchelor, for...for single-operator control of multiple UAVs. Drs. Brian Tsou, Lamar Warfield , Justin Estepp and Benjamin Knott , meanwhile, contributed to our
Dr. Robert G. Heath: a controversial figure in the history of deep brain stimulation.
O'Neal, Christen M; Baker, Cordell M; Glenn, Chad A; Conner, Andrew K; Sughrue, Michael E
2017-09-01
The history of psychosurgery is filled with tales of researchers pushing the boundaries of science and ethics. These stories often create a dark historical framework for some of the most important medical and surgical advancements. Dr. Robert G. Heath, a board-certified neurologist, psychiatrist, and psychoanalyst, holds a debated position within this framework and is most notably remembered for his research on schizophrenia. Dr. Heath was one of the first physicians to implant electrodes in deep cortical structures as a psychosurgical intervention. He used electrical stimulation in an attempt to cure patients with schizophrenia and as a method of conversion therapy in a homosexual man. This research was highly controversial, even prior to the implementation of current ethics standards for clinical research and often goes unmentioned within the historical narrative of deep brain stimulation (DBS). While distinction between the modern practice of DBS and its controversial origins is necessary, it is important to examine Dr. Heath's work as it allows for reflection on current neurosurgical practices and questioning the ethical implication of these advancements.
Fan, Xiaohong; Wu, Qunhong; Li, Yuan; Hao, Yanhua; Ning, Ning; Kang, Zheng; Cui, Yu; Liu, Ruohong; Han, Liyuan
2014-01-01
Vascular endothelial growth factor (VEGF) is a major mediator of angiogenesis, and plays a key role in the pathogenesis of diabetic retinopathy (DR). This study was designed to identify the possible role of VEGF gene polymorphisms in the development of DR in type 2 diabetic patients in Chinese and clarify the relationship between VEGF serum levels and the risk of DR. This cross-sectional study included 1 040 Chinese subjects with type 2 diabetes mellitus. There were 372 patients diagnosed with DR in the case group and 668 patients without DR in the control group. DNA from each patient was analyzed for VEGF polymorphisms of -2578A/C (rs699947), -1154G/A (rs1570360), -460C/T (rs833061), +405C/G (rs2010963), and +936C/T (rs3025039) using MassARRAY compact analyzer. The VEGF serum levels were quantified by enzyme-linked immunosorbent assay (ELISA). No evidence of association was observed between -2578 A/C (rs699947), +405C/G (rs2010963), +936C/T (rs3025039), and DR risk under stringent Bonferroni's correction. However, VEGF serum levels were significantly higher in DR patients than those of control group. The genetic variation of VEGF polymorphisms influenced VEGF serum levels; subjects carrying the VEGF -2578 C/C (rs699947) genotype had greater VEGF serum levels than those carrying the C/A genotype and VEGF serum levels were significantly higher in CC genotype of the +405C/G (rs2010963) compared with those of the other genotypes. The data did not suggest significant association between the VEGF polymorphisms and DR risk under stringent Bonferroni's correction. However, our study indicated that DR patients have higher VEGF levels than diabetic patients without retinopathy, and -2578A/C (rs699947) and +405C/G (rs2010963) may be important factors in determining serum VEGF levels.
ERIC Educational Resources Information Center
Informer, 1980
1980-01-01
Keynoted by Dr. Margaret J. Giannini, Director of the National Institute of Handicapped Research (NIHR), these conference proceedings focus on present concerns and future issues facing the NIHR and researchers and trainers in the field of rehabilitation of the handicapped. In her address, Dr. Giannini outlines priorities for the NIHR for the next…
Founders hope new venture-capital fund will spur medical, biotechnology research
Gray, Charlotte
1995-01-01
Lack of a coherent industrial strategy and venture capital have hindered scientific researchers in Canada, but the Canadian Medical Discoveries Fund (CMDF) Inc. hopes to change that. Under the leadership of Dr. Henry Friesen, president of the Medical Research Council of Canada, and Dr. Calvin Stiller, head of the multiorgan transplant unit at University Hospital, London, Ont., the new fund proposes to invest in promising medical and biotechnology research companies in Canada. The research council's peerreview system gives the new fund scientific credibility.
Leak-Before-Break: Further developments in regulatory policies and supporting research
DOE Office of Scientific and Technical Information (OSTI.GOV)
Wilkowski, G.M.; Chao, K.-S.
1990-02-01
The fourth in a series of international Leak-Before-Break (LBB) Seminars supported in part by the US Nuclear Regulatory Commission was held at the National Central Library in Taipei, Taiwan on May 11 and 12, 1989. The seminar updated the international polices and supporting research on LBB. Attendees included representatives from regulatory agencies, electric utilities, nuclear power plant fabricators, research organizations, and academic institutions. Regulatory policy was the subject of presentations by Mr. G. Arlotto (US NRC, USA) Dr. B. Jarman (AECB, Canada), Dr.P. Milella (ENEA-DISP, Italy), Dr. C. Faidy (EDF/Septen, France ), and Dr. K. Takumi (NUPEC, Japan). A papermore » by Mr. K. Wichman and Mr. A. Lee of the US NRC Office of Nuclear Reactor Regulation is included as background material to these proceedings; it discusses the history and status of LBB applications in US nuclear power plants. In addition, several papers on the supporting research programs described regulatory policy or industry standards for flaw evaluations, e.g., the ASME Section XI code procedures. Supporting research programs were reviewed on the first and second day by several participants from Taiwan, US, Japan, Canada, Italy, and France. Each individual paper has been cataloged separately.« less
Harada, Kumiko; Michibata, Yayoi; Tsukamoto, Hirotake; Senju, Satoru; Tomita, Yusuke; Yuno, Akira; Hirayama, Masatoshi; Abu Sayem, Mohammad; Takeda, Naoki; Shibuya, Isao; Sogo, Shinji; Fujiki, Fumihiro; Sugiyama, Haruo; Eto, Masatoshi; Nishimura, Yasuharu
2013-01-01
Reports have shown that activation of tumor-specific CD4+ helper T (Th) cells is crucial for effective anti-tumor immunity and identification of Th-cell epitopes is critical for peptide vaccine-based cancer immunotherapy. Although computer algorithms are available to predict peptides with high binding affinity to a specific HLA class II molecule, the ability of those peptides to induce Th-cell responses must be evaluated. We have established HLA-DR4 (HLA-DRA*01:01/HLA-DRB1*04:05) transgenic mice (Tgm), since this HLA-DR allele is most frequent (13.6%) in Japanese population, to evaluate HLA-DR4-restricted Th-cell responses to tumor-associated antigen (TAA)-derived peptides predicted to bind to HLA-DR4. To avoid weak binding between mouse CD4 and HLA-DR4, Tgm were designed to express chimeric HLA-DR4/I-Ed, where I-Ed α1 and β1 domains were replaced with those from HLA-DR4. Th cells isolated from Tgm immunized with adjuvant and HLA-DR4-binding cytomegalovirus-derived peptide proliferated when stimulated with peptide-pulsed HLA-DR4-transduced mouse L cells, indicating chimeric HLA-DR4/I-Ed has equivalent antigen presenting capacity to HLA-DR4. Immunization with CDCA155-78 peptide, a computer algorithm-predicted HLA-DR4-binding peptide derived from TAA CDCA1, successfully induced Th-cell responses in Tgm, while immunization of HLA-DR4-binding Wilms' tumor 1 antigen-derived peptide with identical amino acid sequence to mouse ortholog failed. This was overcome by using peptide-pulsed syngeneic bone marrow-derived dendritic cells (BM-DC) followed by immunization with peptide/CFA booster. BM-DC-based immunization of KIF20A494-517 peptide from another TAA KIF20A, with an almost identical HLA-binding core amino acid sequence to mouse ortholog, successfully induced Th-cell responses in Tgm. Notably, both CDCA155-78 and KIF20A494-517 peptides induced human Th-cell responses in PBMCs from HLA-DR4-positive donors. Finally, an HLA-DR4 binding DEPDC1191-213 peptide from a new TAA DEPDC1 overexpressed in bladder cancer induced strong Th-cell responses both in Tgm and in PBMCs from an HLA-DR4-positive donor. Thus, the HLA-DR4 Tgm combined with computer algorithm was useful for preliminary screening of candidate peptides for vaccination. PMID:24386437
1982-09-01
Edwards AFB, CA 93523 Attn: Mr. D. Siegel Attn: Dr. F. Roberto Office of Naval Research 1 AFSC Western Office Andrews AFB, Code DLFP 1030 East Green...Office space Sciences One Hallidie Plaza Suite 601 Bolling Air Force Base San Francisco, CA 94102 Washing.on, DC 20332 Attn: Dr. P. A. Miller Attn: Dr
RT 164: Design and Development Tools for the Systems Engineering Experience Accelerator - Part 3
2017-04-29
Investigator: Dr. Jon Wade, Stevens Institute of Technology Co-Principal Investigator: Dr. Doug Bodner, Georgia Institute of Technology Research Team...Defense Acquisition University: Yvette Rodriguez Georgia Institute of Technology : Jing Liu Stevens Institute of Technology : Dr. Richard Turner...Stevens Institute of Technology : Peizhu Zhang Sponsor: Office of the DASD (Systems Engineering) Report No. SERC-2017-TR-107
Cyber Flag: A Realistic Cyberspace Training Construct
2008-03-27
sincere appreciation to my research committee, Dr Mark Kanko, Dr Bob Bills , and Dr Rick Raines, as well as my faculty advisor, Major Paul Williams ...Graduate School of Engineering and Management Air Force Institute of Technology Air University Air Education and Training Command In Partial... Williams , Ph.D. (Chairman) date ___________//SIGNED//________________ 22 Jan 08 Mark A. Kanko, Ph.D. (Member) date
Chu, Steven [Dept. of Energy (DOE), Washington DC (United States)
2018-06-12
The Fermi Award is a Presidential award and is one of the oldest and most prestigious science and technology honors bestowed by the U.S. Government. On May 7, 2012 it was conferred upon two exceptional scientists: Dr. Mildred Dresselhaus, 'for her scientific leadership, her major contributions to science and energy policy, her selfless work in science education and the advancement of diversity in the scientific workplace, and her highly original and impactful research,' and Dr. Burton Richter, 'for the breadth of his influence in the multiple disciplines of accelerator physics and particle physics, his profound scientific discoveries, his visionary leadership as SLAC Director, his leadership of science, and his notable contributions in energy and public policy.' Dr. John Holder, Director of the White House Office of Science and Technology Policy, opened the ceremony, and Dr. Bill Brinkman, Director of DOE's Office of Science introduced the main speaker, Dr. Steven Chu, U.S. Energy Secretary.
DOE Office of Scientific and Technical Information (OSTI.GOV)
NONE
1995-06-01
This report provided a transcript of an interview of Dr. Karl. Z. Morgan by representatives of the DOE Office of Human Radiation Experiments. Dr. Morgan was selected for this interview because of his research for the Manhattan Project at the Metallurgical Laboratory in Chicago and his work at the Oak Ridge National Laboratory (ORNL). The oral history covers Dr. Morgan`s work as a pioneer in the field of Health Physics, his research at ORNL and his work since he retired from ORNL.
CDAC Student Report: Summary of LLNL Internship
DOE Office of Scientific and Technical Information (OSTI.GOV)
Herriman, Jane E.
Multiple objectives motivated me to apply for an internship at LLNL: I wanted to experience the work environment at a national lab, to learn about research and job opportunities at LLNL in particular, and to gain greater experience with code development, particularly within the realm of high performance computing (HPC). This summer I was selected to participate in LLNL's Computational Chemistry and Material Science Summer Institute (CCMS). CCMS is a 10 week program hosted by the Quantum Simulations group leader, Dr. Eric Schwegler. CCMS connects graduate students to mentors at LLNL involved in similar re- search and provides weekly seminarsmore » on a broad array of topics from within chemistry and materials science. Dr. Xavier Andrade and Dr. Erik Draeger served as my co-mentors over the summer, and Dr. Andrade continues to mentor me now that CCMS has concluded. Dr. Andrade is a member of the Quantum Simulations group within the Physical and Life Sciences at LLNL, and Dr. Draeger leads the HPC group within the Center for Applied Scientific Computing (CASC). The two have worked together to develop Qb@ll, an open-source first principles molecular dynamics code that was the platform for my summer research project.« less
Moniz, Ernest; Dehmer, Patricia
2018-05-04
The Fermi Award is a Presidential award and is one of the oldest and most prestigious science and technology honors bestowed by the U.S. Government. On February 3, 2014 it was conferred upon two exceptional scientists. The first to be recognized is Dr. Allen J. Bard, 'for international leadership in electrochemical science and technology, for advances in photoelectrochemistry and photocatalytic materials, processes, and devices, and for discovery and development of electrochemical methods including electrogenerated chemiluminescence and scanning electrochemical microscopy.' The other honoree is Dr. Andrew Sessler, 'for advancing accelerators as powerful tools of scientific discovery, for visionary direction of the research enterprise focused on challenges in energy and the environment, and for championing outreach and freedom of scientific inquiry worldwide.' Dr. Patricia Dehmer opened the ceremony, and Dr. Ernest Moniz presented the awards.
DOE Office of Scientific and Technical Information (OSTI.GOV)
Moniz, Ernest; Dehmer, Patricia
The Fermi Award is a Presidential award and is one of the oldest and most prestigious science and technology honors bestowed by the U.S. Government. On February 3, 2014 it was conferred upon two exceptional scientists. The first to be recognized is Dr. Allen J. Bard, 'for international leadership in electrochemical science and technology, for advances in photoelectrochemistry and photocatalytic materials, processes, and devices, and for discovery and development of electrochemical methods including electrogenerated chemiluminescence and scanning electrochemical microscopy.' The other honoree is Dr. Andrew Sessler, 'for advancing accelerators as powerful tools of scientific discovery, for visionary direction of themore » research enterprise focused on challenges in energy and the environment, and for championing outreach and freedom of scientific inquiry worldwide.' Dr. Patricia Dehmer opened the ceremony, and Dr. Ernest Moniz presented the awards.« less
50 Years of renal physiology from one man and the perfused tubule: Maurice B. Burg.
Hamilton, Kirk L; Moore, Antoni B
2016-08-01
Technical advancements in research techniques in science are made in slow increments. Even so, large advances from insight and hard work of an individual with a single technique can have astonishing ramifications. Here, we examine the impact of Dr. Maurice B. Burg and the isolated perfused renal tubule technique and celebrate the 50th anniversary of the publication by Dr. Burg and his colleagues of their landmark paper in the American Journal of Physiology in 1966. In this study, we have taken a scientific visualization approach to study the scientific contributions of Dr. Burg and the isolated perfused tubule preparation as determining research impact by the number of research students, postdoctoral fellows, visiting scientists, and national and international collaborators. Additionally, we have examined the research collaborations (first and second generation scientists), established the migrational visualization of the first generation scientists who worked directly with Dr. Burg, quantified the metrics indices, identified and quantified the network of coauthorship of the first generation scientists with their second generation links, and determined the citations analyses of outputs of Dr. Burg and/or his first generation collaborators as coauthors. We also review the major advances in kidney physiology that have been made with the isolated perfused tubule technique. Finally, we are all waiting for the discoveries that the isolated perfused preparation technique will bring during the next 50 years. Copyright © 2016 the American Physiological Society.
van Heemst, Jurgen; Huizinga, Tom J W; van der Woude, Diane; Toes, René E M
2015-05-01
To provide an update on and the context of the recent findings obtained with novel statistical methods on the association of the human leukocyte antigen (HLA) locus with rheumatic diseases. Novel single nucleotide polymorphism fine-mapping data obtained for the HLA locus have indicated the strongest association with amino acid positions 11 and 13 of HLA-DRB1 molecule for several rheumatic diseases. On the basis of these data, a dominant role for position 11/13 in driving the association with these diseases is proposed and the identification of causal variants in the HLA region in relation to disease susceptibility implicated. The HLA class II locus is the most important risk factor for several rheumatic diseases. Recently, new statistical approaches have identified previously unrecognized amino acid positions in the HLA-DR molecule that associate with anticitrullinated protein antibody-negative and anticitrullinated protein antibody-positive rheumatoid arthritis. Likewise, similar findings have been made for other rheumatic conditions such as giant-cell arteritis and systemic lupus erythematosus. Interestingly, all these studies point toward an association with the same amino acid positions: amino acid positions 11 and 13 of the HLA-DR β chain. As both these positions influence peptide binding by HLA-DR and have been implicated in antigen presentation, the novel fine-mapping approach is proposed to map causal variants in the HLA region relevant to rheumatoid arthritis and several rheumatic diseases. If these interpretations are correct, they would direct the biological research aiming to address the explanation for the HLA-disease association. Here, we provide an overview of the recent findings and evidence from literature that, although relevant new insights have been obtained on HLA-disease associations, the interpretation of the biological role of these amino acids as causal variants explaining that such associations should be taken with caution.
Exploiting Auxiliary Information about Examinees in the Estimation of Item Parameters.
1986-05-01
Research. The author is grateful to Kathleen Sheehan and Martha Stocking for their comments and suggestions. a, • ... Am -. ,** . Exploiting...Research Laboratory Dr. Hans Crombag 103 South Mathews Street University of Leyden Urbana, IL 61801 Education Research Center Boerhaavelaan 2 Dr. Susan...Embretson 23-4 EN Leyden University of Kansas The NETHERLANDS Psychology Department Lawrence, KS 66045 CTR/McGraw-Hill Library 2500 Garden Road ERIC
Forecasting Climate-Induced Ecosystem Changes on Army Installations
2011-10-01
W. Hargrove Construction Engineering Research Laboratory (CERL) US Army Engineer Research and Development Center 2902 Newmark Dr. Champaign, IL...unless so designated by other authorized documents. DESTROY THIS REPORT WHEN NO LONGER NEEDED. DO NOT RETURN IT TO THE ORIGINATOR. ERDC/CERL TR-11-36...35 ERDC/CERL TR-11-36 v Preface This study was conducted for Dr. Jeffrey Holland, Director of the Engineer Research and Development
Knowledge Acquisition for Expert Systems in Construction
1988-12-01
following scientific personnel have been closely involved in the execution of this research : Dr R J Allwood Mr A E Bryman Mr C N Cooper Dr J Cullen Mr...alternative methods and should use them flexibly as the position unfolds. This approach has been advocated by other researchers (eg Cordingley - see Diaper...currently engaged in research into methods of knowledge acquisition for expert systems. Although their original focus was on construction industry
Everything is connected: social determinants of pediatric health and disease.
Tarazi, Carine; Skeer, Margie; Fiscella, Kevin; Dean, Stephanie; Dammann, Olaf
2016-01-01
Carine Tarazi, MA, is an Assistant Editor for Pediatric Research in Boston, Massachusetts, USA. Margie Skeer, ScD, MPH, MSW, served as a Guest Editor for this special issue. Dr. Skeer is Assistant Professor of Public Health and Community Medicine at Tufts University. Her research focuses on adolescent substance misuse and sexual risk prevention, both from epidemiologic and intervention-development perspectives. Kevin Fiscella, MD, MPH, served as a Guest Editor for this special issue. Dr. Fiscella is Tenured Professor of Family Medicine, Public Health Sciences and Community Health at the University of Rochester Medical Center. Dr. Fiscella's research focuses on health and health care disparities, particularly practical strategies to improve health equity. Stephanie Dean, MBA, is Managing Editor of Pediatric Research and is based out of editorial office in The Woodlands, Texas. Olaf Dammann, MD, served as a Guest Editor for this special issue. Dr. Dammann is a Professor of Public Health and Community Medicine, Pediatrics, and Ophthalmology at Tufts University School of Medicine in Boston, Massachusetts, USA, as well as Professor of Perinatal Neuroepidemiology at Hannover Medical School, Hannover, Germany. His research interests include the elucidation of risk factors for brain damage and retinopathy in preterm newborns, the theory of risk and causation in biomedical and public health research, and the development of computational chronic disease models.
Lowyck, Benedicte; Luyten, Patrick; Verhaest, Yannic; Vandeneede, Bart; Vermote, Rudi
2013-06-01
Recently, the DSM-5 Personality and Personality Disorders Work Group has proposed a multiple level approach toward the classification and diagnosis of personality disorders (PDs), with the first level entailing a rating of impairments in levels of personality functioning. Although a number of measures that assess levels of personality functioning have been validated, given its prominent status in the DSM-5 proposal and contemporary theories of personality pathology, the Work Group has called for more research in this area (e.g., Bender, Morey, & Skodol, 2011). In response to this call, this study investigates the relationship between two major, well-validated dimensional measures of levels of personality functioning, that is, the Differentiation-Relatedness Scale (DR-S; Diamond, Blatt, Stayner, & Kaslow, 1991), as scored on the Object Relations Inventory (ORI; Blatt, Wein, Chevron, & Quinlan, 1979), and the Inventory of Personality Organization (IPO; Lenzenweger, Clarkin, Kernberg, & Foelsch, 2001), a self-report instrument, and their relationship with different measures of clinical and interpersonal functioning in 70 patients with a PD. First, results showed that higher levels of differentiation and relatedness of descriptions of self and significant others, and of the self in particular, were negatively related to indices of personality functioning as assessed by the IPO. Lower levels of personality functioning, as measured with both the DR-S and the IPO, were positively related to severity of depression, symptomatic distress, self-harm, and interpersonal problems. Finally, results showed that the DR-S and the IPO independently predicted clinical features and interpersonal functioning. Hence, this study lends further support for the concurrent and predictive validity of the DR-S and the IPO in assessing levels of personality functioning. However, more research concerning the validity of these measures in assessing levels of personality functioning is needed. Suggestions for further research are formulated.
Longo-Mbenza, Benjamin; Mvitu Muaka, Moise; Masamba, Wayiza; Muizila Kini, Lucien; Longo Phemba, Igor; Kibokela Ndembe, Dalida; Tulomba Mona, Doris
2014-01-01
To evaluate the rates of retinopathy without diabetes and diabetic retinopathy (DR), associated with some markers of oxidative stress, antioxidants and cardiometabolic risk factors. We determined the prevalence of DR in 150 type 2 diabetes mellitus (T2DM) patients, that of retinopathy in 50 non diabetics, the levels of body mass index (BMI), waist circumference (WC), blood pressure, lipids, 8-isoprostane, 8-hydroxydeoxyguanosine (8-OHdG), gamma-glutamyl transferase GT (GGT), oxidized low-density lipoprotein (OxLDL), thiobarbituric acid reacting substances (TBARS), reduced glutathione (GSH), superoxide dismutase (SOD), uric acid, creatinine, albumin, total antioxidant status (TAOS), zinc, selenium, magnesium, vitamin C, vitamin D, vitamin E, glucose, apolipoprotein B (ApoB). The prevalences of DR at 53y and Rtp at 62y were 44% (n=66) and 10% (n=5), respectively. The highest levels of 8-isoprostane, 8-OHdG, TBARS, SOD, and OxLDL were in DR. The lowest levels of vitamin D, vitamin C, TAOS, and vitamin E were in DR. In the case-control study discriminant analysis, the levels of vitamin C, vitamin D, ApoB, 8-OHdG, creatinine, Zn, vitamin E, and WC distinguished significantly non-diabetics without DR (controls), T2DM patients without DR and T2DM patients with DR. Anticipation of DR onset is significantly associated with the exageration of oxidative stress biomarkers or decrease of antioxidants in African type 2 diabetics. Prevention of oxidative stress and abdominal obesity is needed. Supplementation in vitamin C, D, and E should be recommended as complement therapies of T2DM.
Longo-Mbenza, Benjamin; Mvitu Muaka, Moise; Masamba, Wayiza; Muizila Kini, Lucien; Longo Phemba, Igor; Kibokela Ndembe, Dalida; Tulomba Mona, Doris
2014-01-01
AIM To evaluate the rates of retinopathy without diabetes and diabetic retinopathy (DR), associated with some markers of oxidative stress, antioxidants and cardiometabolic risk factors. METHODS We determined the prevalence of DR in 150 type 2 diabetes mellitus (T2DM) patients, that of retinopathy in 50 non diabetics, the levels of body mass index (BMI), waist circumference (WC), blood pressure, lipids, 8-isoprostane, 8-hydroxydeoxyguanosine (8-OHdG), gamma-glutamyl transferase GT (GGT), oxidized low-density lipoprotein (OxLDL), thiobarbituric acid reacting substances (TBARS), reduced glutathione (GSH), superoxide dismutase (SOD), uric acid, creatinine, albumin, total antioxidant status (TAOS), zinc, selenium, magnesium, vitamin C, vitamin D, vitamin E, glucose, apolipoprotein B (ApoB). RESULTS The prevalences of DR at 53y and Rtp at 62y were 44% (n=66) and 10% (n=5), respectively. The highest levels of 8-isoprostane, 8-OHdG, TBARS, SOD, and OxLDL were in DR. The lowest levels of vitamin D, vitamin C, TAOS, and vitamin E were in DR. In the case-control study discriminant analysis, the levels of vitamin C, vitamin D, ApoB, 8-OHdG, creatinine, Zn, vitamin E, and WC distinguished significantly non-diabetics without DR (controls), T2DM patients without DR and T2DM patients with DR. CONCLUSION Anticipation of DR onset is significantly associated with the exageration of oxidative stress biomarkers or decrease of antioxidants in African type 2 diabetics. Prevention of oxidative stress and abdominal obesity is needed. Supplementation in vitamin C, D, and E should be recommended as complement therapies of T2DM. PMID:24790873
Twelve Scientific Specialists of the Peenemuende Team
NASA Technical Reports Server (NTRS)
2004-01-01
Twelve scientific specialists of the Peenemuende team at the front of Building 4488, Redstone Arsenal, Huntsville, Alabama. They led the Army's space efforts at ABMA before transfer of the team to National Aeronautic and Space Administration (NASA), George C. Marshall Space Flight Center (MSFC). (Left to right) Dr. Ernst Stuhlinger, Director, Research Projects Office; Dr. Helmut Hoelzer, Director, Computation Laboratory: Karl L. Heimburg, Director, Test Laboratory; Dr. Ernst Geissler, Director, Aeroballistics Laboratory; Erich W. Neubert, Director, Systems Analysis Reliability Laboratory; Dr. Walter Haeussermarn, Director, Guidance and Control Laboratory; Dr. Wernher von Braun, Director Development Operations Division; William A. Mrazek, Director, Structures and Mechanics Laboratory; Hans Hueter, Director, System Support Equipment Laboratory;Eberhard Rees, Deputy Director, Development Operations Division; Dr. Kurt Debus, Director Missile Firing Laboratory; Hans H. Maus, Director, Fabrication and Assembly Engineering Laboratory
Origin of Marshall Space Flight Center (MSFC)
2004-04-15
Twelve scientific specialists of the Peenemuende team at the front of Building 4488, Redstone Arsenal, Huntsville, Alabama. They led the Army's space efforts at ABMA before transfer of the team to National Aeronautic and Space Administration (NASA), George C. Marshall Space Flight Center (MSFC). (Left to right) Dr. Ernst Stuhlinger, Director, Research Projects Office; Dr. Helmut Hoelzer, Director, Computation Laboratory: Karl L. Heimburg, Director, Test Laboratory; Dr. Ernst Geissler, Director, Aeroballistics Laboratory; Erich W. Neubert, Director, Systems Analysis Reliability Laboratory; Dr. Walter Haeussermarn, Director, Guidance and Control Laboratory; Dr. Wernher von Braun, Director Development Operations Division; William A. Mrazek, Director, Structures and Mechanics Laboratory; Hans Hueter, Director, System Support Equipment Laboratory;Eberhard Rees, Deputy Director, Development Operations Division; Dr. Kurt Debus, Director Missile Firing Laboratory; Hans H. Maus, Director, Fabrication and Assembly Engineering Laboratory
Social Environmental Influences on the Development and Resolution of Alcohol Problems
McCrady, Barbara S.; Zucker, Robert A.; Molina, Brooke S. G.; Ammon, Lyndsay; Ames, Genevieve M.; Longabaugh, Richard
2006-01-01
This article summarizes the proceedings of a symposium presented at the 2005 Annual Meeting of the Research Society on Alcoholism, Santa Barbara, California, June 25–30. The overall goal of the symposium was to consider the broad impact of the social environment on the development of and successful or unsuccessful resolution of drinking problems. The presentations addressed multiple social environmental influences including: the influence of children on parents (Dr. Zucker), the influence of peers and parents on adolescents (Dr. Molina), the influence of family members on adult drinking (Dr. McCrady), the influence of adult peers/friends (Dr. Kaskutas), and the influence of the occupational environment (Dr. Ames). Dr. Longabaugh, the symposium discussant, addressed models for understanding the relationships between social influences and drinking problems. PMID:16573588
Bruce Thompson: Adventures and advances in ultrasonic backscatter
NASA Astrophysics Data System (ADS)
Margetan, Frank J.
2012-05-01
Over the course of his professional career Dr. R. Bruce Thompson published several hundred articles on non-destructive evaluation, the majority dealing with topics in ultrasonics. One longtime research interest of Dr. Thompson, with applications both to microstructure characterization and defect detection, was backscattered grain noise in metals. Over a 20 year period he led a revolving team of staff members and graduate students investigating various aspects of ultrasonic backscatter. As a member of that team I had the privilege of working along side Dr. Thompson for many years, serving as a sort of Dr. Watson to Bruce's Sherlock Holmes. This article discusses Dr. Thompson's general approaches to modeling backscatter, the research topics he chose to explore to systematically elucidate a better understanding of the phenomena, and the many contributions to the field achieved under his leadership. The backscatter work began in earnest around 1990, motivated by a need to improve inspections of aircraft engine components. At that time Dr. Thompson launched two research efforts. The first led to the heuristic Independent Scatterer Model which could be used to estimate the average grain noise level that would be seen in any given ultrasonic inspection. There the contribution from the microstructure was contained in a measureable parameter known as the Figure-of-Merit or FOM. The second research effort, spearheaded by Dr. Jim Rose, led to a formal relationship between FOM and details of the metal microstructure. The combination of the Independent Scattering Model and Rose's formalism provided a powerful tool for investigating backscatter in metals. In this article model developments are briefly reviewed and several illustrative applications are discussed. These include: the determination of grain size and shape from ultrasonic backscatter; grain noise variability in engine-titanium billets and forgings; and the design of ultrasonic inspection systems to improve defect-signal-to-grain-noise ratios.
Multiplying Electrons With Diamond
NASA Technical Reports Server (NTRS)
2003-01-01
As researchers in the Space Communications Division of NASA s Glenn Research Center in 1992, Dr. Gerald Mearini, Dr. Isay Krainsky, and Dr. James Dayton made a secondary electron emission discovery that became the foundation for Mearini s company, GENVAC AeroSpace Corporation. Even after Mearini departed Glenn, then known as Lewis Research Center, his contact with NASA remained strong as he was awarded Small Business Innovation Research (SBIR) contracts to further develop his work. Mearini s work for NASA began with the investigation of diamond as a material for the suppression of secondary electron emissions. The results of his research were the opposite of what was expected diamond proved to be an excellent emitter rather than absorber. Mearini, Krainsky, and Dayton discovered that laboratory-grown diamond films can produce up to 45 electrons from a single incident electron. Having built an electron multiplier prototype at NASA, Mearini decided to start his own company to develop diamond structures usable in electron beam devices.
An Automated Detection System for Microaneurysms That Is Effective across Different Racial Groups.
Saleh, George Michael; Wawrzynski, James; Caputo, Silvestro; Peto, Tunde; Al Turk, Lutfiah Ismail; Wang, Su; Hu, Yin; Da Cruz, Lyndon; Smith, Phil; Tang, Hongying Lilian
2016-01-01
Patients without diabetic retinopathy (DR) represent a large proportion of the caseload seen by the DR screening service so reliable recognition of the absence of DR in digital fundus images (DFIs) is a prime focus of automated DR screening research. We investigate the use of a novel automated DR detection algorithm to assess retinal DFIs for absence of DR. A retrospective, masked, and controlled image-based study was undertaken. 17,850 DFIs of patients from six different countries were assessed for DR by the automated system and by human graders. The system's performance was compared across DFIs from the different countries/racial groups. The sensitivities for detection of DR by the automated system were Kenya 92.8%, Botswana 90.1%, Norway 93.5%, Mongolia 91.3%, China 91.9%, and UK 90.1%. The specificities were Kenya 82.7%, Botswana 83.2%, Norway 81.3%, Mongolia 82.5%, China 83.0%, and UK 79%. There was little variability in the calculated sensitivities and specificities across the six different countries involved in the study. These data suggest the possible scalability of an automated DR detection platform that enables rapid identification of patients without DR across a wide range of races.
ERIC Educational Resources Information Center
Fontana, Adriano; Gast, Heidemarie; Reith, Walter; Recher, Mike; Birchler, Thomas; Bassetti, Claudio L.
2010-01-01
Human narcolepsy with cataplexy is a neurological disorder, which develops due to a deficiency in hypocretin producing neurons in the hypothalamus. There is a strong association with human leucocyte antigens HLA-DR2 and HLA-DQB1*0602. The disease typically starts in adolescence. Recent developments in narcolepsy research support the hypothesis of…
2007-02-01
Waves in a Cloudy Vortex DAVID A. SCHECTER Department of Atmospheric Science, Colorado State University, Fort Collins, Colorado MICHAEL T. MONTGOMERY...waves account for precessing tilts and elliptical (triangular, square, etc.) deformations of the vortex core. If the Rossby number of the cyclone ex...ceeds unity, its baroclinic VR waves can efficiently ex- Corresponding author address: Dr. David Schecter, NorthWest Research Associates, 14508 NE 20th
ERIC Educational Resources Information Center
Clark, Pat; Zygmunt, Eva; Howard, Tyrone
2016-01-01
Tyrone Howard is Professor of Education at UCLA; Associate Dean of Equity, Diversity, and Inclusion; and former Director of Center X, which is where UCLA's teacher education program is housed. Center X provides a unique setting where researchers and practitioners collaborate to design and conduct programs that prepare and support K-12 teachers and…
Cehofski, Lasse Jørgensen; Honoré, Bent; Vorum, Henrik
2017-01-01
Retinal artery occlusion (RAO), retinal vein occlusion (RVO), diabetic retinopathy (DR) and age-related macular degeneration (AMD) are frequent ocular diseases with potentially sight-threatening outcomes. In the present review we discuss major findings of proteomic studies of RAO, RVO, DR and AMD, including an overview of ocular proteome changes associated with anti-vascular endothelial growth factor (VEGF) treatments. Despite the severe outcomes of RAO, the proteome of the disease remains largely unstudied. There is also limited knowledge about the proteome of RVO, but proteomic studies suggest that RVO is associated with remodeling of the extracellular matrix and adhesion processes. Proteomic studies of DR have resulted in the identification of potential therapeutic targets such as carbonic anhydrase-I. Proliferative diabetic retinopathy is the most intensively studied stage of DR. Proteomic studies have established VEGF, pigment epithelium-derived factor (PEDF) and complement components as key factors associated with AMD. The aim of this review is to highlight the major milestones in proteomics in RAO, RVO, DR and AMD. Through large-scale protein analyses, proteomics is bringing new important insights into these complex pathological conditions. PMID:28452939
NASA Technical Reports Server (NTRS)
1999-01-01
Dr. Thomas Paine, Deputy Administrator of the National Aeronautics and Space Administration, examines an ordinary man's shoe outfitted for use in the Saturn I workshop. Pictured from the left in the Saturn I workshop mockup are William Brooksbank, propulsion and vehicle engineering laboratory; Dr. Paine; Dr. Wernher Von Braun, Marshall Center director; Colonel Clare F. Farley, Executive Officer in the Office Of The Administrator; and Charles J. Donlan, Deputy Associate Administrator for Manned Space Flight, Technical. the shoe Dr. Paine is holding has a unique fastener built into the sole to allow an astronaut to move about on the workshop floor and to remain in one position if he desires.
NORSAR Basic Seismological Research
1990-11-29
AZ 85721 Prof. Christopher H. Scholz Dr. William Wortman Lamont-Doherty Geological Observatory Mission Research Corporation of Columbia University 735...Reston, VA 22091 Mr. William J. Best Prof. Robert W. Clayton 907 Westwood Drive Seismological Laboratory Vienna, VA 22180 Division of Geological...Planetary Sciences California Institute of Technology Pasadena, CA 91125 Dr. N. Biswas Prof. F. A. Dahlen Geophysical Institute Geological and Geophysical
78 FR 24197 - Product Cancellation Order for Certain Pesticide Registrations
Federal Register 2010, 2011, 2012, 2013, 2014
2013-04-24
...; NY050002; OH030003). IN 46268-1054. 66330 Arysta Life Science North America, LLC, 15401 Weston Parkway... (ME090004) Bayer CropScience LP, 2 T.W. Alexander Dr., P.O. Box 12014, Research Triangle Park, NC 27709. 432 Bayer Environmental Science, 2 T.W. Alexander Dr., P.O. Box 12014, Research Triangle Park, NC 27709. 675...
American Graduate Schools of Education. A View from Abroad.
ERIC Educational Resources Information Center
Judge, Harry G.
Dr. Harry G. Judge of Oxford University, England, was asked by the Ford Foundation to conduct a series of visits to American research universities and their schools of education. His purpose was to investigate the role of the school of education in the research university, particularly at the graduate level. Dr. Judge visited ten universities and…
USDA-ARS?s Scientific Manuscript database
Background: Dietary intake assessment with diet records (DR) is a standard research and practice tool in nutrition. Manual entry and analysis of DR is time-consuming and expensive. New electronic tools for diet entry by clients and research participants may reduce the cost and effort of nutrient int...
A Critical Appraisal of Issues in Differential Response: Moving the Field Forward
ERIC Educational Resources Information Center
Winokur, Marc A.; Gabel, George
2013-01-01
This reaction article highlights areas of agreement and disagreement with the study conducted by Hughes, Rycus, Saunders-Adams, Hughes, and Hughes on the current state of research and practice in differential response (DR). Overall, we agree with several of the arguments put forth by Hughes et al. regarding the limitations of DR research and the…
Highly Inventive Explorer of Creativity: An Interview with John Baer
ERIC Educational Resources Information Center
Henshon, Suzanna E.
2009-01-01
Dr. John Baer is a Professor in the Department of Teacher Education at Rider University. Dr. Baer has published 10 books and scores of research articles and book chapters on creativity, cooperative learning, and other educational psychology topics. His research on the development of creativity and his teaching have both won national awards,…
Yilmaz, Ahu; Yilmaz, Tolga; Gunay, Murat
2017-10-25
Fetuin-A is a physiological inhibitor of insulin receptor tyrosine kinase and thus associated with insulin resistance, metabolic syndrome, and an increased risk for type 2 diabetes mellitus (T2DM). This study aims to investigate the possible relation between the serum fetuin-A levels and the stages of diabetic retinopathy (DR) in patients with T2DM. This prospective study included 82 patients with T2DM and 19 age- and gender-matched healthy controls (HCs) (group 1). Diabetic patients were subclassified into three groups according to ocular findings: without DR (group 2; n = 26); non-proliferative DR (group 3; n = 29), and proliferative DR (group 4; n = 27). Serum fetuin-A levels were determined by a spectrophotometric technique using an immulite chemiluminescent immunometric assay. The data were analyzed using a Mann-Whitney U test, and the results were expressed as mean ± standard deviation. Mean fetuin-A values were 256.4 ± 21.3 μg/ml in group 1, 263.5 ± 24.2 μg/ml in group 2, 282.2 ± 31.1 μg/ml in group 3, and 296.3 ± 26.2 μg/ml in group 4. Group 2 had higher mean fetuin-A level compared with group 1, but the difference was not statistically significant (p > 0.05). Serum fetuin-A levels were significantly higher in groups 3 and 4 compared with HCs (both p < 0.05). Compared with group 2, both DR groups had higher fetuin-A levels with a significant difference (both p < 0.05); and patients with proliferative DR had significantly higher serum fetuin-A levels compared with non-proliferative DR (p < 0.05). The mean serum fetuin-A levels increased with the stage of DR, and the highest levels were found in patients with proliferative DR. Our findings suggest an association between fetuin-A levels and DR stage. In diabetic patients, the risk of retinopathy development increases with higher fetuin-A values. Fetuin-A may play an important role in the pathophysiology and progression of DR.
Spring Research Festival Features Visit from FCPS Superintendent | Poster
One of the highlights of the 19th annual Spring Research Festival (SRF), held May 4–7, was a visit from Terry Alban, Ph.D., superintendent of Frederick County Public Schools (FCPS), and Mike Markoe, deputy superintendent, FCPS. They toured the event on May 7, talking to researchers and students about their posters. “Dr. Alban was very interested in hearing what the Werner H. Kirsten students were presenting at their posters,” said Andrea Frydl, public affairs specialist, Office of Scientific Operations, NCI at Frederick. “Many WHK students are also FCPS students, some of whom Dr. Alban and Dr. Markoe knew personally.” Alban tweeted (@FCPSMDSuper) photos and information about four of the students whose posters she visited during the tour.
Tough on Crime? Pfizer and the CIHR
Evans, Robert G.
2010-01-01
The appointment of Dr. Bernard Prigent, vice-president and medical director of Pfizer Canada, to the Governing Council of the Canadian Institutes of Health Research, outraged many Canadian health researchers. Pfizer has been a “habitual offender,” persistently engaging in illegal and corrupt marketing practices, bribing physicians and suppressing adverse trial results. Since 2002 the company and its subsidiaries have been assessed $3 billion in criminal convictions, civil penalties and jury awards. The $2.3-billion settlement in September 2009 – a month before Dr. Prigent's appointment – set a new record for both criminal fines and total penalties. A link with Pfizer might well advance the commercialization of Canadian research – unhindered by law or morality. Is that now the only mandate, Dr. Beaudet? PMID:21532766
Hoffmann, Sarah; Harms, Hendrik; Ulm, Lena; Nabavi, Darius G; Mackert, Bruno-Marcel; Schmehl, Ingo; Jungehulsing, Gerhard J; Montaner, Joan; Bustamante, Alejandro; Hermans, Marcella; Hamilton, Frank; Göhler, Jos; Malzahn, Uwe; Malsch, Carolin; Heuschmann, Peter U; Meisel, Christian; Meisel, Andreas
2017-12-01
Stroke-associated pneumonia is a frequent complication after stroke associated with poor outcome. Dysphagia is a known risk factor for stroke-associated pneumonia but accumulating evidence suggests that stroke induces an immunodepressive state increasing susceptibility for stroke-associated pneumonia. We aimed to confirm that stroke-induced immunodepression syndrome is associated with stroke-associated pneumonia independently from dysphagia by investigating the predictive properties of monocytic HLA-DR expression as a marker of immunodepression as well as biomarkers for inflammation (interleukin-6) and infection (lipopolysaccharide-binding protein). This was a prospective, multicenter study with 11 study sites in Germany and Spain, including 486 patients with acute ischemic stroke. Daily screening for stroke-associated pneumonia, dysphagia and biomarkers was performed. Frequency of stroke-associated pneumonia was 5.2%. Dysphagia and decreased monocytic HLA-DR were independent predictors for stroke-associated pneumonia in multivariable regression analysis. Proportion of pneumonia ranged between 0.9% in the higher monocytic HLA-DR quartile (≥21,876 mAb/cell) and 8.5% in the lower quartile (≤12,369 mAb/cell). In the presence of dysphagia, proportion of pneumonia increased to 5.9% and 18.8%, respectively. Patients without dysphagia and normal monocytic HLA-DR expression had no stroke-associated pneumonia risk. We demonstrate that dysphagia and stroke-induced immunodepression syndrome are independent risk factors for stroke-associated pneumonia. Screening for immunodepression and dysphagia might be useful for identifying patients at high risk for stroke-associated pneumonia.
Core Competencies for Doctoral Education in Public Health
Calhoun, Judith G.; Weist, Elizabeth M.; Raczynski, James M.
2012-01-01
The Association of Schools of Public Health (ASPH) released the Doctor of Public Health (DrPH) Core Competency Model in 2009. Between 2007 and 2009, a national expert panel with members of the academic and practice communities guided by the ASPH Education Committee developed its 7 performance domains, including 54 competencies. We provide an overview and analysis of the challenges and issues associated with the variability in DrPH degree offerings, reflect on the model development process and related outcomes, and discuss the significance of the model, future applications, and challenges for integration across educational settings. With the model, ASPH aims to stimulate national discussion on the competencies needed by DrPH graduates with the new challenges of 21st-century public health practice and to better define the DrPH degree. PMID:22095342
Answering Questions from Oceanography Texts: Learner, Task and Text Characteristics.
1987-09-15
1 275-290. ’S.= Stowe, K. (1983). S , 2nd edition. New York, NY: John Wiley & Sons. ’?o.,i ’S= .. ’S.’ .5.% .5.% r. ** - ’, .* . . . % S 9.. . 9...94305 O Dr. Ed Aiken Leo Seltracchi Dr. John S. Brown " Navy Personnel R&D Center U. S. Nuclear Regulatory Comm. XEROX Palo Alto Research Center " San...iego, CA 92152-6800 Washington, OC 20555 3333 Coyote Hill Road Palo Alto, CA 94304 Or. John R. Anderson Dr. Mark H. Bickhard Dr. Ann Brown Department